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Abstract 
Improving stroke care is a national priority and adherence to national policy and 
guidelines is closely monitored by numerous organisations using a considerable 
number of overlapping indicators of stroke care processes. Demonstration that the 
processes of stroke care are linked to patient outcomes in empirical post-stroke 
populations is confounded by the complexities of patient case-mix.  
Electronic, real-time, point of care data capture of care processes that are 
demonstrably linked to appropriately case-mix adjusted patient reported outcomes 
would increase confidence that the important aspects of patients’ care are 
measured, monitored, and improved. This thesis aims to determine the best 
available case-mix adjuster, process measures and preferred patient reported 
outcome instruments and, through exploration of the relationships between these 
factors, to develop a dataset for use within an electronic data system. The best 
available case-mix adjuster was identified through a systematic literature review as 
the Six Simple Variable (SSV) model. Through group decision making workshops, 
and informed by a previous systematic review, the Subjective Index of physical and 
Social Outcome (SIPSO) was identified as the preferred postal outcome measure. I 
demonstrate how existing process markers for stroke lack variability, such that 
when recorded in their current format, their relative impact on patient outcome is 
difficult to discern.  
Process measures which feature as important predictors of patient outcome are 
shown to act as proxy measures of stroke severity. The SSV case-mix adjustment 
model is overshadowed by a simple univariable predictor (length of stay) which is 
also likely to be acting as a proxy for stroke severity. In this context, length of stay 
may offer a pragmatic alternative to more complex case-mix adjustment models to 
examine the relationships between processes of care and outcome in populations 
of stroke survivors.  
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Chapter 1 Introduction  
1.1 A brief history of stroke 
Until the early part of the 20th Century, stroke was referred to in the medical literature as 
apoplexy. The term originated with the ancient Greeks and, etymologically, derives from 
the Greek ‘to disable by means of a stroke’, with stroke in this context taken to mean “as if 
struck by lightning” or “the stroke of God” (Pound P et al  1997 p 337). In 1802, Heberden 
offered a description of apoplexy: 
“…a sudden, or rapid weakness in some of the muscles of voluntary 
motion, constitutes a palsy, and in this manner it most usually 
begins; and a total loss of motion in every part of the body except 
the heart and organs of respiration, together with insensibility, is 
called an apoplexy; the cause of which is sometimes strong enough 
to put a stop to the motion even of the heart and lungs, and to 
occasion instant death.” (Heberden W 1892 p338)  
This accurate description of the onset of stroke is remarkably similar to the current World 
Health Organisation definition of “rapidly developing clinical signs of focal disturbance of 
cerebral function, lasting more than 24 hours or leading to death with no apparent cause 
other than that of vascular origin” (Hatano S et al  1976). 
Interruption to cerebral blood flow as the pathological cause of stroke was recognised as 
long ago as the ancient Greeks (Galen AD 131) (Pound P et al  1997). Blood-letting was 
commonly employed in an attempt to relieve the symptoms of stroke and, remarkably, it 
was not until the early 20th Century that venesection was deemed to be of no benefit 
(Pound P et al  1997). Treatment options for acute stroke remained dishearteningly limited 
with the Hippocratic aphorism that: “It is impossible to remove a strong attack of apoplexy, 
and not easy to remove a weak attack” remaining a remarkably insightful observation. As 
recently as the 1980s, treatment of stroke remained largely supportive, with emphasis 
being placed on prevention of further events (Petersdorf RG et al  1983 p 2041). In the 
middle of the 20th Century, pioneers of Geriatric Medicine such as Marjorie Warren 
demonstrated the benefits of rehabilitation in longer term conditions including stroke 
(Barton et al  2003); the importance of organised multidisciplinary therapy in stroke has 
been increasingly recognised and encouraged since the early 1960s (Pound P et al  1997).  
However, it was the 1997 Stroke Unit Trialists’ systematic review of randomised trials of 
organised stroke unit care versus general ward care that catalysed a paradigm shift 
towards organised inpatient stroke care delivered in dedicated stroke units (Stroke Unit 
Trialists' Collaboration 2007). This review demonstrated a clear benefit in terms of 
likelihood of survival, return to independence and living at home following a stroke; a 
benefit that was seen in all patients regardless of stroke type or severity. 
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Specific interventions have now been shown in randomised controlled trials to be effective 
in improving patient outcomes following stroke. Early Supported Discharge schemes 
promote the use of community based specialist stroke rehabilitation teams and have been 
shown to be cost effective, improve patient outcomes and reduce length of stay in those 
with less severe strokes (Early Supported Discharge Trialists 2005).  Thrombolytic therapy 
has been shown in meta-analysis of large multicentre randomised trials to be of benefit in 
terms of increasing the likelihood of independent survival in specific subgroups of patients 
with acute ischaemic stroke (Wardlaw JM et al  2009).  
These complex interventions require significant organisational infrastructure to enable 
them to be routinely available to all who may benefit from them - for example the timely 
availability of brain imaging to allow administration of thrombolytic agents in those for 
whom it is indicated, or sufficient capacity on the specialist acute stroke unit to allow 
direct admission from the Emergency Department or from the community. Over the last 
decade, there has been considerable work to define best practice in stroke care based on 
the emerging evidence base and to identify areas of deficiency in stroke care provision. 
This has prompted significant investment in the development of stroke services in an 
attempt to improve access to these interventions. In the next section I discuss the 
evolution of the definition and monitoring of high quality stroke care in England, Wales 
and Northern Ireland.   
1.2 The evolution of stroke care monitoring 
Since their inception in 1998, sequential biennial Royal College of Physicians Clinical and 
Organisational National Sentinel Stroke Audits (RCP NSSA) have allowed local services to 
assess changes over time and in relation to the national situation as regards stroke care 
provision in England, Wales and Northern Ireland (Intercollegiate Stroke Working Party 
2010; Intercollegiate Stroke Working Party 2011). Stroke process data are extracted 
retrospectively from consecutive patients admitted during the audit period (the first 60 
patients in the last audit) and submitted to the RCP via a web based form. The audits 
continue to provide useful information regarding clinical and organisational aspects of 
stroke care provision and, over time, have become central to a number of stroke metrics as 
indicators of the quality of stroke care.  
The National Service Frameworks were introduced in the 1997 White Paper ‘The New NHS; 
modern, dependable’ with the aim of consolidating clinical best practice and cost-
effectiveness to improve service provision in several key areas of healthcare (Department 
of Health 2007c sect. 3.5). In contrast to coronary heart disease for which a dedicated NSF 
was published, and despite 25% of strokes occurring in those under the age of 65 (National 
Audit Office 2005), stroke featured as one of the eight standards in the 2001 NSF for older 
people (Department of Health 2007c).  
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The first National Clinical Guideline for Stroke (NCGS), devised by the Intercollegiate Stroke 
Working Party at the Royal College of Physicians, was published in 2000 (Intercollegiate 
Stroke Working Party 2008). The guideline has undergone two subsequent revisions (2004 
and 2008), with the latest version of the guideline incorporating the National Institute for 
Health and Clinical Excellence (NICE) guidelines for the management of acute stroke and 
TIA (National Institute for Health and Clinical Excellence 2008). The NCGS defines best 
practice in stroke management through consolidation of trial evidence and expert 
consensus opinion, describing the components of a quality stroke service and offering 
recommendations as to how these should be achieved (Intercollegiate Stroke Working 
Party 2008).  
 In 2005, the National Audit Office produced a critical report for the Committee of Public 
Accounts that highlighted deficiencies in the provision of care against the evidence base 
and guidance documents in several key areas of the stroke pathway (National Audit Office 
2005). The National Stroke Strategy (NSS) (Department of Health 2007b) was the policy 
response from the Department of Health (DH) to address these deficiencies.  
The NSS outlines a ten year strategic framework to drive stroke service reconfiguration and 
deliver improvements in the quality of stroke care along the entire stroke care pathway. 
However, the delivery of quality, personalised stroke care in a timely and cost-effective 
manner requires definition of the components of quality care, demonstration that 
delivered care has a positive effect on patient and carer outcome, and reliable metrics with 
which to quantify these effects along the whole stroke care pathway. Drawing heavily on 
previous consensus documents such as the NICE clinical guidelines for acute stroke and TIA 
(National Institute for Health and Clinical Excellence 2008) and the NCGS (Intercollegiate 
Stroke Working Party 2008), the NSS offers 20 ‘Quality Markers’ of a quality stroke service 
and a series of ‘measuring success’ metrics to facilitate quantitative analyses (both within 
and between services) (Department of Health 2007b). 
The NSS has become a major driver of stroke service improvement.  Implementation of the 
strategy features in the NHS Operational Framework and, as a result, a number of markers 
and metrics have been developed in an attempt to measure and monitor its delivery. 
These data are requested by a variety of disparate bodies for the purposes of performance 
monitoring, remuneration or service improvement (see section 1.2.1 below). The quality of 
these data is imperative to ensure that robust, consistent and comparable conclusions 
regarding the delivery and quality of stroke care may be drawn.  
Quality data are “accurate, up-to date, free from duplication and free from confusion” 
(NHS Connecting for Health 2011). In short, data items and how these are used to derive 
indicators should be explicitly defined, captured once and in a timely manner (ideally at the 
point of patient care). The existing ‘cacophony’ of stroke requirements and datasets 
obfuscates the collection of ‘quality data’ in many, if not all, of these areas.  A brief 
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discussion of the current data that are requested from provider trusts is outlined here to 
highlight its complexity. A timeline of the key policy documents and data collections is 
given in Figure 1 (page 9). 
1.2.1 Existing datasets for monitoring the delivery of stroke care 
1.2.1.1  Integrated Performance Measures  
The annual NHS Operating Framework defines national priorities in health care, the 
direction of health reform, and financial objectives of the NHS (Department of Health 
2009b). Every quarter, since the 2008/09 review, service providers have been required to 
provide mandatory performance indicators to the Department of Health (DH) via Primary 
Care Trusts (PCTs) (Department of Health 2008b). In stroke and TIA, these ‘Vital Sign’ (VS) 
indicators (Department of Health 2008d) are designed to demonstrate implementation of 
the NSS. In June 2010, following the formation of the new Government, the Operating 
Framework underwent a series of revisions (Department of Health 2010c). Implementation 
of the NSS has remained in ‘Tier 1’ of the Operating Framework retaining stroke and 
transient ischaemic attack (TIA) as high national priorities (Department of Health 2009b). 
However, in the 2010/11 Operating Framework, the Vital Signs will be renamed ‘Integrated 
Performance Measures’ (IPM), although their content will remain identical (Department of 
Health 2008d; Department of Health 2010e).  
1.2.1.2 CQUINs 
In 2008, ‘High Quality Care for All’ (Darzi A 2008) introduced the Commissioning for Quality 
in Innovation (CQUIN) framework. Goals are locally agreed between commissioners and 
providers to encourage the provision of quality services at a contractual level. A proportion 
of a provider’s income is reliant on meeting these goals (Department of Health 2008c; 
Institute for Innovation and Improvement 2010). Dependent on local priorities, stroke data 
may be required to fulfil CQUIN requirements.  
1.2.1.3 Payment by Results (PbR) 
In England, Payment by Results (PbR) is the mechanism through which, providers are 
remunerated by commissioners for delivery of services. Payments are made according to 
national tariffs calculated from adjusted ‘average’ service costs across similarly grouped 
activities (Healthcare Resource Groups (HRGs)) (Department of Health 2007a). The HRG for 
a particular hospital spell is calculated from ICD-10 and OPCS-4 coding data following the 
patient’s discharge (ibid).  
National Best Practice Tariffs were introduced in England in 2010/11 for selected 
conditions (including stroke) where ‘best practice’ is well defined, but variations in 
delivered care occur (Department of Health 2010b). The BPT framework offers incentives 
for the delivery of high quality care through additional payments above the base tariff for 
aspects of an individual patient’s care that meet specific quality standards (Department of 
Health 2010b).  The base tariff for stroke care is set below the average cost of a stroke 
- 5 - 
hospital spell (and below the ‘conventional tariff’ for stroke that had been used within the 
PbR framework), such that the remuneration of care not meeting the BPT quality standards 
is, on average, less than the cost of the admission (Department of Health 2010b). 
Moreover, specific aspects of care (e.g. CT brain imaging) are not included within the base 
tariff, such that patients scanned outwith the BPT criteria will not be remunerated 
(Department of Health 2010b). Adjustments may be paid outside the BPT framework to 
cover the cost of drugs and the additional resource associated with thrombolytic agent 
treatment (Department of Health 2010b).  
1.2.1.4 National Sentinel Stroke Audits 
The Royal College of Physicians (RCP) Clinical and Organisational National Sentinel Stroke 
Audits (RCP NSSA) (see section 1.2) have had significant and sustained effects on national 
improvements in stroke services (Intercollegiate Stroke Working Party 2010; Intercollegiate 
Stroke Working Party 2011). However, there are a number of deficiencies with the audits. 
They comprise multiple process markers resulting in a large dataset which is complex, 
unwieldy and neither designed nor feasible for prospective, real-time collection. Moreover 
many of the indicators within the dataset are of unproven association with patient 
outcome (e.g. being weighed during the course of the hospital admission) and it is possible 
that such process markers are acting as proxy markers for more complex factors (e.g. 
stroke severity). 
1.2.1.5 Stroke Improvement National Audit Programme (SINAP) 
Funded by the DH, the Stroke Improvement National Audit Programme (SINAP) dataset has 
been developed by the RCP Stroke Programme to capture real-time prospective data 
describing acute stroke care (Royal College of Physicians Stroke Programme 2010). 
Although the dataset is large, only care delivered within the first 72 hours following acute 
stroke is considered, and many of the questions relate to the provision of thrombolysis. 
The audit started in 2010 with data being entered into a web-based form and submitted 
electronically to the Royal College of Physicians. The first report of data for England was 
published in July 2011 covering the reporting periods June 2010 to June 2011 (Royal 
College of Physicians 2011).  Although not currently a mandatory requirement, the SINAP 
audit features as one of the National Clinical Audits within the Quality Accounts for 2011 
and as such, participation is required implicitly (Healthcare Quality Improvement 
Partnership (HQIP) 2011).  
1.2.1.6 NICE quality standards 
The National Quality Board (NQB) was created in March 2009 as a recommendation of 
‘High Quality Care for All’ (Darzi A 2008). The board has a remit to “oversee improvement 
of quality indicators” and to “ensure overall alignment of the quality system” (Department 
of Health 2010d). The NICE Quality Standards Programme, under the direction of the NQB, 
aims to extract or devise quality standards from available evidence, existing guidance 
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documents and expert consensus of health and social care professionals. In early 2010, a 
‘Topic Expert Group’ developed and refined a set of eleven quality standards and metrics 
to describe the stroke pathway (National Institute for Health and Clinical Excellence 
2010b). It is anticipated that these standards will, in part, inform service commissioning 
and act as a stimulus for high quality stroke care (National Institute for Health and Clinical 
Excellence 2010a).  
1.2.1.7 Stroke Improvement Programme, Accelerating Stroke Improvement. 
The Stroke Improvement Programme (SIP), developed in 2007 as part of NHS Improvement 
(NHS Improvement 2010b), oversees 28 regional Stroke Care Networks tasked with the 
local implementation of the NSS (NHS Improvement 2010b).  In early 2010, as a follow up 
to the 2005 report (National Audit Office 2005), the NAO re-examined the national 
situation regarding the provision of stroke care (National Audit Office 2010). 
Improvements in the acute end of the stroke care pathway (with notable exceptions such 
as direct admission to a stroke unit) were identified, but deficiencies in the longer-term 
management of stroke remained (National Audit Office 2010). The DH responded by 
committing the NHS to a year of accelerated improvement in stroke care. The Accelerating 
Stroke Improvement Programme, as part of the SIP, was launched in April 2010 (NHS 
Improvement 2010a). The programme has been extended and continues into 2011/12. 
Nine aspects of the NSS have been targeted for ambitious accelerated improvement with 
particular emphasis on the longer-term care of stroke patients (NHS Improvement 2010a).  
1.2.1.8 Emerging datasets ‘SSNAP’ (Sentinel Stroke National Audit Programme) 
It has been proposed that from spring 2012, SINAP and the Sentinel audits will be 
combined into one prospective audit to cover aspects of the whole stroke pathway. This 
will involve the development of a further, new dataset in place of the existing data 
collections. It is proposed that this new dataset will be funded by HQIP and, at the time of 
writing, the selection of provider for this new data collection is out to tender (Health 
Quality Improvement Partnership (HQIP) 2011).    
1.2.1.9 Data definitions and accuracy 
Accurate between institution or within institution comparisons of performance and quality 
rely on like being compared with like. Effective case-mix adjustment constitutes one aspect 
of this (see Chapter 3), but explicit data definitions form another important factor. 
Consistency in reporting of metrics requires every step in the derivation of indicators to be 
unequivocally defined. Application of these data definitions should occur at the point of 
data capture (or data extraction if these are different). Although derivation of some 
indicators (such as the IPM and BPT) is well defined (Department of Health 2008d; 
Department of Health 2010b), other datasets are more open to interpretation (e.g. the 
Accelerating Stroke Improvement metrics (NHS Improvement 2010a; Stroke Improvement 
Programme 2011)).  
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1.2.1.10 Overlapping datasets and duplication of data capture 
The existing stroke datasets as outlined in section 1.2.1 are complex and replicative often 
containing similar yet subtly different indicators. In the absence of robust IT systems, the 
greater the data burden, the greater the data collection resource required to extract it. 
Capture of data is expensive and resource intensive. Every data item that is requested 
comes at a cost. Duplication of data extraction for different bodies therefore reflects 
wasted resource. The benefit that every data item confers should be weighed up against 
the cost of collecting it. Thus the capture of large and unwieldy datasets comprising 
process markers of little or unproven link to patient outcome are unlikely to be cost or 
resource effective (See section 2.1.5). Intuitively, the more data that are requested, the 
less likely it is that these data will be extracted and reported accurately. Moreover, 
frequent changes to data requirements are likely to have an impact on the accuracy and 
consistency of reporting.  
1.3 Background to CIMSS 
This MD thesis forms part of the preliminary work for the CIMSS project (Clinical 
Information and Management System for Stroke), the stroke theme of the National 
Institute for Health Research (NIHR) funded Leeds, York, Bradford (LYBRA) Collaboration 
for Leadership in Applied Health Research and Care (CLAHRC).  
The CIMSS project has the overall aim of defining, iteratively refining and implementing, a 
novel core stroke dataset that is clinically relevant and feasible for electronic collection at 
the point of care by members of the multidisciplinary team responsible for delivering that 
care. The CIMSS dataset has an emphasis on patient reported outcomes, with the 
anticipation that routine collection and feedback of relevant CIMSS data to healthcare 
professionals and commissioners will result in measurable improvements in the 
effectiveness of stroke care in the stroke services within the Yorkshire and the Humber 
region that are participating in the implementation phase of the CIMSS CLAHRC project. 
This thesis describes the research led process to define and test the preliminary CIMSS 
dataset and refine the preliminary fields to a dataset suitable for wider implementation.  
This CIMSS dataset differs from existing and previous data collections as it includes 
routinely collected patient reported functional outcomes data within an infrastructure that 
allows these outcomes data to be linked directly to information relating to patients’ 
inpatient stay (process data) and their individual characteristics (case-mix). Moreover, 
through consideration of the current ‘data environment’ in stroke, an alternative approach 
to stroke data collection is suggested, offering standardisation, reproducibility and 
consistency of data collection and reporting across provider trusts. This solution ensures 
that existing data requirements are met (e.g. participation in SINAP - see section 1.2.1.5), 
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but that stroke data collection is simplified, rather than compounded by the collection of 
CIMSS data.  
1.4 Aims of thesis 
Through examination of the literature and a prospective observational cohort study I aim 
to address the following research questions:  
• Which combination of postal outcomes instruments best captures the physical and 
social functioning of patients following stroke?  
• Which is the best available case-mix adjuster in stroke? 
• How does care process relate to patient outcome after stroke? 
• Which process, case-mix and outcomes markers should be included in a routinely 
collected stroke dataset’? 
I begin by critically appraising the literature regarding both process and outcomes driven 
approaches to the monitoring of healthcare, and will consider the implications of the 
application of these arguments to stroke care. I then describe a systematic review to 
identify the best available case-mix adjuster in stroke. Subsequent chapters describe the 
design, execution and results of a prospective cohort study to test the utility of the 
preliminary dataset to capture care process, case-mix and physical and social outcomes 
following stroke. Finally I discuss the refinement of this dataset to a set of core fields for 
wider implementation where CIMSS fields are combined with existing datasets to provide a 
flexible core minimum dataset from which all existing stroke metrics may be derived.  
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Figure 1 Timeline of best practice guidelines, reports and data collections 
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Chapter 2 Literature review 
2.1 Measuring quality in stroke care 
There is much debate in the medical literature as to how the quality of delivered health 
care should be measured, monitored and improved. Two discrete approaches have 
attracted significant debate: the reflection of quality through measurement of care 
processes, or through patient outcome. In this chapter, through discussion of the benefits 
and pitfalls of process and outcomes driven approaches, I will discuss how assessment of 
healthcare delivery depends on the definition of quality, the purpose of quality 
measurement and the perspective from which these assessments are made. Moreover, in 
order to achieve a broad quality perspective that captures the entire stroke pathway, I will 
argue that measures of both process and outcomes are required. 
2.1.1 What is quality in healthcare? 
2.1.1.1 The political background in England, Northern Ireland and Wales 
The National Health Service (NHS) is underpinned by the principles of Clinical Governance, 
the system “through which NHS organisations are accountable for continuously improving 
the quality of their services and safeguarding high standards of care” (Department of 
Health 1999). The system was introduced in 1998, to ascribe formal accountability to the 
requirements of clinical audit and quality assessment, assurance and improvement that 
had previously been the informal responsibility of healthcare professionals, commissioners 
and health services management (Buetow SA et al  1999).  
A decade of health reforms following the 1997 General Election saw a series of 
government policy initiatives aimed at increasing capacity in the NHS (Darzi A 2008 
preface). Key policies included the introduction of Performance Assessment Frameworks, 
disease specific National Service Frameworks (with compliance markers) and the Quality 
Outcomes Framework in Primary Care. In addition, the establishment of the National 
Institute for Clinical Excellence (NICE) (latterly the National Institute for Health and Clinical 
Excellence) introduced a series of frameworks of evidence based, cost effective best 
practice guidance for a range of health technologies, pharmaceuticals and interventions 
across a range of disease areas (McLaughlin V et al  2001).  
In 2008, the political focus shifted from capacity building within the NHS towards the 
delivery of care based on quality, productivity and value (Department of Health 2009a). 
“High Quality Care for All” (Darzi A 2008), a report commissioned by the DH and led by a 
senior clinician, was a vision of a 21st Century NHS with specific focus on achieving 
improvements in patient centred, quality care through the provision of safe and effective 
treatments. Notable outputs from the Darzi review include the National Quality Board 
(NQB), developed in March 2009 (Department of Health 2010d).The NICE Quality 
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Standards Programme, under the direction of the NQB, aims to extract or devise quality 
standards from available evidence, existing guidance documents and expert consensus of 
health and social care professionals (see also section 1.2.1.6). 
Since the formation of the Conservative/Liberal Democrat coalition government in May 
2010, there has been a further shift of focus in the NHS with emphasis being placed firmly 
with the measurement of patient outcome indicators as markers of the quality of care 
(Department of Health 2010e). These outcomes, however, tend to focus on hard objective 
endpoints such as mortality and length of hospital stay and any patient reported outcomes 
are limited to quality of life and satisfaction surveys (Department of Health 2010e). 
Although at the time that the Outcomes Framework was written it was proposed that an 
indicator for stroke recovery should be included, it was yet to be developed.  
2.1.2 Defining quality in healthcare 
Quality of care is a complex, multi-dimensional concept that has been variously defined 
and described. Campbell et al (2000) have suggested that care quality centres on two 
constructs: efficiency (in the use of resources including needs-based access to care) and 
effectiveness (in both the delivery of personalised care and in technical aspects of clinical 
care) (Campbell SM et al  2000). Anavedis Donabedian described three interrelated aspects 
of quality in healthcare in his influential 1966 paper “Evaluating the Quality of Medical 
Care” (Donabedian A 1966; Frenk J 2000). Processes of care describe technical aspects of 
care delivery – whether particular aspects of care occurred e.g. patients undergoing timely 
imaging or the most appropriate operation. These hard aspects of healthcare delivery are 
often measured through process metrics which may be used for clinical audit and 
benchmarking to encourage the delivery of care according to evidence-based practice. 
Whilst some of these care processes are directly related to an individual clinician (e.g. 
operative skill, choice of drug), some will require adequate staffing or care pathways and 
are the responsibility of the organisation. These latter, organisational aspects reflect the 
structure of care – the infrastructure necessary to deliver high quality care. Finally, there is 
patient outcome - this is defined in the NHS Outcomes Framework (Department of Health 
2010e) as “… a change in the health status of an individual, group or population, which is 
attributable to an intervention from a healthcare provider”. The premise that the way in 
which care is organised (care structure) affects the care that is delivered (care processes) 
which in turn affect patient outcome remains fundamental to the considerable and 
ongoing debate in the medical literature as to whether care process or patient outcomes 
should be monitored in order to reflect the quality of patient care. There is a dynamic 
relationship between these three dimensions of quality, the full understanding of which 
requires a fourth factor: case-mix, to account for the severity of an index condition in an 
individual patient (Figure 2). Case-mix is an important, but often ignored factor if between-
organisation quality comparisons are to be attempted. 
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Figure 2 The interrelationship between care process, structure, case-mix and 
patient outcome 
The Care Quality Commission (CQC) (formerly the Healthcare Commission), is the 
independent regulator of health and adult social care in England. The CQC broadly define 
quality care as that which is “safe; has the right outcomes (including clinical outcomes); is a 
good experience for the people who use it, their carers and their families; helps to prevent 
illness and promotes healthy, independent living; is available to those who need it when 
they need it; and provides good value for money” (The Care Quality Commission 2009).This 
definition encompasses three main perspectives of quality care: Patients and their families 
(safety, experience and clinical outcome), commissioners and service providers (resource 
availability and value for money), and society as a whole (prevention and health 
promotion). The CQC definition of quality has formalised the need to account for and 
quantify the experience of a health care encounter from the perspective of the patient, 
family and carer. The patient experience of care adds an additional layer of complexity to 
the measurement of quality. In order to ensure that patients are receiving care that meets  
emotional as well as physical needs, the Department of Health defines  good patient 
experience as that which ensures that patients are “getting good treatment in a 
comfortable, caring and safe environment, delivered in a calm and reassuring way; having 
information to make choices, to feel confident and to feel in control; being talked to and 
listened to as an equal and being treated with honesty, respect and dignity” (Department 
of Health 2007d).  
It can be seen therefore, that although much discussed, quality in healthcare remains a 
concept complicated by its multidimensional nature; measurement needs to encompass 
- 13 - 
the perspectives of patient and healthcare professional as well as logistical, organisational, 
financial and procedural aspects of care. Markers of quality are not, therefore, 
synonymous with markers of performance. 
2.1.3 How can quality be measured? 
"Not everything that counts can be counted and not everything that 
can be counted counts.”  
(Albert Einstein 1879-1955) 
In order to improve the quality of delivered care, it must be measurable. There are no 
‘units of quality’ and therefore proxy markers must be used. The nature of these markers 
will depend on the purpose of the measurement. Regardless of which markers are used, 
they must be valid (in their reflection of quality), explicitly defined to allow measurement 
against agreed standards or against similar services, and their measurement reliable 
(stable) over time and between raters. Indicators should also be sensitive to change (i.e. be 
able to detect and discriminate between small changes), relevant and acceptable to 
clinicians and patients, and provide relevant and useful information to wider stakeholders 
(Davies HTO 2005).  
The populations in which quality markers are used should be standardised for baseline 
characteristics and case-mix (variation in e.g. stroke severity between individual patients 
and populations of patients) to allow legitimate and meaningful comparative 
measurements. The important issue of case-mix is discussed further in Chapter 3. 
2.1.4 Why measure healthcare quality? 
2.1.4.1 Performance monitoring and remuneration  
Commissioning bodies require reassurance that services are being planned and delivered 
in line with commissioning contracts and national guidance. As such, specific (usually 
process) markers may be used to examine performance often with associated financial 
incentives (Department of Health 2010b). Remuneration of individual service providers has 
been based on volume and activity through the Payment by Results framework. However, 
increasingly, remuneration is only provided for care provided in line with explicit ‘Best 
Practice’ guidelines within the Best Practice Tariff structure (Department of Health 2010b). 
The origins and current data requirements for performance monitoring and remuneration 
of stroke service delivery have been described in detail in sections 1.2.1. Open competition 
for the commissioning of health services from NHS and non-NHS (public and private) 
organisations was introduced by the last Labour administration (Department of Health 
2009a sect 4.19 p 54). Planned NHS reform under the coalition government aims to extend 
this competition and proposes that commissioning responsibilities are moved from Primary 
Care Trusts to consortia of General Practitioners (GPs) (Department of Health 2010a). This 
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is likely to heighten the emphasis on the requirements for, and demonstration of, value for 
money through performance monitoring.  
The requirements for data regarding quality of care from the perspective of patients and 
commissioners highlight two different aspects of quality care – patient satisfaction and 
value for money. Indeed, the data obtained through ‘quantification of quality’ through the 
measurement of patient satisfaction surveys as compared with performance metrics 
provide very different types of information. The first could be considered an outcome (a 
broad patient-centric opinion on the healthcare experience), whist the second reflects 
measurement of process based around volume (e.g. PbR) or delivery of care against pre-
specified standards (e.g. BPT). Collecting data to describe aspects of the patient experience 
may be achieved through patient surveys, although focus groups or patient interviews may 
provide richer information in specific areas. There are, however, issues with the 
representativeness and feasibility of collecting data in this way. Therefore, the aspect of 
quality that is measured should reflect the purpose of the ‘quality assessment’. 
2.1.4.2 Patient centred care 
There has been a gradual, yet sustained evolution of the concept of personalised care 
within the NHS since the introduction of the Patients’ Charter in 1991 (The King's Fund 
2011). Since 2009, as a consequence of the Darzi Review (Darzi A 2008), NHS trusts have 
been required to collect and report routinely Patient Reported Outcome Measures 
(PROMs) following specific operative procedures (Department of Health 2008a). Although 
the scope of this framework is currently limited, it is anticipated that the scheme will 
“extend … across the NHS wherever practicable” (Department of Health 2010a). 
The PROMs framework is designed to capture patient reported disease specific and 
subjective outcomes data in an attempt to reassure patients, commissioners, healthcare 
providers and the tax-payer that delivered care has a positive effect on the types of 
outcomes that are relevant to patients. Moreover, it is intended that these may be used to 
differentiate good from poor quality care. Indeed, the Information Centre (IC) website 
(currently responsible for the PROMs data) states: “The health status information collected 
from patients by way of PROMs questionnaires before and after an intervention provides 
an indication of the outcomes or quality of care delivered to NHS Patients” (The 
Information Centre 2011b). Raw and case-mix adjusted PROMs data collected since 2009 
are available in the public domain from the Information Centre via the Hospital Episode 
Statistics (HES) website (Hospital Episode Statistice (HESonline) 2011). In this context 
PROMs – subjective measures of an individual’s disease specific outcome and quality of 
life– are likely to be used to make assumptions about the relative quality of delivered care 
(process) between institutions, regardless of whether or not this is the intent of capturing 
the data.  
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2.1.5 Linking process and outcome 
The reflection of quality through markers of process is dependent on the demonstration of 
robust linkages between the process marker and patient outcomes in unselected 
populations - in order for the processes of care to reflect quality they must be known to 
explain some variability in patient outcome. The measurement of process becomes an 
abstract concept “of little intrinsic interest” (Mant J 2001), a marker of the quality of 
process and not the quality of care, unless it has been demonstrated to have some impact 
on outcome. Similarly, the use of outcomes of care as markers of quality is of little benefit 
in terms of improving the quality of care unless it is known which specific aspects of care 
process are responsible for the variation in patient outcome and whether optimisation of 
specific aspects of process could indeed improve these outcomes (Lilford RJ et al  2007). 
Therefore, regardless of whether processes or outcomes of care are to be used to monitor 
care quality, it should be clear that variation in outcome is explained through variation in 
care processes rather than, for example, unexplained differences in case-mix or chance 
(Lilford RJ et al  2007; Mant J 2001). 
Evidence based healthcare relies on the translation of processes and interventions shown 
to be beneficial in the clinical trial setting into routine care. However, an important caveat 
to the development and legitimacy of process markers based on trial interventions for the 
purposes of monitoring quality of patient care is that this depends on the demonstration of 
linkages between process and outcome in unselected populations. Clinical trials often 
involve the measurement of both processes of care (or specific interventions) and patient 
outcomes. However, there are important differences between measurement of process 
and outcome in the research setting and for quality assessment. 
Randomised controlled trials (RCTs) and meta analyses of RCTs are generally considered 
the ‘gold standards’ in terms of the hierarchy of research evidence (Scottish Intercollegiate 
Guidelines Network (SIGN) 2008 p 51), as the effect of confounding variables can be 
minimised through randomisation.  Indeed, RCTs have demonstrated that many processes 
of care to be effective in reducing the hard endpoints of death or dependency in stroke 
(e.g. thrombolysis, stroke unit care, early supported discharge, aspirin). However, direct 
translation of RCT results into routine care (generalizability to unselected populations) may 
be limited by trial inclusion and exclusion criteria (Black 1996). For example, the proportion 
of patients recruited over the age of 80 in the Cochrane review of thrombolysis for acute 
ischaemic stroke, was just 0.5% (Wardlaw JM et al  2009). It is possible that the benefits 
(and risks) of some interventions may be attenuated or accentuated in certain subgroups 
of patients that were excluded from the original trials. Extrapolation of research findings to 
these subgroups is not necessarily valid and, in the absence of studies to demonstrate 
generalizability into unselected populations, subgroup treatment effects remain untested. 
Randomised rehabilitation trials pose particular challenges. For example, blinding and 
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sustained adherence to rigid treatment protocols may be difficult due to the complexities 
of the interventions (Horn SD et al  2005; Black N 1996). Basing generic performance 
markers on randomised trial evidence should therefore be with the caveat that this may be 
in the absence of empirical evidence of generalizability into unselected populations.  
Evans et al (2001) aimed to identify processes of care within the complex intervention of 
stroke unit care that may predict dichotomised patient modified Rankin Score (mRS) at 
three months (Evans A et al  2001). Logistic regression analysis was performed using data 
from 304 patients collected for a previous randomised controlled trial of stroke unit vs. 
general ward care.  Limited case-mix variables (age and baseline Barthel Index) were also 
entered into the regression models.  Of the factors that were identified as being associated 
with outcome in this study (prevention of aspiration pneumonia, early feeding, stroke 
progression, chest infection, dehydration and management on a stroke unit) (Evans A et al  
2001), many are likely to reflect the severity of stroke rather than a discrete process of 
care; chest infections, stroke progression and dehydration are more likely to be markers of 
stroke severity or comorbidity rather than deficiencies in care process. Although these data 
were taken from a randomised trial, case-mix adjustment is still important as patients were 
randomised to receive stroke unit care and not individual care processes. Additionally, the 
data for intervention and control arms were pooled to form the study dataset such that 
the randomisation is no longer effective.  
Observational studies offer an alternative way to examine populations that may produce 
more generalizable (externally valid) results than RCTs (Black N 1996). Capture of data 
describing processes of care that actually occur rather than through RCT treatment 
protocols allows a pragmatic exploration of delivered care.  The broad external validity that 
is conferred through examination of non-randomised, unselected populations is, however, 
attenuated through the uncertainty that is introduced through the heterogeneity of these 
populations (i.e. a loss of internal validity) (Horn SD et al  2005). Observational studies can 
therefore facilitate exploration of correlation (as opposed to causation) between processes 
of care and outcomes. However, these relationships are complicated by the effects of 
additional and potentially unmeasured confounding factors (Lilford RJ et al  2007).  
Several groups have tried to correlate process markers with patient outcomes (at an 
institutional level) across a variety of conditions in empirical (unselected) populations with 
limited success (Lilford RJ et al  2004). In a review of 36 studies examining 51 such 
relationships between process and outcomes, Pitches et al found a positive correlation in 
51%, no correlation in 31% and a paradoxical relationship (where ‘better’ care process was 
associated with higher mortality) in 18% (Pitches DW et al 2007).  Of the four studies 
included in this review that specifically examined stroke (Dubois et al  1987; McNaughton 
H et al  2003; Mohammed MA et al  2005; Weir N et al  2001), one study found no 
correlation between individual processes of care and patient outcomes (Dubois RW et al  
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1987), and one identified a paradoxical association where the hospital with the highest 
summed (unweighted) process scores (RCP NSSA process markers) (Intercollegiate Stroke 
Working Party 2011) reported poorer patient outcomes (McNaughton H et al  2003). The 
two remaining (multicentre) stroke studies each found higher mortality rates persisted at 
one of their study sites following adjustment for case-mix (using the variables of the Six 
Simple Variables case-mix adjustment model (Counsell et al  2002)), and that these sites 
were also deficient in aspects of care process (Mohammed MA et al  2005; Weir N et al  
2001). No differences in between site mortality (Weir N et al  2001), or relationships 
between processes of care and standardised mortality rate (SMR) (Mohammed MA et al  
2005) remained at other sites following case-mix adjustment, despite significant 
differences in process delivery across sites.  
A systematic review performed in 2007, pooling data from 16 observational stroke studies 
where adjustment for case-mix or baseline variables had been performed (N=42,236), 
demonstrated a clear survival benefit at one year for patients receiving organised stroke 
unit care vs. general ward care (OR 0.79 [0.73,0.86]) (Seenan P et al  2007). These figures 
are comparable to those demonstrated in the SUT systematic review of randomised trials 
of stroke unit vs. general ward care (OR 0.86 [0.76-0.98]) (Stroke Unit Trialists' 
Collaboration 2007). 
However, commentators have argued that variations in observed outcome between 
institutions are more likely to reflect systematic differences in between institution 
populations (e.g. differences in case-mix, data quality or the role of chance) than true 
differences in the quality of care.   
2.1.6 Case-mix 
Case-mix, discussed in detail in Chapter 3, represents the range of disease severity and 
baseline characteristics that may be the cause of variation in outcomes between 
individuals and populations (Lilford et al  2004; Mant J 2001). Case-mix has been argued to 
be a major barrier to the demonstration of process-outcome linkages in empirical studies. 
Differences in observed outcome between groups have been shown to be wholly or partly 
attributable to case-mix in a number of experimental stroke studies (Davenport RJ et al  
1996; Lingsma et al  2008; Mohammed MA et al  2005; Weir N et al  2001). In other 
studies, process markers identified as potentially important in determining patient 
outcome in unadjusted analyses were no longer significant following case-mix adjustment 
whilst other variables, became statistically significant predictors of outcome following 
adjustment (Bravata DM. et al  2010).  
Where differences in outcome remain after case-mix adjustment in observational studies 
or empirical populations, it has been argued that this is more likely to reflect unmeasured 
case-mix variables or confounders than true differences in delivered care (Lilford RJ et al  
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2004; Mant J 2001). It is unlikely that any case-mix adjustment model will ever account for 
all potential confounders and as such, many prognostic or specific case-mix variables may 
remain unmeasured and their effect unaccounted for (Mant J 2001).  
2.1.7 Process saturation 
A further barrier to the linkage of processes of care with outcome is a consequence of the 
heightened delivery of specific aspects of care according to existing stroke care monitoring 
indicators. Many existing markers of process for stroke care have evolved from a 
systematic evaluation of the key aspects of stroke care process consistently delivered in 
the effective stroke units identified in the SUT systematic review of organised stroke unit 
care (Langhorne et al  2002; Stroke Unit Trialists' Collaboration 2007). However, robust RCT 
evidence to link many of these and other individual processes of care that occur on a 
stroke unit with improved patient outcomes is often lacking. Where there is expert 
consensus on specific aspects of care delivery (for example early mobilisation), processes 
are often adopted into clinical guidance in the absence of RCT trial evidence 
(Intercollegiate Stroke Working Party 2008). Inclusion of these processes as an accepted 
part of standard quality care precludes, on ethical grounds, the randomisation that would 
be required to allow formal clinical trial evaluation of the potential benefit of receiving the 
process (Black N 1996). Comprehensive adoption of these processes into routine care 
reduces the variability in care process delivery such that detecting the effect of omitting 
the process through observational studies becomes more difficult due to a lack of 
statistical power (see also section 6.1.2.1). As saturation of the process reaches 100%, 
demonstrating a process is effective becomes impossible. For processes of care where 
there is a logical rationale for clinical benefit this is unlikely to be problematic. However, 
for process indicators where the potential benefit to individual patients is not clear cut (for 
example being weighed at least once during the course of the admission (Intercollegiate 
Stroke Working Party 2011) it remains unclear whether the process has any impact on 
patient outcome. 
2.1.8 The role of chance 
Statistical analyses can offer confidence limits and levels of statistical significance, 
however, it should be remembered that these are simply reflections of the likelihood of an 
event being due to chance. Differences in outcome between centres or within centres over 
time may therefore be due to random variation rather than delivered care.  The risk of 
associations being due to chance is higher when either the numerator (outcome) or 
denominator (total number of cases) is small (Mant J 2001) – i.e. for rare events or small 
sample sizes. For example, in an attempt to demonstrate the effect of the introduction of a 
stroke unit on 30 day and 1 year stroke mortality, Davenport et al collected data on 216 
patients pre and 252 patients post introduction of the new service (Davenport RJ et al  
- 19 - 
1996). Having adjusted for case-mix adjustment, no difference in mortality was observed 
following introduction of the stroke unit. In response, Mant et al identified that in order to 
be adequately powered to detect the differences in mortality comparable to those seen in 
the SUT RCT of organised stroke unit care with 5% confidence and at 80% power, the 
before and after study would have needed to recruit 2066 patients (Mant J et al  1996).  
Where multivariable models have been constructed to explore relationships between 
process and outcome whilst adjusting for confounding factors (e.g. linear or logistic 
regression analyses), ensuring that the number of variables entered into the model is 
appropriate for the sample size is critical in reducing the identification of spurious or 
chance associations. This is discussed in detail in 3.5.8.1.  
2.1.9 Data quality  
In order for the routine measurement of process markers to be reliable in longitudinal or 
cross-sectional (between institution) comparisons, there needs to be standardisation in the 
data that are recorded (Lilford RJ et al  2004; Mant J 2001). This relies on strict data 
definitions such that it is clear that precisely the same aspects of care are being measured 
between individuals and between institutions (Lilford RJ et al  2007). In order for this to 
occur, there should be minimal subjectivity in measurement. Ideally, process markers 
should be observations (or derivations) of whether and when an explicitly defined event 
occurred. Variations in measurement of processes (such as could occur if data definitions 
do not exist or if there are no validation checks to ensure that they have occurred) can lead 
to spurious data and unfair comparisons.  
Some processes appear to have been particularly poorly completed within the SINAP 
dataset in the 2010/11 data collection period (where data collection and submission were 
not mandatory) (Royal College of Physicians Stroke Programme 2010). For example, bundle 
12 reflects the proportion of eligible patients receiving antiplatelet therapy within 72 
hours, and “adequate” fluids and nutrition within each 24 hours of the 72 hour audit 
period. The SINAP data reveal that 25% of trusts achieve this process marker in just 43% of 
their patients (Royal College of Physicians 2011). The RCP national sentinel audit report 
(2010) states that 99% of patients (nationally) receive fluids within 24 hours, 95% receive 
nutrition within 72 hours and 93% are commenced on antiplatelet therapy within 72 hours 
of admission. It therefore would appear somewhat incongruous that the SINAP data reflect 
such low achievement of a similar (but not directly comparable) marker, perhaps reflecting 
differences or difficulties in data reporting rather than true deficiencies in patient care. It 
should, however, be considered that SINAP as a prospective audit, includes all patients 
admitted to a particular trust with a stroke diagnosis, whereas the RCP NSSA is performed 
on the first 60 consecutive stroke admissions in the reporting period (Intercollegiate Stroke 
Working Party 2011; Royal College of Physicians Stroke Programme 2010). 
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Missing data is a further important consideration in data quality. Routine documentation 
of the delivery of specific processes of care may be deficient, thus complicating 
retrospective data extraction (Walsh et al  2002). In terms of measurement of process, 
data may be missing because a process was not performed or because data were either 
not extracted or recorded incorrectly (i.e. non-sense data). If possible, differentiation 
between these types of missing data adds additional and useful information. For example, 
actively identifying a process that is consistently not performed (i.e. recording that the 
data are not available) may indicate a problem with staff training or resource, whilst data 
that are consistently not recorded may indicate that these data are difficult to extract, 
highlighting a problem with the indicator itself. Examination of missing data can help to 
identify missingness patterns (i.e. subgroups of patients that tend to have missing data) as 
these may lead to bias. Metadata (‘data about data’) can help to explore these patterns – 
for example examination of the missing data in relation to disease severity, or by 
institution. 
2.1.10 Data sources 
Studies that have attempted to link care process with patient outcome have utilised data 
from a variety of sources: retrospective routine data (e.g. stroke registers or routine 
hospital data), retrospective data obtained from case-note review, secondary use of trial 
data (e.g. data from control arms of RCTs) and prospective observational data defined a 
priori and obtained expressly for the purposes of the study. The data source affects both 
data quality, and the conclusions that may be drawn. Often, more than one of these 
approaches is employed to obtain the necessary data.  
There are many sources of routine healthcare data such as locally held stroke databases, 
hospital records systems (such as Patient Administration Systems (PAS)) and anonymised 
data held in large central databases (e.g. Hospital Episode Statistics (HES) held by the 
Information Centre) (The Information Centre 2011a). However, the specific data fields that 
are recorded and available in these routine databases are likely to limit their use, i.e. the 
information to answer specific questions may not have been routinely captured within 
existing systems. If a proxy marker is available this could be used to reflect data that are 
unavailable (e.g. marital status could be used as a proxy marker of living alone). However, 
the validity of the proxy marker will depend on how well it reflects the underlying 
construct (there are many reasons why patients who are married may live alone and many 
reasons why people who are not married may not). Definitions for data that are collected 
routinely may not be standardised, and this will be reflected in the quality of the data. In 
addition, data available from routine data sources for case-mix adjustment is often limited 
to variables such as age, sex and comorbidity based on hospital coding data and these may 
not be sufficiently detailed to support complex case-mix adjustment (The Information 
Centre 2011a).  
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A further caveat to the use of retrospectively collected data is that the outcomes data that 
are routinely recorded (or that may be extracted retrospectively) are limited and often 
restricted to mortality and length of stay. Prevention of post-stroke mortality is not the 
only goal of therapy or stroke unit care. Many of the complex therapy interventions that 
occur on a stroke unit are aimed not at preventing death, but at achieving improvements 
in function and independence. Using death as an outcome fails to capture a ‘middle band’ 
of patients who survive but with disability. There are crude measures which would allow 
this middle band to be quantified (i.e. independent survival, discharge home or modified 
Rankin Score), although these measures fail to capture the nuances of an individual’s post-
stroke recovery, and are not currently recorded routinely in England, Wales and Northern 
Ireland.  
Patient case-notes are a rich source of patient specific data. However, data within patient 
case-notes are not usually recorded in a standard format and as such data extraction from 
the case-note narrative requires specific expertise. The data that are required may not 
always be available and extrapolation or ‘best guesses’ may occur especially if data 
extraction is not performed by stroke experts. The data extraction process is therefore 
time consuming and as a result expensive and resource intensive. Case-note data captured 
retrospectively are often not timely; the 2010 RCP sentinel stroke clinical audit report was 
published 11 months after the end of the data extraction period (Intercollegiate Stroke 
Working Party 2011). 
An alternative approach to obtaining process and outcomes data in empirical populations 
is through prospective data collection as part of usual care. The development of electronic 
systems has facilitated data capture and submission such that routine, prospective and 
cumulative data collection is now feasible. As a consequence many countries now host 
electronic stroke databases (Australian Stroke Clinical Registry 2011; Dennis M et al 2011; 
Royal College of Physicians Stroke Programme 2010; Asplund K et al 2011). Routine 
collection of functional outcomes is currently in operation in the Australian and Swedish 
registries (Australian Stroke Clinical Registry 2011; Asplund K et al 2011). Co-ordinating 
large scale data collection requires robust electronic infrastructure and methods for 
ensuring data quality, cleaning and obtaining missing data. 
 
2.2 Measuring quality through Process 
2.2.1 Benefits of process driven care 
It has been argued that identification of deviations from care processes can detect 
discrepancies in quality of patient care with more sensitivity than can be achieved through 
the measurement of outcomes (Mant J 2001).  
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In a simulation study, Mant and Hicks (1995) demonstrated the relative sensitivity of 
process and outcomes measurement to detect discrepancies in quality of care using the 
specific example of mortality following myocardial infarction (MI) (Mant J et al  1995). The 
calculated combined effect of proven acute pharmacological interventions was used to 
model the effect of different rates of uptake of therapies on mortality between two 
theoretical ‘hospitals’ identical in all other respects. Calculations of sample size revealed 
that the deviations from care process (defined as a failure to administer treatment to 
patients in whom it is indicated) that would result in a difference in mortality of 9% 
between institutions (0% vs. 55% process compliance) could be detected within 2 weeks 
(12 patients in each institution). Detecting this difference through direct measurement of 
mortality (with power of 80%, 2p=0.05) would take just over ten months and 389 patients 
(Mant J et al  1995). This demonstration does, however, assume a linear relationship 
between mortality rates and the use of effective interventions, and a linear cumulative 
effect of interventions (Mant J et al  1995). This simulation study elegantly demonstrates 
that detection of deviation from process is likely to be a more efficient way of detecting 
poor compliance with care processes than waiting for the effect of defective processes to 
be borne out through mortality rates. However, the measurement of process for the 
purposes of quality monitoring, simply informs whether a particular process occurred or 
not. No inference can be drawn about the effect of missing a particular process on an 
individual patient’s outcome.  
Detection of deviation from care processes identifies deficiencies in procedural aspects of 
care. Through this direct detection of deficiencies in care process delivery, improvements 
to the average quality of care can be achieved in all institutions regardless of baseline 
quality of care or observed outcomes (Lilford RJ et al  2007; Lilford RJ et al  2004).  In other 
words, there is a paradigm shift towards improved care (Lilford RJ et al  2004; Lilford RJ et 
al  2010).  
A major argument in support of the measurement of process as a marker of quality care is 
the immediacy with which data are available. Lilford et al have consistently argued that the 
delay between the delivery of process and detection of the effects of deviations from 
process through outcome measurement makes it hard to ascribe differences in outcome to 
deficiencies in care process (Lilford RJ et al  2007). Moreover, it is easier and more timely 
to record and rectify deficiencies in process delivery through audit, than waiting to 
estimate the effect of an event not occurring through observing patient outcomes (Lilford 
RJ et al  2007; Lilford RJ et al  2010; Lilford RJ et al  2004).  
2.2.2 Drawbacks to process driven care 
The validity of datasets made up of process metrics for the monitoring of quality of care in 
clinical situations rely on some key assumptions:  
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a. Patients benefit equally from interventions.  
The use of process metrics as measures of quality of care could increase the likelihood 
that, providing specific interventions are not contraindicated in individuals, all patients 
receive similar care.  An assumption that all patients require the same ‘bundles’ of care 
processes, overlooks the possibility that particular interventions may be of more, or less 
relevance to particular subgroups of patients and could “result in standardised care of little 
relevance to individuals” (Walsh K et al  2002).  Some existing process measures for stroke 
(e.g. the RCP NSSA markers) circumvent this problem through the inclusion of explicit 
criteria to allow patients to be allocated a ‘no but’ code. These codes are allocated to 
patients in whom an intervention is either not indicated (e.g. a patient with no speech or 
language deficit that does not require a SLT assessment) or contraindicated (e.g. patients 
receiving palliative care). Patients allocated ‘no but’ codes are removed from the 
denominator in RCP NSSA process scores. 
Other datasets, however, calculate percentage compliance with interventions using the 
whole population as the denominator, but build in ‘tolerances’ to account for patients in 
whom interventions are not indicated, or contraindicated. For example, the ASI metric that 
60% of patients admitted with stroke and in atrial fibrillation should be on anticoagulation, 
or have a plan for anticoagulation by discharge from hospital (Stroke Improvement 
Programme 2011). Here, patients in whom anticoagulation is contraindicated, or that 
refuse, are included in the 40% tolerance limit. This approach requires careful planning to 
ensure that the tolerances are reasonable and to reduce the risk of gaming, or 
inappropriate prescribing.   
The Stroke Unit Trialists’ (SUT) concluded that all patients benefit from stroke unit care 
(regardless of the severity of stroke) (Stroke Unit Trialists' Collaboration 2007) and that the 
improved outcomes observed in patients treated on a stroke unit vs. general wards is likely 
to be due to the prevention of post-stroke complications (Langhorne P et al  2002). 
However, there is likely to have been significant heterogeneity in the processes of care 
delivered on the units within the included trials as participants were randomised to 
organised stroke unit or other “conventional care” rather than to specific treatment 
protocols (Stroke Unit Trialists' Collaboration 2007). The SUT review could therefore be 
interpreted to suggest that the average care delivered on the stroke units included in the 
systematic review is beneficial to a population of heterogeneous post-stroke patients as 
compared with the average care that is delivered on conventional wards.  
b. The measurement of individual processes is equally important 
 There are likely to be some care processes that are more important than others in terms 
of the effect that their omission may have on patient outcomes (Sudlow C et al 2009). If 
care process is to be used to assess the quality of delivered care, especially if institutions 
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are to be compared on the basis of the delivery of these processes, weighting to account 
for this relative importance may be appropriate. For example, a unit that achieves delivery 
of complex care processes of benefit a few patients may do so to the detriment of delivery 
of care that is of potential benefit to all. A failure to apply weighting to metrics designed to 
reflect capture of care processes that are only indicated in small subgroups of a population 
may result in disproportionate emphasis on particular aspects of care. For this reason, the 
denominator (case-volume or the number of patients in whom a process is indicated) 
should form an important consideration of between or within institution comparisons of 
process delivery (see section 2.4). However, it has been argued that the denominator for 
the measurement of process should be the number of opportunities for a process to have 
occurred, rather than the number of patients in whom it is indicated (Lilford RJ et al  2004). 
This approach incorporates a form of case-mix adjustment for process measures as there is 
more scope for omission of processes of care that occur repeatedly (e.g. administration of 
aspirin), or in patients who require more interventions (e.g. those with severe strokes)  
(Lilford RJ et al  2004). 
Some stroke care processes (e.g. stroke unit care or antiplatelet therapy) have been shown 
to be of benefit to patients regardless of stroke severity (Chen Z-M et al  1997; Stroke Unit 
Trialists' Collaboration 2007), whilst the use of other interventions (for example 
thrombolysis) is restricted to those fulfilling specific criteria (Boehringer Ingelheim 2009; 
Intercollegiate Stroke Working Party 2008).  
The numbers needed to treat (NNT) to prevent an adverse outcome is greater for some 
processes of care than others. For example the NNT with aspirin to prevent one death or 
dependent outcome following an ischaemic stroke is 67, as compared with a NNT of 10 to 
avert the same outcomes following treatment with alteplase (rtPA) (Sudlow C et al  2009). 
However, the relatively small treatment effect of aspirin is offset by the treatment 
achievability and eligibility i.e. the administration of aspirin is a relatively simple task and 
should be achieved consistently and completely in all patients in whom it is not 
contraindicated (the proportion of the acute post stroke population in whom antiplatelet 
therapy is indicated is estimated at 80% (Langhorne P et al  2009). In contrast, an 
estimated 10% of patients admitted to hospital with acute stroke are eligible for 
thrombolytic therapy (Langhorne P et al  2009). Moreover, achievability of thrombolysis is 
currently limited by the considerable infrastructure required to deliver it safely (Sudlow C 
et al  2009) (5% of patients admitted to hospital with acute stroke in England, Wales and 
Northern Ireland received thrombolysis in the 2010 RCP NSSA (Intercollegiate Stroke 
Working Party 2011)) . Despite a relatively small NNT to prevent an adverse outcome 
following thrombolysis (large treatment effect), the number of adverse outcomes actually 
averted is attenuated by limited achievability and eligibility as compared with other 
treatments (Sudlow C et al  2009).  
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c. The process is important and missing it has a detrimental effect to individuals  
rather than the institution 
Some processes may be correlated with patient outcome, although the nature of this 
relationship may be complex (Rubin HR et al 2001). For example, it is difficult to see how 
the RCP NSSA process measure “Is there evidence that the patient was weighed at least 
once during their admission?” (Intercollegiate Stroke Working Party 2011) would relate 
directly to patient outcome. However, patients who are weighed may be more likely to 
also receive other aspects of care relating to nutrition that may have a more causal 
relationship with outcome; such processes have been termed ‘tracers’ (Walsh et al 2002). 
Weighing a patient may therefore be acting as a proxy marker for other aspects of care 
that may be more difficult to capture. Close examination of markers where there is 
correlation with outcome may reveal what these additional markers could be, although it 
may be difficult to estimate the effect of failing to achieve proxy measures of care on 
patient outcome if the underlying constructs are unmeasured and unknown.    
2.2.3 Quality and interpretability of data  
2.2.3.1 Gaming 
The use of process data for remuneration, performance ratings or for between institution 
comparisons runs the risk that the care is focused on the meeting of targets rather than 
reflecting the broader context of care that the process markers are designed to represent 
(Davies HTO 2005). There is a possibility that situations will be manipulated to allow such 
targets to be met (Mears et al  2010), indeed examples of gaming in the health service are 
well documented (Bevan G et al  2006). Pejorative comparison of institutions based on 
unadjusted process (or outcome) measures can therefore be potentially damaging both to 
those institutions and to the patients they treat:  
“Reward and punishment strategies do not produce knowledge; 
they produce fear and anxiety often leading to distortion of the data 
or the process” (Lilford RJ et al  2004)  
2.2.3.2 Representation of data 
The importance of data interpretation and presentation is highlighted here using the 
example of the first Royal College of Physicians SINAP report (2011). During the reporting 
period, participation in data collection for SINAP was not mandatory, indeed nationally 
only 82 out of 157 trusts submitted data, with nine of these trusts submitting insufficient 
data for analysis (Royal College of Physicians 2011). Seventy-three trusts were therefore 
included in the data analysis. The SINAP report presented the number and percentages of 
(eligible) patients receiving specific processes, ‘bundles’ of care (patients receiving 
combinations of processes) and an average process score as the unweighted mean of the 
percentages of eligible patients receiving each of 12 key processes.  
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There are a number of problems with this approach. Firstly, presentation of an unweighted 
score fails to account for the relative importance or difficulty of delivering individual 
processes of care – i.e. processes that are simple to achieve are given the same scoring 
weight as more complex processes. The use of total scores as a summary measure also has 
implications in terms of scaling properties (i.e. an assumption that a summary score may 
be treated as an interval scale may not be valid).  
Calculating a mean from  a series of percentages, as has occurred with the SINAP data, is a 
flawed approach, as the denominator (case volume) for each individual process has not 
been accounted for. Centres with small volumes of cases are more likely to demonstrate 
extreme values as variations in process delivery would have a disproportionately influential 
effect on their overall score (O'Brien S et al  2008). The denominator for each process 
marker can be calculated from the numerator and proportion of eligible patients as 
detailed in the SINAP data spreadsheet (available from the RCP SINAP website (Royal 
College of Physicians 2011)).  Notwithstanding the fundamental problems with calculating 
summed process scores (see above), the analyses performed by SINAP have been repeated 
here simply to demonstrate the effect of consideration for case volume on the relative 
position of patients in ‘league tables’. If the sum of patients at each site receiving all the 
processes of care for which they are eligible are presented as a proportion of the sum of 
patients eligible for each of the processes, 13 of the 73 trusts move up a quartile, 10 move 
down a quartile and one trust moves from the top (1st) to the third quartile of all the trust 
scores. These marked movements in the relative ‘position’ of trusts based purely on the 
volume of patients treated, without consideration of the problems encountered with 
summed total scores or more complex factors such as case-mix, are an indication of the 
potential difficulties in publishing data in the public domain. This is discussed further in 
section 2.4. 
2.3 Outcomes driven stroke care 
The distinction between outcome indicators and patient reported outcomes (as outlined in 
section 2.1.4.2) is an important one. Hard, objective endpoints (e.g. mortality following 
stroke) offer no information as regards the complexities of stroke recovery from the 
perspective of the individual, indeed prevention of mortality is not the only goal of 
therapy. Patient reported outcomes can offer information regarding aspects of patient 
outcome that cannot be measured through other means (Mant J 2001), but the question 
remains: how can or should this information be used at a population level?  
Comparison of institutions based on patient reported outcomes as subjective measures 
runs the risk that any between institution differences are attributed to the quality of 
delivered care. However, aside from arguments regarding the availability of more 
appropriate methods to detect deficiencies in the quality of care processes (2.1.5), 
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differences in patient reported outcome are dependent on the way in which individuals 
perceive their healthstate (Lilford RJ et al  2007).  Moreover, good outcome may occur 
despite failures in the delivery of care process and vice versa (Mant J 2001; Walsh K et al  
2002).  
2.3.1 What is outcomes measurement good for? 
Subjective outcomes assessment by patients offers some benefits that cannot be achieved 
through the isolated measurement of care processes: 
a. Useful information at individual level  
Outcomes measurement is arguably of more importance and relevance to individuals than 
individual aspects of care process. When considered at an individual level, patient reported 
outcomes offer a valuable resource. Interventions may be tailored to specific needs to 
inform care at an individual patient level i.e. to facilitate discussions regarding targeted 
longer-term treatments or therapy goals for individuals. Cumulatively, this information 
could help to inform the identification of gaps in local service delivery. Outcomes 
measurement may therefore be useful as part of a feedback loop to plan ongoing care, 
rather than as a method of evaluating the care that has already been delivered.  
A broad overview of delivered healthcare at a population level   
“…every hospital should follow every patient it treats long enough 
to determine whether or not the treatment has been successful, and 
then should inquire, “If not, why not?” with a view to preventing 
similar failure in the future” 
Ernest Codman (1869-1940) 
The measurement of outcomes measurement can provide a ‘broad barometer’ of 
delivered care (Lilford RJ et al  2007; Mant J 2001) – i.e. the cumulative effects of complex 
interventions, service structure and individual characteristics. Identification of substantial 
outliers, i.e. where there is deviation beyond that expected through ‘normal variation’ 
following case-mix adjustment could allow identification of institutions where outcomes 
are particularly good, or less good than expected (Lilford RJ et al  2004; Mohammed MA 
2001). Examination of these institutions may reveal areas for further exploration, or 
systematic differences may lead to generation of hypotheses regarding ‘what might work’ 
(Lilford RJ et al  2007). Identification of such outliers is likely to be best achieved through 
funnel plots and this approach is discussed in detail in 2.4.1.  
2.3.2 Drawbacks of outcomes measurement 
Aside the problems in linking care process with outcome (2.1.5), there are a number of 
technical and logistical difficulties in the routine collection of patient reported outcomes.  
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One of the major considerations in terms of outcomes measurement is which instrument 
should be used. Outcomes such as mortality or length of stay data are more readily 
available and may already be routinely recorded in existing systems. However, these offer 
no information regarding post stroke function in stroke survivors, and are not useful to 
inform individual patient care. The alternative is the collection of patient reported 
outcomes. There are a number of stroke specific and generic questionnaires to assess 
various domains of patient functioning following stroke. Any measurement scale for this 
purpose should be valid and reliable in stroke populations and should ideally have had 
these psychometric properties tested in a number of different datasets. Previous reviews 
(Jenkinson C et al 2009; Teale EA et al  2010) and online resources (Salter K et al 2010) aim 
to identify the optimal outcomes instrument for stroke, but consensus is lacking.  
Routine collection of patient reported outcomes requires considerable infrastructure. 
Collection of outcomes data face to face is unlikely to be feasible in routine care due to 
resource costs and time restraints. Existing infrastructure could be exploited (e.g. clinic 
attendance, or the community stroke team) in order to collect outcomes information, 
although these assessments are unlikely to be sufficiently standardised to ensure robust 
data collection. Postal questionnaires are an alternative, but introduce problems with 
return and completion rates, proxy completion and stroke specific problems such as the 
impact of dysphasia on the questionnaire completion. Postal questionnaires also need to 
be triggered at an appropriate time, following checks of residency and survival. All patient-
completed questionnaires (unless completed and submitted electronically) will require 
some form of data entry resource.  
2.4 Problems with presentation of data in the public domain  
Process and outcomes data are readily available in the public domain, including patient 
reported outcome data (The Information Centre 2011c), satisfaction ratings (Ipsos MORI 
2011) and league tables (Dr Foster 2010) for a variety of conditions including stroke (Dr 
Foster 2010; Intercollegiate Stroke Working Party 2011; Royal College of Physicians 2011). 
Often the data presented are standardised or adjusted for case-mix variables, but these 
are often those that are available from existing resources such as the Hospital Episode 
Statistics database (HES) (e.g. Dr Foster 2010). Data may therefore have been adjusted by 
the case-mix variables that are available, rather than those that have been validated 
through research or that make the most clinical sense.  
Appropriate interpretation of complex activity or outcomes data by the public, clinicians 
and commissioners is dependent on the way in which these data are presented (Davies 
HTO 2005). As patient choice becomes more prevalent and increasingly likely to drive 
commissioning decisions (Department of Health 2010a), the interpretation of data that 
may be used to inform decision making is key. It is unclear how well the public are able to 
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interpret these complex data (Scott IA et al  2006). However, the presentation of data that 
are flawed or difficult to interpret is likely to be damaging to individual provider trusts both 
financially and in terms of reputation (Davies HTO et al  1997; Lilford RJ et al  2004).  
2.4.1 Common cause versus special cause variation 
Mohammed et al explored the potential use of Shewhart charts (or statistical process 
control charts) to identify common cause (expected random) variation in outcome from 
special cause variation (due to an external influence on an otherwise stable process) 
(Mohammed MA 2001). A funnel plot presents similar information, but takes account of 
case volume. The funnel plot represents interval level data, and can be used for normally 
distributed data, proportions (based on a binomial distribution) or count data (based on a 
Poisson distribution). For example, observed cases as a proportion of potentially eligible 
cases could be plotted against the potentially eligible cases to account for differences in 
sample size (Speigelhalter DJ 2005; Speigelhalter D 2002).  
Providing that the markers approximate the appropriate distribution, funnel plots may be 
used to present either deviations from process or special cause variation in objective or 
patient reported outcomes either between institutions (Gale CP et al  2006) or within 
institutions over time (Henderson GR et al  2008). Special cause variations (greater than 3 
standard deviations from the mean or a chance probability of 1 in 500 (0.2%)) are highly 
unlikely to be due to chance and could be examined further for external causes or 
influences (Mohammed MA 2001; Speigelhalter DJ 2005). Special cause variation could 
indicate an important case-mix variable or confounder that has not been accounted for but 
that is particularly important at an individual site or at a particular time (e.g. temporary 
loss of scanning resource due to a broken scanner). Examination of the data in this way 
allows rational interpretation and may lead further exploration or investigation as 
required.  
Figure 3 uses data extracted from the 2011 RCP SINAP data spreadsheet (Royal College of 
Physicians 2011) to  highlight that similarly, funnel plots may be a more useful way to 
present complex stroke  data than the summed averages of percentage process scores that 
have been presented on the SINAP website (Royal College of Physicians 2011) (see also 
section 2.2.3.2). The proportion of patients receiving the processes that they require 
across trusts and the sum of the patients in whom these processes are indicated were 
calculated as discussed in section 2.2.3.2. The sample sizes from which these proportions 
have been calculated are large enough for the binomial distribution of the proportions to 
approximate a normal distribution (according to the central limit theorem).These data 
were therefore used to create a funnel plot (Figure 3). A number of hospitals are outwith 
the 3SD limits and therefore show ‘special cause variation’ from the average proportion 
(across all trusts) of patients in whom required processes are achieved. Trusts within the 
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outer limits are within “common cause” variation – i.e. their deviation from the mean is 
within the bounds of chance variation. There are benefits to examining both high and low 
outliers – to learn lessons from those that perform well and to explore further those that 
appear to perform less well. There are a number of possible reasons for the apparent 
differences between sites e.g. differences in measurement or data recording or case-mix 
that should be explored before the disparity is attributed to a true failure to achieve the 
process markers (Lilford RJ et al  2004).  
In 2011, The Information Centre moved towards the presentation of PROMs data in the 
form of funnel plots as they are “…relatively easy to produce, readily interpretable and 
allow for additional variability in institutions with small volumes.” (Department of Health 
2011b) 
Figure 3 Funnel plot to present total process scores from SINAP 2011 audit as a 
function of case volume 
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2.5 Conclusions 
Both process and outcomes driven approaches to the measurement of the complex and 
multifaceted construct of quality in healthcare have been advocated. In order for such 
measurements to be meaningful it is important to be mindful of the purposes of the data 
collection. It is unlikely that exclusive measurement of process, objective outcomes 
indicators or patient reported outcome measures will capture all aspects of patient care.  
Process monitoring is useful for detecting deviations from agreed protocols and best 
practice, although the effect of these deviations may not be detectable through the 
measurement of outcome. Monitoring of processes of care may also lead to a data driven 
approach to care provision that may fail to meet the needs of individual patients. 
Measurement of patient reported outcomes offers a unique insight into broader aspects of 
care, and may identify areas of service deficiency and need at an individual and population 
level.  
The complexity of the relationships between process, outcome and case-mix make 
interpretation of routine data problematic. Monitoring of quality through process 
measurement requires knowledge that the process (or omission of the process) has an 
effect on patient outcome, whilst routine measurement of patient outcomes would be 
enhanced through knowledge of whether processes of care are affecting outcome such 
that they may be monitored and improved. Both approaches are therefore dependent on 
the demonstration of robust adjusted process outcome linkages.  Case-mix adjustment is 
key to the exploration of these linkages and this will be discussed in more detail in Chapter 
3.  
It is likely that a combined approach to the measurement of stroke care that encompasses 
aspects of care process and patient reported outcome will give the most useful perspective 
of the stroke care pathway of interest to commissioners, service providers, clinicians, 
patients, and researchers. Routine capture of a dataset that includes these key aspects of 
care could also allow further exploration of the complexities of case-mix adjustment in 
stroke care.  
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Chapter 3 Systematic review case-mix adjustment model(s) 
in stroke 
3.1 Introduction 
Stroke is a heterogeneous and complex clinical syndrome. The clinical course and outcomes 
for individual patients following stroke are dependent not only on the site and/or size of 
the pathological lesion, but on the context of the injury in relation to combinations of 
mediating factors that are unique to individuals. For example, pre-stroke function, co-
morbidities, social environment and rehabilitation potential are all likely to affect an 
individual’s functional, cognitive and social outcomes. It is the combination of these 
complex factors that contribute to case-mix and make direct comparisons between 
individuals or empirical populations following stroke problematic and unreliable. It is, 
therefore, over simplistic and potentially misleading to consider the effect of treatments 
and therapies on patient outcome following stroke without considering the mediating 
effects of these other factors (see Chapter 2, section 2.1.6).  
Randomisation in clinical trials aims to balance the unmeasured confounders and biases 
between intervention and control groups. As such, in adequately randomised stroke trials, 
outcomes in two (or more) populations may be legitimately compared. Nevertheless, 
through the role of chance in random allocation, differences in important prognostic 
factors may remain between groups (Altman D 1985) and differences in outcome may 
reflect these imbalances rather than the true effect of the intervention.  For recognised and 
measurable risk factors, effects may be tempered by minimisation procedures (active 
balancing of patients with certain characteristics between intervention and control arms). 
Biases introduced by more immeasurable confounders may be attenuated by stratification 
according to predicted outcome prior to randomisation. 
In routine care and in unadjusted observational studies, the possible contributions of 
mediating factors are not accounted for and their effect on outcomes remains unmeasured 
and unknown. Inadequate (or absent) case-mix adjustment may therefore preclude 
meaningful examination of the relationships between care process and outcomes in 
observational studies (Mant J 2001) (see also section 2.1.6). Through prognostic modelling, 
case-mix adjustment of empirical post-stroke populations allows stratification into more 
homogenous groups according to predicted outcomes. Within such strata, observed 
outcomes between groups of individuals may be directly compared more legitimately. The 
influence of specific prognostic factors on patient outcome may be non-uniform across the 
spectrum of stroke severity (i.e. some factors are more or less important in certain 
subgroups of patients) (Lilford RJ et al  2007). In observational studies, adjustment for 
these factors can result in the ‘constant risk fallacy’ – a paradoxical increase in bias 
between groups (Nicholl 2007). 
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Stratification of populations according to predicted outcomes therefore has uses in both 
clinical care (e.g. targeting of appropriate therapies) and research (e.g. in examination of 
non-randomised populations or for stratified randomisation) (Counsell C et al  2001). 
However, such analyses must still be interpreted with caution as important differences and 
a degree of heterogeneity are likely to remain within strata even following case-mix 
adjustment (Mant J 2001).  
3.2 Assessment of prognostic models 
 There are no universally accepted criteria to assess the quality of prognostic studies 
(Altman D 2001; Hemingway H et al  2010; Mallett S et al  2010b). However, there is both 
generic and disease specific literature that has identified key clinical and statistical criteria 
that should be considered in model development or assessment (Altman D 2001; Counsell 
C et al  2001; Harrell FE et al  1996; Hayden JA. et al  2006; Kwakkel et al  1996; Laupacis A 
et al  1997; Mallett S et al  2010b; Mallett S et al  2010a; Perel P et al  2006; Wyatt JC 1995).  
This broadly concerns consideration of model internal, external and statistical validities.  
A “systematic review of reviews” published by Hayden et al in 2006 considered the quality 
of reviews to identify clinical prediction models across a range conditions (Hayden JA. et al  
2006). This review suggests a “framework of potential biases” that should be considered in 
the assessment of the quality of studies to develop prognostic models. This framework 
largely considers internal validity of models across the broad categories of 
representativeness of the study population, attrition (and consideration of whether loss-to 
follow up could be systematic), inclusion and accurate measurement of appropriate 
prognostic information, accurate definition and measurement of valid and reliable 
outcomes, consideration of confounding and the use of appropriate modelling techniques. 
Within each of these categories a number of criteria are specified to aid consideration of 
whether or not the study to develop the model is adequate (Hayden JA. et al  2006). 
However, this framework does not address key issues relating to the models that have 
been developed, for example external validity or feasibility of prognostic models in terms 
of their clinical utility and ease of data collection.  
Several authors have provided detailed discussion regarding the development of robust 
models (Harrell FE et al  1996; Mallett S et al  2010a; Wyatt JC 1995). There are several 
factors that should be taken into account during model development and failure to do so 
may affect the stability and utility of models. This includes consideration of sample size and 
the number of variables that may be entered into the model, prospective data collection, 
representativeness of population samples, coding of variables (and proper classification of 
continuous variables) and variable selection. 
In a 2001 review, Counsell et al tabulate 25 separate criteria for assessing the quality of 
studies to develop prognostic models in stroke. The broad categories of internal, external 
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and statistical validities, model evaluation, and feasibility are considered. These criteria 
incorporate many of the methodological quality markers identified in other studies 
(Counsell C et al  2001).  
Previous reviews have been undertaken to identify prognostic models specifically in stroke 
(Counsell C et al  2001; Hier HB et al  1991; Jongbloed L 1986; Kwakkel G et al  1996; Meijer 
et al  2003a; Meijer et al  2003b; Meijer et al  2004; Segal M et al  1997) and show these 
models to be generally poor. One of these reviews identified studies describing models to 
predict stroke survival, survival in an independent state or alive and at home (Counsell C et 
al  2001). The vast majority of the 83 discrete prognostic models identified demonstrated 
significant flaws in statistical or internal validities. Only four met 8 simple quality criteria of 
internal and statistical validity defined by the authors, and none was fit for purpose to case-
mix adjust in routine clinical care (Counsell C et al  2001). Other authors have attempted to 
identify case-mix adjustment models which were developed to predict functional outcomes 
following stroke (Jongbloed L 1986; Kwakkel G et al  1996). However, these have tended to 
be limited to prediction of activities of daily living; most commonly the Barthel Index which 
has limitations due to its marked, and well documented, ceiling effects (Salter K et al 2010). 
Since these reviews were performed, clear evidence demonstrating the benefits of 
organised specialist multidisciplinary stroke care over general ward care (Stroke Unit 
Trialists' Collaboration 2007) has led to the widespread adoption of this model and 
fundamental changes to the delivery and monitoring of stroke care across health care 
systems (American Stroke Association's Task Force on the Development of Stroke Systems 
2005; Lindsay MP et al 2010; Thomassen L et al 2006). It is possible that prognostic factors 
previously unknown or overlooked are important in determining patient outcomes and 
these should be modelled explicitly.  In addition, increasing scrutiny of the quality of 
prognostic research (Altman D 2001; Hayden JA. et al  2006; Hemingway H et al  2010) and 
more sophisticated statistical modelling techniques (e.g. multilevel modelling, latent 
variable analysis and structural equation modelling) are likely to have altered the type and 
quality of models to predict outcomes following stroke.  
A systematic review of the literature was therefore undertaken in order to update previous 
reviews (in light of the above factors) and identify any externally validated prognostic 
model to predict outcome in unselected populations following acute stroke comprising 
simple clinical variables feasible for collection in routine care.  
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3.3 Methods 
3.3.1 Review team 
To minimise bias and in accordance with suggested guidelines (Altman D 2001; Centre for 
Reviews and Dissemination 2009), this review was designed and conducted by a team with 
a variety of skills led and co-ordinated by Elizabeth Teale (ET). The search strategy was 
developed in collaboration with a colleague at Leeds University Library (Deidre Andre (DA), 
Research Support Officer). Development and definition of inclusion criteria was undertaken 
by ET. Screening of titles was performed by Anita Ranjendran (AR, Medical Student 
University of Leeds Medical School) and Anne Forster (AF, Professor of Stroke 
Rehabilitation, University of Leeds). Subsequent screening of titles for which consensus had 
not been met was performed by ET. Review of abstracts and selection of studies for 
inclusion was performed by AF and ET. Double data extraction was performed by Ruth 
Lambley (RL, Research Assistant, Academic Unit of Elderly Care and Rehabilitation) and ET. 
Statistical appraisal of identified models was performed by Theresa Munyombwe (TM, 
Medical Statistician, University of Leeds) and ET.  Consolidation and synthesis of findings 
was performed by ET. 
3.3.2 Information sources 
A comprehensive search strategy was developed with a colleague at Leeds University 
Medical Library (DA) combining terms to identify stroke studies (as developed by the 
Cochrane Stroke Group (Cochrane Database of Systematic Reviews Stroke Review Group 
2009) with terms to describe prognostic modelling. The full search strategy is included in 
Appendix A-1 Searches were run in MEDLINE, EMBASE, CINAHL, PsycInfo, AMED and ISI 
Web of Science with no date or language limits until 30th May 2009. Results were 
downloaded into EndNote™ (version X2.0.1) and duplicates removed.  
3.3.3 Study selection 
Titles were examined by two independent reviewers (AR and AF) and obviously irrelevant 
titles excluded. A third reviewer (ET) examined titles where there was no agreement to 
ensure all relevant titles were included. Abstracts of potentially relevant papers where 
there was agreement between at least two of the three reviewers were then further 
examined by two reviewers (AF and ET). Papers fulfilling inclusion criteria were retrieved in 
full text.  
Studies were included if they described development or external validation of a discernible 
prognostic model at a fixed time point following ischaemic or haemorrhagic stroke. Studies 
referring to ‘adjustment for baseline variables’ were excluded unless the method of 
adjustment was further qualified.  
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Only studies describing models with variables considered to be feasible for collection in a 
routine care setting, by ward staff and within two weeks of stroke were included. 
Prognostic models that required specific radiological or laboratory test results were 
excluded as the aim is to identify a case-mix adjustment model comprising variables that 
may be collected at the bedside.  
For the purposes of this review, an assumption was made that not all services are currently 
set up to facilitate data collection requiring specialist assessment on, or within a few hours 
of, admission to hospital. Models that require collection or measurement of case-mix 
variables requiring a level of expertise above that expected on a typical medical assessment 
unit by non-specialist stroke clinicians (for example the National Institute of Health Stroke 
Score (NIHSS)) were therefore excluded.  
Similarly, models requiring the collection of case-mix variables within six hours of 
presentation were excluded as patients not admitted directly to a stroke unit (or those 
transferred to a stroke unit from the Emergency Department within four hours) are unlikely 
to have case-mix variables collected reliably within this time frame. The rates of direct 
admission to specialist stroke units are improving in England, Wales and Northern Ireland. 
The proportion of patients admitted directly to an acute stroke unit increased from 29% to 
56% between the 2008 and 2010 RCP clinical audits (Intercollegiate Stroke Working Party 
2011; Royal College of Physicians 2009b). A continuation in this trend is likely to occur with 
the expansion of thrombolysis services with initial assessments increasingly likely to be 
made by more senior and specialist stroke clinicians. This may, in the future, facilitate the 
collection of more complex baseline data at the point of admission (e.g. complex clinical 
prognostic scoring systems) and shorten the time frames within which collection is feasible. 
Previous reviews have either limited their searches to identify models predicting functional 
outcomes (Kwakkel G et al  1996) or have limited the scope of their review to consider the 
outcomes of death and dependency (as defined by a dichotomised modified Rankin 
Score)(Counsell C et al  2001). We aimed to identify all available prognostic models to 
predict any post stroke outcome (including mortality, disability and functional outcomes).   
Models developed in populations unlikely to be representative of the wider stroke 
population (e.g. exclusion of the oldest old, or patients at the extremes of stroke severity) 
were excluded as models developed in such populations are unlikely to be generalisable to 
unselected stroke populations. Similarly, prognostic factors for stroke are likely to differ 
from those of transient ischaemic attack (TIA) and subarachnoid haemorrhage (SAH). 
Models developed to predict outcome following TIA or SAH were therefore excluded.  
External validation refers to the testing of models in populations independent to those in 
which the model was developed. Ideally, this should occur in an unselected population in a 
different institution from that in which the model was developed. Models without evidence 
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of external validation were excluded from this review. Where it was not clear whether a 
model had been externally validated, the paper was retained for further scrutiny.  
A flow chart of inclusion and exclusion criteria is presented in Figure 4. 
Figure 4  Citation screening inclusion and exclusion criteria 
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3.3.4 Data extraction  
Data extraction was performed in duplicate by ET and a fourth independent reviewer (RL).  
Details regarding the name of the case-mix model, author, model variables, reference 
population (inception cohort and study exclusion criteria), prospective or retrospective 
data collection, losses to follow up, outcome measures (and time point of measurement), 
sample size, external validation of model and feasibility of collection of independent 
variables were extracted if available. Studies describing the development of models and 
subsequent validation studies were then grouped together.  
3.3.5 Data items 
Initially, criteria to assess the quality of each model were applied. These were extracted 
from a framework of criteria used to assess internal validity of models (Hayden JA. et al  
2006) and a broader set of criteria to examine quality of models as used by Counsell et al in 
their 2001 review (Counsell C et al  2001). The criteria used at this stage in the review were 
selected to cover the aspects of model quality considered to be essential: adequate 
inception cohort, prospective data collection, a description of patients lost to follow up 
(and no systematic exclusion or drop out of particular patient subgroups), clinical relevance 
of prognostic factors, assessment of valid and reliable outcomes at a fixed time point, no 
inclusion or exclusion criteria that might limit generalisability, and variables that are 
feasible to collect in routine care.  
Independent statistical appraisal of the model development was then performed by TM to 
assess aspects of statistical quality as regards model fitting. This included consideration of 
sample size, variable selection techniques, consideration of collinearity and interaction 
terms (Harrell FE et al  1996). Regression models require a linear relationship between the 
independent and dependent variables, and normally distributed model residuals with 
constant variance (the difference in observed and predicted outcome for each case) (Fox J 
1997p 113). These assumptions should have been checked explicitly to demonstrate that 
that the models are statistically robust. Information regarding any testing of modelling 
assumptions was therefore also extracted. 
3.3.6 Model performance 
Measures of model performance were extracted from external validation studies for each 
model. These comprise measures of discriminatory function (e.g. the c statistic) 
sensitivity/specificity analysis and calibration of models in independent populations 
(Altman D et al  2000; Altman D et al  2009). 
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3.4 Results 
After the removal of duplicates, the initial search identified 19,867 titles. Screening of titles 
(to exclude obviously irrelevant citations) and abstracts (based on inclusion and exclusion 
criteria (Figure 4) led to two independent reviewers agreeing to the retention of 176 
citations. In 487 further citations where consensus between these two reviewers was not 
met, the opinion of a further independent reviewer (ET) resulted in the inclusion of an 
additional 183 potentially relevant citations. A discussion (based on abstracts) between AF 
and ET regarding relevance for inclusion in the review of the 359 identified papers resulted 
in the retention of 119 papers for examination in full text. Handsearching of the reference 
lists of these papers (ET) identified a further 15 potentially relevant citations. A total of 43 
of the papers were retained for data extraction. In addition, five previous reviews were 
examined to identify any models that may otherwise have been overlooked. A flow-
diagram of the selection process can be found in Figure 5. 
Figure 5 Identification of citations for inclusion in the review (Teale et al 2012) 
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Twenty-one case-mix or prognostic models predicting a range of outcomes were described 
in 43 papers (Table 1). In addition, two studies described the use of 3 existing impairment 
scales to predict patient outcome post-stroke (Lai et al  1998; Muir KW. et al  1996). Of 
these 3 models, only one was used in isolation to predict outcomes whilst the other two 
were incorporated into existing models, such that their independent performance was not 
discernible. Following data extraction, therefore, these two models, the Canadian 
Neurological Score and the Middle Cerebral Artery Neurological Score (MCANS or Orgogozo 
score) were not considered further. Of the remaining 22 models, one was developed to 
predict outcome following intracerebral haemorrhage and was retained (Weimar et al  
2006). Examination of previous reviews did not identify any additional externally validated 
models comprising variables that were feasible for collection in routine care.  
 Prognostic models identified through review (Teale et al 2012) Table 1
 Model Citation 
Anderson (Anderson et al  1994) 
Belfast (Fullerton KJ et al  1988) 
Bristol (Wade DT et al  1983) 
Edinburgh (Prescott et al  1982) 
G score (Gompertz et al  1994) 
Guys (Allen CMC 1984) 
Johnston (Johnston et al  2000) 
Lincoln (Lincoln et al  1990) 
Masiero (Masiero et al  2007) 
Modified National Institute of Health Stroke Scale (mNIHSS) (Lyden et al  2001) 
Shortened National Institute of Health Stroke Scale (NIHSS_8) (Tirschwell et al  2002) 
National Institute of Health Stroke Scale + age (NIHSS+age) (Weimar et al  2004) 
Orpington (Kalra et al  1993) 
Six Simple Variables (SSV) (Counsell C et al  2002) 
Tilling (Tilling et al  2001a) 
Uppsala (Frithz G et al  1976) 
Wang (Wang et al  2003) 
Weimar (Weimar et al  2002) 
Weimar intracerebral haemorrhage model (Weimar_ICH) (Weimar C et al  2006) 
Williams (Williams et al  2000) 
Young (Young et al  2001) 
Existing prognostic models Citation 
Canadian Neurological Scale (CNS) (Muir KW. et al  1996) 
Middle Cerebral Artery Neurological Score (Orgogozo score) (Muir KW. et al  1996) 
National Institute of Health Stroke Scale (NIHSS) 
(Lai SM et al  1998; Muir KW. et 
al  1996) 
Four models (Anderson CS et al  1994; Masiero S et al  2007; Wang Y et al  2003; Williams G 
et al  2000) were validated using a ‘split-sample’ technique. Here, the model is developed 
in a training set (a subgroup of the study population) and validated in the remaining study 
population. This represents a form of internal (not external) validation and should not be 
considered to represent evidence that the models perform adequately in independent 
populations (Altman D et al  2009). These models were not considered further. The G score 
is unusual in the identified models in that it is identical to the Guys score, but the model 
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beta co-efficients have been simplified to create a new model (Gompertz P et al  1994). The 
G score is therefore a modification of the Guys score rather than a model developed de 
novo and no further validation studies were identified. The Guys model has however been 
externally validated and as such, the G score was retained for further discussion. 
Where included studies described the external validation of models, the papers describing 
model development were also retrieved (if these did not feature in the output from the 
original searches). Data extraction was therefore performed from papers describing 
seventeen prognostic models. Data extraction tables are included in appendix 7.2A-2. 
Studies describing model development are grouped with subsequent validation studies. 
Table 2 offers a summary of the studies describing model development.   
3.5 Discussion 
Results are discussed according to each criterion on which the models were assessed. 
Models fulfilling criteria are then discussed further in terms of their statistical properties 
and performance. A brief overview of the modelling assumptions and statistical criteria 
against which the models were assessed is offered in section 3.5.6. Assessment of 
individual models against the initial criteria and subsequent assessment of statistical 
methods used in model development are summarised in Table 4 and Table 6. Complete 
data extraction tables are presented in appendix A-2. 
3.5.1 Inception cohort 
An inception cohort is a group of patients at the same point in the disease process – in the 
context of stroke an inception cohort is taken to mean a group of patients assessed or 
recruited into a study within (and preferably at) a specific time-period following their 
stroke (Altman D 2001; Counsell C et al  2001).  
Four of the models identified in this review (Bristol, Edinburgh, Lincoln and Young) 
described cohorts assessed at greater than two weeks following the stroke event and were 
not considered further (Lincoln et al,  1990; Prescott RJ et al  1982; Wade DT et al  1983; 
Young J et al  2001). Measurement of variables for development of the Edinburgh model 
was at four weeks following acute stroke and this is likely to limit the utility of this model in 
the acute stroke setting (Prescott RJ et al  1982). The Orpington score is an adaptation of 
the Edinburgh score to include an assessment of cognition (Kalra L et al  1994; Kalra L et al  
1993). Unlike the Edinburgh model, the Orpington score was developed on an adequate 
inception cohort and is therefore retained.  
The models developed by Young et al (Young J et al  2001) and Lincoln et al (Lincoln et al,  
1990) were developed using variables collected on admission to (or discharge from) a 
rehabilitation facility and therefore the inception cohort (time from  stroke to assessment) 
was not uniform. The SSV model was developed using retrospective data (collected 
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prospectively) from the OCSP cohort (Bamford J et al  1988; Counsell C et al  2002). 
Although in the original OCSP cohort about three quarters of assessments were performed 
within two weeks of the stroke event (median time to assessment 4 days) (Bamford J et al  
1988), the SSV model was developed using data on the 86% of assessments performed up 
to 30 days following stroke(Counsell C et al  2002). This model was, however, retained as 
the proportion of assessments performed after 14 days was small. 
Further discussion of models is restricted to the 13 models that are externally validated and 
developed on an adequate inception cohort. The NIHSS is also included for further 
discussion as a prognostic model as its use has been described as a predictor of outcome in 
studies identified through this review (Counsell C et al  2002; Lai SM et al  1998; Muir KW. 
et al  1996).  
3.5.2 Sources of data for model development 
Models should ideally be developed from prospective data – i.e. data that are collected 
according to a protocol with the express purpose of developing the model (Wyatt JC 1995). 
The convenience of data extracted from retrospective databases, may be offset by 
limitations in the data that are available, or its quality (Wyatt JC 1995). There were three 
main identified sources of data used for model development and validation in this review: 
prospective data collection for the purposes of model development, retrospective use of 
data collected within stroke registers, and the secondary use of data from previously 
conducted randomised controlled trials.  Five of the remaining 13 models identified during 
this review were developed through studies where the primary purpose of the research 
was to develop the model (Belfast, G score, Guys, Orpington, Weimar_ICH) (Allen CMC 
1984; Fullerton KJ et al  1988; Gompertz P et al  1994; Kalra L et al  1993; Weimar C et al  
2006). These tended to be small studies (sample size 96-361, median 206).  
The secondary use of retrospective data may introduce bias either due to inclusion and 
exclusion criteria of clinical trials, or to non-standardised methods of collection and 
definitions of prognostic variables (such as may be seen in the extraction of data from 
existing databases) (Wyatt JC 1995). Ideally, the external validation of models in 
independent datasets should also use data that is prospectively collected (to prevent any 
bias that could be introduced if prognostic information is recorded when the outcome is 
known) (Wyatt JC 1995). Models developed from retrospective data where cases are 
selected and extracted on the basis of concordance with inclusion criteria and complete 
outcomes data are particularly prone to selection bias as there may be systematic reasons 
why outcomes data are missing in certain patient groups. The reasons why certain types of 
patients might be lost to follow-up and their baseline characteristics should be examined 
and compared to cases with complete data to ensure that there is no systematic bias 
(Hayden JA. et al  2006). 
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Three models were developed using data extracted from stroke registries or prospective 
cohorts. These were the Weimar (ischaemic stroke) model (Weimar C et al  2002), the 
NIHSS+age (Weimar C et al  2004) and the SSV models (Counsell C et al  2002). Of these, 
two models were developed from prospectively collected data extracted from the German 
Stroke Database (Weimar and NIHSS+age) (Weimar C et al  2002; Weimar C et al  2004). 
Although only patients fulfilling inclusion criteria and with complete data were selected, 
baseline characteristics of patients with complete and incomplete outcomes data were 
compared during the development of two of the models and no statistically significant 
differences found (Weimar C et al  2002; Weimar C et al  2004).  
The Six Simple Variable model (SSV) (Counsell C et al  2002) was developed retrospectively 
using prospectively collected data from a community cohort of stroke patients of whom 
about half were never admitted to hospital (Bamford J et al  1988). Patients excluded from 
model development included those who died before assessment or who were not assessed 
by a study neurologist within 30 days of the stroke event. Outcomes data for the remaining 
530 patients was complete. The SSV model has, however, been subsequently externally 
validated using prospective data (Dennis et al  2006; Lewis S et al  2007; Reid J et al  2007), 
with collection of variables within a week of the stroke event. One further model (Uppsala) 
was developed using data extracted retrospectively from patient case-notes (Frithz G et al  
1976). 
Four models identified used data from previously conducted RCTs (Johnston, mNIHSS, 
NIHSS_8, Tilling) (Johnston KC et al  2000; Lyden PD et al  2001; Tilling K et al  2001a; 
Tirschwell DL et al  2002). RCTs performed on an intention to treat basis may ascribe the 
last available score, or worst outcome to patients lost to follow up or unable to complete 
assessments (Tirschwell DL et al  2002). Secondary use of data (from RCTs, databases or 
previously conduced cohort studies) means that patients with incomplete data (or those 
lost to follow up) may be excluded (Johnston KC et al  2000; Johnston et al  2003) with the 
risk of systematic bias. Moreover, inclusion or exclusion criteria of RCTs (e.g. exclusion of 
patients unable to transfer from bed to chair (Tilling K et al  2001a) or exclusion of patients 
with contraindications to thrombolysis (Tirschwell DL et al  2002)) may affect the ability of 
models developed from trial data to predict outcomes in the groups that were excluded 
from the training dataset. If validation studies were also performed in selected populations, 
the performance of models in empirical populations may remain untested and uncertain. 
Of four model development studies making secondary use of RCT data, only one (Johnston 
KC et al  2000) reported the number of patients excluded through incomplete outcomes 
data and none compared the characteristics of patients excluded through missing data with 
the study population (Table 2). 
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 Summary of studies describing construction of models identified in the review (Teale et al 2012) Table 2
 Reference Sample 
size 
Data 
source 
Adequate 
inception 
cohort 
Less than 
10% loss to 
follow up 
No systematic 
difference in 
patients lost to 
follow up? 
Valid 
outcome 
measured 
at fixed 
time point 
Modelling 
methods 
Adequate 
EPV 
Linearity 
assumptions 
tested and 
met 
Control for 
collinearity 
Belfast Fullerton (1988)  206 P + +  - CDA 0 - - 
Bristol Wade (1983)  162 P - - + + LinR + 0 + 
Edinburgh Prescott (1982)  155 T - +  - LinR - - - 
G score Gompertz (1994)  361 P + - 0 + N/A + 0 0 
Guys Allen (1984)  148 P + + 0 - S LR - - + 
Johnston Johnston (2000)  256 T + - 0 + LR + + - 
Lincoln Lincoln (1990)  70 P - - 0 - S LR - - + 
mNIHSS Lyden (1999)  291 T + 0 0 + FA NA NA NA 
NIHSS_8 Tirschwell (2002)  233 T + 0 0 + S LR - - + 
NIHSS+age Weimar (2004)  1079 D + +  + S LR + + + 
Orpington Kalra (1993)  96 P + +  + LinR + - - 
SSV Counsell (2002)  530 D + +  + S LR + + + 
Tilling Tilling (2001a)  299 T + 0 0 + MM + + 0 
Uppsala Frithz (1976)  344 CN + +  + LR + 0 + 
Weimar Weimar (2002)  1754 D + +  + S LR + + + 
Weimar_ICH Weimar (2006)  260 P + - + + S LR + 0 + 
Young Young (2001)  207 T - +  + S LR - + + 
P = Prospective data collection, T = retrospective use of RCT data, D = Data extracted from database or cohort study, 
CN= data extracted from case notes 
(S) LR = (stepwise) logistic regression, LinR = linear regression, MM = multilevel modelling FA =factor analysis CDA Canonical Discriminant Analysis 
+ = condition met, - = condition not met, 0 = unclear from study reports 
Highlighted studies were not developed on an adequate inception cohort and are not considered further 
- 45 - 
 
In developing the NIHSS_8, Tirschwell et al extracted 223 cases with complete prognostic 
variable data from the placebo arms of three RCTs (239 patients randomised to placebo in 
these trials) (Tirschwell DL et al  2002).Two of these trials were analysed on an intention-to-
treat basis with ‘last observation carried forward’ for patients who died (combined rate 
27/191) or who were not followed-up (combined rate 8/191 patients). It is not clear if the 
patients who died but were ascribed the last available functional outcome score from these 
trials were coded as deaths during development of the shortened NIHSS models (Tirschwell 
DL et al  2002).  
Johnson et al extracted data from both placebo and intervention arms of a therapeutic trial 
where no overall treatment effect was demonstrated (Johnston KC et al  2000). Patients with 
incomplete predictor or outcomes variables were excluded, and their characteristics were not 
compared to the baseline characteristics of the complete study sample (222/256 patients).  
Tilling et al analysed all patients randomised into a trial of early supported discharge 
compared against usual care (Tilling K et al  2001a). To enable multilevel modelling of 
recovery trajectories, outcomes measurements were performed at a number of time points 
following stroke. All patients had at least one outcome measurement and were included in 
the model development. Mean Barthel Indices for patients in whom measurements were not 
made on all occasions were compared to patients with complete data.  
Data for external validation studies of identified models were similarly obtained through 
secondary use of trial data, existing cohort data or gathered prospectively. The number of 
validation studies for individual models ranged from one (Belfast, mNIHSS, NIHSS_8, Tilling, 
Uppsala, Weimar and Weimar_ICH) to six (SSV), with cumulative validation sample sizes of 27 
(mNIHSS) to 8964 (SSV), median 762 (see appendix 7.2A-2). Larger validation populations 
were generally those from databases and registries, whilst smaller sample sizes reflect studies 
with data collected prospectively to meet the a priori intention to validate a specific model. 
Some studies used the same study population to validate several models (Gladman et al  
1992).  
3.5.3 Clinically relevant prognostic variables 
Statistical credibility of a prediction model in isolation is not useful unless the prognostic 
variables make clinical sense. Predictor variables in the identified models fell into three broad 
categories: markers of stroke severity at onset, possible confounding variables (e.g. age) and 
co-morbidities (Table 3). Generally, variables used to construct the identified models made 
clinical sense. However, some of the covariates are less convincing clinically e.g. the presence 
of ‘non-specific ST or T wave changes’ was included as a predictor in the Belfast model 
(Fullerton KJ et al  1988). During the development of this model, multiple univariate analyses 
of binary and categorical variables had been performed to identify candidate predictors for 
multivariable analysis. Some variables had several categories (up to 11), and variable 
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selection was data driven (Fullerton KJ et al  1988). This highlights the importance of clinical, 
as well as statistical judgement during model development.  
 Variables included in identified models (Teale et al 2012) Table 3
 Variables included in model 
SSV Age, living alone,  independent pre stroke ,normal GCS verbal score ,able to lift both 
arms, able to walk  
Tilling Age, Sex, ethnicity, pre-stroke handicap, limb weakness, dysphasia, dysarthria, 
incontinence, conscious, swallowing deficit, stroke subtype 
Johnston Age, NIHSS score, small vessel stroke, previous stroke, diabetes, prestroke disability, 
infarct volume 
Orpington Arm power, proprioception, balance, cognition 
Guys Limb paralysis, higher cerebral dysfunction+ hemiparesis+ hemianopia, drowsy, age, 
unconscious at onset, uncomplicated hemiparesis 
Belfast Albert’s test score, leg function, conscious level, arm power, weighted mental score, 
non-specific ECG changes 
Uppsala Adaptation of Mathew’s score (0-100) Conscious level, orientation, dysphasia, 
conjugate gaze palsy, facial weakness, arm power, Performance Disability scale, 
reflexes, sensation 
Weimar Model 1: Neurological complications, fever, lacunar infarct, diabetes, previous stroke, 
sex, age, mRS, NIHSS score on admission 
Model 2: Fever, age, NIHSS score on admission 
NIHSS_age Age, NIHSS 
Weimar_ICH Age, NIHSS 
NIHSS_8 NIHSS_15 items 1a, 2,3,4 6a&b 9, 10 
conscious level, gaze visual fields, facial paresis and lower limb motor scores, language 
and dysarthria 
mNIHSS Items 1B, 1C, 2,3,5 a&b, 6 a&b, 8, 9, 11 from the NIHSS: 
Conscious level, gaze, visual fields, upper and lower limb power, sensory function , 
language and neglect 
 
Counsell et al (2001) argue that the variables included in a prognostic model for stroke should 
include a marker of stroke severity (Counsell C et al  2001). It is possible, if not likely, that 
some clinical variables may act as proxy markers for stroke severity; e.g. patients with more 
severe strokes are more likely to develop new urinary incontinence. In this way, the presence 
of urinary incontinence may reflect constructs related to stroke severity such as mobility 
(difficulty in self-toileting), communication problems (difficulty in communicating the need 
for assistance with toileting) or conscious level. The potential for such collinearity between 
independent (predictor) variables should be examined and addressed during model 
development, but raises the possibility that more simple (univariate) case-mix adjustment 
may be possible. Indeed, it has been argued that multivariable prognostic models add little 
additional accuracy for prediction of discharge home over and above that of urinary 
incontinence alone (Barer et al  1989). A more recent examination of the role of urinary 
incontinence as a univariable predictor of outcome by Counsell et al found that although 
urinary continence was able to identify patients with good outcome (mRS  ≤2), the specificity 
(correct identification of patients with unfavourable outcome) was poor (0.44, 0.40-0.48) 
(Counsell C et al  2004). This would tend to suggest that absence of urinary incontinence is a 
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predictor of good outcome, rather than presence of urinary incontinence necessarily 
predicting poor outcome. This raises the question of whether there are particular subgroups 
of patients with new urinary incontinence following stroke that are more likely to have a poor 
outcome.  
3.5.4 Feasibility of data collection at ward level 
Three models require baseline data to be collected within six hours of admission (Johnston, 
NIHSS+age and Weimar_ICH models (Johnston KC et al  2000; Weimar C et al  2004; Weimar C 
et al  2006). A further three require variable collection within 24 hours (G score, mNIHSS, 
NIHSS_8) (Gompertz P et al  1994; Lyden PD et al  2001; Tirschwell DL et al  2002). One 
further model was developed using variables collected “on admission”, although the exact 
time frame within which variables were collected is not specified (Uppsala) (Frithz G et al  
1976).   
The type of ward to which the patient is admitted also has implications for the types of data 
that may be collected to enter into prognostic models. The availability of staff trained to 
perform complex clinical assessments (e.g. the NIHSS) may limit the use of some models to 
specialist staff in stroke units.  In addition, data collection is resource dependent. In funded 
research projects assessments are likely to differ from those that may be performed as part 
of routine care. Eight identified models (Johnson, Lincoln, Weimar & Weimar ICH models, 
Uppsala , Belfast, NIHSS+age, mNIHSS) (Frithz G et al  1976; Fullerton KJ et al  1988; Johnston 
KC et al  2000; Lincoln et al,  1990; Tirschwell DL et al  2002; Weimar C et al  2002; Weimar C 
et al  2004; Weimar C et al  2006) and one pre-existing severity score used to predict outcome 
(the NIHSS) (Muir KW. et al  1996)  require complex clinical assessments for completion and 
are therefore unlikely to be feasible for collection in non-specialist settings or in routine care.  
3.5.5 Assessment of valid and reliable outcomes at a fixed time point 
The models identified through this review may be classified according to the outcomes that 
they were developed to predict. Some authors describe development of similar models to 
predict different outcomes, and these therefore counted more than once. Outcomes should 
be of proven validity and reliability in stroke populations. In addition, the outcome should be 
measured at a particular time point following the stroke event, such that time to 
measurement of outcome is standardised.  
Two of the identified models predict the Barthel Index as an interval dependent variable 
(Orpington, Tilling) (Kalra L et al  1993; Tilling K et al  2001a). The Tilling model is a multilevel 
model and, as such, predicts average recovery trajectories (measured with Barthel Index) 
over time following a stroke event (Tilling K et al  2001a). The Orpington score was developed 
to predict the Barthel Index at three time points following stroke (Kalra L et al  1993). In a 
subsequent validation study of the Orpington score and the NIHSS (a pre-existing stroke 
severity scale), Lai et al predicted Barthel Index as an interval variable (Lai SM et al  1998). 
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The validity of this approach is dependent on some statistical assumptions which are 
discussed further in section 3.5.8.2.  
Seven of the remaining 13 models predict dichotomised Barthel Index (Johnston, G score, 
Weimar ICH, Weimar, NIHSS+age, NIHSS_8, mNIHSS). Time to outcomes measurement for 
these models varied from two to six months.  
Three models predict dichotomised modified Rankin Score (or Oxford Handicap Score) (SSV, 
mNIHSS, NIHSS_8) (Counsell C et al  2002; Lyden PD et al  2001; Tirschwell DL et al  2002), and 
two predict other dichotomised impairment scores (Johnston, NIHSS_8) (Johnston KC et al  
2003; Johnston KC et al  2000; Tirschwell DL et al  2002)). The Johnston model predicts 
devastating outcome with the NIHSS, dichotomised BI or dichotomised Glasgow Outcomes 
Score whilst the NIHSS_8 model predicts a global outcome score (good/poor outcome) 
calculated from four other dichotomised outcomes: BI, NIHSS_15, mRS, and the Glasgow 
Outcomes Score. The authors of the Guys and Belfast models developed study specific 
impairment scales (Allen CMC 1984; Fullerton KJ et al  1988). 
Four of the 13 models were developed to predict mortality – Uppsala, SSV, Weimar and 
NIHSS+age) (Allen CMC 1984; Counsell C et al  2002; Weimar C et al  2002; Weimar C et al  
2004).  
3.5.6 Statistical quality of studies describing model development 
The majority of the models identified in this review comprise variables that are not feasible 
for collection in routine care (for reasons of time to assessment or complexity of assessment), 
require training for administration (NIHSS) or were developed on an inception cohort 
established more than two weeks following the stroke event (Table 2). No model was 
excluded solely on the basis of the characteristics of the cohort from which it was developed 
if there was evidence that it had been validated (and performed acceptably) in a more 
general post stroke population (e.g. the SSV model and Tilling models) (Counsell C et al  2004; 
Tilling K et al  2001a) (see data extraction tables in appendix 7.2A-2). Six models were 
therefore further scrutinised according to statistical criteria: the Tilling model, Orpington 
score, G score, Guys model, NIHSS_8 model and the Six Simple Variable model (see Table 4). 
Five of these six remaining models use single level regression modelling for the prediction of 
outcomes. The sixth (Tilling model) uses multilevel modelling and is considered in 3.5.7.4 as a 
special case. Regression models are based on the ‘generalised linear model’ comprising a 
linear predictor (1) and random effects (ԑ) such that the general form of the equation to 
calculate the mean expected values of the dependent variable E(Y) from a linear model is 
given by (2) where μi =the predicted outcome for individual i, β = variable coefficient between 
limits i k, x= independent variable and ԑ= random effects. The generalised linear model (2) 
contains a ‘link function’ f(μi), dependent on the underlying distribution of the data (3). The 
inverse of which transforms the linear prediction to the probability distribution of the 
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underlying data (Fox J,  1997 pp 487-488). For example, the logit function is used in logistic 
regression models to predict binomial probability distributions (dichotomous outcomes), and 
the transformation function is given by (3)(Fox J,  1997). The inverse of this function is 
therefore used to calculate the fitted values μ. The probability distribution of these fitted 
values should therefore follow a binomial distribution. For normally distributed linear 
outcomes, the function is f(μ) = μ.  
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3.5.7 Checking model assumptions – (Multiple) linear regression 
Multiple linear regression modelling requires a number of assumptions to be fulfilled in order 
for the approach to be valid (Fox J,  1997 p 113; Harrell FE et al  1996). Firstly, there must be 
an underlying linear relationship between the independent and dependent variables (or a 
transformation thereof). Secondly, the residuals (the difference in observed and predicted 
outcomes) must be normally distributed. Providing this assumption is met, individual 
continuous (or ordinal) variables entered into the model need not be normally distributed. 
Thirdly, the distribution of variance of predicted values of y should be inspected to ensure it is 
uniform across all values of the independent variables (homoscedasticity), i.e. there should 
be no pattern in a plot of model residuals against fitted values (Fox J,  1997).  Finally, there 
must be no linear relationship (collinearity) between independent variables. A possible 
example of collinearity would be to include variables measuring leg weakness and mobility 
into a model: there is likely to be a strong relationship between these two variables. Entering 
highly correlated predictor variables into a model means that the individual effect of each 
variable is hidden within their combined effect such that the individual contribution of the 
variables cannot be discerned. Inclusion of collinear variables can overestimate the individual 
effects and result in inflated and unstable beta coefficients, i.e. estimates may vary widely 
with the addition or exclusion of individual cases, often reflected in wide confidence intervals 
around co-efficient estimates (Fox J,  1997 p 337). Collinearity between independent 
variables should be identified, through logical or clinical reasoning, and explored. Variables 
likely to be correlated should either be excluded from the model (if they add little to the 
explanation of outcome) or combined to form a sensible composite measure. Stepwise 
variable selection procedures in statistical software help to overcome collinearity through 
automatic exclusion of variables that are highly correlated (Concato J et al  1993). 
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  Models retained for statistical appraisal Table 4
Model Citation 
Inception 
less than 
2 weeks 
Clinically 
relevant 
prognostic 
factors 
Feasible to 
collect at 
ward level 
Prospective data 
collection (or validation 
in prospective 
population) 
No 
systematic 
loss to 
follow up 
Valid and reliable 
outcome measured 
at a fixed time 
point? 
Generalisable 
to other 
stroke 
populations? 
Retained 
for 
statistical 
appraisal? 
Bristol Wade (1983)      ?    
Edinburgh Prescott (1982)  ?        
Lincoln Lincoln (1990)          
Young Young (2001)         
Belfast Fullerton (1998)      ?    
Johnson Johnston (2000)      ?  ?  
mNIHSS Lyden (2001)          
NIHSS 
Lai (1998); Muir 
(1996)  
NA        
NIHSS+age Weimar (2004)        ?  
Uppsala Frithz (1976)      ?    
Weimar Weimar (2002)      ?    
Weimar ICH Weimar (2006)          
G score Gompertz (1994)      ?  ?  
Guys Allen (1984)        ?  
NIHSS_8 Tirschwell (2002)      ?    
Orpington Kalra (1993)      ?  ?  
SSV Counsell (2002)      ?  ?  
Tilling Tilling (2001a)      ?    
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Model assumptions should be checked during development, and attempts made to overcome 
violations if they occur. Most assumption checks can be achieved through examination of 
simple scatter plots. Non-random distribution of model residuals in a scatter plot of residuals 
across values of individual independent variables may reveal a non-linear relationship 
between independent and dependent variables (Altman D 1999 p 346).  In addition, a scatter 
plot of residuals against fitted values can demonstrate heteroscedasticity (non-uniform 
variance in residuals across fitted values of the dependent variable) which may indicate the 
omission from the model of an important factor exerting a systematic effect (Fox J,  1997 
p302). Figure 6 is a plot of fitted values against model residuals and demonstrates 
homoscedascticity (constant variance across fitted values).  
Figure 6 Model fitted values vs. residuals to demonstrate homoscedasticity  
 
A histogram of (studentised) residuals can indicate a deviation from a normal distribution1.  A 
(standardised) normal (Q-Q) plot can be used to examine the distribution of residuals against 
the normal distribution (Fox J,  1997 p42; Altman D,  1999 p 133), see also section 4.4.3.2.  
Non-normally distributed residuals may be another indication of non-linear relationships 
between predictor and outcome. Transformations of the independent variable may 
overcome this non-linearity, and may also help to solve problems with non-uniform variance 
(Altman D,  1999 p 303; Royston P et al  2008). 
                                            
1 The theory behind the derivation of studentised and standardised residuals is 
discussed in appendix A-3 
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Independent variables in regression models may be continuous, ordinal or dichotomous. 
Prediction of dependent variables from categorical independent variables requires the 
creation of ‘dummy variables’. A dummy is created for each level of the categorical variable 
apart from the ‘reference category’ coded 0 by convention (Fox J,  1997 142). Each dummy 
variable is then compared to the reference category in order to create a series of 
dichotomous pairs (Altman D,  1999 p 339). The beta coefficient of the dummy variable in the 
model is then equivalent to the difference in mean expected outcome for patients in the 
dummy category as compared with the reference category.  As this could markedly increase 
the number of variables that need to be considered in the EPV calculation of sample size, the 
inclusion of categorical variables and creation of dummies should be considered during 
model development.  
3.5.7.1 Model assumptions: Logistic regression models 
In the models identified in the review, continuous dependent variables were often 
dichotomised to circumvent some of the requirements for linear regression, e.g.  
dichotomised Barthel Index to reflect ‘good/poor’ outcome)  (Gladman JR et al  1992; 
Gompertz P et al  1994; Johnston KC et al  2000; Lyden PD et al  2001; Weimar C et al  2004; 
Weimar C et al  2006). This allows a logistic regression model to be used to predict a binary 
outcome where the assumptions on the underlying distributions are less stringent. However, 
dichotomising continuous variables means that detailed information may be lost (Mallett S et 
al  2010a; Royston P et al  2008).  
Logistic regression is used to predict a log transformation of the odds of a binary outcome 
(the ‘logit function’ see Equation (3) p 49) (Fox J,  1997 p 78). A linear relationship between 
the predictors and this logit function is assumed (Harrell FE et al  1996). There are no 
assumptions placed on the distributions of the independent variables but there must be no 
correlation (collinearity) between them (Bewick V et al  2005).  
3.5.7.2 Interaction terms 
Interaction is a problem with both linear and logistic regression analyses and occurs when the 
effect of one variable is mediated by the effect of another (Fox J,  1997 p 145). For example, 
the relationship between height and age would be mediated by gender if girls tend to be 
taller than their male counterparts when they are younger but relatively shorter as they grow 
older. This could be controlled for by entering an interaction term into a regression equation 
(as the product of the two terms). Interaction terms should be carefully considered through 
clinical reasoning, ideally a priori. In contrast with composite terms to control for collinearity, 
where the number of variables may be reduced, inclusion of an interaction term will increase 
the number of variables entered into a model (Harrell FE et al  1996). Interaction terms may 
be demonstrated by plotting independent against dependent variables at different levels of 
the mediating variable.  If the two lines are not parallel, then an interaction term is likely (see 
example, Figure 7). 
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Figure 7 Theoretical example of an interaction term between age and height 
 
3.5.7.3 Variable selection  
Selection of variables to include in a logistic regression model may be data driven, or made 
through clinical reasoning. A common, but not recommended data driven approach is to 
perform multiple univariable analyses and discard variables which do not reach a pre-
specified p-value (often 0.2) (Mallett S et al  2010a). This approach can result in selection bias 
(Royston P et al  2008) - predictors with larger co-efficients (perhaps through chance) are 
more likely to be statistically significant and therefore more likely to be retained in the model 
over variables with smaller co-efficients (Royston P et al  2008). Clinically unimportant 
variables may therefore be included, or relevant variables discarded on the basis of their p 
value (Mallett S et al  2010a; Royston P et al  2008). Predictor variables may also be selected 
for inclusion through automated (forwards or backwards) selection procedures with 
statistical software. Here, variables are selected on the basis of their influence on maximising 
the model R2 statistic. The retention or rejection of variables previously entered or removed 
from the model is re-considered following the addition or removal of subsequent variables 
during the stepwise procedure (Fox J,  1997 p 356).  
It has be argued that any clinically relevant predictor (or confounder) should be included in a 
model even if it does not reach statistical significance in univariable or multivariable analysis 
(Mallett S et al  2010a); variables may be excluded through chance and a model based solely 
on statistical criteria may lack generalizability due to the exclusion of these clinically 
important predictors (Rothwell PM 2008). Ideally the most parsimonious model that 
maximises explanation of the dependent variable should be developed through both clinical 
and statistical reasoning (Altman D et al  2000; Concato J et al  1993).  
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3.5.7.4 Multilevel (hierarchical) models 
The Tilling model (Tilling K et al  2001a) was derived using multilevel modelling techniques. 
For this reason it is considered here as a special case. Multilevel modelling exploits the 
hierarchical nature of data by considering e.g. repeated Barthel Index measurement over 
time (Level 1) as a property of individuals (Level 2) (Tilling K et al  2001a). Consideration of 
higher levels (e.g. ward or hospital) may help to explain further residual variation in patient 
outcome. This clustering of data can be used to explain fixed and random effects at different 
levels of the model and to explore the interdependence of the measurements (Kline RB 2005 
p 332),  thereby providing additional information as to the structure of the data over and 
above that which is offered through single level regression modelling (Tilling et al  2001b).   A 
multilevel modelling approach allowed Tilling et al to estimate average recovery trajectories 
based on baseline characteristics. From these, iterative calculations of an individual’s 
outcome could be made at any time point conditional on both baseline characteristics and 
observed outcome trajectory (Tilling K et al  2001a).  
3.5.8 Reporting of checks of model assumptions for models identified in the 
review 
Checks of model assumptions are discussed in two parts: assumptions and checks during 
model development, and post-estimation checks of model assumption (i.e. after calculation 
of model beta-coefficients). Model fit and performance in external validation studies are 
discussed in subsequent sections.  
3.5.8.1 Construction of models  
The Guys score was developed by Allen et al and its utility re-examined in an independent 
cohort by Gladman et al (Allen CMC 1984; Gladman JR et al  1992). Twenty-nine candidate 
variables were identified for possible inclusion in the original model. Selection of variables for 
inclusion in a multivariable model was made through identification of univariate predictors 
where observed and expected frequencies were significantly different (at the 0.05 level) 
between patients with ‘good’ or ‘poor’ outcome (Chi-squared or t-test). At this significance 
level, examination of more than 20 variables makes it likely that at least one will reach 
statistical significance by chance. There was no control for collinearity or consideration of 
potential interaction terms in the development of the model (Allen CMC 1984).  
The G score was developed from the Guy’s score through simplification of the regression co-
efficients to integers (Gompertz P et al  1994). Although this is, therefore, technically a new 
model, the method of variable selection is the same as in the original study (as described 
above). 
The Six Simple Variable models (Counsell C et al  2002) were developed to predict 
dichotomised functional outcome (alive and independent vs. not, as measured with an 
Oxford Handicap Score <3), and survival at 30 days. Many of the issues surrounding variable 
selection were addressed explicitly. Variables were selected initially through clinical 
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reasoning and feasibility of data collection. Remaining variables were separated into a core 
group of clinical variables (‘set 1’) and groups of additional variables of increasing complexity 
(‘sets 2 & 3’). Eighteen clinical variables were included in set 1 to be entered into a forward 
stepwise regression model. Linearity of the relationship between the only continuous 
independent variable (age) and the dependent variables were tested and met.  Interaction 
terms were tested between variables where interactions were clinically suspected (age, sex 
and previous disability), but none were found (Counsell C et al  2002).  
The authors of the SSV models highlight that many regression analyses were performed in the 
development of the final SSV models and acknowledge that these multiple analyses may have 
led to the inclusion (or exclusion) of variables from the models by chance (Counsell C et al  
2002).  
The predictive accuracy of any regression model is dependent on the correct variables being 
included in the model and the stability of the beta co-efficient estimates. Too many variables 
included in the model may result in overfitting (Type 1 error). Here, the model has high 
predictive accuracy in the sample from which it was drawn but performs poorly in 
independent datasets (Peduzzi P et al  1996). Type 2 errors arise from a lack of power, e.g. 
where the effect of an individual predictor is too small to be detected given the sample size.  
Sample size is also important in determining the number of variables that may be entered 
into a model. The number of variables that may be entered into a model to predict a binary 
outcome is determined by the ratio of observed events to the number of variables (including 
dummies) – the events per variable ratio (EPV). The number of events in this context applies 
to whichever is less frequent between the binary outcome pair. An EPV of greater than 10 has 
been suggested and widely accepted following a simulation study by Peduzzi et al (Peduzzi P 
et al  1996). Here, retrospective data from a study where binary outcomes had been 
predicted using a logistic regression model were used with a re-sampling technique (Monte 
Carlo) to simulate model variable co-efficients  over a series of pre-specified EPV ratios 
(between 2 and 25). The distribution of estimated co-efficients was then examined and 
compared with the parameters derived from the original regression model. Below a cut-off 
EPV ratio of 10 the regression co-efficient estimates were unstable: there was lack of 
convergence (i.e. the simulated models did not ‘settle’ onto a value for the regression co-
efficient), predicted co-efficients were not normally distributed and their confidence-intervals 
unacceptably wide (Peduzzi P et al  1996).  
Thus, the number of variables that may be entered into a logistic regression model (but not 
necessarily retained (Rothwell PM 2008)) may be calculated by dividing the total number of 
events (e.g. number of deaths or dependent patients) by ten. If there are interaction terms, 
or dummy variables, these needed to be counted as separate variables for the purposes of 
the calculation. If data are to be collected prospectively, an estimation of the expected events 
should be calculated from previous studies or epidemiological data.  Linear regression models 
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should also meet an ‘events per variable’ ratio of ten, but here the number of events is the 
number of observations for the dependent variable. 
Of the retained models in this review, the Guys score and Bristol model have an EPV of less 
than ten (Gladman JR et al  1992; Gompertz P et al  1994). The G-score, Orpington, Tilling and 
SSV (Set 1) models have adequate EPV (Counsell C et al  2002; Gompertz P et al  1994; Lai SM 
et al  1998; Tilling K et al  2001a).  
3.5.8.2 Post-estimation checks of model assumptions 
The Orpington model is a single level regression model that predicts the Barthel Index score 
(Lai SM et al  1998). During their examination of the predictive properties of the Orpington 
score, Lai et al entered individual items from the Orpington score into a linear regression 
model to predict the (ordinal) Barthel Index thereby treating the Barthel Index as a 
continuous variable.  Although Lai et al acknowledge the potential problems due non-
normally distributed ordinal data (and the question this raises regarding a linear relationship 
between predictor and outcome), normality assumptions (of model residuals) were not 
tested (Lai SM et al  1998). The variance of the Orpington score was noted to decrease over 
time (with successive measurements) (Lai SM et al  1998). This may suggest a non-linear 
relationship between predictor and dependent variable or perhaps some interaction between 
the score and time. This is not unexpected, as recovery trajectories are known to be non-
linear (Jorgensen HS 1996; Tilling K et al  2001a). However, in the presence of this variability 
related to time, analyses should be cross-sectional as opposed to longitudinal.  
Violation of the normality of residuals assumption in the Tilling model was felt, by the 
authors, to be due to the effect of 19 individual patients for whom the model did not fit well 
rather than the underlying distribution of the dependent variable (Tilling K et al  2001b). Thus, 
the dependent variable (Barthel Index) was treated as a normally distributed continuous 
variable. Tilling et al recognise that this assumption is violated due to the ceiling effect of the 
Barthel Index. Strategies to overcome this were explored through more complex modelling 
techniques that allow for censoring at the upper limit (ceiling) of the Barthel Index (Tilling K et 
al  2001b; Twisk J et al  2009). However, application of these techniques affected neither the 
estimates of model coefficients nor predicted Barthel Index values (Tilling K et al  2001b).  
3.5.9 Model performance (external validation) 
External validation (performance in independent population) for the models with acceptable 
properties as regards model development is considered in section 3.5.9.3 following a brief 
discussion of the methods used to measure model performance (sections 3.5.9.1 & 0). Two 
aspects of the models’ predictive function are discussed: discrimination (ability to distinguish 
between individuals with good and poor outcome) and calibration (accuracy of predicted 
outcomes).  
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3.5.9.1 Discrimination 
Discrimination is a measure of how well a model is able to correctly distinguish patients with 
good over poor outcome (Harrell FE et al  1996), and is measured with the ‘c statistic’. This is 
calculated as the overall proportion of correct (good over poor) predictions across all non-
concordant outcome pairs in the sample (Harrell FE et al  1996; Justice AC et al  1999). For 
binary outcomes, this is equivalent to the area under the Receiver Operating Characteristic 
(ROC) curve (Hanley et al  1982). Models with no discrimination (i.e. no better than chance) 
would be represented by a c-statistic, or area under ROC curve (AUC) of 0.5. Perfect 
discrimination is represented by a c statistic, or AUC of 1.0.  
Sensitivity and specificity are often presented as a measure of how well a model predicts 
individual patient outcome. Patients predicted to have a poor outcome who are observed to 
have poor outcome are ‘true negatives’ whilst those with poor outcome predicted to have 
good outcome are ‘false positives’ (see Table 5). Acceptable values for sensitivity and 
specificity is dependent on the purposes of measurement, i.e. the tolerability of false positive 
and false negative rates depends on the clinical context (Altman D,  1999 p 418). For the 
purposes of this review, models were retained if sensitivity and specificity were both greater 
than 0.75.  
 Contingency table Table 5
 
  Observed Outcome 
  0 1 
P
re
d
ic
te
d
 
o
u
tc
o
m
e
 0 True negative False Negative 
1 False Positive True Positive 
 
3.5.9.2 Calibration 
Calibration is a marker of how well a model can make correct predictions (e.g. patients 
actually have the outcome that is predicted). Calibration of a model can be examined through 
plotting proportions of predicted outcome in deciles against the proportion of patients with 
the observed outcome within each decile (Counsell C et al  2002). Perfect calibration is 
represented by a line y=x.  
3.5.9.3 Predictive accuracy of included models 
The performance of each model in external validation studies (external datasets) are given in 
the data extraction tables (appendix A-2).  
Two SSV models predict either survival at 30 days (developed through a Cox proportional 
hazards model) or alive and independent at six months (logistic regression analysis) (Counsell 
C et al  2002). The AUC (equivalent to the c-statistic) for prediction survival was 0.84 in the 
external validation study by the developers of the model (Counsell C et al  2002) and 0.73 in 
an independent study (IST3 trialists 2008). Discrimination of the model to predict 
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independent survival was greater than 0.75 in each of 4 external validation studies (Dennis et 
al  2003; Lewis S et al  2007; Reid J et al  2007; Weir N et al  2001).  
The remaining models report sensitivity and specificity analysis to demonstrate model 
performance (see appendix A-2). Although the Guys has an acceptable specificity of 83% to 
predict death at three weeks (i.e. a low rate of false negatives), the sensitivity is poor (58%) 
representing a high rate of false positives (Gladman JR et al  1992). Conversely, the G score 
has a sensitivity of 72% but a low specificity (63% i.e. it will predict 37% of patients with an 
ultimately poor outcome as having good outcome) (Gompertz P et al  1994). A sensitivity 
analysis was performed for the Bristol model in a prospective observational study by 
Gladman et al (Gladman JR et al  1992). This aimed to ascertain the predictive ability of the 
Bristol score at one week to predict a BI>10 at 3 months. The sensitivity was found to be 
100%, but the specificity 0% (highlighting the inverse relationship between these two 
parameters). The Tilling model predicted the Barthel Index to within 3 points on 49% of 
occasions. This was increased to 69% if the recovery trajectory (i.e. last BI score) was included 
in subsequent predictions (Tilling K et al  2001a). The average difference in predicted and 
observed outcome using the Tilling model was -0.4 with 90% limits of agreement between -7 
and 6 (i.e. 90% of predicted values lie between -7 and +6 of the observed values) (Tilling K et 
al  2001a).   
3.5.9.4 Reliability 
The mNIHSS was derived from the NIHSS through removal of poorly performing and 
redundant items and through exploratory and confirmatory factor analysis using data from 
the two parts of the NINDS rtPA Stroke Trial (Lyden PD et al  2001; The National Institute of 
Neurological Disorders and Stroke rt-PA stroke study group 1995) as a means to simplify risk 
stratification and prognostication following stroke for the purposes of stratified 
randomisation in clinical trials (Lyden PD et al  2001). Correlations with the Barthel Index and 
mRS formed an assessment of concurrent validity. Substituting the modified scale into the 
original regression models yielded similar results to the parent NIHSS to predict a ‘global 
outcome score’ developed from four stroke outcome measures. To assess criterion validity, 
correlations between the mNIHSS and NIHSS were assessed. Inter-rater reliability for 
individual items was shown to be high between neurologists trained in the use of the NIHSS 
although reliability for non-trained practitioners remains untested (Lyden PD et al  2001). 
However, the mNIHSS may offer a simple and practical alternative to the NIHSS for risk 
adjustment if it can be shown to be reliable when used by non-stroke specialists.
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3.6 Limitations of the review 
This review provides a systematic overview of available externally validated prognostic 
models in stroke, updating previous reviews (Counsell C et al  2001; Kwakkel G et al  1996) to 
include more recent models and modelling methodologies. This review was based on a 
comprehensive and replicable search strategy producing a vast amount of literature for 
consideration. Despite this process, it is possible that relevant citations describing model 
development or validation of existing models have been overlooked. In addition, models that 
are yet to be externally validated and may yet prove to be good predictors of patient 
outcome may have been excluded from the review. Information regarding modelling 
techniques may not have been reported in detail in individual studies, and where this detail 
was lacking I have not attempted to obtain this information directly from authors. It is 
therefore possible that further robust models may have been excluded. Apparently poor 
performance of individual models in independent populations may reflect the methodology 
of external validation studies. It has not been possible to offer a quantitative summary of the 
performance of individual models in external populations due to the heterogeneity of 
external validation studies. Instead, validation studies have been presented individually to 
allow comparative assessment of their methodological quality and generalisability.  
This review presented a number of methodological challenges. Firstly, a lack of universal 
criteria for scrutiny of prognostic research meant that the criteria against which the models 
were assessed are open to debate. Secondly, few of the included studies were based on data 
which was collected expressly for the purposes of model development. The secondary or 
retrospective use of data was common and models were often derived from available as 
opposed to desirable data. It is therefore possible that although the variables within the 
models make clinical sense, they are not necessarily the optimal factors to explain variability 
in patient outcome. Often, detailed descriptions of model development were lacking 
especially as regards checking of model assumptions and the characteristics of patients lost to 
follow up. Where such checks were not explicitly discussed, we have assumed that they did 
not occur, and this assumption may not be valid.   
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 Summary of statistical appraisal of models identified in the review Table 6
Model Valid method of variable selection? Control for 
Multicollinearity 
Consideration 
of interaction 
terms 
Events per 
variable 
>10? 
linearity assumptions 
tested and met? 
External Validation 
Acceptable discrimination (or 
sensitivity/specificity) 
Guys  
Multiple variables selected 
through identification of 
‘statistically significant’ 
univariate predictors 
   ? 
Sens 0.83 
Spec 0.58 
G score  
Variables extracted from Guys 
model (simplified regression co-
efficients to integers) 
   ? 
Sens 0.72 
Spec 0.63 
Bristol ?  ?   
Sens 1.00 
Spec 0 
SSV  
Use of stepwise variable 
selection and clinical reasoning 
Stepwise 
variable 
selection 
    
C statistic acceptable for 
prediction of alive and 
independent or dead/alive 
Tilling ?  ?  
Tested; attempts to 
correct for censoring 
effects of Barthel Index 
did not affect the model 
Predicts Barthel Index to within 3 
points on 49% of occasions (increases 
to 69% if recovery history is included 
in the model). 
90% limits of agreement -0.4 (-7, +6) 
Orpington ? 
Stepwise 
variable 
selection 
?   
R
2 
values used to assess model fit. 
Discrimination not tested 
Teale  
Variables selected through 
identification of important 
predictors in univariate 
analyses, regression trees and 
clinical reasoning 
Stepwise 
variable 
selection 
   Not externally validated 
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3.7 Conclusions 
Prognostic modelling has a number of applications in stroke. In the research setting 
prognostic models can be used in both randomised trials (for risk stratification) and 
observational studies (for case-mix adjustment) (Counsell C et al  2001). Potential 
applications in routine care range from the prediction of outcomes in individuals or groups 
of similar individuals (to facilitate treatment planning) to case-mix adjustment in the 
context of performance management within or between institutions.  The usefulness of 
any prognostic model in these situations is likely to rely heavily on feasibility of data 
collection, and simplicity of application. In addition, any prognostic model should be robust 
in terms of the statistical methods used in its development, and in its predictive and 
discriminatory properties.  
Of the six models that were subject to statistical scrutiny, only one (the SSV model) fulfilled 
all statistical criteria (Table 6 p 60). This model has been used in both randomised (Dennis 
MS et al  2003; IST3 trialists 2008) and observational (Reid J et al  2007) studies. Although 
the Tilling model has additional utility in terms of predicting individual recovery trajectories 
(Tilling K et al  2001a; Tilling K et al  2001b), the use of the Barthel Index as the predicted 
outcome is limiting due to its well documented ceiling effects (Salter K et al 2010). 
This review aimed to update previous reviews (Counsell C et al  2001; Jongbloed L 1986; 
Kwakkel G et al  1996; Seenan P et al  2007) to identify risk adjustment models in light of 
the significant changes in stroke care that have occurred over the last decade. Twenty-
three models were identified predicting a variety of outcomes following stroke. Of these, 
only six met quality criteria as regards the populations from which they were developed 
and the clinical utility of the covariates (Table 6 p 60). These factors are, to some degree, 
subjective and based around the specific requirements of a model for the CIMSS project. 
The exclusion of some models where the prognostic variables were felt to be too complex, 
or the time frames unrealistic for data capture as part of routine care by non-stroke 
specialists could be criticised for being over pessimistic. However, although there has been 
significant progress in direct admission to stroke units for patients presenting to hospital 
with stroke, this does not occur universally. Thus, any model which relies on specialist 
skills, or laboratory and radiological tests may result in systematic inconsistencies in data 
capture with the consequent introduction of bias.  
With the exception of the Tilling model where multilevel modelling techniques were used, 
all the models included in this review were developed through single level regression 
modelling techniques. Alternative and more sophisticated modelling techniques exploit 
many of the conditions that make regression modelling difficult (e.g. the hierarchical or 
clustered nature of data) to provide more meaningful and clinically relevant models. 
Alternative modelling techniques such as latent class analysis, structural equation 
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modelling or decision trees may offer additional explanations as to the relationships 
between case-mix and patient outcome and warrant exploration in the stroke setting.  
Case-mix and risk adjustment is central to the validity of observational studies and also has 
utility for stratification in randomised trials. However, this review has not identified any 
new clinically useful and feasible model that can be used for these purposes since the 
Counsell model was developed ten years ago (Counsell C et al  2001). Despite advances in 
statistical modelling techniques, the available stroke risk adjusters are largely derived using 
regression modelling techniques with all their inherent problems. The use of more 
sophisticated techniques to develop robust case-mix adjustment models may increase 
confidence in the conclusions that may be drawn from observational studies of unselected 
populations.  
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Part II CIMSS research phase study
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Chapter 4 Methods 
To address the research questions posed in section 1.4 and to define a core stroke dataset 
for further testing, a prospective observational cohort study was performed (the CIMSS 
research phase study). The aims of this study were to test the feasibility of prospective 
data collection, to identify important (or redundant) data items, assess return and 
completion rates of postal questionnaires and explore case-mix adjusted relationships 
between care processes and patient reported outcomes.   
4.1 Patient identification and recruitment 
4.1.1 Study sites 
Three study sites were selected as representative of the stroke services across Yorkshire 
and the Humber. Leeds Teaching Hospitals Trust (LTHT) is a large, multi-site teaching 
hospital and a tertiary referral centre within Yorkshire offering interventional radiological 
and neurosurgical services. Bradford Teaching Hospitals Foundation Trust (BTHFT) is a 
smaller teaching hospital with foundation status, and York Hospitals NHS Foundation Trust 
(YHFT) is a smaller foundation trust. All three sites have both acute and rehabilitation 
stroke units offering organised multidisciplinary acute and rehabilitation stroke services 
with the aim of direct admission to these units from the Emergency Department. The 
structure of stroke services at each trust is given in Table 7. During the study period, 
thrombolysis was offered at all sites Monday to Friday, during office hours. The main 
differences between the sites are the number of stroke beds, the provision of Early 
Supported Discharge (ESD) seven day rehabilitation services – both only available at LTHT. 
However, both BTHFT and YHFT offered ongoing community rehabilitation following 
discharge from hospital (Table 7).  
4.1.2 Ethical and Research and Development (R&D) approvals 
Ethical approval for the study was sought and obtained from the Bradford Regional Ethics 
Committee. R&D approvals were obtained individually from each of the three study sites.  
4.1.3 Research staff  
Researchers with a background in healthcare were employed to collect data in each of the 
three study sites. All the researchers underwent Good Clinical Practice (GCP) training and 
also attended an afternoon training session regarding the aims and objectives of the study, 
patient and carer recruitment and data collection processes. Specifically, training was 
provided on the processes for identification of potentially eligible patients and carers and 
obtaining informed consent. In addition, training was provided in the use of the data 
extraction forms (case report forms (CRFs)), use of the site file, creation of file notes and 
special processes for ‘unscheduled’ events such as patient death or withdrawal.  
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 Characteristics of stroke services at each study site Table 7
 Bradford Leeds York 
Type of service Hyperacute  
(Mon-Fri 9-5) 
Rehabilitation 
Hyperacute 
(Mon-Fri 9-5) 
Rehabiliation 
Hyperacute 
(Mon-Fri 9-5) 
Rehabilitation 
Type of stroke unit Acute Stroke Unit 
Rehabilitation Unit 
2 Acute Stroke Units 
Rehabilitation Unit 
Acute Stroke Unit 
Rehabilitation Unit 
Total acute stroke beds 14 18, 15 15 
Rehabilitation stroke 
beds 
22 30 19 
7 day rehabilitation?  No Yes No 
ESD service available?  
Members of team 
No Yes  
CNS, SW, SLT, PT, OT, 
Dietician* 
No 
Community rehab team Yes Yes Yes 
Restrictions for access 
to SU 
No No No 
*CNS = Clinical Nurse Specialist (stroke), SW = Social Worker, SLT = Speech and Language Therapist, 
PT = Physiotherapist, OT = Occupational Therapist 
 
4.1.4 Screening data 
Patients admitted to each Trust with stroke were identified by researchers through liaison 
with stroke care co-ordinators and stroke unit staff. Through this approach, patients that 
were admitted to wards other than the acute stroke unit were also identified.  
Anonymous screening data were collected onto screening forms for all patients potentially 
eligible to take part in the study. This was in order to allow examination of the 
representativeness of the study sample through comparison of patients that consented to 
participate compared with the general post stroke population admitted to each site. 
Screening data comprising demographic details (age, sex and ethnicity) and a baseline 
functional score (Barthel Index (BI)) were collected on all patients admitted to participating 
centres with stroke during the study period. Reasons why patients were either not eligible 
or did not consent to participate in the study were also collected where this information 
was available.  
4.1.5 Patient selection 
Following screening, patients meeting eligibility criteria were approached for consent to 
participate in the study. Broad inclusion criteria were applied with the aim of recruitment 
of consecutive patients admitted to the study site with stroke. All patients were eligible for 
inclusion in the study if they had a primary diagnosis of stroke, and were recruited within a 
week of the onset of symptoms (or within two weeks if case-mix variable data could be 
extracted from the case-notes with respect to the week post stroke). Patients with 
subarachnoid haemorrhage and transient ischaemic attack were excluded, as were 
patients in whom it was clinically inappropriate to approach for consent (i.e. patients 
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receiving palliative care). Patients were included if they provided informed consent to 
participate or, for patients unable to provide informed consent, only if they had a 
consultee (e.g. relative or carer) able to provide proxy consent. Patients unable to provide 
consent (i.e. patients who lacked capacity) were excluded from the study if they had no 
appropriate consultee. Therefore patients with cognitive impairment and dysphasia were 
not excluded from the study unless they lacked capacity and had no appropriate consultee. 
The main carer of patients (when available) was asked to provide consent to receive 
follow-up questionnaires regarding carer strain following stroke. 
Consent was sought to extract data from patient case-notes and to send a questionnaire 
booklet to patients and carers at six months. A ‘tiered’ consent process was adopted 
whereby patients could consent to participate in certain parts of the study (e.g. baseline 
assessments), but withhold consent for e.g. follow-up.  
Once patients had agreed to participate in the study and the consent forms were 
completed, the researchers telephoned the Academic Unit of Elderly Care and 
Rehabilitation in Bradford where a verbal eligibility and consent checklist was performed. 
Researchers were then given a study number which was added to all pages of the CRF.  
Patients and carers were able to withdraw consent at any time during the study without 
offering a reason. Where a patient lost capacity during the course of the study, the 
decision to continue in the study was made by the main carer. Carers who had consented 
to participate in the study were withdrawn from further follow-up if the patient died 
between recruitment and follow-up.  
4.1.6 Data collection 
Data were extracted from case notes, therapy records and patient interview onto case 
report forms (CRFs) designed for the study. These included flowcharts for the completion 
and return of study paperwork, checklists to ascertain eligibility for the study and a patient 
and carer registration checklist. The CRFs were designed to reflect the patient pathway 
during their hospital stay with questions requiring data extraction at similar points in the 
pathway grouped together. A discharge checklist (including check of survival and discharge 
address) was completed and returned at patient discharge from hospital.  
Researchers were asked to note any difficulties in recruitment, data extraction or 
particularly hard to collect data items for discussion in regular teleconferences. These 
teleconferences were also used to identify data items where differences in interpretation 
existed between researchers and sites. This information was used iteratively to improve 
standardisation of data collection processes and reduce any variability in application of 
data definitions that could impact negatively on the robustness of the study results.  
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Pages requiring collection of patient identifiable data contained no clinical data. Similarly, 
pages containing clinical data contained no patient identifiable data. Participant records 
were linked only by a unique identifier provided at registration. 
4.1.7 Sample size 
The study sample size was based on pragmatic consideration of the average number of 
patients admitted to each study site with stroke over a proposed recruitment period of six 
months. A formal power calculation was not performed as the ‘treatment effect’ of 
complex stroke care is difficult to quantify, and is likely to depend on process and care 
structure variables.  
A conservative estimate of 30 patients per month per site admitted to each of the three 
sites was made based on the number of stroke admissions to the smaller study sites 
(Bradford Teaching Hospitals Trust and York Hospitals NHS Foundation Trust). Of the 
patients admitted with stroke it was assumed that one fifth would have suffered severe 
strokes and not be expected to survive until six month follow-up, and a further quarter 
would not be able to (or wish to) provide informed consent. A recruitment target of 300 
(one hundred patients at each site) over six months was therefore set.  
4.2 Development of the research dataset 
The research dataset comprises four components: process markers, case-mix variables 
care structure variables and patient reported outcomes. The best available case-mix model 
and the outcome measures were defined through comprehensive examination of the 
literature as described in the following sections.  The process variables included in the 
study were restricted to variables extracted from the RCP NSSA dataset and existing 
mandatory data requirements for stroke. Additional univariable case-mix variables were 
included in the study dataset based on the RCP dataset and clinical reasoning as described 
in section 4.2.3. 
4.2.1 Patient reported outcomes dataset 
A previously conducted systematic review of outcome indicators, valid and reliable for 
postal administration, examined as a thesis for a Master of Public Health was used to 
inform the choice of patient and carer outcomes questionnaires (Teale EA et al  2010). Six 
patient and three carer instruments with acceptable psychometric properties for self or 
proxy completion in physical, social and psychological domains (Table 8) were identified. 
Acceptable psychometric properties in terms of patient proxy agreement are particularly 
pertinent, as patients with dysphasia or cognitive problems were not excluded from study 
recruitment and some proxy completed questionnaires were returned.  
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 Patient and carer outcomes instruments identified in previously Table 8
conducted systematic review (Teale EA et al 2010) 
Patient outcomes instruments 
Nottingham Extended Activities of Daily Living (NEADL) 
Frenchay Activities Index (FAI) 
Subjective Index of Physical and Social Outcome (SIPSO) 
EuroQoL (EQ5D) 
London Handicap Score (LHS) 
London Stroke Satisfaction Questionnaire (LSSS) 
Carer strain instruments 
Carer Strain Index (CSI) 
Carer Burden Score (CBS) 
Bakas Carer Outcomes Score (BCOS) 
 
In order to refine these instruments to create the battery of questionnaires for use in the 
CIMSS research study, consensus expert and consumer group consensus was sought. A 
stroke consumer group (Consumer Research Advisory Group (CRAG) for the Yorkshire 
Stroke Research Network) was consulted for views and opinions regarding utility of 
questionnaires including layout, wording and content. 
A workshop with stroke clinicians and members of the stroke multidisciplinary team was 
also conducted and used group decision making techniques (nominal group theory) to rank 
the instruments identified through the postal stroke outcomes systematic review. 
Participants were asked to first list the important features of an outcomes measurement 
instrument in terms of utility (e.g. depth of questions, breadth of questions, important 
constructs to measure). These features were then ranked by all participants and the five 
most consistent important features identified. Participants were then asked to perform 
pairwise comparisons of all permutations of the outcomes instruments to create a ranking 
of all the identified instruments. These rankings were then combined to give an overall 
ranking of the individual outcomes measurement instruments. The instructions given to 
participants at the group decision making workshop is included in appendix B-1. Three 
patient questionnaires and one carer outcome questionnaire were identified through this 
process for inclusion in the outcomes datasets. These were the Nottingham Extended 
Activities of Daily Living (NEADL) (Lincoln et al  1992), the Subjective Index of Physical and 
Social Outcome (SIPSO) (Trigg et al  2000) and EuroQoL (EQ5D) (The EuroQoL Group 1990) 
patient outcomes questionnaires and for carers, the Carer Strain Index (Robinson B 1983). 
The use of visual analogue scales (VAS) has been shown to be unreliable in patients 
following stroke (Price et al  1999). For this reason, the EQ5D questionnaire was used, but 
the VAS was not included in the outcomes booklet.  
The SIPSO instrument is provided in appendix B-3. It is a stroke specific scale in two 
subscales measuring physical and social reintegration following stroke (each comprising 
five questions with a five level response). The SIPSO has been shown to be well completed 
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when administered by post (88-97% of returned questionnaires fully completed (Trigg 
2000, 2003; Kersten et al 2004)) and to have acceptable patient-proxy agreement in total 
scores despite some variation in individual item agreement (Trigg et al 2003). A ceiling 
effect has been noted in the physical subscale in one validation study, although this study 
excluded dependent patients (Trigg et al 2000). The original validation studies suggest that 
the scores from the two subscales should be considered together (Trigg 2000), however, 
subsequent Rasch and Mokken analysis has suggested that the two subscores should be 
considered independently (Kersten 2010) (see also section 4.4.4).  
The Nottingham Extended Activities of Daily Living instrument addresses four domains of 
functioning (see Table 9). The NEADL was completed at baseline (with respect to the week 
prior to completion) and again at six months. The instructions given with the questionnaire 
indicated that patients should “record what you have actually done over the last week”. At 
the time the baseline surveys were designed, it was anticipated that patients would be 
recruited within a few days of admission to hospital such that the previous week would 
relate to their pre-stroke function. However, as recruitment was often delayed, patients 
may have completed the baseline questionnaire with respect to their immediate post-
stroke function. In future work, further clarification of the instruction to complete the 
baseline NEADL with respect to pre-stroke function will be required.   
The Six Simple Variable case-mix adjuster model was developed to predict the 
dichotomised Oxford Handicap Scale (OHS) (Counsell C et al  2002). A postal version of the 
OHS questionnaire (as used in the FOOD trial (Dennis MS et al  2003)) was therefore 
included in the outcomes dataset to allow stratification of patients according to the SSV 
case-mix adjuster (see appendix B-2).  
The systematic review of patient outcomes following stroke did not identify any measure 
of patient mood following stroke that was valid and reliable for postal administration. The 
GHQ_12 has been shown to be valid in patients following stroke, but lacks evidence of 
postal reliability (Teale EA et al  2010). In order to evaluate the reliability of the GHQ_12 
collected by postal survey following stroke, a postal test-retest reliability study of the 
instrument was incorporated into the CIMSS research phase study.  
In addition to these outcomes questionnaires, questions regarding return to work, return 
to driving and information provision were included in the outcomes questionnaire pack. 
These aspects of patient recovery are included as quality markers in the National Stroke 
Strategy (Department of Health 2007b) and were therefore collected to explore any 
relationship between these markers and processes of care.  
Information regarding how the questionnaires were completed was also collected (self-
completed, own answers but completed by carer or proxy responses). In all, six outcomes 
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measurement instruments, and seven additional questions were included in the outcomes 
booklet. These are outlined in Table 9 (p 74) with a brief description of each instrument. 
4.2.2 Process data set 
A discussed in 1.2.1, best practice in stroke is described in national documents and there 
are several existing stroke process markers which have been developed to reflect the 
evidence base. The RCP NSSA audit dataset has evolved over the 12 years since its 
inception to reflect the emerging evidence base and consensus opinion on best practice 
(Intercollegiate Stroke Working Party 2011). Feasibility of retrospective extraction of these 
data from patient case-notes has been demonstrated through sequential audits. However, 
the audit datasets were not designed for prospective collection and, in addition, some of 
the markers are of unproven association with patient outcome. The process variables used 
in the CIMSS research phase were restricted to those used within the 2008 RCP NSSA 
dataset to allow specific exploration of case-mix adjusted process-outcome relationships. 
Through examination of systematically missing data, feasibility of prospective collection of 
RCP audit data will be tested. Components of the audit that were outwith the remit of the 
CIMSS research study were excluded (pre-hospital care and information regarding 
secondary prevention of stroke).  
The latent traits of the SIPSO subscores are those of (physical and social) reintegration 
following stroke. These are complex constructs and are likely to rely not only on physical 
recovery, but also on psychosocial factors such as mood, social networks and community 
services. The process variables included in the study reflect these factors through 
recording assessment of impairments (e.g. speech and language assessments, occupational 
therapy and physiotherapy assessments); social care needs assessment, mood assessment 
and whether or not patients were able to return to their pre-admission address. The 
provision of community rehabilitation is likely to influence patients’ functional and social 
reintegration following stroke. Collection of detailed data regarding post-hospital care was 
beyond the scope of the study. However, two markers post-discharge care delivery were 
collected: whether the patient was discharged to an intermediate care facility, and 
whether or not the patient received Early Supported Discharge (ESD) support. Whether or 
not a service included an ESD facility was also noted. For the purposes of the study, specific 
criteria as regards what comprises an ESD service were not stipulated, and ESD was said to 
be available providing a service was in place that facilitated early discharge from hospital 
with additional support and community therapy.  
Times and dates of admission to hospital, admission to a stroke unit and imaging were 
collected to allow the derivation of metrics in line with the mandatory Integrated 
Performance Measures and Best Practice Tariff metrics (direct admission to a stroke unit, 
proportion of a patient’s inpatient stay spent on a stroke unit and timeliness of brain 
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imaging) (Department of Health 2008d; Department of Health 2010b). The complete 
process dataset is provided in  Appendix B .  
4.2.3 Case-mix adjustment variables 
The best available case-mix adjuster was identified through a systematic review described 
in detail in Chapter 3. The Six Simple Variable case-mix adjustment model was used to 
adjust the study population for case-mix (Counsell C et al  2002). The SSV model was 
developed to predict independent survival with the dichotomised Oxford Handicap Score 
(OHS). The OHS is similar to the mRS, but with slight differences to the wording. A postal 
version of the OHS has also been developed (as used in the FOOD trial (Dennis et al 2006)). 
The postal OHS and mRS are included in Appendix 0 for comparison.  
The SSV model was derived on an inception cohort of up to 30 days post-stroke onset 
(Counsell C et al  2002), although subsequent testing has shown that the model functions 
well if the variables are collected within a week of the stroke event (Dennis MS et al  2003). 
In order to define a discrete inception cohort, case-mix variables were therefore collected 
on patients within one week of stroke onset.   
Additional case-mix adjustment variables were collected to investigate for a univariate 
predictor which may function as a simple case-mix adjuster. These variables were chosen 
as variables that either featured in the RCP NSSA dataset (e.g. reduced conscious level) or 
that have been postulated as predictors of post-stroke outcome (e.g. new urinary 
incontinence, or the Oxford Community Stroke Project (OCSP) classification of stroke 
(Bamford et al 1988)). Factors that may have a relationship with post-stroke function (e.g. 
the presence of speech or language deficits or the side of stroke), or that may confound 
the relationship between the baseline impairment and patient outcome (e.g. a previous 
disabling stroke or cognitive impairment) were also captured. For the purposes of the 
study, a pragmatic definition of drowsiness and confusion were applied. If there was 
documentation in the case-notes that there was evidence of the patient being drowsy or 
having a reduced conscious level between onset of stroke and recording of case-mix 
variables then patients were classified as having been drowsy. Similarly, if there was 
documented confusion (either through a narrative description or through more formal 
testing with a score such as the Abbreviated Mental Test or Mini Mental State 
Examination), patients were classified as having had confusion since the onset of the 
stroke. These pragmatic descriptions were applied in an attempt to reflect the ways in 
which these data may have been recorded during the course of routine patient care.  
There is likely to be a degree of correlation between some of these univariable case-mix 
variables and the SSV model, as they are likely to be proxy markers for stroke severity. 
However, redundant markers (where there is significant collinearity) will be removed 
through construction of regression trees and stepwise variable selection during the 
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modelling process. Case-mix variables collected during the study are tabulated in Appendix 
B.   
There are likely to be a number of additional factors that confound the relationships 
between processes of care and patient outcome. For example, pain could act as a true 
confounder through restricting the delivery of specific care processes (e.g physiotherapy) 
and limiting functional outcome following stroke. However, the complexity of case-mix in 
the post-stroke population makes it unlikely that all of these factors could ever be 
accounted for. It is anticipated that the case-mix variables and process markers will act as 
summary measures or proxies for additional features of case-mix that are not measured 
explicitly (for example, a question regarding pain is included in the baseline EQ5D).  An 
impression of how much variability in patient outcome is not explained by the variables in 
the model will be offered through examination of model fit. A poorly fitting model implies 
that there are important variables that have been excluded from the model. These could 
represent aspects of care process, organisational structure or case-mix.   
4.2.4 Care-Structure 
Organisational structure is likely to be an important mediator in the relationship between 
care process and patient outcome. The structure of stroke services in terms of staffing 
levels, capacity, patient monitoring, therapy time and specialist clinician input may all have 
an effect on patient outcome. However, in the CIMSS research study, it is unlikely that 
variability in organisational structure will be sufficiently diverse, nor the sample size large 
enough, to confidently attribute the effect of differences in patient outcome to variation in 
the organisation of stroke services.  
However, information regarding the organisation of stroke services at each of the study 
sites was captured at the beginning and end of the data collection period according to the 
RCP NSSA organisational audit proforma (Royal College of Physicians 2009a), to ensure that 
there were no significant changes in the delivery of care over the data collection period 
that may present otherwise unmeasured confounding variables in the determination of 
patient outcome within or between sites.  
4.3 Data collection processes 
4.3.1 Baseline data 
Following collection of screening data, patients and their carers were approached to 
provide informed consent. Patients receiving or likely to receive, palliative care (or their 
carers) were not approached to participate in the study. Once consent had been obtained, 
process data were extracted from patient case-notes. Data were extracted from existing 
records (case-notes and electronic hospital data systems) as far as possible in an attempt 
to mirror the capture of routine data. In this way, data items that are not routinely 
- 73 - 
 
recorded (or that may require additional data extraction resource) were highlighted. Data 
were recorded onto Case Report Forms (CRFs) designed for the study. Case-mix data were 
extracted with respect to the week immediately following the stroke.  
Patients (or their proxies) were asked to complete baseline outcome questionnaires (the 
Nottingham Extended Activities of Daily Living (NEADL), the General Health Questionnaire-
12 (GHQ-12) and the EuroQoL). This was to allow the baseline assessments to be used to 
adjust for six month outcomes (i.e. to account for a change in the outcome score from 
baseline). The instructions for completion of the NEADL refer to activities actually 
performed in the week prior to questionnaire completion. The GHQ-12 and EuroQoL are 
completed with respect to the day of completion, and therefore represent measures of 
mood and quality of life in the immediate post stroke period. The environment in which 
these data are collected (i.e. the acute stroke unit) and the sudden change of circumstance 
in the immediate post-stroke period may make these measures difficult to interpret.  
4.3.2 Data entry and verification of data 
Baseline assessments and the CRFs were returned to the Academic Unit of Elderly Care and 
Rehabilitation in Bradford, and data entered into a bespoke web-based browser electronic 
data collection system. Double data entry was performed to flag and reduce data 
transcription errors. Attempts to obtain missing data identified at the data entry stage 
were made by data entry clerks.  
4.3.3 Outcomes data 
Follow-up questionnaire packs containing the outcomes instruments and instructions for 
completion were sent to surviving patients with a covering letter at six months post 
recruitment. In an attempt to maximise the return rates of the postal questionnaires, the 
outcomes packs were endorsed by the Stroke Association (TSA) and carried the Stroke 
Association logo (no additional funding for the study was provided by TSA). Checks on 
residency and survival were made through access to the “NHS spine portal” and through 
contacting patients’ General Practitioners. Participants who did not respond to the initial 
questionnaire were contacted by telephone and a further outcome pack sent if necessary. 
Outcomes packs were returned to the Academic Unit of Elderly Care and Rehabilitation in 
Bradford and entered into a bespoke electronic data collection system. Hard copies of 
identifiable and non-identifiable data were stored separately under a unique identifying 
study number. Patients who did not respond following reminders were deemed ‘non-
responders’. The first 25 patients and carers at each site to respond to the outcomes 
questionnaire were sent a second (retest) questionnaire pack containing the postal version 
of the GHQ-12. The patient retest pack also contained the postal version of the modified 
Rankin Score.  
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  Outcomes questionnaires included in questionnaire packs  Table 9
Patient pack Number of items Comments 
“I would like more information 
about my stroke” 
1 question Quality marker from National Stroke Strategy. 
Post-discharge review 1 question Quality marker from National Stroke Strategy. 
Return to work 2 questions Quality marker from National Stroke Strategy. 
“Two simple questions” (Lindley 
RI et al  1994) 
2 questions 
Two questions to place patients into one of three groups: independent completely recovered (1), 
independent some residual problems (2), residual problems requires at least daily assistance (3). These 
can be mapped onto  the dichotomised OHS (1 = OHS of 0 or 1, 2 = OHS of 2, and 3 = OHS of at least 3) 
Nottingham Extended Activities of 
Daily Living (Lincoln NB et al  
1992) 
22 questions in 4 domains, 
four level responses 
Domains are: mobility, ‘in the kitchen’, domestic tasks, leisure activities. Questions are filled in with 
respect to what the patient has actually done in the last few weeks. Certain questions may be of limited 
relevance to some patients (do you write letters; do you manage your own garden; do you drive a car?) 
Subjective Index of Physical and 
Social Outcome (Trigg et al  2003) 
10 questions, 2 domains, 3 
level responses 
Physical and social subscores. 
EuroQoL (The EuroQoL Group. 
1990) 
5 questions, 3 level 
responses 
A measure of quality of life. A continuous utility score is calculated from which Quality Adjusted Life Years 
(QALYs) may be calculated.  
GHQ-12 (Goldberg D et al  1988) 
12 questions, 4 level 
responses 
A screening tool for anxiety and depression. Lacks evidence of postal test-retest reliability in stroke 
populations and included in order to test this. 
Postal Oxford Handicap Score 
(Dennis M et al  2006) 
6 mutually exclusive 
questions 
Scored from 0-5 to indicate level of dependency following stroke. An extra category (6) is often used to 
represent patients that have died. Often dichotomised <=2 and>=3 to represent independent vs. 
dependent survival 
Proxy completion 3 questions Respondents were asked to indicate if they completed the questionnaire unaided or with assistance 
Carer pack   
Carer Strain Index (Robinson B 
1983) 
13 questions, yes/no 
responses 
Questions relating to different aspects of caring and the effect on the carer 
GHQ-12 (Goldberg D et al,  1988) 
12 questions, four level 
responses 
A screening tool for anxiety and depression. Lacks evidence of postal test-retest reliability in stroke 
populations and included in order to test this. 
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4.4 Statistical methods 
A statistical plan designed to answer the research questions outlined in section 1.4 was 
developed a priori (see appendix B-4). Statistical support was offered by colleagues in the 
department of Biostatistics at Leeds University (Theresa Munyombwe, Brian Cattle and 
Robert West).  
4.4.1 Data cleaning, outliers and missing data pattern analysis  
Data were inspected for outliers and where these were identified, the original data were 
checked to ensure that there had not been data entry errors or data likely to reflect errors 
in recording data (for example, negative lengths of stay).  
Tables were constructed (using STATA software) to examine the numbers of cases where 
there were missing data for individual item responses in patient reported questionnaires, 
and whether or not there were any patterns to this missingness. 
 
4.4.2 Examination of return rates for outcomes questionnaire packs 
The return rate for the six month questionnaire was calculated as the proportion of 
survivors to six month follow up who returned the questionnaire.  
 
4.4.3 Descriptive statistics  
4.4.3.1 Floor and ceiling effects of baseline and six month patient completed 
questionnaires 
Floor and ceiling effects were identified through examination of histograms of patient 
reported questionnaires and presented as the percentage scoring minimum or maximum 
scores on each scale. Floor or ceiling effects were noted if questionnaires had more than 
10% of respondents scoring at the extremes of the scale.  
4.4.3.2 Tests of normality of continuous variables 
Normality of continuous variables (and model residuals) was assessed through 
examination of histograms, and quantile normal (Q-Q) plots. In a normal (Q-Q) plot, the 
observed sample data is ranked in percentiles and plotted against the percentiles that 
would be expected if the data fitted a normal distribution. Deviation from a straight line in 
a Q-Q plot therefore indicates likely deviation from a normal distribution. Statistical 
significance at the 0.05 level on Shapiro-Wilk testing was used as a quantitative marker of 
deviation from a normal distribution. 
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4.4.3.2.1 Hypothesis testing 
In order for continuous variables to be treated as parametric data for hypothesis testing 
(e.g. in the examination of representativeness of the study sample), they must 
approximate a normal distribution. If normality assumptions were not met, data were 
treated as non-parametric data.  
4.4.3.2.2 Distributions of dependent regression model variables 
The link function that is applied to the generalised linear model in order to derive the 
equation that fits a model is dependent on the underlying distribution of the outcome 
(dependent) variable (see section 3.5.6). Normally distributed continuous dependent 
variables may be modelled through linear regression and binary outcomes (binomial 
distribution) through logistic regression models. Examination of the distribution of 
dependent variables may identify that the variables are likely to fit an alternative 
distribution (e.g. a Poisson distribution for count data (Fox J,  1997)).  
For the purposes of the linear regression modelling used in this study, continuous 
outcomes measurements should ideally be normally distributed. However, providing 
linearity assumptions (between individual independent predictors) and normality of 
residuals assumptions are met for any linear regression model, then non-normality of the 
dependent variable may be overlooked (see section 4.4.6.1.4). Where continuous 
outcomes variables are not normally distributed a variety of transformations have been 
explored to ascertain if the data can be normalised.  This function is performed in STATA 
using the ‘ladder’ and ‘gladder’ commands. Lower (and statistically significant) chi-squared 
values in the STATA output suggest a better fit of the data to a normal distribution 
following the transformation. A Shapiro-Wilk test and p value are provided to indicate the 
confidence with which the null hypothesis (that data are normally distributed) may be 
accepted or rejected.  Normal (Q-Q) plots are provided. Deviations at the tails of a 
distribution may represent the floor and ceiling effects of the measurement instruments. A 
mathematical function is unlikely to remove the presence of floor and ceiling effects, it is 
therefore unlikely that these distributions could be normalised through a simple 
transformation. An alternative model that accounts for censored data (such as a Tobit 
regression model) may be more appropriate in these instances (Twisk J et al  2009), 
although this is beyond the scope of this thesis.  
4.4.3.2.3 Independent regression model variables 
Normality of independent continuous variables in regression models is not essential, 
providing that model residuals are normally distributed (see 4.4.6.1.4). However, 
independent variables were examined to ascertain whether any transformation of the data 
improved normality, as this may improve model fit.  
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4.4.3.3 Examination of representativeness of study sample 
Analyses were performed to ascertain whether there were significant differences in 
baseline variables between sites, between patients recruited and not recruited into the 
study (through examination of screening data) and between patients who responded to 
the six month survey and those who did not respond, who died or who withdrew from the 
study.  
Examination of observed versus expected frequencies for categorical data were made with 
Chi squared tests (of Fischer’s exact tests for contingency tables with cells containing less 
than five patients).  
Identification of statistically significant differences between medians (non-parametric 
data) or means (parametric data) were made with Mann-Whitney U tests or independent 
sample t-tests respectively. Where these tests were across more than one group (e.g. 
comparisons across sites), a Kruskall-Wallis test (non-parametric) or oneway ANOVA 
(parametric) was performed. Pairwise examination of groups to identify the differences 
following a statistically significant Kruskall-Wallis or oneway ANOVA was then performed 
with Mann-Whitney U or independent sample t-tests. 
4.4.4 Conversion of SIPSO to interval level data  
The SIPSO outcome is an ordinal score and, as such, cannot be used in parametric 
statistical analyses. Rasch analysis is a statistical method whereby, providing the data fit 
the Rasch model, ordinal data can be converted to interval level data (thereby allowing 
mathematical manipulation and parametric analyses). Normality of the transformed score 
is not essential, providing that the assumptions of parametric analyses are met. The Rasch 
model generates a latent distribution of the probability of endorsement of an item in a 
scale (p) based on both person and question characteristics. In the context of the SIPSO, 
this means that patients with more of the latent trait (better social and physical 
reintegration) following their stroke are more likely to answer questions favourably, and 
that questions representing  lower functioning are more likely to be endorsed by all 
(Kersten et al 2010).  
Mokken analysis is a measure of the hierarchical nature of a scale. The hypothesis is that, 
patients will endorse items reflecting a level of function up to and including their actual 
function, but not items reflecting a greater level of function. Acceptable test statistics 
(Loevinger statistic >0.3) for this hypothesis, suggest that the scale is a valid, hierarchical 
scale (Kersten et al 2010).     
The Rasch model is a logit function of the generalised linear equation containing two 
terms: person characteristics and item difficulty (equation (4)). The number of patients 
within each decile of logit (p) may then be plotted to give a histogram of the distribution of 
‘endorsement’ (which should be approximately normal). If the item difficulty term is 
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plotted against this histogram, it can be seen whether or not the items in the scale reflect 
the person characteristics (i.e. patients with more of the trait are more likely to endorse 
more difficult items and vice versa) and whether the scale items cover the whole of the 
distribution of the latent trait, or it there are areas that the scale does not address.  
(4) &(4)  	
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&	... 		5'	. 	
The Rasch model relies on there being no interaction effects between person 
characteristics and item difficulty – i.e. older patients with a similar level of functioning 
should not answer questions differently to younger patients (differential item functioning). 
Differential item functioning should be explored to ensure that the scale properties do no 
vary according to baseline characteristics.  
Rasch and Mokken analyses have been performed for the SIPSO in a population of younger 
stroke survivors (aged under 65) (Kersten et al 2010), and transformation factors provided 
such that the discrete scale may be transformed to interval level data measuring the latent 
trait. This Rasch analysis identified a two factor scale and confirmed unidimensionality of 
the two subscores. Mokken analysis confirmed that these two subscores behaved as valid 
ordinal scales (Kersten et al 2010). Differential Item Functioning (DIF) was observed for 
gender for some items in both subscores and this was dealt with by collapsing items such 
that both subscales conformed to the Rasch model. No DIF was observed for age, however, 
as the population excluded patients over 65, this is not surprising. For the purposes of the 
study, the SIPSO subscores were transformed using the transformation factors provided by 
Kersten et al (2010), with the caveat that the absence of DIF for age needs to be confirmed 
in an older population. This is, however, beyond the scope of this thesis and limitations 
based on the assumption that the transformations are valid in an older population are 
discussed in section 6.3.1.  
4.4.5 Exploration of process-outcome linkages in the study population 
4.4.5.1 Univariate (unadjusted) analyses 
Unadjusted univariate analyses were performed to identify significant differences in 
patient outcome for patients that did, and did not receive specific process markers. 
Process markers coded “no”, “yes” and “no but”, would ideally be assessed with a oneway 
ANOVA. However, this relies upon normality assumptions being met for the outcome 
variables. Where these assumptions were not met, a Kruskall-Wallis test (non-parametric 
equivalent to the oneway ANOVA) was performed.  
Variables reaching statistical significance at the 1% level were identified for inclusion in 
subsequent regression models providing their relationship with patient outcome made 
clinical sense. Conversely, variables failing to reach statistical significance in univariate 
analyses were entered into regression models if they were felt to be clinically important 
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predictors. This helps to overcome problems with overfitting the model to the study 
population through inclusion or exclusion of variables on statistical rather than clinical 
grounds. 
4.4.5.2 Construction of decision trees to predict CIMSS study outcomes to identify 
important predictors 
Regression and classification trees are both types of decision tree and allow the graphical 
representation of the relative importance of independent variables in the prediction of the 
dependent outcome variable. Regression trees are used for the prediction of continuous 
outcomes, and classification trees for binary or categorical outcomes. As interval level 
outcomes have been used in the study (Rasch transformed SIPSO subscores), regression 
trees have been used. These have been constructed in R software (version 2.13.0) with no 
specification of the distribution of the dependent variable (i.e. a normal distribution of the 
outcome has not been assumed).   
In the construction of regression trees, study participants are categorised into groups of 
predicted outcome based on their combination of predictor variable values. Starting with a 
full model (including all the predictor variables in the dataset), each predictor variable is 
considered in turn in order to identify the predictor which defines two groups between 
which the difference in mean outcome score is maximal. The value at which this split 
occurs is the cut point for that predictor and forms the first branch of the tree. This 
variable is the most important predictor in the dataset in terms of explaining diversity in 
outcome. The process is repeated, conditional on preceding branches such that, at the 
bottom of the tree, several outcome groups are created based on the tree algorithm 
defined from the dataset. Trees were ‘pruned’ (lower branches removed) in order to 
remove less influential variables and prevent over interpretation of the data.  In 
interpreting regression trees, the left branch should be followed if the condition at the top 
of the branch is met (see Figure 95, Appendix C ).  
Regression trees do not rely on assumptions as regards the underlying distribution of the 
variables and there is no limit to the number or type of variables that may be entered into 
the equations to construct the trees (StatSoft Inc 2011). This allows the number of 
potential independent variables to be reduced before constructing final linear regression 
models.  For the purposes of this study, the regression trees have been used to identify 
prominent variables (and therefore potentially important variables in the prediction of 
patient outcome) rather than for the prediction of absolute values of the SIPSO outcomes. 
Two trees were created for each outcome. The first included baseline questionnaires (the 
Nottingham Extended Activities of Daily Living (NEADL), General Health Questionniare_12 
(GHQ_12) and the EuroQoL utility score (EQ5D)). The second did not include these 
variables. Both models contained the Barthel Index as a marker of baseline stroke severity. 
The reason for excluding baseline assessments from one set of models was to ascertain 
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whether outcome can be predicted without the need to collect baseline questionnaires, as 
collection of these data has implications in terms of resource and practicality in routine 
care. Variables entered into the regression tree models are given in Table 10 (p 81).  
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 Independent variables to be entered into regression tree models for prediction of the SIPSO subscores. Table 10
Demographic 
variables 
Prognostic/severity variables Patient movement Process Variables 
Baseline 
questionnaires 
Gender Length of stay 
Admitted to stroke unit on same 
day, or day after admission 
Scan within 24 hours of admission 
Baseline Barthel 
Index 
Ethnic group 
Propensity score 
(calculated from age, independence pre-stroke, living 
circumstances alone pre-stroke, normal or abnormal 
verbal GCS score, ability to lift arms above head and 
ability to walk independently) 
Ward type (ward patient first 
admitted to) 
tPA given Baseline NEADL 
Study site Pathological classification No stroke unit care Swallow screen in 24 hours Baseline EQ5D 
 Clinical classification (OCSP classification) Early supported discharge Aspirin in 48 hours Baseline GHQ_12 
 Weak side Discharged same address Physio in 48 hours  
 Dysphasia  OT in 4 days  
 Confusion at onset  MDT rehab goal setting  
 New urinary incontinence  Weighed during admission  
 Previous stroke  Mood assessment  
 Drowsy since presentation  Visual fields assessed  
   Sensory testing  
   Formal swallow in 72 hours  
   SLT communication assessment  
   Social worker assessment  
   Cognition screen  
   Malnutrition screen  
   Urinary incontinence care plan  
   Fluids within 24 hours of admission  
   Nutrition within 72 hours of admission  
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4.4.6 Construction of linear regression models to predict SIPSO using 
important clinical variables and predictors identified in decision trees  
The cut points defined in the regression trees are data driven – i.e. their absolute values 
are specific to the study data. The failure of important clinical predictors to feature in 
regression trees may represent peculiarities of the study dataset. The inclusion of these 
clinically important variables in the models may mediate the effect of variables which have 
been identified as important from the regression trees. As the focus of the study was the 
identification of potentially important predictors of patient outcome for further testing 
rather than the definition of prognostic models for external use, linear regression 
modelling was performed In order to explore the role of any clinically important predictors 
on variables identified through the data driven regression trees. 
4.4.6.1 A priori model variable selection 
4.4.6.1.1 Adjustment of the study sample using the SSV model  
In observational studies, the propensity score is often referred to as the probability that a 
patient will have received a particular intervention on the basis of their characteristics. 
Instead, I have used the propensity score to denote the probability of the patient having a 
good or poor outcome (alive and independent vs. not as measured with the dichotomised 
OHS). The propensity score was calculated from the SSV model (probability of poor 
outcome as measured with the OHS) using the published, and externally validated beta 
coefficients (Counsell C et al  2002). Propensity score was added to regression tree 
equations and to linear regression models as an independent, continuous predictor. This 
approach has previously been adopted to adjust for case-mix in stroke studies (Bravata DM 
et al 2010). 
The propensity score includes age and therefore age is not entered into the models as a 
separate variable (to avoid collinearity). Where propensity score does not feature in 
models, they have been re-run with age as an independent predictor as, in the absence of 
the propensity score, age may represent an important independent predictor of outcome. 
Additional case-mix or stroke severity variables are also added into the models to identify 
any further potentially important determinants of outcome that may be further 
investigated to see if they enhance the prognostic predictions of the SSV model.  
4.4.6.1.2 Process variables 
Independent variables included in each model are summarised in Table 11. These were 
identified for each SIPSO subscore, with and without baseline assessments, through clinical 
reasoning, the regression trees and through univariate analyses as described in sections 
5.7 & 5.8. 
The ‘no but’ codes of swallowing assessment, communication assessment and urinary 
incontinence variables indicate patients who do not require these assessments, either 
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because their strokes are too mild, or too severe. Examination of twoway tables of 
association between individual process markers (receipt of communication or continence 
assessments) and the respective specific impairments (presence of dysphasia or 
incontinence) reveals strong correlations (Chi-squared tests, p=<0.001 see appendix E-1.1). 
As such, the process variables may act as proxy markers for the presence of these deficits, 
and the presence of the deficits is therefore not modelled explicitly.  
Tests of linearity between individual predictors and the outcome were tested post model 
estimation as described in section 4.4.6.1.4. However, it was hypothesised a priori that the 
relationship between length of stay and physical outcome was likely to be non-linear, and 
this relationship was therefore explored prior to model development (see section 5.9.1).   
Forwards and backwards stepwise automated variable selection procedures were applied 
to the variables identified through clinical reasoning, regression trees and variables that 
featured prominently in the univariate analyses. Model parameters were set such that 
variables reaching the 0.05 significance level were added to the model, and those 
consequently failing to reach significance at the 0.05 level were automatically removed. 
Models were also run with these parameters set at 0.5 to ensure that the statistically 
important predictors did not change appreciably when additional clinically (but not 
statistically) significant variables were included in the models. Variables where there is 
evidence of collinearity are automatically removed by the STATA software during stepwise 
variable selection procedures. Dummy variables were created automatically by the STATA 
software to represent levels of categorical data. Each dummy variable is entered as a 
dichotomous variable with respect to the reference variable which has been selected as 
the zero category for consistency. As the models created are linear, the beta co-efficients 
represent change in SIPSO subscore that would be expected for a one unit change in the 
independent variable when all other variables are held constant (Altman D,  1999 p 337). 
For categorical (and dummy variables), the beta co-efficient represents the difference in 
mean SIPSO between the level of the variable and the reference variable with all other 
independent variables being held constant (Altman D,  1999 p 339). Variables within the 
model that reach statistical significance can either be identified through examination of 
the 95% confidence intervals (to see if they include zero implying non-significance) or 
through examination of the p value. Equations to predict the SIPSO score can be 
constructed from the beta-coefficients calculated through the modelling using the general 
linear equation (equation (2), page 49). 
A table identifying statistically significant predictors, with beta co-efficients and confidence 
intervals is provided for each model. The adjusted R-squared value gives the ‘variance 
explained’ by the model (Altman D,  1999 p 345). A model with an R-squared of 0.4, 
therefore, would therefore explain 40% of the variation in patient outcome through the 
predictor variables. An F statistic that reaches statistical significance implies that the model 
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explains a significant amount of variability in the dependent variable (Altman D,  1999 p 
346). Each model is followed by tests to ensure that the final models meet linearity, 
normality of residuals, homoscedasticity and absence of collinearity assumptions (see 
section 4.4.6.1.4).  
4.4.6.1.3 Pre-estimation checks 
The study dataset contains several potential independent predictors of outcome. The 
STATA software will automatically exclude cases where there are missing data for 
independent variables – i.e. a complete case analysis is performed. There are therefore a 
number of cases that may be excluded from the analysis. Imputation techniques may be 
employed to overcome this difficulty, although this is beyond the scope of this thesis. It is 
important to consider whether these missing data may bias any analyses and in order to 
investigate this I compared the Barthel Indices of patients with complete data (that would 
be included in models) and those where data is incomplete (that would be automatically 
excluded). The baseline Barthel Index has been chosen for the comparison as there is only 
one missing case for this measure.  
Pre-estimation checks of sample size for each model were performed, based on an event 
per variable (EPV) ratio of 10, as suggested by Peduzzi et al (Peduzzi P et al 1996). The 
number of variables entered into each linear model was limited to n/k where n=sample 
size and k=number of independent variables (including dummy variables).  
Interaction effects between independent variables occur when the effect of one predictor 
on the dependent variable is mediated by the effect of another (see section 3.5.7.2). 
Inclusion of interaction terms (as the product of the two independent variables) into 
regression models as dummy variables accounts for these interaction effects. However, 
due to the size of the study dataset, the number of interactions that would need to be 
modelled and the potential reduction in EPV that would occur through inclusion of 
interaction terms, these have not been modelled explicitly.  
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 Dependent and independent variables included in each model. Total number of variables (including dummies) presented. Table 11
 Model  
 1 2 3 4 5 6 7 8 9 
Dependent variable Physical 
SIPSO 
Physical SIPSO Physical 
SIPSO 
Physical 
SIPSO 
Physical SIPSO Social 
SIPSO 
Social SIPSO Social 
SIPSO 
Social SIPSO 
Description of model  
(independent variables) 
Full 
model   
Age instead of 
SSV 
Influential 
cases 
removed 
No baseline 
Ax 
No baseline Ax, 
influential 
cases removed 
Full 
model 
Influential 
cases 
removed 
No 
baseline Ax 
No baseline Ax, 
influential cases 
removed 
Independent variables Number of variables including dummies 
Length of stay 1 1 1 1 1 1 1 1 1 
Propensity score 1   1 1 1 1 1 1 
Age  1 1       
Baseline NEADL 1 1 1   1 1   
Baseline EQ5D 1 1 1   1 1   
Baseline Barthel Index    1 1     
Admitted to stroke unit on day, or 
day after admission  
       1 
1 
Lacunar vs non-lacunar stroke         1 1 
Early supported discharge        1 1 
Imaging within 24 hours        1 1 
Old stroke    1 1     
Formal swallowing assessment 2 2 2 2 2 2 2 2 2 
Communication assessment 2 2 2 2 2 2 2 2 2 
Social worker assessment 2 2 2 2 2 2 2 2 2 
Urinary incontinence care plan 2 2 2 2 2 2 2 2 2 
tPA given 2 2 2 2 2 2 2 2 2 
First admitted to ward for 
hyperacute stroke care 
1 1 1 1 1 1 1 1 
1 
Discharge to same address 1 1 1 1 1 1 1 1 1 
Total variables (including dummies) 16 16 16 16 16 15 15 18 18 
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4.4.6.1.4 Post-estimation checks 
a. Linearity assumptions 
In order for the model to be valid, there must be a linear relationship between the 
continuous (or ordinal) predictors (independent variable) and the outcome (dependent 
variable) (Fox J,  1997 p 113). This may be assessed in different ways. The simplest way is 
to plot the model residuals against the individual predictors to identify obviously non-
linear patterns (Chen X et al 2003). However, for this approach to be valid, there is an 
assumption that there is no relationship between the predictors in the model i.e. the 
presence of one predictor in a model does not affect the relationship between another 
predictor and the outcome. This is unlikely to be true for complex multivariable models 
(i.e. there is likely to be a degree of collinearity between variables). In order to circumvent 
this problem, a partial residual plot can be examined. Partial residuals are the component 
of variance attributable to a predictor having accounted for the variance due to other 
variables in the model.  Post estimation ‘augmented component plus residual plots’ 
(acprplot) may be constructed easily using STATA software (Chen X et al 2003) and can 
identify more complex (e.g. polynomial) relationships between independent and 
dependent variables  (Fox J,  1997 p 283). 
An alternative approach to detect non-linearity is to categorise the independent variable 
and fit a model to predict the outcome. Comparison of the estimates from a univariable 
linear regression model, with those from a model using the categorised variable can 
identify whether the two models are significantly different (i.e. whether the model created 
from the categorised data, which allows a more complex relationship to be revealed, 
deviates significantly from a simple linear prediction – the likelihood ratio test) (UCLA: 
Academic Technology Services 2011). If there is no significant difference between the two 
models, the relationship may be assumed to be linear.  
For the purposes of detecting non-linearity between predictors and outcome in the study 
data, I first plotted augmented component plus residual plots (acprplot). Where there is 
apparent deviation from linearity, I performed a likelihood ratio test to ascertain whether 
categorising the variable improves the model fit. However, it should be considered that 
categorisation of variables for the final models would result in the creation of dummy 
variables and this would therefore increase the number of variables which would need to 
be entered into the models. 
Where linearity assumptions between continuous independent the dependent variables 
are not met, transformations that have been shown to improve the normality of the 
distributions (as outlined in section 5.3) have been substituted and the models re-run. 
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b. Normality of residuals 
Residuals were estimated for each model constructed. These were tested for normality 
through Q-Q plots and Shapiro-Wilk testing (see 4.4.3.2) 
c. Homoscedasticity 
Homoscedasticity describes constant variance of model residuals across all fitted values. 
There should be no pattern in a scatter plot of fitted values against model residuals. Non-
uniform variance may indicate an omitted variable exerting a systematic effect on the 
model (Fox J, 1997 p302). Homoscedasticity has been assessed through inspecting scatter 
plots of fitted values vs residuals and through quantitative hypothesis testing where 
rejection of the null hypothesis of homogeneity of variance occurs when the test reaches 
statistical significance at the 0.05 level (Breusch-Pagan test (Chen X et al 2003)).   
d. Absence of collinearity 
Entering independent predictor variables that are linearly related into regression models 
can lead to inflated or unstable beta co-efficients with wide confidence intervals. This can 
potentially result in poorly generalizable models where the relative importance of 
individual predictors is overestimated (Fox J, 1997 p337). Collinearity has been addressed a 
priori through application of clinical reasoning to model variable selection and during 
model construction through stepwise variable selection procedures, which reduces 
collinearity (Concaco J et al 1993). In addition, variance inflation factors (as a measure of 
any effect of collinearity on beta coefficients) were examined post-estimation (Fox J 1997).  
Variance inflation factors (VIF) greater than 10 are of concern and may indicate collinearity 
between independent predictors.  
e. Influence and Leverage (DFBetas and Cook’s D statistics) 
The influence of individual cases on the model regression co-efficient or individual beta co-
efficients depends on leverage (where a point lies relative to the distribution of the 
independent variable (X)), and it’s residual. In simple terms, in the same way that torque is 
the product of distance from a pivot and force applied, the influence of a case on a 
regression line is a product of its leverage (distance from the centre of the distribution of 
X) and its residual (deviation of a point from the regression line for a given value of X).  
High leverage points occur where individual cases occur at the extremes of the distribution 
of the independent variable (Fox J,  1997 p 268). Cases with unusual values for 
independent variables (at high leverage points) do not exert undue influence if the 
observed outcome is as predicted by the model (small residual) as they lie on, or near, the 
regression line (they are not regression outliers). Cases with large residuals exert less 
influence if the value of the independent variable is within the distribution of the variable 
for other cases (low leverage points). Conversely, cases with large residuals at high 
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leverage points can exert considerable influence on the model co-efficients (Fox J 1997 
p269).  
A plot of leverage against the square of residuals can identify cases that are exerting 
particular influence on a regression model (Chen X et al 2003), and these have been 
provided for each specified model. The horizontal and vertical lines on the leverage vs. r-
squared plot represent the mean leverage and r squared for all the points in the model. 
 Influence can be explored quantitatively through calculation of Cook’s D statistic (D) - an 
overall marker of influence on the regression coefficient for each individual case (Fox J,  
1997 p 277). The cut-off value of Cook’s D above which individual points are likely to be 
exerting influence is determined as 4/n where n = the number of complete observations 
from which the model has been constructed (Chen X et al 2003). Cook’s D statistics have 
been calculated for each model to identify particularly influential cases. 
A measure of the effect of influential cases on individual beta-coefficients may be obtained 
through the calculation of DFBETA statistics. For each variable in a model, the beta co-
efficients are calculated with all cases included, and then with each case excluded in turn. 
The modulus of the difference between these values is the DFBETA value for an individual 
case. This value is scaled by the standard error of the omitted co-efficient to enable the 
values to be compared on a single scatter plot (Fox J 1997 p276). Particularly influential 
cases are those where the magnitude of this difference is greater than 2/√n, (where n= the 
number of observations in the model (Chen X et al 2003). These limits may be presented 
the scatter diagram, such that outlying cases for particular variables can be seen. 
It should be remembered that outliers do not necessarily represent ‘wrong’ data, but cases 
where outcomes are different to that which would be expected from the specified model.  
4.4.7 Performance of the SSV case-mix adjuster to predict study outcomes 
Utility of the SSV case-mix adjuster was explored through examination of its discriminatory 
properties (c-statistic) and calibration in the study dataset. These methods have been 
discussed in sections 3.5.9.1 and 3.5.9.2. In short, discrimination is the ability of a model to 
determine which, from of a pair of participants with incongruous outcomes, will have the 
outcome of interest (Harrell FE et al 1996). Calibration is the ability of a model to correctly 
predict outcome in the population of study participants.  
In order to examine discrimination and calibration of the SSV and any identified univariable 
predictor to predict the SIPSO outcomes requires the SIPSO to be dichotomised to reflect 
‘good’ over ‘poor’ outcome. Such a cut point for the SIPSO has not been determined in the 
literature. The cut point was therefore created at the level that represented a score of 3 on 
each of the individual SIPSO questionnaire items (representing a mild residual deficit that 
does not interfere appreciably with daily living), and the SIPSO subscores were 
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dichotomised at 15. This was felt to be clinically comparable to an OHS dichotomised at 
<=2. Analyses were also performed using the data driven median of the SIPSO subscores to 
represent good over poor outcome. The calculations of c statistics were also performed 
first excluding, and then including and ascribing a score of zero, to patients who died.  
4.4.7.1 Model discrimination (measured with c statistics) 
For examination of the c statistics of the SSV model, covariates from the original published 
model were used to calculate the probability of outcome for each study participant 
(propensity score) using the generalised linear equation with a logit function (equation (3) 
p 49). These were then used against dichotomised study outcomes to plot Receiver 
Operating Curves (ROC).The area under a ROC curve for a binary outcome is equal to the c 
statistic. Confidence intervals were also calculated. 
 There is no value above which a c statistic is ‘good’ as this depends on both the clinical 
context and the purposes for which the model will be used. For the purposes of this study, 
the c statistics have therefore been used to examine the relative performance of the SSV 
model with any identified univariate predictor.  
4.4.7.2 Calibration of the SSV in the CIMSS study population (calibration plots) 
Within each decile of predicted probability (between 0 and 1), the proportion of patients 
(p) with observed good outcome (OHS <=2) was calculated and plotted (Counsell C et al 
2002). Errors bars were created based on calculation of 95% confidence intervals for 
proportions, given by equation (5). 
(5) 95%	confidence	interval	of	p		p	±	1.96IJ(
+J)K 	
Perfect calibration would be represented by all points falling on a line x=y (i.e. where 
predicted probability equals observed probability). 
4.4.8 Exploration of potential univariate predictors of outcome that could be 
used in addition to, or instead of the SSV case-mix adjuster 
Prominent variables in the models that may have utility as univariate case-mix adjusters 
were identified. In order to test their utility, they were entered as a single predictor into a 
logistic regression model to predict the dichotomised outcome. Fitted values from this 
model represent predicted probability of outcome using the univariable predictor. These 
fitted values were then used to plot ROC curves to examine discriminatory properties.  
Calibration curves for variables identified through the study to predict the dichotomised 
outcomes have not been constructed as the predicted outcomes are derived from the 
observed outcome and these values would therefore be dependent on each other. In order 
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to test calibration of univariable study variables, external validation in an independent 
dataset would be required.  
4.4.9 Markov Chain MonteCarlo (MCMC) simulation iterations  
In order to test the stability and convergence of model beta coefficients, single level 
regression models were recreated in MLWiN software and Markov Chain MonteCarlo 
iterations performed. A model is specified in the study dataset and the beta-coefficients 
and their standard errors are used to simulate latent distributions model beta co-efficients 
for each variable. This distribution is used to perform multiple automated calculations of 
estimates of the coefficient for one variable conditional on the other variables. The 
procedure is then repeated iteratively for each variable in turn resulting in estimations of 
model beta coefficients which ‘settle’ on an approximation of the true model co-efficients 
(central limit theory). If estimates of beta co-efficients fail to converge on a value after 
repeated iterations, the model is unstable. For the purposes of this study, 5000 MCMC 
post-estimation iterations were performed, with a ‘burn in’ of 50 iterations.  
 
4.5 Data manipulation 
Data were stored as comma separated variable (.csv) files within the data collection system 
and exported directly to statistical software. STATA version 11 was used for statistical 
analysis. Manipulation of variables was performed through creation of syntax files (.do 
files) to allow real time data exports to be used in data analysis.  
Dates and times were converted from string variables to numerical variables, and 
categorical variables coded. For consistency, ‘no’ or ‘false’ was assigned a value of zero, 
and ‘yes’ or ‘true’ a value of one. ‘No but’ scores (processes that are either not indicated or 
contraindicated) are assigned a score of 2.  
Where possible, durations were calculated from dates and times:  
• Length of stay 
• Time from hospital admission to scan 
• Time to stroke unit admission 
• Length of stay on stroke unit 
• Length of stay post stroke unit discharge 
Baseline and six month outcomes questionnaires were scored or coded as suggested in the 
literature, or by the authors of the instruments.  
The NEADL and Barthel Index use a total summed score. Providing linearity and normality 
of residuals assumptions are met, these may be entered into regression models as 
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continuous variables. If model assumptions are not met (see section 4.4.6.1.4.), they must 
be analysed as non-parametric data and treated as either ordinal data or categorised and 
treated as categorical data. 
The General Health Questionnaire-12 (GHQ-12) has been scored using the dichotomised 
rather than Likert scoring system (Goldberg D et al,  1988). This system of GHQ-12 scoring 
ascribes a score of 0 for patients reporting absence of problems or no better/worse than 
usual and a score of 1 otherwise. A total GHQ-12 score is therefore out of a maximum of 
12 (with higher scores indicating more problems). The GHQ-12 is again treated as 
continuous data unless violations to assumptions are encountered when it will be 
dichotomised. This is with the acceptance of the loss of information that this will incur. 
Both the SIPSO and EuroQoL have conversion algorithms that allow the summed score to 
be converted to an interval score. These variables are therefore treated as continuous 
variables providing linearity and normality of residuals assumptions are met. Although 
performed on a population of younger patients (Kersten et al  2010), the output from the 
Rasch analysis of the SIPSO should not be dependent on the underlying population and the 
conversion should therefore be transferable. However, this is with the caveat that specific 
examination of differential item functioning of age has not been performed in an older 
population. Using ‘time trade off (TTO) techniques and visual analogue scales based on 
‘value sets’ the creators of the EQ5D have developed formulae to allow conversion of an 
individual’s answers across the five EQ5D questions to a continuous score (between -1 and 
1) to reflect perceived quality of life. These norms are country specific and the UK ‘time 
trade off’ values have been used for the purposes of this study (Rabin R et al 2011).  
The SSV case-mix model is used to calculate the probability of good outcome using the 
beta coefficients from the equation created through the original logistic regression analysis 
(Counsell C et al  2002). This probability of outcome was then dichotomised at 0.8 to give 
the probability of good (≥0.8) over poor (<0.8) outcome. The value of 0.8 was chosen as 
this is the cut off that was used to stratify in the FOOD trial (M Dennis, personal 
communication), the data from which formed a large external validation study of the SSV 
model (Dennis MS et al  2003).  In observational studies, a propensity score usually refers 
to the calculated likelihood of a patient receiving a specific treatment based on their 
characteristics, however, for the purposes of this thesis, the propensity score has been 
used to denote the probability of a patient having a good outcome (defined in this case as 
a dichotomised modified Rankin Score of less than three) based on their baseline 
characteristics. 
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Chapter 5 Results 
5.1 Data cleaning 
5.1.1 Outliers in continuous process data 
Inspection of continuous process variables was performed to identify any outliers. This 
revealed some anomalies requiring further inspection of the variables ‘date and time of 
hospital admission’ and ‘date and time of admission to the stroke unit’. For four patients the 
date and time to admission to the stroke unit is before the date and time of admission to 
hospital. This may be possible for in-hospital strokes, but the differences in time are small (-
4.3 to -0.8 hours). This is therefore more likely to reflect an error or inconsistency in the way 
that the time of admission was recorded.  Discussion with researchers revealed that this 
variable was extracted from either ED records or from the Patient Administration System 
(PAS) where the ED records were not available. It is possible therefore, that the unreliability 
of the data stems from inconsistencies within the PAS database.  This inconsistency has 
implications for the reliability of other variables that rely on time of hospital admission for 
calculation (e.g. time to scan). These variables have therefore been excluded from further 
analysis as the number of cases where there may be inconsistencies is not apparent. 
Variables that rely on date of admission (e.g. length of stay), are however unaffected by the 
time of admission and may therefore be calculated. The variable “scan within 24 hours of 
admission”, was recorded as a dichotomous yes/no response. Although the derivation of this 
variable requires knowledge of both the time of admission and time of scan, it does not rely 
on these times having been recorded in the CRF.  There is an assumption in the use of this 
variable that the times of hospital admission and time of scan were available for the 
researchers to calculate whether or not the scan occurred within 24 hours of admission to 
hospital (and that this calculation was correct). However, this assumption may not be valid. A 
preferable approach would have been to record the primary data from which the variable 
was calculated rather than recording the derived variable. The relative merits and difficulties 
of recording data in this way are discussed in section 6.3.3.  
There were marked inconsistencies between the length of stay on a stroke unit recorded as 
number of days by the stroke researchers and the calculated length of stay from dates of 
admission and discharge where these were available. The date of discharge from the stroke 
unit is missing in 203/298 (68%) of patients who received treatment on a stroke unit. As a 
consequence, the number of missing data for days on a stroke unit and proportion of stay 
spent on a stroke unit make the use of these variables unviable as the risk of systematic error 
is too great (39% each). Length of stay on a stroke unit has therefore not been used as a 
variable as the data were deemed to be unreliable.  
For the purposes of analysis therefore, admission to a stroke unit for any part of the inpatient 
spell (vs. no stroke unit care), admission to stroke unit on the same day or day after hospital 
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admission and total length of hospital stay (calculated from date of hospital admission and 
date of hospital discharge) have been used as markers of timeliness of stroke unit admission. 
Length of acute hospital stay in whole days was derived from the date of admission and date 
of discharge from the acute hospital, as recorded by the study researchers in the CRF. 
Additional post discharge lengths of stay in geographically distinct inpatient rehabilitation 
facilities, intermediate care facilities or any time spent under the care of post-discharge 
community rehabilitation or early supported discharge teams were not recorded. Patients 
discharged from the acute trust to receive further community therapy are likely to represent 
patients from a different subgroup of the post-stroke population to those patients that 
require protracted lengths of acute hospital care due to the severity of, or complications 
from, their stroke. It would therefore have been beneficial to measure and model the 
duration and nature of community rehabilitation separately from the acute hospital stay; the 
approach to the measurement of lengths of stay used in the study could be argued to be over 
simplistic, and to exclude important aspects of additional post-stroke rehabilitation. 
However, the study was not resourced to capture these post-acute hospital data. 
Spurious data for length of stay were identified through examination of negative values and 
identification of cases where duration from hospital admission to stroke unit admission or 
stroke unit discharge to hospital discharge were particularly long (two cases) or where there 
were negative values for length of stay (one case). This identified three cases with spurious 
data which, when checked against the original CRF reflected data recording or data entry 
errors of exactly one month in either hospital admission or hospital discharge dates. These 
were assumed to be erroneous and were corrected. 
After correction for the spurious data, an examination of a histogram of length of stay reveals 
that there is still a very wide distribution. However, on examination of individual records for 
patients with lengths of stay greater than 100 days, these were felt to reflect true lengths of 
stay. They were therefore retained.  
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Figure 8 Distribution of length of stay in study population 
 
The distribution of patient age at stroke demonstrates marked negative skew. This reflects 
the increased incidence of stroke with increasing age. Although there are two outliers 
markedly younger than the rest of the population, this is clinically feasible.  
Figure 9 Distribution of age at stroke in study population 
0
1
0
2
0
3
0
F
re
q
u
e
n
c
y
0 50 100 150
Length of stay
0
1
0
2
0
3
0
4
0
F
re
q
u
e
n
c
y
20 40 60 80 100
Age_at_stroke
- 95 - 
 
5.2 Missing data   
5.2.1 Continuous process data 
The process markers selected to represent length of stay and timeliness of stroke unit 
admission are generally well completed. 
 Missing data regarding stroke unit treatment and length of stay by site Table 12
Variable Site Number 
recruited 
Number missing 
data 
Proportion of missing 
data 
Treated on a 
Stroke Unit for 
part of inpatient 
stay 
Bradford 71 1 1.5% 
Leeds 125 1 0.8 
York 
116 0 - 
Admission to SU 
same day, or day 
after admission 
Bradford 71 3 4.2% 
Leeds 125 14 11.2% 
York 116 4 3.4% 
Length of stay Bradford 71 1 1.5% 
Leeds 125 11 9% 
York 116 4 3% 
The rates of missing data for length of stay are small (16 cases in total, with the majority of 
missing data from Leeds). A Kruskall-Wallis (equivalence of populations test) between sites 
reveals that there is a significant difference in the median length of stay between sites (chi-
squared (χ2) = 21.1, degrees of freedom (ν) = 2, p<0.001).  
Figure 10 Length of stay by study site 
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If the median length of stay (for all sites) is imputed for missing values at each site (10 days), 
the difference in median length of stay between sites remains significant (χ2 = 21.4, ν = 2, 
p<0.001). This difference also remains significant if the median length of stay at each site is 
imputed (Bradford 13 days, Leeds 14 days, York 6 days) rather than the median across sites 
(χ2 = 21.5, ν = 2, p<0.001).  
A box plot to examine the effect of imputation of the median length of stay (LOS_imput) on 
the distribution of length of stay reveals that this does not significantly change the median 
length of stay. Missing data for length of stay may therefore be ignored.  
Figure 11 Box plot of length of stay across sites and with imputation of median 
length of stay  
  
5.2.2 Categorical process data 
Missing data for categorical data were infrequent (Table 12). Researchers reported particular 
difficulty in extracting the time of imaging as this was often not recorded in patient case 
notes. These data were therefore obtained from the electronic results servers at each trust.
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 Missing categorical data Table 13
Variable Missing (%) 
Patient not treated on a stroke unit 2  
Discharge address the same as admission address 2 
Admitted to stroke unit on same day, or day after presentation 21 (7) 
Type of ward patient first admitted to  3 
Patient discharged with Early Supported Discharge team input 18 (6) 
Radiological classification of stroke (infarct or haemorrhage) 2 
OCSP classification of stroke 17 (5) 
Side of weakness 1 
Lived alone or cohabited pre-stroke, or admitted from nursing or residential care 10 (3) 
Independent activities of daily living prior to stroke 0 
Normal verbal GCS score 0 
Able to lift arms above head (or MRC power score >=3) in week following stroke 1 
Able to walk unaided in week following stroke 1 
Drowsy since presentation to hospital  4 
Evidence of dysphasia 0 
Evidence of confusion 2 
New urinary incontinence or newly catheterised since stroke 5 
Previous disabling stroke 1 
Imaging performed within 24 hours 5 
Thrombolysis (rtPA) given 2 
Swallowing screen performed within 24 hours of admission 2 
Aspirin (or alternative antiplatelet) given within 48 hours of admission 1 
Physiotherapy assessment within 48 hours of admission 1 
Occupational therapy assessment within 4 working days of admission 4 
Evidence of multidisciplinary team goal setting 1 
Patient weighed during the admission 1 
Evidence of an assessment of patient mood 7 
Documented visual field assessment 2 
Documented sensory assessment 3 
Formal swallowing assessment (by Speech and Language therapist) within 72 hours 2 
Formal communication assessment by Speech and Language therapist 1 
Assessment by social worker 2 
Assessment of cognitive function 3 
Patient screened for malnutrition 0 
Documented continence promotion plan 2 
In receipt of fluids within 24 hours of admission  0 
In receipt of nutrition within 72 hours of admission  0 
As cases with missing data will be excluded automatically when entered as independent 
variables into regression models, the outcomes of those with missing data (and therefore 
excluded from the analysis) will be compared with those with complete data to ensure that 
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there is no systematic difference between patients with complete data and those in whom 
data are missing. 
5.2.3 Missing Baseline questionnaire data 
Baseline questionnaire packs were not returned for ten patients. There was only one 
participant where a baseline Barthel Index was not available.  
5.2.3.1 The Nottingham Extended Activities of Daily Living (NEADL) baseline 
questionnaire 
The NEADL was fully completed by 90% of patients at baseline. Missing values were spread 
across seven variables (managing garden, writing letters, driving, going out socially, reading 
books, managing money and using the phone). Management of the garden was the most 
frequently omitted item (8 participants for whom baseline assessments were available 
excluded the item). Missing items tend to be from the ‘leisure activities’ subscale of the 
NEADL. The total number of missing items for each of the subscores is shown in Table 14, 
with the number of patients responsible for the missing data. The majority of the missing 
data are in the domestic tasks and leisure activities subscales of the questionnaire. Three 
participants missed the last 11 items which may reflect omitting (or overlooking) an entire 
page of the questionnaire.  
 Missing data by domain for NEADL questionnaire (missing baseline packs Table 14
excluded)  
NEADL Subscore Total number of missing data 
Number of participants with 
missing data 
Mobility 13 8 
‘In the Kitchen’ 4 1 
Domestic tasks 27 10 
Leisure activities 42 16 
 
5.2.3.2 The EuroQoL 
The number of missing data items for each question of each questionnaire is presented. The 
‘missing value patterns’ tables identify if there are patterns in the combinations of missing 
data by displaying number of patients with missing responses (indicated by a 1) for each  
question. In these tables a 1 that the item was missing. For example, in Table 15, 6 patients 
omitted only the question pertaining to ability to perform usual activities on the EQ5D, whilst 
three omitted two questions pertaining to pain and anxiety - highlighted in grey in the table.
- 99 - 
 
 
 Missing data patterns by domain in the baseline EuroQoL (including ten Table 15
missing baseline packs) 
Number of 
patients  
1 1 2 2 3 5 6 10 282 
Total missing 
data  
Mobility 0 0 0 0 0 0 0 1 0 10 
Self-care 1 1 0 1 0 0 0 1 0 14 
Usual activities 1 1 0 0 0 0 1 1 0 18 
Pain/discomfort 0 1 1 0 1 0 0 1 0 16 
Anxiety/depression 1 0 0 0 1 1 0 1 0 19 
  Nine returned baseline questionnaires had missing data for the anxiety question.  
5.2.3.3 GHQ-12 baseline 
The authors of the GHQ_12 instrument suggest that missing GHQ-12 items are replaced with 
the most pessimistic score (Goldberg D et al,  1988) . However, missing data analysis of the 
raw data from returned baseline questionnaires reveals missing data across all questions 0. 
Again, ten baseline assessments were not returned and these are included in the table of 
missing data. Three patients who returned a baseline questionnaire pack did not complete 
any of the GHQ-12 questionnaires.  
 Key for Table 17 (questions of the GHQ-12) Table 16
Key Question: Have you recently… 
1 been able to concentrate on whatever you’re doing 
2 lost much sleep over worry? 
3 felt that you are playing a useful part in things? 
4 Felt capable of making decisions about things? 
5 felt constantly under strain? 
6 felt you couldn’t overcome your difficulties? 
7 been able to enjoy your normal day-to-day activities? 
8 been able to face up to your problems? 
9 been feeling unhappy and depressed? 
10 been losing confidence in yourself? 
11 been thinking of yourself as a worthless person? 
12 been feeling reasonably happy, all things considered? 
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 Missing data patterns for baseline GHQ_12 Table 17
   Question number 
  1 2 3 4 5 6 7 8 9 10 11 12 
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13 1 1 1 1 1 1 1 1 1 1 1 1 
3 0 1 0 0 0 0 0 0 0 0 0 0 
3 0 0 1 0 0 0 0 0 0 0 0 0 
3 0 0 0 0 0 0 0 0 0 1 0 0 
2 0 0 0 1 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 1 0 0 0 0 0 
1 1 0 1 0 0 0 1 0 0 0 0 0 
1 1 0 0 1 0 0 0 0 0 0 0 0 
1 1 0 0 0 0 0 0 0 1 1 0 0 
1 1 0 0 0 0 0 0 0 1 0 0 0 
1 0 0 0 0 1 1 1 1 1 1 1 1 
1 0 0 0 0 1 1 0 0 1 0 0 0 
1 0 0 0 0 1 0 0 0 0 0 0 0 
1 0 0 0 0 0 1 0 0 1 1 0 0 
1 0 0 0 0 0 1 0 0 0 0 1 1 
1 0 0 0 0 0 1 0 0 0 0 0 1 
1 0 0 0 0 0 1 0 0 0 0 0 0 
1 0 0 0 0 0 0 0 1 0 0 0 0 
1 0 0 0 0 0 0 0 0 1 1 1 1 
1 0 0 0 0 0 0 0 0 1 1 1 0 
1 0 0 0 0 0 0 0 0 1 0 0 0 
1 0 0 0 0 0 0 0 0 0 0 0 1 
270 0 0 0 0 0 0 0 0 0 0 0 0 
Total 17 16 17 16 16 19 17 15 21 21 17 18 
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5.2.4 Outcomes data 
5.2.4.1 Missing outcome packs 
The flow of patients recruited into the study is shown in Figure 12. The overall response rate 
was calculated as the proportion of survivors responding to the questionnaire at six months 
(after reminders if these were required).   
Figure 12 Questionnaire returns at six month follow up 
 
Response rate  = 188 / 266 = 71% 
 
5.2.4.2 Missing individual items 
Figure 13 to Figure 18 represent the total number of missing questions for each outcome 
broken down by subscales where these apply (NEADL and SIPSO). For example, Figure 13 
concerning the NEADL shows that seven respondents missed one item from the mobility 
subscale, one respondent missed three items from the domestic subscale and two 
respondents missed four items across all the NEADL subscales. There is no pattern to the 
missing items in the NEADL (i.e. missingness is spread across items).   
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Figure 13 Frequency of missing NEADL data items in returned 6 month 
questionnaires 
 
There is no pattern to this missing data in terms of individual items that are not completed.  
Figure 14 Frequency of missing SIPSO data items in returned 6 month 
questionnaires 
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 Key for table Table 19 (Physical subscore of SIPSO) Table 18
Key Question 
1  Since your stroke, how much difficulty do you have dressing yourself fully? 
2 Since your stroke, how much difficulty do you have moving around all areas of the home? 
3 Since your stroke, how satisfied are you with your overall ability to perform daily activities 
in and around the home? 
4 Since your stroke, how much difficulty do you have shopping for and carrying a few items       
(1 bag of shopping or less) when at the shops? 
5 Since your stroke, how independent are you in your ability to move around your local 
neighbourhood? 
 Missing-value patterns in physical subscore of SIPSO Table 19
 Question 
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 1 2 3 4 5 
4 0 0 0 1 0 
2 0 0 0 0 1 
1 1 0 0 0 0 
1 0 1 0 0 0 
1 0 0 1 0 0 
Total 2 2 1 4 2 
There is no pattern to the missing items on the physical subscore of the SIPSO. However, 
examination of the social subscore of the SIPSO reveals that five patients did not respond to 
the question “since your stroke, how do you feel about your appearance when out in 
public?”. 
 Key for Table 21 (social subscore of the SIPSO) Table 20
Key Question 
1  Since your stroke, how often do you feel bored with your free time at home? 
2 Since your stroke, how would you describe the amount of communication between you 
and your friends/associates? 
3 Since your stroke, how satisfied are you with the level of interests and activities you share 
with your friends/associates? 
4 Since your stroke, how often do you visit friends/others? 
5 Since your stroke, how do you feel about your appearance when out in public? 
 Missing-value patterns in social subscore of the SIPSO Table 21
 Question 
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 1 2 3 4 5 
4 0 0 1 0 0 
3 0 0 0 0 1 
2 1 0 0 0 0 
1 1 0 0 0 1 
1 0 0 0 1 1 
1 0 0 0 1 0 
174 0 0 0 0 0 
Total 3 0 4 2 5 
The Rasch analysis of the SIPSO suggests that the structure of the scale is such that the 
subscales should be considered separately (Kersten P et al  2010). Each SIPSO subscore is 
better completed than the total NEADL scale. 
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Figure 15  Frequency of missing EQ5D data items in returned 6 month 
questionnaires 
 
No patterns were identified in the missing data for the six month EQ5D questions.  
Figure 16 Frequency of missing GHQ_12 data items in returned 6 month 
questionnaires 
 
- 105 - 
 
 
 Key for Table 23 (six month GHQ_12) Table 22
Key Have you recently… 
1 been able to concentrate on whatever you’re doing 
2 lost much sleep over worry? 
3 felt that you are playing a useful part in things? 
4 Felt capable of making decisions about things? 
5 felt constantly under strain? 
6 felt you couldn’t overcome your difficulties? 
7 been able to enjoy your normal day-to-day activities? 
8 been able to face up to your problems? 
9 been feeling unhappy and depressed? 
10 been losing confidence in yourself? 
11 been thinking of yourself as a worthless person? 
12 been feeling reasonably happy, all things considered? 
 Missing value patterns in six month GHQ_12 Table 23
   
  Question number 
  1 2 3 4 5 6 7 8 9 10 11 12 
N
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5 0 0 0 0 0 0 0 1 0 0 0 0 
3 0 0 0 0 1 0 0 0 0 0 0 0 
2 1 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 1 0 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 1 0 0 0 0 0 0 
2 0 0 0 0 0 0 1 0 0 0 0 0 
1 1 0 0 0 1 0 0 1 0 0 0 0 
1 0 1 0 0 0 0 0 0 0 0 0 0 
1 0 0 1 1 0 0 0 0 0 0 0 0 
1 0 0 0 1 0 0 0 0 0 0 0 0 
166 0 0 0 0 0 0 0 0 0 0 0 0 
Total 3 1 3 2 4 2 2 5 0 0 0 0 
 
The ‘do you feel able to face problems’ question was the question omitted by five of the 18 
respondents who only omitted one question from the GHQ-12.  
One hundred and thirty five patients completed all the questionnaires in their entirety. The 
numbers of incomplete questionnaires are presented in Figure 17 .  
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Figure 17 Number of  incomplete scales within returned questionnaires (excluding 
OHS) 
 
The majority of missing outcomes data is due to one item missing from 1 scale (31 cases, 
Figure 18). Data were most frequently missing from the NEADL and GHQ_12 scales.  
Figure 18 Frequency of all missing items by scale  
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5.2.4.3 Management of individual missing outcomes items 
As with the baseline GHQ_12 (see section 5.2.3.3) the most pessimistic score (0) has been 
entered for patients with missing six month GHQ_12 data. For the most part, imputation of 
outcomes is not advisable and records with missing data will therefore be excluded from the 
analysis. The calculation of EQ5D scores and SIPSO subscales scores excludes records with 
missing data.  
5.3 Distributions of continuous and ordinal variables 
Examination of the distributions of continuous and ordinal variables can identify both 
significant floor and ceiling effects that may limit the sensitivity of the variable at the 
extremes of measurement, and unusual patterns that may require further exploration. If 
these are to be used as dependent variables, their distributions may affect the type of 
regression analysis that may be performed, or may cause problems with meeting linearity 
assumptions (see section 5.4, and also sections 4.4.6.1.4 & 3.5.7.1 ).  
5.3.1 Distribution of the propensity score 
The propensity score calculated from the SSV case-mix adjuster demonstrates a marked floor 
effect (prediction of poor outcome) with 111/312(35.6%) of patients in the lowest decile of 
predicted outcome. However, if the propensity score is entered into a model as an 
independent variable, providing the residuals from that model are normally distributed and 
that linearity assumptions are met, then this deviation from normality may be ignored. 
Failure to meet linearity assumptions may require transformation or categorisation of the 
variable.  
Figure 19 Distribution of propensity score in the CIMSS study population 
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5.3.2 Length of stay 
Length of stay demonstrates marked positive skew (see Figure 8, section 5.1.1). It is likely, 
therefore that this variable will need to be transformed in order to linearize the relationship 
between length of stay and outcome and this will be explored further during model 
construction.  
5.3.3 Distributions of baseline assessments 
The presence of significant floor or ceiling effects (10% of patients scoring at extremes of the 
scale) suggests a lack of responsiveness of the instrument to detect change at the extremes 
of measurement. Large floor and ceiling effects in baseline functional assessments may 
reflect the immediacy of the assessment following the stroke event (i.e. reflection of 
immediate post-stroke disability) or the recruitment of patients that tended to have milder 
strokes.  
 Floor and ceiling effects of baseline functional assessments Table 24
 Floor effect Ceiling effect 
Barthel Index 25/311 = 3.2% 70/311 = 23% 
NEADL_baseline 14/302 = 4.6% 32/302=10.6% 
EuroQoL_baseline 0/302 = 0% 38/302 = 12.6% 
GHQ_12 baseline 125/302 = 41.4% 12/302 = 4.0% 
Figure 20 Baseline Barthel Index 
 
0
2
0
4
0
6
0
8
0
F
re
q
u
e
n
c
y
0 5 10 15 20
Total baseline Barthel Index
- 109 - 
 
 
5.3.3.1 Distribution of the baseline EQ5D 
Figure 21 Baseline EQ5D 
 
The baseline EQ5D appears to be biphasic, with peaks around zero and 0.7. There is also a 
ceiling effect of 12.6%. This may reflect a correlation with baseline function, as three of the 
questions within the EuroQoL questionnaire relate directly to constructs measured with the 
Barthel Index (mobility, self-care and usual activities), and may therefore be acting as a proxy 
marker for the floor and ceiling effects seen with this instrument at baseline.   
5.3.3.2 Distribution of the baseline NEADL 
The NEADL score is filled out according to an individual’s function over the last week. For 
some patients (in whom the time from stroke to recruitment was more than a week), this 
period will include the period since the onset of the stroke. For others, where time to 
recruitment was short, the NEADL is more likely to reflect pre-stroke function. The 
instructions for completion of the NEADL in the context of the study were therefore unclear.  
In addition to the factors that contribute to floor and ceiling effects of the Barthel Index, this 
timing of completion may account for the marked floor and ceiling effects of the baseline 
NEADL. The distribution of time from stroke (as reported by patients or their carers) to 
completion of baseline questionnaires are shown in Figure 22 (7 days to recruitment is 
marked with the black line). The lack of clarity as regards the instruction as to the period with 
which the NEADL should be completed with respect to may also account for the wide 
distribution of the baseline NEADL Figure 23. 
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Figure 22 Time (days) from stroke to completion of baseline questionnaires 
 
Figure 23 Distribution of responses on baseline NEADL 
 
5.3.3.3 Distribution of the baseline GHQ-12 
Marked floor effects are seen with the baseline GHQ_12 (46%). This may reflect 
understandable anxiety or low mood in the immediate post-stroke period (Figure 24).  
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Figure 24 Distribution of responses on the baseline GHQ_12 
 
5.3.4 Floor and ceiling effects of outcomes instruments at six months 
 Floor and ceiling effects in returned questionnaires Table 25
Outcomes instrument (fully 
completed six month 
questionnaires) 
Floor effect Ceiling effect 
NEADL total 1/165 = 0.6% 16/165 = 9.7% 
NEADL_mobility subscale 13/177 = 7.3% 57/177 = 32.2% 
NEADL_kitchen subscale 9/186 = 4.8% 110/186 = 59.1% 
NEADL_domestic subscale 28/178 = 15.7% 42/178 = 23.6% 
NEADL_leisure subscale 8/178 = 4.5% 32/178 = 18.0% 
SIPSO (physical) 10/176 = 5.7% 41/176 = 23.2% 
SIPSO (social) 2/174 = 1.1% 19/174 =10.1% 
EQ5D 2/179 = 1.1% 35/179 =  19.6% 
GHQ_12 53/166 = 31.2% 13/166 = 7.8% 
Ceiling effects are seen with the physical subscale of the SIPSO and the EQ5D. Marked floor 
effects are seen with the GHQ_12. The EQ5D and the SIPSO subscales only contain 5 items 
and are therefore more prone to ceiling and floor effects  Consideration of the two SIPSO 
subscales together to give a total score eliminates the ceiling effect seen within the physical 
subscale (ceiling effect of total SIPSO score 41/176 = 9.0%).  The subscores of the NEADL have 
significant ceiling effects (most pronounced in the kitchen subscore). In addition there are 
marked floor effects in the domestic subscale. This is likely to limit the use of the NEADL in 
the CIMSS population. These effects have not been noted in previous studies using the 
instrument, although floor effects in the mobility domain have previously been noted in more 
dependent patients (Gladman et al  1993; Gladman et al  1994).  
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5.4 Distributions of patient reported measures (six month 
questionnaires) 
5.4.1 Conversion to continuous variables 
Two of the patient reported instruments have scoring systems or conversion tables that allow 
them to be converted into interval level variables (the EuroQoL and the SIPSO). The EuroQoL 
is converted into a continuous utility score between -1 (lowest) and 1 (highest quality of life) 
(Rabin R et al,  2011). The SIPSO has been subject to Rasch and Mokken analyses which 
confirmed a two factor structure with two subscores which may be considered separately, 
but where the summed (total) score fails to meet scaling assumptions (Kersten P et al  2010). 
The two SIPSO subscales are therefore considered as two separate interval level outcomes. 
Limitations of this approach are discussed in sections 4.4.4 and 6.3.1.   
Four of the patient reported measures are ordinal (the baseline and six month NEADL and 
GHQ_12, baseline Barthel Index and six month OHS). They may be treated as continuous data 
if linearity and normality of residuals assumptions are met, and models using these outcomes 
will be constructed first using parametric techniques (linear regression). Where linearity and 
normality of residuals assumptions are not met, the outcomes will be dichotomised and 
treated as non-parametric data with the caveat that this is with the loss of information.  
5.4.2 Continuous patient reported measures 
5.4.2.1 EuroQoL 6 months 
The six month utility score for the EuroQoL deviates significantly from a normal distribution 
(Figure 25), and looks to follow a censored distribution. This cannot be normalised through 
transformation (Figure 26), and if the EQ5D were to be used as the dependent variable, a 
Tobit regression model (to account for the censored data) may be appropriate.  
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Figure 25 Distribution of the six month EQ5D 
 
Figure 26 Transformations of the six-month EQ5D 
 
5.4.2.2 SIPSO subscores at six months 
A normal (Q-Q) plot deviates from the reference line; thereby suggesting that the physical 
subscore of the SIPSO is not normally distributed. The untransformed physical subscore of 
the SIPSO is highly statistically significant (p<0.01) on Shapiro-Wilk testing confirming that the 
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variable cannot be assumed to be normally distributed. However, as no transformation 
appears to improve the distribution towards normality (Figure 28), the untransformed 
physical subscore of the SIPSO will be entered into the models. Linearity and normality of 
residuals assumptions must, however, still be met on testing of model diagnostics.  
Figure 27 Normal (Q-Q) plot for untransformed six month SIPSO physical subscore 
  
 
Figure 28 Transformations of the Rasch transformed six-month SIPSO physical 
subscale  
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A normal probability plot suggests that the social subscore of the SIPSO follows 
approximately a normal distribution, although there is some deviation at the tails. A Shapiro-
Wilk test fails to reach significance (p=0.095), suggesting that a normal distribution can be 
assumed.   
Figure 29 Normal (Q-Q) plot of SIPSO social subscore 
 
 
5.4.3 Ordinal patient reported measures 
5.4.3.1 NEADL 6 months 
The six month total NEADL score deviates markedly from a normal distribution as suggested 
by the normal plot (Figure 30) and confirmed by the highly significant Shapiro-Wilk statistic 
(p<0.001) . If the NEADL is to be used as an outcome in a regression model and residuals are 
not normally distributed the scale would need to be categorised and a multivariate ordinal 
regression, or logistic regression performed depending on the number of categories created.  
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Figure 30 Q-Q plot for the six month NEADL (total summed scores across subscales) 
 
 
5.4.3.2 GHQ_12 baseline 
The six month GHQ_12 can also not be considered to be normally distributed as there is 
marked deviation from the reference line on a Q-Q plot, and the Shapiro-Wilk statistic is 
again, highly statistically significant. For ease, if, the GHQ-12 is to be treated as a dependent 
outcome variable it will be dichotomised into ‘case’ and ‘non case’ and treated as a 
categorical variable in a logistic regression model (with a score of >=3 out of a total of 12 
signifying a ‘case’ when using the dichotomised scoring system as described by the authors 
(Goldberg D et al,  1988)). This categorisation is not necessary for the creation of decision 
trees (with the baseline GHQ-12 being entered as a predictor, or the six month GHQ-12 as an 
outcome), as no assumptions are made regarding the underlying distribution of the data (see 
section 4.4.5.2).  
5.4.3.3 Oxford Handicap Scale (six months) 
The Oxford Handicap Scale (OHS) is an ordinal outcome, and will be dichotomised into 
good/poor outcome using the same cut of at <=2 as good outcome, 3 to 6 as poor outcome 
(which includes 6, dead) such that these classifications match those used in the development 
of the SSV case-mix adjuster (Counsell C et al  2002).  
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Figure 31 Distribution of responses on the postal modified Rankin Score 
 
5.5 Choice of outcome measures for the CIMSS study 
The GHQ-12 questionnaire was included in the outcomes questionnaire in order to examine 
its test-retest reliability when collected by post in stroke populations. It has not, therefore 
been examined as a primary outcome of the study for the purposes of this thesis. The postal 
version of the OHS was collected in order to calculate the SSV predicted probability of good 
outcome for the purposes of case-mix adjustment. The postal OHS will be used to ascertain if 
there are any univariable predictors which may perform as well as the SSV in terms of 
predicting patient six month OHS scores, and also to ascertain if there are any additional 
predictors which, when added to the SSV model, improve its utility in outcome prediction.  
The distributions of the outcomes measures have important implications on the types of 
analyses that may be performed and the types of conclusions that may be drawn. The NEADL 
and SIPSO both measure aspects of post stroke function and activities of daily living. 
However, the property of the SIPSO that allows it to be treated as interval level variable 
offers significant advantages over the NEADL. Firstly, it is likely that it may be predicted 
through linear regression modelling whilst the NEADL is more likely to require categorisation 
and multivariable ordinal modelling. Linear modelling increases the number of predictor 
variables that may be entered into models, as the EPV reflects the number of observations 
and not the number of outcome events. Secondly, the SIPSO is less prone to the marked 
subscore ceiling and floor effects that are apparent with the NEADL and may, therefore, be a 
more sensitive instrument in patients nearing the extremes of the scale. Finally, and possibly 
due to its relative brevity as compared with the NEADL, the individual subscores of the SIPSO 
are well completed. However, the SIPSO does have drawbacks. It is less well externally 
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validated than the NEADL, and the validation studies that have been performed are either by 
the authors of the instrument (Trigg R et al  2003), or have been performed on samples not 
necessarily transferrable to the wider stroke population (i.e. a population of younger stroke 
survivors (Kersten et al  2004)). This may have implications for the validity of the scale in 
reflecting the latent trait of reintegration in older stroke survivors (see sections 4.4.4 & 6.3.1) 
Finally, and importantly, the SIPSO is completed after the stroke event, and therefore does 
not allow direct comparisons with individual baseline function. The advantages of the SIPSO 
however, outweigh these drawbacks and it has been used at the primary outcome 
throughout the study analysis. Each subscore of the SIPSO is considered separately as an 
individual score (physical and social domains). This approach was encouraged in a recent 
study examining the scaling properties of the SIPSO (Kersten P et al  2010).  
5.6 Descriptive statistics of study population and representativeness of 
sample 
Descriptive statistics for the patients recruited into the study (study population) are 
compared with the stroke population screened at each site (as a marker of the wider stroke 
population) as a measure of sample representativeness. Descriptive statistics regarding 
process markers are provided for the study population. The characteristics of patients that 
respond to the six month questionnaire as compared with those that do not are also 
described to identify any systematic differences between those that did and did not respond 
to the outcomes questionnaires.  
5.6.1 Barriers to data collection across study sites 
Regular teleconferences were held with researchers in each site to identify and, where 
possible, resolve difficulties with patient recruitment and data collection. There were some 
barriers to recruitment that were common across the study sites. Identification of patients 
with stroke that were not admitted to the stroke unit was problematic, though close liaison 
with the stroke care co-ordinators at each site helped with both patient identification and 
tracking patients that had moved wards. It was not possible to include patients admitted and 
discharged during the course of a weekend as the researchers’ working week was Monday to 
Friday. The omission of these patients may have introduced bias to the study sample. Often 
patients and their carers were unwilling to discuss participation in a study soon after the 
stroke event and researchers expressed difficulties in identifying, recruiting and collecting 
case-mix data within a week of admission following stroke. Consequently, providing that 
case-mix data could be extracted retrospectively from case notes with respect to the week 
following admission, patients were recruited up to two weeks following admission.  
It was found that carers were particularly difficult to recruit to the study, often because they 
visited the ward outside normal working hours. In York, the researcher liaised with the ward 
sister to allow carers to visit the ward at other times such that they could be approached for 
- 119 - 
 
consent to participate in the study. In Leeds, the researcher worked flexibly and visited the 
ward during the early evening to obtain consent from carers.  
5.6.2 Screening and recruitment  
In total 656 patients were screened across the three study sites during the six month 
recruitment period. Initially 320 patients were consented, but 8 were not recruited as they 
were found not to  meet eligibility criteria (one did not have information available regarding 
case-mix variables from the week following the stroke, one deteriorated and was receiving 
palliative care, one died prior to recruitment and four were found to have subarachnoid 
haemorrhage on imaging). 
Table 26 outlines the absolute numbers and proportions of patients screened and recruited 
at each of the study sites. It can be seen that higher proportion of screened patients were 
recruited in Leeds than in both Bradford and York. Reasons why patients that were screened 
were not subsequently recruited (either through a failure to meet eligibility criteria, or 
through informed consent not being obtained) are shown in Figure 32 & Figure 33. 
 Proportion of screened patients recruited into study by site Table 26
Site Number screened Number eligible 
patients recruited 
Proportion recruited 
Bradford 176 71 40% 
Leeds 193 125 65% 
York 287 116 40% 
Total 656 312  
 
The most common reason for patients being ineligible for inclusion was that the diagnosis 
was not a primary stroke. The proportion of patients in whom this was the case is surprisingly 
high (74/193 = 38%). This may reflect the number of patients admitted with “query stroke” 
and commenced on the stroke care pathway prior to specialist assessment. The most 
common reason for eligible patients not being recruited was a lack of capacity and no 
available carer to provide consent to take part in the study.  
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Figure 32 Reasons screened patients not eligible for recruitment 
 
Figure 33 Reasons eligible patients not recruited into study 
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5.6.3 Demographic data 
5.6.3.1 Differences in age at stroke and gender between screened and study 
population 
The median age of patients recruited into the study was 74 (IQR 65-82), with a range of 31 to 
95 years. Fifty-one percent of the study population were female.  
An equivalence of proportions test reveals no difference in the proportion of women 
between screening and study populations (p=0.165 working shown in appendix D-1).  
The distribution of age by sex in patients recruited into the study is shown in the boxplot 
(Figure 34) 
Figure 34 Distribution of age by sex in study sample 
 
This difference in age by sex is highly statistically significant (Mann-Whitney U test of 
equivalence of medians) and is likely to represent the longer life expectancy of women in the 
general population (working shown in appendix D-1.2).  
Figure 35 reveals that patients who are not recruited into the study have a higher median age 
than those who are (the median is used as the data are negatively skewed). This difference is 
confirmed as statistically significant on a Mann Whitney U test (the non-parametric 
equivalent to a t-test – appendix D-1.3).  
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Figure 35 Distribution of age by recruitment into study 
 
 Difference in median age between patients recruited and not recruited Table 27
into study 
 Range Median IQR 
Recruited 31-95 74 65-82 
Not-recruited 39-98 81 71-86 
The difference in medians between patients recruited and not recruited is seen at each site 
(Table 28) 
 Difference in median age between patients recruited and not recruited Table 28
by site 
Site Median age 
recruited  
Median age 
non recruited 
Significance level for 
equivalence of medians 
(Mann Whitney U) 
Bradford 72 79 0.012 
Leeds 76 81.5 0.003 
York 74 81 <0.001 
Significance level for equality of 
population medians (Kruskall-
Wallis1 test) 
0.34 0.20  
However, a difference is not seen in median age between sites for patients who are, and are 
not recruited into the study (Kruskall-Wallis tests for median age by site for patients recruited 
and not recruited into the study are not statistically significant). 
 
                                            
1 A Kruskall-Wallis test is the non-parametric equivalent to a oneway ANOVA 
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5.6.3.2 Ethnicity 
The vast majority of patients recruited were white (see Table 29) 
 Ethnicity of patients recruited and not recruited into the study Table 29
Ethnic Group Screened not recruited (N (%)) Recruited (N (%)) 
White 311(90.4) 298(95.5) 
Mixed White & Black Caribbean 2 (0.6) 0 
Asian- Indian 3(0.9) 3(1.0) 
Asian - Pakistani 11(3.2) 6(1.9) 
Asian - Bangladeshi 2(0.6) 1(0.3) 
Other Asian background 1(0.3) 1(0.3) 
Black Caribbean 0(0) 3(1.0) 
Chinese 2(0.6) 0 
Missing 12(3.5) 0 
Total 344 312(100) 
There does not appear to be a difference in ethnicity between patients recruited and not 
recruited into the study (Table 29). Formal testing for association with a Fisher’s exact test (to 
account for the low frequencies in some cells) confirms there is no association (p=0.31).  
5.6.3.3 Availability of carer and living circumstances 
The majority of patients recruited to the study cohabit (60%), 38% lived alone and 2% were 
admitted from nursing or residential care.  
A two way measure of association (chi-squared test) showed that patients with carers 
available were no more likely to be recruited to the study than those without carers (p=0.06). 
5.6.3.4 Baseline stroke severity  
The descriptive statistics for the baseline Barthel Index in screened and recruited populations 
are shown in Table 30. 
 Descriptive statistics for baseline Barthel Index Table 30
 Range Median IQR 
Recruited 0-20 13 5-19 
Screened 0-20 4 0-13 
 
There is a marked difference in the Barthel Index scores between patients recruited into the 
study when compared with those that are not. An equivalence of medians test (Mann-
Whitney U test), confirms a highly significant difference in baseline BI between patients 
recruited and not recruited into the study (p<0.001 – working shown in appendix D-2.1).  
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Figure 36 Difference in baseline Barthel Index between patients recruited and not 
recruited into the study 
 
This difference in baseline disability is seen in all sites, and is most marked in Leeds. Patients 
with very severe strokes (i.e. those that were in receipt of, or likely to receive palliative care) 
were not recruited into the study and this is likely to have been reflected in this difference. 
The study sample is therefore more representative of a population that is more likely to 
survive to six month follow up rather than all strokes. For the purposes of the definition of a 
routine dataset with outcomes data being collected at six months, this should not be 
problematic.  
Figure 37 Difference in baseline Barthel Index between patients recruited and not 
recruited into the study by site 
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Kruskall-Wallis equivalence of medians tests for baseline Barthel for patients not recruited by 
site reveals no statistically significant difference in medians (appendix D-2.2). Inspection of 
the boxplot (Figure 37) would tend to suggest that the difference in medians between sites 
for patients not recruited into the study is marked, however inspection of the histograms by 
site reveals very large floor effects close to the median of 4 which may explain why the 
difference has not reached statistical significance (Figure 38). There is a statistically significant 
difference in median baseline Barthel Index across sites for patients recruited into the study, 
with York tending to recruit less disabled patients (median baseline 14 see Table 31). Two-
way examination of medians in patients recruited into the study by site reveals this difference 
to be significant between Leeds and York (p=0.001) and of borderline statistical significance 
between Bradford and York (p=0.017) (appendix D-2.3). The difference in median baseline 
Barthel Index between patients recruited and not recruited is statistically significant at each 
site (Mann-Whitney U test (Table 31).  
 Significant difference in median baseline Barthel Index between screened Table 31
and recruited patients at each site 
Site Median BI 
recruited 
(N) 
Median BI 
not recruited 
(N) 
Sig level for 
equivalence of medians 
(Mann Whitney U) 
Bradford  12 (71) 3.5 (175) <0.001 
Leeds 12 (125) 0 (68) <0.001 
York 14 (116) 5 (171) <0.001 
Sig level for equality of population 
medians (Kruskall-Wallis test) 
0.003 0.24  
Figure 38 Distribution of baseline Barthel Index in patients screened but not 
recruited into study, by site 
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5.6.4 Admission data (patients recruited into study) 
5.6.4.1 Differences in age at stroke and gender between responders and non-
responders 
A Kruskal-Wallis equivalence of medians test reveals a significant difference in age between 
groups that responded, died or withdrew from the study (χ2 = 38.4, ν = 3, p<0.001). 
Two way examination of the difference in median age between these groups reveals that 
there are statistically significant differences in median age between patients that do not 
respond and each of those that respond, die or withdraw and also between patients who 
respond and those that die Figure 39.  
Figure 39 Boxplot of age at stroke by response to six month questionnaire, death or 
withdrawal 
 
5.6.5 Age and sex of patients who respond to six month questionnaires  
Patients who responded to the questionnaire were significantly older (by 7 years) than those 
that did not respond (two sample t-test, p<0.001) 
 Age of patients who responded to six month questionnaires Table 32
 Mean age (95% CI) 
Response 72.9 (71.3-74.6) 
No response 65.7 (62.2-69.1) 
A Chi squared test confirms that there was no difference in the likelihood of questionnaires 
being returned from males or females (Χ2 0.19 p=0.663). 
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5.6.6 Length of stay  
The distribution of length of stay demonstrates marked positive skew. For this reason, the 
median as opposed to the mean has been used at the marker of central tendency. Median 
length of hospital stay is ten days (range 1-147). The length of stay varies markedly and 
significantly with study site (see Figure 10 in section 5.2.1, p 95). 
 Length of stay by study site Table 33
 Median Range IQR 
Bradford 13 1-85 5-46 
Leeds 14 1-118 6-40 
York 6 1-147 3-14.5 
 
A Kruskall-Wallis equality of populations rank test is highly statistically significant p< 0.001, 
indicating that there is a significant difference in length of stay between at least two of the 
sites.  
Pairwise examination of median length of stay (Mann-Whitney-U tests) between sites reveals 
the length of stay to be significantly shorter at York than the other two sites Table 34. This 
could reflect factors of organisational structure, but may also reflect the patients admitted to 
York had a higher baseline Barthel Index (i.e. were less disabled at baseline - see section 
5.6.3.4.  
 Pairwise comparison of length of stay across study sites Table 34
  Bradford Leeds York 
 
Median length 
of stay 
13 14 6 
Bradford 13    
Leeds 14 0.802   
York 6 0.001 <0.001  
 
There was no significant difference in length of stay for patients who returned six month 
questionnaire as compared with those that did not respond (Figure 40). This was confirmed 
on a Mann-Whitney U test (p=0.79). 
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Figure 40 Length of stay in patients that did, and did not respond to the six month 
questionnaire 
 
5.6.6.1 First ward to which patient was admitted  
The majority of patients were admitted to a medical admissions unit, with just over a third 
(34%) being admitted onto a stroke unit, coronary care unit or intensive care/high 
dependency bed. Two hundred and thirty four of 291 patients with available data (80%) were 
admitted to a stroke unit on the same day, or day after presentation to hospital. Two 
hundred and ninety eight patients out of 310 patients with available data (96%) across the 
three sites spent at least some of their stay on an acute or rehabilitation stroke unit. Time of 
hospital admission has not been recorded with sufficient consistency to allow the time to 
stroke unit admission to be reliably calculated.  
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Figure 41 First ward to which patients were admitted  
 
5.6.7 Stroke severity and case-mix variables   
5.6.7.1 Stroke type 
Two hundred and ninety five (94%) of the 312 patients enrolled in the study had a cerebral 
infarction, and 15 (5%) suffered haemorrhagic strokes. 48 patients (15%) presented with a 
recurrent stroke. Data on pathological stroke type was missing in one patient.  
Clinical classification according the Oxford Community Stroke Project Classification of Stroke 
(Bamford J et al  1988) reveals just under a quarter of strokes to be total anterior circulation 
strokes (TACS) (23%), and a third partial anterior circulation strokes (PACS) (33%). Posterior 
circulation strokes (POCS) were least common at 14%, with the remainder (30%) lacunar 
strokes (LACS). A one way ANOVA (analysis of variance) reveals no significant difference in 
age (using a square transformation to normalise the data) between patients suffering 
different types of stroke.  
Left sided weakness was more common (128/311) than right sided weakness (115/311). One 
patient had global weakness and 67 no weakness.  
Table 35 shows other markers of stroke severity and their relative frequencies.  
 Frequency of markers of stroke severity in the study population Table 35
Prognostic variable Number (%)   
Able to walk unaided at presentation 147/311 (47.2)  
Dysphasia (speech or language deficit) 195/312 (62.5)  
Confusion at presentation 58/310  (18.7)  
New urinary incontinence 70/308 (22.7)  
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Chi-squared tests for association between response and markers of stroke severity revealed 
there to be no difference between responders and non-responders in the OCSP stroke 
subtype or in the presence of new urinary incontinence.  
Patients who did not respond to the questionnaires were no more likely to have dysphasia 
than those that responded. Of the 69 patients who required assistance in completing 
questionnaires, 40 received help in recording their own responses, proxy answers were 
returned in 29. Twenty one of the 29 patients returning proxy responses had a speech or 
language disturbance at presentation (Table 36). A Chi-squared test of association between 
proxy response and dysphasia failed to reach significance, however, the severity of dysphasia 
was not recorded at baseline and it is possible that the patients for whom proxy responses 
were returned had more severe speech or language deficits.  
 Association between dysphasia and proxy responses Table 36
  Proxy response 
  No Yes 
D
ys
p
h
a
si
a
 No 109 8 
Yes 174 21 
Χ2 = 1.34 (p=0.25) 
5.6.7.2 Differences in baseline Barthel Index between responders and non-responders 
There is no significant difference in median baseline Barthel Scores between patients that 
respond to six month questionnaires and those that do not (Mann-Whitney U test). However, 
including deaths and withdrawals in this analysis to create four groups (no response, 
response, dead, withdrawn) revealed a highly significant difference between the groups. 
Examination of pairwise combinations of these groups (using a Mann Whitney U test) reveals 
highly significant differences in baseline Barthel Index between patients who did not respond 
and patients who died; and patients who did respond and those that died (appendix D-2.4). 
There was, however, no significant difference in baseline Barthel Index between patients who 
withdrew and those who did not respond; died or did respond; or between responders and 
non-responders (see Table 37). 
 Pairwise comparison of p values (Mann-Whitney U tests) for median Table 37
baseline Barthel Indices (BI) by response 
  Responder 
Non-
responder 
Death Withdrawal 
 
Median 
Baseline BI 
17 13 1.5 12 
Responder 17     
Non-responder 13 0.267    
Death 1.5 <0.001 <0.001   
Withdrawal 12 0.017 0.112 0.022  
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5.6.7.3 Propensity score 
The propensity score was calculated from the six variables included in the SSV model (age at 
stroke, living alone pre-stroke, independent before stroke, able to walk independently within 
a week of admission, an MRC power score (arms) greater than 3 (i.e. able to lift arms against 
gravity), a normal verbal Glasgow Coma Score (orientated) (Counsell C et al  2002)). The 
covariates used to construct the original model were used to calculate this score (see 
equation (3)). The cut off for distinguishing good over poor outcome (as determined with a 
postal OHS ≤3) was set at 0.8. This value was chosen as it was the cut off used in a previous 
external validation of the SSV model (the FOOD trial, personal communication M Dennis).  
The range of propensity scores was 0-0.96 (median 0.36, IQR 0.04-0.77). It can be seen, 
therefore, that the SSV predicts that the vast majority (243/312 = 78%) of patients in the 
study dataset to have a poor outcome (predicted dichotomised OHS of >=3) following their 
stroke.  
 Differences in predicted outcome  between responders and non-Table 38
responders 
 Range Median IQR 
Non-responder 0.00074-0.95 0.37 0.078-0.85 
Responder 0.00040-0.97 0.56 0.095-0.79 
Dead 0.00051-0.91 0.013 0.006-0.10 
Withdrawal 0.0016-0.93 0.10 0.015-0.56 
 
Figure 42 Propensity score by response 
 
Pairwise examinations of the differences between these groups (Mann-Whitney U tests) 
reveal that the propensity scores of both responders and non-responders are significantly 
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higher than the median propensity score (probability of a good outcome) for patients who 
died (Table 39).  
 Pairwise comparison of p values for differences in propensity score by Table 39
response to six-month questionnaire (Mann-Whitney U tests) 
  Responder 
Non-
responder 
Death Withdrawal 
 Median propensity score 0.56 0.37 0.013 0.10 
Responder 0.56     
Non-responder 0.37 0.95    
Death 0.013 <0.001 <0.001   
Withdrawal 0.10 0.077 0.169 0.048  
5.6.8 Process data 
The proportion of patients receiving process markers, and the percentage of eligible patients 
in whom these were achieved are shown in Figure 44 (p 135). Specific aspects of care were 
delivered to patients in whom they were indicated (or not contraindicated) in over 80% of 
cases for fourteen of the nineteen processes shown. The care processes that were measured 
as part of the study (reflecting the indicators of the RCP NSSA (Royal College of Physicians 
2009b)) are therefore often ‘saturated’ with little variability as regards receipt of specific 
aspects of care. It is therefore possible, if not likely, that these care processes will be poor 
discriminators of patient outcome.  
There are exceptions, with some care processes being poorly achieved, for example, the 
proportion of eligible patients receiving a social worker assessment was particularly low 
(34%). Twenty five of all patients in the study received thrombolysis with recombinant tissue 
plasminogen activator (rtPA). Fifteen patients had a definite contraindication to thrombolysis 
(haemorrhagic stroke, two of whom had had a previous stroke event). The proportion 
receiving thrombolysis across sites was therefore 25/297 = 8.4%. A further 46 had had a 
previous ischaemic stroke which, in the presence of diabetes (which we have not recorded) is 
a further contraindication to thrombolysis for acute ischaemic stroke. It is therefore likely 
that the proportion of eligible patients receiving thrombolysis is higher than it appears in the 
study population. It should also be remembered that the CIMSS study population excluded 
patients with very severe stroke who were unlikely to survive to discharge. This is likely to 
have reduced the denominator such that the proportion of patients ‘eligible’ for thrombolysis 
within the study population is falsely elevated.  
Much of the variability in whether patients received different aspects of care process is due 
to whether or not a particular care process is indicated. The variability in achievement of care 
processes in patients in whom they are indicated tends to decrease as the proportion of 
patients in whom a “no but” code is recorded decreases (moving left to right in Figure 44). 
This would tend to suggest that as a proportion of eligible patients, the care processes that 
are universally applicable are more readily achieved than processes that are not.  
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The exceptions to this are admission to a stroke unit the same day or day after the stroke, 
and an assessment of mood. Despite being relevant to all (stroke unit) or nearly all (mood 
assessment) patients admitted with stroke, the proportion actually achieving these processes 
was 77% and 81% respectively.  
The reasons that specific processes are not indicated (“no but” codes) are either that the 
stroke is too mild or too severe (not possible or inappropriate to achieve). For example, 
patients with no speech deficit will not require a formal Speech and Language Therapist (SLT) 
communication assessment, and such an assessment would be inappropriate in some 
patients with very severe strokes (e.g. the drowsy or comatose). Patients with very severe 
stroke receiving or likely to require palliative care were excluded during recruitment for the 
study. It is possible, therefore, that in the study population the “no but” codes are more likely 
to reflect patients at the milder end of the spectrum of stroke severity. A summed score of 
the number of processes of care achieved for individual patients in whom they were 
indicated has been calculated  using the 20 process indicators in Table 40 to give an overall 
picture of ‘compliance’ with the process markers measured in the study. This approach of 
summing process measures has been adopted by the RCP in the reporting of the NSSA data 
(Intercollegiate Stroke Working Party 2011). However, a summed process score is not useful 
either as a predictor of outcome or as a summary of process delivery, as this approach 
assumes that care processes are both additive and equally weighted. These assumptions are 
unlikely to be valid and would be particularly misleading if such a score were to be used as a 
single variable. For example, a simple summation of processes would fail to reflect that 
receipt of thrombolysis is likely to be a greater determinant of outcome than being weighed 
during the course of the admission.  Moreover, this histogram is difficult to interpret, as the 
proportions of patients in whom particular processes are not indicated (“no but” codes) is not 
represented and as such it is difficult to appreciate what the maximum summed process 
score could be for individuals.  
 Process markers measured in the study population Table 40
Process markers 
Admitted to stroke unit on day or day following 
admission  
Visual fields assessed 
Brain imaging within 24 hours of admission Sensory testing 
Patient given rtPA Formal swallowing assessment within 72 hours 
Swallowing screen within 24 hours 
Speech and Language Therapy (SLT) 
communication assessment 
Aspirin given within 48 hours Social worker assessment 
Physiotherapy assessment within 48 hours Cognitive screening 
Occupational therapy assessment within 48 hours Malnutrition screening 
MDT rehabilitation goal setting Care plan for urinary incontinence 
Weighed during admission Fluids within 24 hours 
Mood assessed during admission Nutrition within 72 hours 
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Figure 43 Total number of processes received in those for whom they were 
indicated 
 
 The median number of processes received was 14 (range 6-19 IQR 12-15) 
Figure 44 presents the individual processes of care as the proportion of patients eligible for 
individual care processes that received them, and the proportion of patients in whom individual care 
processes were not indicated (“no but” codes). This offers a more useful summary of process 
delivery than presentation of summed process scores. 
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Figure 44 Proportion of patients receiving specific aspects of care by proportion eligible for individual care processes 
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5.6.9 Baseline questionnaires 
The median, range and interquartile range for each of the baseline questionnaires is given in 
Table 41. These questionnaires offer a measure of stroke severity and baseline function. 
Scores on baseline questionnaires between patients who have responded and failed to 
respond to the six month questionnaire have been examined to ascertain if there are any 
systematic differences.  
 Distribution of scores on baseline questionnaires Table 41
Instrument Min-max score Median Range IQR 
Barthel Index 0 to 20 14 0-20 6-19 
NEADL 0 to 66 53.5 0-66 36-60 
EQ5D -1 to 1 0.63 -0.429-1 0.082-0.814 
GHQ-12 (dichotomised scoring) 0 to 12 1 0-12 0-4 
 
5.6.9.1 Differences in baseline questionnaires between responders and non-
responders 
A Kruskall-Wallis test demonstrates that there are significant differences in both median 
NEADL and EQ5D scores at baseline between patients who responded and those that did not. 
Figure 45 Baseline NEADL by response to six month questionnaire 
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 Pairwise comparison of baseline NEADL by response (Mann-Whitney U Table 42
tests) 
  Responder Non-responder Death Withdrawal 
 Median Baseline NEADL 56 52.5 42 39 
Responder 56     
Non-responder 52.5 0.215    
Death 42 <0.001 0.012   
Withdrawal 39 <0.001 0.011 0.466  
 
Patients who died or withdrew from the study had significantly lower baseline NEADL scores 
than those who remained in the study regardless of whether or not they responded to the six 
month questionnaire.  
Due to the biphasic and non-normal distribution of the EQ5D, the median has been used as 
the measure of central tendency with non-parametric analyses. Patients who did not respond 
to the six month questionnaire had lower median quality of life scores than those who 
responded. Patients who subsequently died reported the lowest baseline quality of life 
scores, and this was significantly lower than patients who responded at six months.  
 Pairwise comparison of baseline EQ5D by response (Mann-Whitney U Table 43
tests) 
  Responder Non-responder Death Withdrawal 
 Median Baseline EQ5D 0.691 0.551 0.267 0.640 
Responder 0.691     
Non-responder 0.551 0.013    
Death 0.267 0.004 0.302   
Withdrawal 0.640 0.331 0.886 0.502  
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Figure 46 Baseline EuroQoL by response to six month questionnaire 
 
5.6.10 Six month outcomes questionnaires 
The theoretical range of each outcomes questionnaire score, study median, observed range 
and interquartile range for returned questionnaires are given in Table 44.  
  Descriptive statistics for individual outcomes questionnaires Table 44
Instrument Returned completed 
questionnaires (N) 
Min-max score Median Range IQR 
NEADL 165 0-66 47 0-66 21-60 
EQ5D 179 -1 to 1 0.71 -0.349-1 0.414-0.85 
SIPSO 
physical 
176 0-20 13.2 0-20 8.36-17.8 
SIPSO social 174 0-20 12.1 1.79-20 7.5-15.8 
GHQ-12  
(dichot 
scoring) 
166 0-12 2 0-12 0-6 
OHS 219 
(includes 44 deaths) 
0-6 
(6=dead) 
2 0-6 1-5 
 
5.6.10.1 Proxy completion 
Sixty two out of 175 (35%) participants in whom information was available on proxy 
completion of the outcomes questionnaires required some help in completing the 
questionnaire. In twenty nine returned questionnaires the responses were those of a proxy 
on behalf of the patient. In the remaining cases, the proxy recorded the patient’s own 
responses. 
n=67 n=188
n=44
n=13
-.
5
0
.5
1
B
a
s
e
lin
e
 E
Q
5
D
no response response dead withdrew
- 139 - 
 
5.6.11 Change in outcomes scores 
For the Nottingham, GHQ_12 and EQ5D where assessments were made at baseline and at six 
months, a change in score may be plotted and this should be approximately normally 
distributed (data presented as histograms). ‘Waterfall’ plots are also presented which 
represent the change in scores between baseline and six-month assessments for individuals. 
This allows the proportion of patients with positive, unity and negative differences in scores 
to be seen.  
Figure 47 Change in NEADL scores between baseline and six months 
 
On inspection of the histogram, the change in NEADL score from baseline to six months is 
approximately normally distributed, but there is a negative skew to the distribution 
suggesting that the scores at six months were worse than the score at baseline. This is to be 
expected as the NEADL questionnaire is completed with respect to function and activity in 
the preceding week. Depending on the time of stroke relative to completion of the 
questionnaire, therefore, for some patients this may have represented function immediately 
before their stroke and for others soon afterwards.  
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Figure 48 Waterfall plot for change in NEADL between baseline and six months 
 
Figure 49 Change in GHQ_12 score 
 
Median change in GHQ score between baseline and six months is zero, and the IQR is 0-3. 
Therefore changes in GHQ-12 between baseline and six months tend to be small, although 
there are a few outliers where there are marked changes in scores (in both positive and 
negative directions). 
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Figure 50 Waterfall plot of change in GHQ-12 score between baseline and six 
months 
 
Figure 51 Change in EQ5D 
 
Similarly for the quality of life score (EQ5D), the distribution is approximately normally 
distributed centred on zero. Large differences between baseline and six month EQ5D scores 
were therefore infrequent. The EQ5D is measured with respect to how an individual feels at 
the time of filling in the questionnaire.   
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Figure 52 Waterfall plot of change in EQ5D utility score between baseline and six 
months assessments.  
 
  
5.7 Univariate analyses 
The relationship between individual process markers and patient outcome in univariate 
analyses may offer an indication of important factors that contribute to patient outcome. 
However, interpretation of these relationships should be made with the caveat that there is 
no adjustment for confounding or mediating factors and markers which may appear to be 
important may cease to be so when other factors are taken into consideration. Entering 
univariate predictors that reach statistical significance into regression models without clinical 
reasoning may result in the inclusion of statistically, but not clinically, important predictors. 
Moreover, the risk of uncovering a statistically significant relationship (or refuting an 
important relationship) between process markers and outcome increases as the number of 
analyses increases, especially if the sample size is small. For example a 5% significance level 
means that if twenty analyses are performed, one is likely to be statistically significant 
through chance alone. Primary analyses have been performed using the SIPSO physical and 
social outcomes. This is due to the relatively superior properties in terms of absence of floor 
and ceiling effects when compared with the NEADL (see section 5.5) In addition, the Rasch 
analysis of the SIPSO that has been performed by previous authors allows the instrument to 
be considered as an interval scale (Kersten P et al  2010). The authors of this Rasch analysis 
argue that the population in which the Rasch analysis was performed should not affect the 
transformation of the ordinal scores to continuous scores in other populations, and the same 
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transformation factors may be used (Kersten P et al  2010). ). However, further exploration of 
the scale with respect to differential item functioning in an older population is required (see 
section 6.3.1).  
Examination of the relationships between categorical data with two level responses (usually 
whether a process did, or did not occur) and the subscores of the SIPSO would ideally be 
analysed with a parametric test (ANOVA). However, as discussed in section 5.4.2.2, the 
physical subscore of the SIPSO is not normally distributed and this may lead to violation of 
the assumption of normality of residuals for an ANOVA.  Univariate analyses for the physical 
subscore of the SIPSO have therefore been performed with the non-parametric equivalent to 
an ANOVA (Kruskall-Wallis test). ANOVAs have been used for the normally distributed social 
subscore of the SIPSO. Where an ANOVA demonstrates a statistically significant difference 
between groups, pairwise examination of the mean SIPSO scores (and confidence intervals) in 
each of the three levels of categorical outcome have been performed to identify where the 
differences lie.  
5.7.1 Correlation of process variables with SIPSO physical subscore 
 Univariate analyses of process measures and physical subscore of SIPSO Table 45
Care process Kruskall Wallis test p value 
Admitted to stroke unit on day or day after admission 0.25 
Scan within 24 hours of admission 0.56  
tPA given 0.31 
Swallow screen in 24 hours 0.04 
Aspirin in 48 hours 0.46 
Physiotherapy within 48 hours 0.55 
Occupational therapy assessment within four days 0.32 
MDT rehab goals set 0.17 
Weighed during the course of the admission 0.035 
Mood assessed during admission  0.13 
Visual fields assessed 0.08 
Sensory testing 0.39 
Formal swallow assessment by SLT within 72 hours 0.005 
Communication assessment by SLT  0.001 
Social worker assessment 0.0016 
Cognition screen  0.15 
Malnutrition screen 0.41 
Urinary incontinence care plan <0.001 
In receipt of fluids within 24 hours of admission N/A 
In receipt of nutrition within 72 hours of admission  0.14 
Variables failing to reach significance at the p ≤0.01 level were not explored further unless 
there were strong clinical reasons for doing so because of the small size of the data set and 
the number of univariate analyses (which increases the risk of spurious or chance 
correlations). Four variables (formal swallow and communication assessments by Speech and 
Language therapist, social worker assessment and a urinary incontinence care plan) all 
reached statistical significance at the 0.01 level for the prediction of the physical subscore of 
- 144 - 
 
the SIPSO (highlighted in Table 45). In addition, a swallow screen within 24 hours of 
admission is a potentially clinically important process marker and will be considered further. 
Two-way examination of the relationships between these variables and the physical subscore 
of the SIPSO are highlighted in Table 46 with a Mann-Whitney U test. The levels of the 
variable between which there are statistically significant differences in six month SIPSO 
outcomes are presented in bold – for example, patients who require and receive a formal 
swallowing assessment (“Yes”) have significantly lower SIPSO scores at six months than 
patients in whom such an assessment is not required (“No but”). This is also true for patients 
receiving a swallowing screen within 24 hours and those with a urinary incontinence care 
plan. For patients in whom assessments are indicated (“No” or “Yes”), there is no significant 
difference between those that do, and do not receive the assessments for any of the 
variables reaching significance at the p≤0.001 level the oneway ANOVA.  
 Pairwise identification (Mann-Whitney U tests) of statistically significant Table 46
differences in distributions of Rasch transformed physical SIPSO scores 
between levels of response for process variables significant at the 1% 
level on Kruskall-Wallis testing  
Formal swallowing assessment within 72 hours  
 No Yes No But 
No    
Yes p=0.80   
No but p=0.051 
 
Medians (p=0.0032) 
Yes=11.4 
No but=15.0 
 
SALT communication assessment  
 No Yes No But 
No    
Yes p=0.19   
No but Medians(p=<0.001): 
No=9.1 
No but=15.0 
Medians (p=0.032): 
Yes=13.6 
No but=15.0 
 
Social worker assessment  
 No Yes No But 
No    
Yes p=0.25   
No but Medians (p=<0.001): 
No=8.4 
No but=15.0 
p=0.21  
Urinary incontinence care plan  
 No Yes No But 
No    
Yes p=0.26   
No but p=0.064 Medians (p=<0.001): 
Yes=8.4 
No but=14.0 
 
Swallow screen in 24 hours  
 No Yes No But 
No    
Yes p=0.55   
No but Medians (P=0.009):  
No But=20 No=14 
Medians (p=0.001):  
No But=20 Yes=12.8 
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Further exploration of whether or not patients were weighed during their admission revealed 
that no patients received a “no but” code for this variable. There is therefore a statistically 
significant difference in the distributions of physical SIPSO scores between patients that were 
weighed and those that were not, with patients not being weighed having higher median 
SIPSO scores at six months than those that are not (medians Yes=13.2 No=16.2,  z=2.13 p 
=0.033 Mann-Whitney U test).   
Being weighed is used as a marker of process in the RCP NSSA audit. However, in this dataset 
there is an inverse relationship between being weighed and physical outcome. If this 
relationship was also evident in external datasets, the relevance of being weighed as a 
marker in the RCP summed process scores could be questioned – patients who are weighed 
have poorer six month physical SIPSO scores than those that were not. It is possible, that this 
phenomenon is a chance finding (there were only 22 patients that were not weighed during 
the course of their admission), but the difference in scores between the groups is large 
enough to be of some clinical significance (three points on SIPSO scale) if it were true. The 
characteristics of patients who were not weighed have therefore been explored further.  
There is no significant difference in age or clinical classification of patients that were or were 
not weighed during their admission. However, the characteristics of patients who were not 
weighed differed significantly in terms of stroke severity variables as outlined in Table 47 
below. Medians have been presented as the marker of central tendency due to the non-
normal distributions of the variables. 
 Characteristics of patients who were, and were not weighed during the Table 47
course of their admission  
Variable Weighed (median{IQR}) Not weighed (mean[95%CI]) 
Propensity score 0.31[0.03-0.74] 0.69[0.21-0.83] 
Length of stay 12[5-38] 4[2-9] 
Baseline Barthel Index 13{6-19} 18{12.5-20} 
Patients that have had more severe strokes are more likely to have longer hospital stays and 
therefore more opportunity to be weighed. It is likely that it is this relationship that results in 
the seemingly poorer outcomes in patients who are not weighed, i.e. being weighed is acting 
as a proxy marker of stroke severity. It is therefore unlikely that the apparent statistical 
significance of being weighed in univariate analysis would remain once stroke severity 
variables are controlled for in multivariable analysis.   
5.7.2 SIPSO social subscore  
A Q-Q plot and Shapiro Wilk test suggest that the social subscore of the SIPSO approximate a 
normal distribution such that parametric analyses may be performed (see Figure 29). 
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 Univariate relationships between processes of care and SIPSO social Table 48
subscore 
Care process ANOVA p value  
Admitted to stroke unit on day or day after admission 0.0073 
Scan within 24 hours of admission 0.16 
tPA given 0.26 
Swallow screen in 24 hours 0.034 
Aspirin in 48 hours 0.17 
Physiotherapy within 48 hours 0.38 
Occupational therapy assessment within four days 0.09 
MDT rehab goals set 0.24 
Weighed during the course of the admission 0.50 
Mood assessed during admission  0.15 
Visual fields assessed 0.13 
Sensory testing 0.48 
Formal swallow assessment by SLT within 72 hours 0.006 
Communication assessment by SLT  <0.001 
Social worker assessment 0.021 
Cognition screen  0.036 
Malnutrition screen 0.80 
Urinary incontinence care plan <0.001 
In receipt of fluids within 24 hours of admission N/A 
In receipt of nutrition within 72 hours of admission  0.066 
 Identification of statistically significant differences in mean social SIPSO Table 49
scores between levels of response for process markers reaching 
significance at the 1% level in a oneway ANOVA  
 mean social SIPSO scores [95% confidence interval]  
 No Yes No But 
Admitted to stroke unit on day or 
day after admission 
9.9 [8.1-11.6] 12.6[11.8-13.4] N/A 
Formal swallow assessment by 
SLT within 72 hours 
10.9 [8.5-13.4] 10.6[9.2-12.0] 13.0 [12.1-13.8] 
Communication assessment by 
SLT  
10.2 [8.4-11.9] 10.3 [9.0-11.6] 13.5 [12.6-14.3] 
Urinary incontinence care plan 10.7 [7.7-13.6] 9.1 [7.6-10.5] 13.0 [11.4-12.9] 
The darkest shaded box for SLT communication assessment in Table 49 indicates a significant 
difference between “No”/“No But” and “Yes” / “No But”. There is no significant difference 
between “No” and “Yes” responses.  
Patients admitted to a stroke unit on the same day or the day after their presentation to 
hospital have better six month social SIPSO scores, although this just fails to reach statistical 
significance at the p=0.01 level. Patients who are formally assessed by speech and language 
therapists for both swallowing and communication have worse six month outcomes than 
patients that do not require such assessments (“no but” codes). This likely reflects patients 
without deficits rather than patients too unwell to undergo assessments. In addition, patients 
in whom a communication assessment is indicated but not performed also have significantly 
lower six month social SIPSO scores than patients in whom such assessments are not 
indicated, but they do not have worse outcomes than patients who receive formal 
- 147 - 
 
communication assessments. This would tend to suggest that it is the presence of the deficit 
rather than the communication assessment itself that is correlated with the six month social 
outcome. In a similar way, patients who require and have a urinary incontinence care plan in 
place, have significantly worse social outcome scores at six months than patients in whom 
such an assessment is not required.  
Consistently in univariate analysis, the significant differences are between the ‘no but’ group 
and the ‘no’ or ‘yes’ groups. This would tend to suggest that it is the requirement for, and not 
the receipt of, particular processes that is associated with outcome.   
 
5.8 Regression trees 
5.8.1 Prediction of Physical subscore of SIPSO 
Entering the variables from Table 10 p 81 (including the baseline assessments) into a 
regression tree model to predict the Rasch transformed physical SIPSO subscore results in 
Figure 53. Pruning this tree to remove the variables that explain less of the SIPSO physical 
outcome gives the tree shown in Figure 54. 
It can be seen from the regression tree that length of stay is the main determinant of physical 
SIPSO score at six months. Baseline NEADL is also an important predictor, and propensity 
score does not feature in the regression tree. It is likely that there is collinearity between the 
baseline EQ5D and the baseline NEADL variables. This however will be addressed further 
through both clinical reasoning and stepwise variable selection procedures during the 
construction of regression models. 
Construction of the trees without the baseline assessments gives Figure 55 (unpruned) and 
Figure 56 (pruned tree). Inspection of these regression trees reveals length of hospital stay to 
be the most important predictor (see pruned tree Figure 54). It is likely that length of stay is 
acting as a proxy marker for stroke severity and there is therefore likely to be collinearity 
between length of stay and other prognostic or severity variables. Again, this will be 
considered explicitly during linear regression model development.  
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Figure 53 Regression tree of physical subscore of SIPSO on variables in Table 10 (including baseline assessments) 
     Baseline EQ5D   utility score <0.79 
Length of stay >=33.5 
Propensity Score <0.10 
Baseline NEADL < 45.5 
Baseline EQ5D utility score <0.63 Baseline NEADL < 61.5 
Formal SLT swallowing assessment = Yes 
              Baseline GHQ_12 >=4.5 
Baseline BI   <16.5 
 Baseline BI   >=11.5 
3.35 8.23 
9.50 
4.74 8.83 
12.62 
10.37 
10.20 16.43 
16.51 
16.56 19.42 
 Length of stay > =56.5 
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.  
Figure 54 Pruned regression tree of physical subscore of SIPSO on variables in Table 
10 (including baseline assessments) 
Length of stay >=33.5 
6.35 
7.40 12.6
2 
14.94 18.13 
Baseline NEADL < 45.5 
Baseline EQ5D utility score 
<0.63 Baseline NEADL < 61.5 
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Figure 55 Regression tree of physical subscore of SIPSO on variables in Table 10 (excluding baseline assessments)
Length of stay >=33.5 
Propensity Score <0.10 Propensity Score <0.06 
 Length of stay >=56.5 
Formal SLT   communication   
assessment = No 
     Previous stroke? 
First admitted to CCU, MAU or general ward 
Swallow screen required? 
Non PACS  stroke 
3.35 8.23 
9.27 
10.73 
10.64 
17.35 
9.50 
14.00 17.05 
18.54 
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Figure 56 Pruned regression tree of physical subscore of SIPSO on variables in Table 
10 (excluding baseline assessments) 
 
5.8.2 Prediction of social subscore of SIPSO 
Examination of the regression tree to predict the social subscore of the SIPSO that includes 
baseline questionnaires is shown in Figure 57. Here the major determinant of social outcome 
at six months is the baseline EQ5D. Pruning the tree reveals baseline EQ5D, the requirement 
for a formal speech and language assessment and the baseline NEADL as the most important 
predictors of outcome (Figure 58) 
Length of stay >=33.5 
Propensity Score <0.06 
First admitted to CCU, MAU or 
general ward 
6.35 
9.27 
14.24 17.35 
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Figure 57 Regression tree of social subscore of SIPSO on variables in Table 10 (including baseline assessments)
Baseline EQ5D Utility Score <0.59 
Formal SLT communication 
assessment required Baseline NEADL <47.5 
     Length of  stay >=64          ESD provided Female?      Length of  stay >=9.5 
     Baseline EQ5D Utility Score <0.74 
Admitted to 
general medical ward 
      Baseline  NEADL >=56 
     Baseline  NEADL <62 
4.98 7.96 9.00 12.80 
9.10 12.73 
11.77 
12.15 15.45 
13.47 16.25 15.15 18.52 
      Propensity  Score <0.77 
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Figure 58 Pruned regression tree of social subscore of SIPSO on variables in Table 
10 (including baseline assessments) 
 
Length of stay is revealed as the most important predictor in the tree to predict social 
outcome that does not include the baseline assessments (Figure 59). Whether or not patients 
were treated on a stroke unit, stroke type (lacunar vs. other types of stroke) and imaging 
within 24 hours of admission were other important predictors, and these remained in the 
trees following pruning (Figure 60)  
Categories of formal communication assessment by a speech and language therapist feature 
as predictors in three out of the four trees (Figure 53, Figure 55 & Figure 57), although it only 
features prominently in the model to predict the social SIPSO with baseline assessments 
(Figure 57). This variable, the type of ward a patient is admitted to, are the only two process 
markers that feature prominently in the regression trees. The majority of variables which 
feature in the trees are markers of stroke severity and these overshadow the other variables. 
Some variables describing more organisational aspects of patient care do appear in the trees 
(e.g. whether a patient was first admitted to a ward capable of delivering hyperacute stroke 
care) and this may reflect local differences in service provision. 
.
7.24 10.98 
Baseline EQ5D Utility Score < 0.59 
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Figure 59 Regression tree of social subscore of SIPSO on variables in Table 10 (excluding baseline assessments) 
Length of stay >=10.5 
Non LACS stroke Some of hospital spell spent on a SU = No  
Length of stay > =52 
ESD support provided 
Propensity Score <0.57 
     Formal SLT communication Assessment 
= No 
Propensity Score >=0.25 
Propensity Score <0.77 
Propensity Score>=0.87 
Swallow screen required? 
6.45 9.26 9.71 13.73 
9.06 
10.33 
11.67 
13.77 17.46 
16.62 
13.54 
13.92 17.75 
Imaging within 24 hours of 
admission = No  
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Figure 60 Pruned regression tree of social subscore of SIPSO on variables in Table 
10 (excluding baseline assessments) 
  
Length of stay 
 
Non LACS 
 
Some on hospital spell spent 
on a SU = No 
Imaging within 24 hours of 
admission = No  
8.09 11.89 
9.06 13.6
8 
15.8
1 
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5.9 Construction of linear regression models 
Linear regression models were constructed to explore the association between individual 
processes of care and the physical and social subscores of the SIPSO. Modelling 
methodology including post-estimation checks of assumptions is discussed in section 4.4.6. 
Two models were created for each outcome – one that includes and one that excludes 
baseline functional assessments. This was in order to ascertain whether there are 
prominent predictors of outcome in the absence of baseline assessment, as this would 
increase the utility of these predictors in routine care where the infrastructure to collect 
baseline assessments may be limited.  
Models were re-run for each analysis with exclusion of influential cases to ascertain 
whether the prominent predictors changed (as a measure of model stability). However, 
post-estimation analyses were made on the full models.   
5.9.1 Transformation of length of stay 
A pre-estimation examination scatter plot of length of stay against SIPSO physical score 
revealed a likely logarithmic or reciprocal relationship (the line represents a fractional 
polynomial line of best fit calculated by STATA).  
 Scatter plot of length of stay against SIPSO physical subscore with Table 50
fractional polynomial line of best fit 
 
A logarithmic transformation of the variable length of stay was performed in an attempt to 
improve the linearity of the relationship with the physical subscore of the SIPSO prior to 
modelling. A value of one was added to length of stay to ensure that there were no zero 
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values prior to taking logarithms. However, as time of discharge had not been recorded in 
the study, cases where discharge was on the same calendar day of admission (discharge 
within 24 hours) had already been rounded up to one whole day (i.e. there were no zero 
values). A scatter plot of the logarithm of length of stay plus one against the physical 
subscore of the SIPSO reveals a linear relationship, but there is deviation from linearity at 
small values of length of stay. This may represent the rounding of length of stay, although 
it would be expected that patients discharged rapidly who survive to six month follow up 
(i.e. not discharged for palliative care) would have better  outcomes than those with longer 
lengths of stay. It is possible, therefore, that this line of fit is being ‘pulled’ by influential 
cases (such as cases 232 and 50, highlighted on Figure 61), where outcomes are poorer 
than would be expected based on their length of stay.  
A logarithmic transformation of length of stay plus one was used in all the models.  
Figure 61 Scatter plot of logarithmic transformation of (length of stay + 1) 
against physical subscore of SIPSO with polynomial line of best fit 
demonstrating linearity 
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5.9.2 Prediction of physical subscore of the SIPSO with baseline assessments 
(Model 1) 
 Independent variables to be entered into regression models for Table 51
prediction of physical subscore of the SIPSO 
 Variables Number of variables 
(including dummy 
variables) 
Variables identified from 
regression trees 
Length of stay 
Baseline NEADL 
Baseline EQ5D 
1 
1 
1 
Variables identified from 
univariate analysis 
Formal swallowing assessment 
Communication assessment 
Social Worker assessment 
Urinary incontinence care plan 
2 
2 
2 
2 
Probable important variables 
through clinical reasoning 
tPA given 
First admitted to a stroke unit, 
CCU/HDU/ICU vs. general ward/MAU 
Propensity score (or age if propensity 
score removed) 
Discharge to same address 
2 
1 
 
1 
 
1 
Total   16 
A variable was created to distinguish whether a patient was admitted to a ward for 
hyperacute stroke care (stroke unit (SU), coronary care unit (CCU), high dependency unit 
(HDU), or intensive care unit (ICU)) or to a medical admissions unit or general medical 
ward. The reasoning for the creation of this variable is discussed in section 5.9.3.1. 
5.9.2.1 Effective sample size for Model 1 
An EPV calculation has been performed using the number of completed outcomes There 
are 176 completed SIPSO physical subscore questionnaires, therefore 17 variables 
(including dummy variables) may be entered into the models in order to achieve 10 events 
per variable  as recommended by Peduzzi et al (Peduzzi P et al  1996). 
Figure 62 demonstrates that the baseline Barthel Index was lower in patients automatically 
excluded from the Model 1 due to incomplete predictor variables than in patients included 
in the model. However, a Mann-Whitney U test shows this difference is not statistically 
significant (p=0.555).  
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Figure 62 Difference in baseline Barthel Index for patients with complete and 
incomplete independent variables selected for entering into regression 
model to predict physical subscore of SIPSO (only cases with complete 
physical SIPSO shown). 
   
Model 1 Linear regression of predictor variables (Table 51) on physical subscore of 
SIPSO, logarithmic transformation of length of stay 
 
     R
2 
= 0.54 
Adj R
2
 =0.52  
N
o
 Obs  =145  
F  =31.99  
P>|F|<0.001  
     
     
     
     
 
Beta 
coefficient 
Standard 
error 
t P>|t| 
95% confidence 
interval 
Baseline NEADL 0.13 0.024 5.35 <0.001 0.08 0.17 
Baseline EQ5D 4.43 1.23 3.58 <0.001 1.99 6.87 
Log (length of stay +1) -1.39 0.41 -3.40 0.001 -2.20 -0.58 
Discharged to same 
address 
3.73 1.24 3.00 0.003 1.27 6.19 
Constant 3.92 2.14 1.83 0.069 -0.31 8.15 
 
Propensity score has been automatically removed from this model, therefore the model 
has been re-run with age at stroke entered as an independent variable as it is likely to be 
an important predictor (Model 2), and is used to calculate the SSV.  
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Model 2 Linear regression of predictor variables (Table 51) on physical subscore of 
SIPSO, including age at stroke 
     R
2 
= 0.54 
Adj R
2
 =0.52  
N
o
 Obs  =145  
F  =31.99  
P>|F|<0.001  
     
     
     
     
 
Beta 
coefficient 
Standard 
error 
t P>|t| 
95% confidence 
interval 
Baseline NEADL 0.11 0.024 4.72 <0.001 0.07 0.16 
Baseline EQ5D 4.73 1.23 3.86 <0.001 2.31 7.16 
Log (length of stay +1) -1.27 0.41 -3.10 0.002 -2.07 -0.46 
Discharged to same 
address 
3.49 1.23 2.84 0.005 1.06 5.92 
Age at stroke onset -0.07 0.33 -2.28 0.024 -0.14 -0.01 
Constant 9.73 3.31 2.94 0.004 3.19 16.27 
Age reaches statistical significance in this model and is therefore retained. 
 
5.9.2.2 Post estimation checks 
5.9.2.2.1 Linearity 
Linearity assumptions were checked for continuous baseline predictors in the model. There 
are apparently non-linear relationships between the logarithmic transformation of length 
of stay and physical SIPSO subscore identified through augmented component plus 
residual plots (see section 4.4.6.1.4) (Figure 63). However, the estimates from a model 
where length of stay is divided into six categories and treated as a categorical variable data 
does not differ significantly from a linear prediction of physical SIPSO with length of stay 
treated as a continuous variable (likelihood ratio test - see appendix E-1.2). 
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Figure 63 Augmented component plus residual plots (acprplot) for continuous 
independent predictors in Model 2 (Baseline NEADL,  baseline EQ5D, 
length of stay and age at stroke) 
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5.9.2.2.2 Influential cases and leverage  
The deviation from linearity for both transformed length of stay and baseline NEADL seen 
on acprplots may be due to outlying cases with particularly large residuals at high leverage 
points (e.g. those highlighted in Figure 64 below). 
Figure 64 Augmented component residual plots labelled by study number to 
identify likely cause of deviation from linearity 
  
 
A histogram of studentised residuals for Model 2 reveals a few extreme outliers where 
observed outcome is different from that predicted from the model. Examination of the 
cases with studentised residuals ≥|3| reveals these to be cases 239 and 232. 
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Figure 65 Histogram of studentised residuals (Model 2) 
 
When the augmented component residual plots for transformed length of stay and 
baseline NEADL are re-examined and individual points labelled (Figure 63), it can be seen 
that some of the cases identified in Figure 66 as likely to be exerting undue influence on 
the whole model may also be contributing to the deviations from linearity, i.e. these points 
may be distorting the relationship between individual covariates and the dependent 
variable.  
Figure 66 Leverage vs. r squared plot for prediction of physical subscore of the 
SIPSO 
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There are a number of cases of concern, study numbers 239, 172 and 116 are all outliers in 
both r-squared value and leverage and are therefore likely to exert influence on the model 
regression coefficient (i.e. the slope of the fitted regression line). Troublesome cases with a 
Cooks D statistic of >4/n = 0.028 (n=145 for this model) are shown below (see section 
4.4.6.1.4). It can be seen that, as predicted, cases 239, 232, 172, 239 and 116 are of 
concern.  
Study number  Cooks D 
239  0.104 
232  0.069 
172  0.055 
116  0.051 
236  0.038 
Examination of DFBETA for the independent predictors reveals that the cases identified on 
an acprplot as possible contributors to non-linearity between the baseline NEADL and 
physical SIPSO subscore are also particularly influential on the beta coefficient for the 
baseline NEADL in the model (identified with black circles on Figure 67 i.e. cases 239, 172). 
Similarly, for the length of stay (grey triangles on Figure 67), it is the points identified on 
the acprplot that appear to be exerting undue influence.  
Figure 67 Scatter plot of DFBeta for independent variables across study numbers 
(prediction of physical subscore of the SIPSO with baseline 
assessments) 
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However, although none of these cases are extreme outliers in terms of their individual 
values for either baseline NEADL (172,239) or length of stay (232, 116), they represent 
cases with particularly good or poor outcome relative to that which would be predicted on 
the basis of the independent variable (i.e. they have high residuals). This can be seen from 
a simple scatter plot of the predictor against the SIPSO physical score. For example, cases 
172 and 239 represent individuals that have much better physical scores at 6 months than 
would have been expected on the basis of their baseline NEADL scores.   
 
Removing the 4 particularly influential cases from the regression model (232, 239, 172 and 
116) makes a large difference to the R squared (variance explained) of the model and 
increases the proportion of the total variance that is explained by the model as opposed to 
the model residuals (Model 3), but this is to be expected as some of the residual variation 
has been artificially removed. However, omission of the influential cases does not alter 
which of the variables reach statistical significance in the model, nor are there large 
differences to the size or polarity of the beta co-efficients. For the purposes of 
identification of important predictor variables for the development of a dataset, the 
influential cases can remain in the model as small changes to the values of the individual 
beta co-efficients is of little importance.  Moreover, removing the influential cases is likely 
to overfit the model as the identified cases do not represent ‘wrong’ data, but cases better 
or worse outcomes are observed than predicted with the model (Fox J,  1997 p 286). It may 
be useful, therefore, to examine these cases qualitatively to identify any salient features of 
management that may warrant further exploration.  
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Model 3 Linear regression of predictor variables (Table 51) on physical subscore of 
SIPSO, with influential cases removed 
     R
2 
= 0.63 
Adj R
2
 =0.62  
N
o
 Obs  =141  
F  =45.85  
P>|F|<0.001  
     
     
     
     
 
Beta 
coefficient 
Standard 
error 
t P>|t| 
95% confidence 
interval 
Baseline NEADL 0.15 0.022 6.71 <0.001 0.11 0.19 
Baseline EQ5D 4.50 1.08 4.16 <0.001 2.36 6.64 
Log (length of stay +1) -1.37 0.36 -3.79 <0.001 -2.09 -0.66 
Discharged to same 
address 
3.57 1.08 3.30 0.001 1.42 5.71 
Age at stroke onset -0.059 0.029 -2.00 0.05 -0.12 -0.001 
Constant 7.05 3.00 2.35 0.02 1.12 12.99 
 
5.9.2.2.3 Normality assumptions 
Normality of residuals for the full model (with transformed length of stay and age at stroke 
included) (Model 2) is assessed through examination of standardised normal probability 
plots. There is some deviation from normality at the extremes of the distribution of the 
residuals (which may reflect the influence of the cases already highlighted). However, this 
deviation does not look too serious.  
Figure 68 Normal probability (Q-Q plot) for Model 2  
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Figure 69 Scatter plot of fitted values vs. residuals demonstrating 
homoscedasticity for Model 2 
 
There is no pattern in a plot of residuals against fitted values, so the variance of the model 
is assumed to be homoscedastic. Formal diagnostics reveal that the null hypothesis of 
constant variance can be accepted (p=0.46).  
5.9.2.2.4 Tests for collinearity in Model 2 
Variance inflation factors (VIF) were examined to identify any collinearity between 
predictor variables (see section 4.4.6.1.4). The variance inflation factors were all less than 
ten and therefore do not imply that there is any collinearity between the predictor 
variables. However, this is not surprising, as the model was constructed using stepwise 
variable selection such that collinear variables are automatically excluded from the model. 
A table of variance inflation factors is provided for Model 2 in appendix E-1.3; however 
these have not been repeated for subsequent models.  
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5.9.3 Prediction of physical subscore of SIPSO, no baseline assessments 
The variables identified through regression trees, univariate analysis and clinical reasoning 
for the prediction of physical SIPSO without baseline assessments are provided in Table 52. 
 Independent variables to be entered into regression model to predict Table 52
physical subscore of the SIPSO 
 Variables Number of 
variables (including 
dummy variables) 
Variables identified from 
regression trees 
Length of stay 
Propensity score  
Old stroke 
Ward type 
Communication assessment 
1 
1 
1 
7 
2 
Variables identified from 
univariate analysis 
Formal swallowing assessment 
Social Worker assessment 
Urinary incontinence care plan 
2 
2 
2 
Probable important variables 
through clinical reasoning 
tPA given 
Discharge to same address 
Age if propensity score removed 
Baseline Barthel Index 
2 
1 
0 
1 
Total   22 
Boxplots of baseline BI in patients with, and without complete predictor variables reveal 
that patients automatically excluded from the model to predict physical SIPSO subscore 
(without the baseline assessments) are more disabled than those in whom data are 
complete. However, this difference does not reach statistical significance in a Mann-
Whitney U test (p=0.187) 
Figure 70 Difference in baseline BI between patients with complete and 
incomplete model variables  
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5.9.3.1 Sample size 
If the predictors outlined in Table 52 were to be entered into the models as shown, the 
number of variables to be entered into this model would exceed 10 EPV, largely due to the 
large number of dummy variables associated with ward type. Examination of the 
regression trees and dummy variables for ward type reveals that the significant predictor is 
whether patients were admitted to an environment with facilities to provide hyperacute 
stroke care (coronary care unit (CCU), high dependency unit (HDU)/ intensive care unit 
(ITU), or acute stroke unit (ASU)). Although treatment on CCU appears alongside ‘other 
ward’ or ‘medical admissions unit’ in the regression tree to predict physical SIPSO without 
baseline assessments, this represents only one patient in the study. CCU has therefore 
been grouped with the other wards where hyperacute stroke care may be provided. The 
‘ward type’ variable has therefore been re-categorised to reflect the receipt of specialist 
acute stroke care or not by combining CCU, HDU, ITU and ASU care into one category, and 
admissions unit and general ward care into another. 
Entering the new variable (admitted ASU) into a regression tree reveals that it remains an 
important predictor of the physical subscore of the SIPSO Figure 71.  
Figure 71 Regression tree to demonstrate prominence of composite variable of 
direct admission to a unit providing hyperacute stroke care on 
prediction of physical outcome  
 
The number of variables entered into the model can therefore be reduced to 16. Length of 
stay will again be entered into the model as a logarithmic transformation.  
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Model 4 Linear regression of predictor variables (Table 52) on physical subscore of 
SIPSO, without patient reported baseline assessments 
     R
2 
= 0.45 
Adj R
2
 =0.43  
N
o
 Obs  =167  
F  =18.53  
P>|F|<0.001  
     
     
     
     
 
Beta 
coeffici
ent 
Standard 
error 
t P>|t| 
95% confidence 
interval 
Log (length of stay + 1) -2.11 0.49 -4.92 <0.001 -2.96 -1.26 
Propensity score (SSV) 3.18 1.43 2.22 0.028 -0.35 6.01 
Admitted to hyperacute bed 2.11 0.78 2.75 0.007 0.60 3.62 
SLT communication Ax “yes” 2.87 1.10 2.61 0.01 0.70 5.04 
SLT communication Ax “no 
but” 
2.76 0.97 2.85 0.005 0.84 4.67 
Previous stroke -2.61 1.06 -2.48 0.014 -4.70 -0.53 
Discharged to same address 3.94 1.23 3.19 0.002 1.50 6.38 
Constant 10.36 2.13 4.86 <0.001 6.16 14.57 
 
5.9.3.2 Post estimation checks 
5.9.3.2.1 Linearity assumptions 
The augmented partial residual plots (acprplot) for the propensity score appears to be 
influenced by some points at the extremes, but this deviation is not serious. As before, 
there is deviation on the acprplot for length of stay which is likely to reflect the influential 
points at the extremes of the distribution. Linearity assumptions are therefore assumed to 
have been met.  
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Figure 72 Augmented component plus residual plots for continuous predictors in 
Model 4 
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5.9.3.2.2 Leverage 
The most influential cases in this model would be expected to be case 232, 264, 116, and 
196. Examination of Cook’s D statistic (as discussed in 4.4.6.1.4e) confirms the most 
influential points to be 232, 264, 50, 254, and 196.  
Figure 73 Leverage vs. r-squared plot for Model 4 
 
Study number  Cooks D  
 
232  0.12 
264  0.047 
50  0.043 
254  0.041 
196  0.039 
The effect of individual cases on the beta co-efficients of each individual variable is shown 
in (Figure 74). It can be seen that the influential cases are similar to those that exert 
influence on the regression coefficient of the whole model. 
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Figure 74 DFBeta for independent variables across individual cases (prediction of 
physical subscore of SIPSO without baseline assessments) - Vertical 
lines identify potentially influential cases 
 
Removing the influential cases and re-performing the regression analysis removes previous 
stroke as an important predictors of outcome. This may be due to the large DFBETA for 
case 232 for this variable. Again, this represents unexpected, but not spurious data and 
influential cases are retained for interpretation of the models.  
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Model 5 Linear regression of predictor variables (Table 52) on physical subscore of 
SIPSO, without baseline assessments and with  influential cases removed 
     R
2 
= 0.48 
Adj R
2
 =0.46  
N
o
 Obs  =163  
F  =24.21  
P>|F|<0.001  
     
     
     
     
 
Beta 
coefficient 
Standard 
error 
t P>|t| 
95% confidence 
interval 
Log (length of stay + 1) -2.56 0.42 -6.16 <0.001 -3.38 -1.74 
Propensity score (SSV) 3.10 1.36 2.27 0.024 0.41 5.79 
Admitted to hyperacute 
bed 
1.98 0.73 2.71 0.01 0.54 3.42 
SLT communication Ax 
“yes” 
3.57 1.06 3.36 0.001 1.47 5.67 
SLT communication Ax 
“no but” 
2.53 0.92 2.76 0.007 0.72 4.34 
Previous stroke       
Discharged to same 
address 
4.01 1.24 3.24 0.001 1.56 6.46 
Constant 11.21 2.08 5.37 <0.001 7.09 15.34 
 
5.9.3.2.3 Normality of residuals 
A standardised probability normal plot (for Model 4, with influential cases included) 
suggests there is deviation of the residuals from normality at the extremes of the 
distribution. This is confirmed on Shapiro-Wilk testing (z=1.89, p=0.03).   
Figure 75 Normal probability plot for model residuals (Model 4) 
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5.9.3.2.4 Homoscedasticity 
A plot of residuals against fitted values does suggest a downward linear trend in the data. 
This is again likely to represent a missing variable from the model. Diagnostics to assess for 
heteroscedasticity, however, fail to reach significance such that the null hypothesis of 
homogeneity of variance is accepted.  
Figure 76 Scatter plot of model residuals against fitted values to identify 
heteroscedasticity (Model 4) 
  
5.9.4 Prediction of social subscore of the SIPSO with baseline assessments 
Variables to be entered into a model to predict the social subscore of the SIPSO (with 
baseline assessments) are shown in Table 53. 
 Variables to be entered into regression model to predict social Table 53
subscore (with baseline assessments)  
 Variables Number of variables 
Variables identified from 
regression trees 
Baseline EQ5D 
Baseline NEADL 
SALT  communication assessment 
Length of stay 
1 
1 
2 
1 
Variables identified from 
univariate analysis 
Formal swallowing assessment 
Urinary incontinence care plan 
1 
2 
Probable important variables 
through clinical reasoning 
Propensity score (or age if 
propensity score excluded) 
First ward admitted to 
Discharged same address 
tPA given 
Social Worker assessment 
1 
 
1 
1 
2 
2 
Total   15 
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There were 144 completed and returned SIPSO subscore questionnaires, therefore 
entering these 15 variables into a model gives an EPV of 9.6. 
Figure 77 Difference in baseline BI between patients with complete and 
incomplete model variables to predict social subscore of SIPSO  
 
The apparent difference in the baseline BI between patients who are included in the 
models (complete predictor variables) vs. those who are automatically excluded 
(incomplete predictor variables) is demonstrated not to be statistically significant on 
Mann-Whitney U testing (p=0.504) 
Model 6 Linear regression of predictor variables (Table 52) on social subscore of SIPSO 
(with baseline assessments) 
     R
2 
=0.40  
Adj R
2
 =0.39  
N
o
 Obs  =144  
F  =23.59  
P>|F|<0.001  
     
     
     
     
 
Beta 
coefficient 
Standard 
error 
t P>|t| 
95% confidence 
interval 
Baseline EQ5D 3.53 1.05 3.37 0.001 1.46 5.61 
Baseline NEADL 0.06 0.02 2.89 0.004 0.02 0.10 
Log (length of stay +1) -0.81 0.37 -2.21 0.029 -1.53 -0.086 
SLT communication Ax 
“no but” 
2.11 0.65 3.22 0.02 0.81 3.40 
Constant 7.78 1.67 4.65 <0.001 1.42 11.1 
 
The propensity score again fails to reach significance in this model. Substitution for age 
instead of propensity also fails to reach significance, and make no real difference to either 
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the beta-coefficients or total fit of the model. Propensity score is therefore retained in the 
model. 
5.9.4.1 Post estimation checks 
5.9.4.1.1 Linearity 
Augmented component plus residual plots reveal that the largest deviation from linearity 
occurs with the baseline NEADL. 
Figure 78 Augmented component plus residual plots of continuous variables 
entered into Model 6 (baseline NEADL, baseline EQ5D and length of 
stay) 
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A likelihood ratio test for improved model fit using a continuous vs. a categorised NEADL 
variable fails to reach significance such that it can be assumed that categorising the NEADL 
will not significantly improve the model (p=0.332 working not shown).  
As with the prediction of the physical subscore of the SIPSO, it is possible that some 
influential points are ‘pulling’ the fitted line away from linearity (large residuals). These are 
highlighted on the acprplots (Figure 78), and particularly influential points in terms of 
leverage will be explored further in the next section.  
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5.9.4.1.2 Influence and leverage 
A plot of leverage against r squared for individual cases is shown below 
Figure 79 Leverage against r squared Model 6 
 
There are a few potentially influential cases highlighted on this plot. It is likely that cases 
239, 172, 94, 167, 259 may be problematic.  
Determination of Cook’s D statistic (n=144) reveals that these are indeed the 5 most 
influential cases in terms of overall leverage. 
Study number Cooks D 
167  0.09 
94  0.07 
172  0.06 
259  0.05 
239  0.05 
A DFBETA plot (below) shows cases that are likely to be exerting undue influence on the 
beta coefficients for individual variables. Several cases are outwith the limits of 2/√144 
(0.167). However, the cases which exert influence on individual variable beta coefficients 
(with high |DFBeta| values) tend to be the same cases as those which exert influence on 
the overall model regression co-efficient (high Cook’s D).  
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Figure 80 Scatter plot of individual cases against DFBeta values for individual 
variables. Vertical lines represent cases likely to be of particular 
influence.  
 
Re-running the regression models with cases with high Cook’s D and with high DFBeta 
values removed (i.e. cases that are influential on the model regression coefficient and 
individual variable beta co-efficients) results in the propensity score entering the model 
reaching statistical significance at 0.05. The omission of this variable in the full model may 
therefore be due to the influential cases. However, as previously discussed, these cases 
represent unexpected, not spurious data and therefore are retained in the models to 
prevent overfitting. 
Model 7 Linear regression of predictor variables (Table 52) on social subscore of SIPSO 
with influential cases removed 
     R
2 
=0.53  
Adj R
2
 =0.51  
N
o
 Obs  =139  
F  =29.45  
P>|F|<0.001  
     
     
     
     
 
Beta 
coefficient 
Standard 
error 
t P>|t| 
95% confidence 
interval 
Baseline EQ5D 4.48 0.93 4.82 <0.001 2.64 6.32 
Baseline NEADL 0.10 0.02 4.90 <0.001 0.06 0.14 
Log (length of stay +1) -1.29 0.38 -3.39 0.001 -2.04 -0.54 
SLT communication Ax 
“no but” 
-1.86 0.70 -2.75 0.01 -3.21 -0.52 
Propensity score -2.25 1.13 -1.99 0.05 -4.49 -0.01 
Constant 7.78 1.65 5.33 <0.001 5.55 12.1 
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5.9.4.1.3 Normality assumptions (all cases included)  
A normal probability plot is straight suggesting that residuals are normally distributed and 
this is confirmed on a Shapiro-Wilk test (z= 0.16, p=0.44)  
Figure 81 Normal probability plot (Model 7) 
    
Figure 82 Fitted values against model residuals demonstrating homoscedasticity 
in Model 6 
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Therefore, although this model explains little in the way of variation in social SIPSO score 
at six months, modelling assumptions are met. The variance explained by the fixed (fitted) 
component of the model is considerably less than the proportion of variance explained by 
the random effects. It is therefore likely, that there are important factors that have 
significant influence on the social outcome of patients following a stroke other than the 
baseline assessments and process markers that have been recorded during the study.  
5.9.5 Prediction of the social subscore of the SIPSO without baseline 
assessments 
Variables to be entered into the model to predict the social subscore of the SIPSO without 
baseline assessments are presented in Table 54. 
 Identified variables to be entered into linear regression models to Table 54
predict the social subscore of the SIPSO without baseline assessments 
 Variables Number of 
variables 
Variables 
identified from 
regression trees 
Length of stay 
Admitted to stroke unit on day, or day after admission 
Clinical classification 
Early supported discharge 
Imaging within 24 hours 
SALT  communication assessment 
1 
1 
3 
1 
1 
2 
Variables 
identified from 
univariate 
analysis 
Formal swallowing assessment 
Urinary incontinence care plan 2 
2 
Probable 
important 
variables 
through clinical 
reasoning 
Social Worker assessment 
Baseline Barthel Index 
tPA given  
Propensity score 
First admitted to a stroke unit, CCU/HDU/ICU vs. general 
ward/MAU 
Discharged to same address 
2 
1 
2 
1 
1 
 
1 
Total   21 
In the classification tree to predict the social subscore of the SIPSO without baseline 
assessments, the clinical classification of stroke ‘splits’ on partial anterior (PACS) vs. other 
type of stroke (see section 5.8.2, Figure 59). For the purposes of reducing the number of 
dummy variables to enter in the model, this variable will therefore be classified in this way. 
Admission to a stroke unit on the same day, or day after admission is likely to capture 
similar constructs to the first ward that the patient was admitted to. The latter variable will 
therefore be excluded from this analysis.   
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 Variables to be entered into the model to predict social subscore of Table 55
the SIPSO without baseline assessments following refinements 
Length of stay  Formal SLT swallowing assessment  
Some of hospital spell spent on a SU Urinary incontinence care plan 
LACS vs. other stroke Social Worker assessment 
Early supported discharge  Baseline Barthel Index 
Imaging within 24 hours rtPA given 
SALT  communication assessment Propensity score 
Discharged same address  = 18 variables (including dummies) 
 
Figure 83 Difference in baseline Barthel Index for patients with complete and 
incomplete independent variables selected for entering into regression 
model to predict social subscore of SIPSO without patient reported 
baseline assessments (only cases with complete social SIPSO shown) 
 
Patients with missing predictor variable data (and therefore automatically excluded from 
the model) appear to have higher baseline BI than those with complete data (included in 
the models). However, Mann-Whitney U testing shows that this difference fails to reach 
statistical significance (p=0.116) such that the median BI between the two groups is 
assumed to be equal.  
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Model 8 Linear regression of predictor variables (Table 55) on social subscore of SIPSO, 
without baseline assessments 
     R
2 
= 0.36 
Adj R
2
 =0.35  
N
o
 Obs  =153  
F  =21.02  
P>|F|<0.001  
     
     
     
     
 
Beta 
coefficient 
Standard 
error 
t P>|t| 
95% confidence 
interval 
Log(length of stay+1) -1.69 0.31 -5.5 <0.001 -2.30 -1.08 
SLT communication Ax 
“no but” 
2.22 0.66 3.35 0.001 0.91 3.53 
Discharged same 
address 
2.67 1.18 2.26 0.03 0.34 5.00 
Some of hospital spell 
on stroke unit 
2.26 0.67 3.36 0.001 0.93 3.59 
Constant 11.58 1.53 7.58 <0.001 8.56 14.61 
 
Propensity score has been automatically removed from this model as it fails to reach 
significance at the p<0.05 level. If age at stroke is substituted for propensity score in the 
regression equation, it too is automatically removed from the final model. Neither age nor 
propensity score therefore feature as important predictors in this model.   
The model explains only 35% of the variance in patient outcome as measured with the 
SIPSO social subscale. In addition, the majority of this variance is attributable to the 
residuals rather than the fitted values of the model.  
Post estimation checks 
5.9.5.1.1 Linearity  
Length of stay is the only non-categorical variable that appears in the model. The 
relationship between a logarithmic transformation of length of stay and the SIPSO social 
subscale is linear on an acprplot.  
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Figure 84 Augmented component plus residual plot for log transformed length of 
stay in Model 8 
 
5.9.5.1.2 Leverage 
Examination of studentised residuals reveals very few outlying values where |r| is >2. 
Figure 85 Histogram of studentised residuals Model 8 
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Figure 86 Leverage vs. r-squared plot Model 8 
 
Cases 26, 167, 94, 85 appear as if they may exert undue influence on the beta-coefficients. 
Cook’s D reveals the most influential case to be 85 (cut off value for d = 4/153 = 0.026). 
Study number  Cooks D 
26  0.07 
94  0.05 
167  0.05 
85  0.04 
279  0.04 
Displaying DFBeta statistics with limits around 2/√153 reveals a number of cases outwith 
these limits across the variables.  Removal of the most influential case (85) in terms of the 
regression coefficient for the whole model does not change appreciably the overall fit of 
the model. Removal of the cases with particularly high |DFBeta| values (50, 85, 94, 167, 
196, 279) that are likely to exert influence on the individual beta co-efficients, results in the 
variable ‘discharged to the same address no longer reaching statistical significance, and the 
entry of ‘scan within 24 hours’ into the model. There are minor changes to other beta-
coefficients in the models, but no other variables change significance or polarity (Model 9).  
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Figure 87 Scatter plot to identify individual cases with particularly large DFBeta 
values across variables (Model 8) 
  
 
Model 9 Linear regression of predictor variables (Table 55) on social subscore of SIPSO, 
without baseline assessments and with the most influential cases removed 
(study numbers 50, 85, 94, 167, 196, 279)  
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5.9.5.1.3 Normality of residuals (Model 8) 
A normal probability plot and Shapiro-Wilk test confirm normality of residuals. 
Figure 88 Normal probability plot Model 8      
  
5.9.5.1.4 Homoscedasticity 
There is no apparent pattern in the residuals vs. fitted values plot, and therefore 
homogeneity of variance across fitted values from Model 8 is assumed.  
Figure 89 Fitted values vs. residuals demonstrating homoscedasticity 
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5.10 Stability of models 
5.10.1 Markov Chain MonteCarlo iterations 
The models for physical and social SIPSO outcomes, with and without baseline assessments 
(four models in total) were recreated in MLWiN software, and MCMC iterations performed 
to assess convergence of the beta coefficients (see section 4.4.9). Five thousand iterations 
were performed, with a ‘burn in’ of 50 iterations for each model. All variables in each 
model converged on values similar to those of the models generated through the linear 
regression modelling. Diagnostics of the iterations were acceptable suggesting that the 
model beta co-efficients are stable.  
5.10.2 Significance level for stepwise selection procedures 
Models were also run with the significance level for stepwise variable selection procedures 
set at 0.5 instead of 0.05. This allows examination of the effect of inclusion of clinically but 
not necessarily statistically significant variables in the models. This resulted in propensity 
score failing to reach statistical significance in model 3 (prediction of physical subscore of 
SIPSO without baseline predictors), and imaging within 24 hours reaching statistical 
significance in model 8 (prediction of social subscore of SIPSO without baseline 
assessments). This may reflect the relative inferiority of models where baseline 
assessments are not included (see 6.1.4). 
 
5.11 Utility of the six simple variable case-mix adjuster in the study 
population 
In order to test the utility of the SSV case-mix adjuster in the population, I will examine the 
discriminatory function (c statistic) and calibration.  
5.11.1 Discrimination  
The three original SSV models were derived to predict survival, alive and independent 
(based on the OHS dichotomised at <=2) or alive and living at home. Of these three 
outcomes, alive and independent is the most relevant to the study, and so it is this model 
that has been selected to case-mix adjust the study population.  
C statistics were calculated through creating receiver operating curves (ROC) of the 
propensity score (as calculated from the original SSV model to predict survival, alive and 
independent) against the observed outcome (OHS <=2). It can be seen that the AUC (which 
is equivalent to the c statistic for dichotomous outcomes) is 0.77 (95% CI 0.71-0.82), 
indicating that the SSV model has good discrimination in the study population to predict 
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the outcome alive and independent (OHS<=2) at six months. The reference line represents 
discrimination no better than chance is given for comparison.  
The ROC curve obtained is shown in Figure 90 
Figure 90 Receiver Operating Curve (ROC) for propensity score against observed 
dichotomised OHS 
 
C-statistic = 0.77 [95% CI: 0.71-0.84] 
5.11.2 Calibration 
Calibration is the ability of a model to correctly predict outcomes in patients that 
ultimately have the outcome. Deviation from the reference line (y=x) signifies over or 
under optimistic predictions as outlined in Figure 91. 
Figure 91 Calibration of the SSV model to predict alive and independent at six 
months in the study population 
192It has been previously observed that the proportion of patients with predictions of 
good outcome as determined with the SSV model tends to be over optimistic when 
compared with observed outcomes (Counsell C et al  2002). Conversely, the model tends to 
make over pessimistic predictions of the proportion of patients with poor outcome (death 
or inability to return to own home) (Dennis MS et al 2003). However in the CIMSS study 
population (where patients with very severe strokes are excluded from recruitment), the 
SSV makes both over pessimistic and over optimistic predictions in patients with 
predominantly good observed outcomes (Figure 91). However, it should be noted that 
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some of these proportions are calculated from small absolute numbers of patients as 
reflected in the size of the error bars.  
5.11.3 Utility of the SSV case-mix adjuster to predict the SIPSO outcomes.  
In order to ascertain whether the SSV case-mix adjuster may be used to adjust for the 
SIPSO outcomes, it is necessary to determine that the SSV model can discriminate good 
over poor outcome and is reasonably calibrated for the SIPSO subscores (i.e. that it makes 
correct individual predictions). The SIPSO was dichotomised to reflect good over poor 
outcome as described in the statistical methods section (4.4.7). 
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5.11.3.1 Discrimination 
 C statistics for the SSV model to predict dichotomised study outcomes Table 56
 
Centile within 
which score of 
15 lies 
C 
statistic 
95% 
confidence 
interval 
SIPSO physical subscore    
Dichotomised at 15    
Dead patients excluded 60 0.73 0.65-0.79 
Dead patients ascribed a score of zero 60 0.76 0.70-0.82 
Dichotomised at median (data driven)    
Dead patients excluded (median 12.6)  0.75 0.68-0.81 
Dead patients ascribed a score of 0 (median 10.2)  0.89 0.74-0.85 
SIPSO social subscore    
Dichotomised at 15    
Dead patients excluded 70 0.66 0.58-0.72 
Dead patients ascribed a score of zero 70 0.70 0.64-0.76 
Dichotomised at median (data driven)    
Dead patients excluded (median 11.7)  0.70 0.63-0.76 
Dead patients ascribed a score of zero (median 9.5)  0.75 0.70-0.81 
C statistics were not significantly different with dead patients included (and ascribed a 
score of zero) or with them excluded, and patients who had died were therefore excluded 
from the further analysis. The SSV model performs poorly in the prediction of the social 
subscore of the SIPSO (if dead patients are excluded from the sample (c statistic 0.66). 
5.11.3.2 Calibration 
Figure 92 Calibration plot for prediction of the physical (top) and social (bottom) 
subscore of the SIPSO with the SSV model 
Calibration of SSV to predict dichotomised SIPSO physcial subscore
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Calibration of SSV to predict dichotomised SIPSO social subscore
Predicted proportion with outcome
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In contrast to the prediction of survival in independent state (Figure 92), the SSV model 
tends to make over optimistic predictions of six month physical and social functioning as 
measured with the SSV case-mix adjuster (Figure 92).  As before, small numbers of patients 
used to calculate some of these proportions (reflected in the wide confidence intervals) 
limit the conclusions that may be drawn from these graphs. However, if the SSV case-mix 
adjuster is not transferable to outcomes other than the OHS, its utility and generalisability 
in studies and populations where the OHS as not an endpoint may be limited.  
5.11.4 Use of Length of stay to predict patient outcome 
Length of stay has featured prominently in the regression models as a strong predictor of 
patient outcome. Moreover, the presence of length of stay has resulted in the SSV model 
not appearing in some models. It is therefore likely that length of stay is acting as a marker 
of stroke severity. The utility of length of stay as a univariable case-mix adjuster has been 
explored to determine whether or not it may offer a pragmatic alternative to more 
complex case-mix adjustment methods.  
The discriminatory function of the length of patient stay can be examined through 
determining the predicted probability of a dichotomised (good/poor) outcome (as 
measured with the OHS or dichotomised SIPSO subscale scores) through a logistic 
regression model (see section 4.4.8). This predicted probability was then used to plot ROC 
curves for length of stay to predict each of the dichotomised study outcomes.  
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 C-statistics for SSV model and length of stay to predict dichotomised Table 57
study outcomes with 95% confidence intervals 
  C statistic [95% confidence interval] 
Dichotomised outcome SSV model Length of stay 
Dichotomised OHS 0.77 [0.71-0.84] 0.79 [0.73-0.85] 
Physical subscore of SIPSO (>15) 0.73 [0.65-0.79] 0.75 [0.68-0.81] 
Social subscore of SIPSO (>15) 0.66[0.58-0.72] 0.73 [0.66-0.79] 
It can be seen from the above table that there is a tendency for length of stay to be a 
better discriminator of good over poor outcome for all three of the outcome measures, 
although these differences are not significant. Length of stay would therefore appear to be 
non-inferior to the SSV model in terms of discrimination. The ROC curves for length of stay 
are provided appendix E-2.1. 
5.12 Comparison of statistical validity of study models with case-mix 
adjusters identified through systematic review 
Table 6 has been reproduced here, with an additional row to represent the statistical 
methods used in generating the models in this study. It can be seen that aside from the 
limitations due to a lack of external validation, and a failure to consider interaction terms 
(due to sample size), that the modelling methodology used here is robust 
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 Reproduction of Table 6 to compare statistical validity of ‘Teale’ models with models identified in systematic review of case-mix adjusters Table 58
Model Valid method of variable selection? Control for 
Multicollinearity 
Consideration 
of interaction 
terms 
Events per 
variable 
>10? 
linearity assumptions 
tested and met? 
External Validation 
Acceptable discrimination (or 
sensitivity/specificity) 
Guys  
Multiple variables selected 
through identification of 
‘statistically significant’ 
univariate predictors 
   ? 
Sens 0.83 
Spec 0.58 
G score  
Variables extracted from Guys 
model (simplified regression co-
efficients to integers) 
   ? 
Sens 0.72 
Spec 0.63 
Bristol ?  ?   
Sens 1.00 
Spec 0 
SSV  
Use of stepwise variable 
selection and clinical reasoning 
Stepwise 
variable 
selection 
    
C statistic acceptable for 
prediction of alive and 
independent or dead/alive 
Tilling ?  ?  
Tested; attempts to 
correct for censoring 
effects of Barthel Index 
did not affect the model 
Predicts Barthel Index to within 3 
points on 49% of occasions (increases 
to 69% if recovery history is included 
in the model). 
90% limits of agreement -0.4 (-7, +6) 
Orpington ? 
Stepwise 
variable 
selection 
?   
R
2 
values used to assess model fit. 
Discrimination not tested 
Teale  
Variables selected through 
identification of important 
predictors in univariate 
analyses, regression trees and 
clinical reasoning 
Stepwise 
variable 
selection 
   Not externally validated 
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Chapter 6 Discussion 
6.1 Identification of variables to be included in a routinely collected 
stroke dataset 
6.1.1 Patient outcomes variables 
In order to ascertain which combination of postal outcomes instruments best captures 
physical and social functioning following stroke, instruments identified in a previous review 
as valid and reliable for postal administration (Teale EA et al  2010) were further examined 
for utility and acceptability for patients and healthcare professionals. Discussion at a 
consumer group and a group decision making workshop identified the SIPSO as the 
preferred instrument, and this outcome was therefore selected as the primary outcome in 
the CIMSS study. The SIPSO was non-inferior to the NEADL in terms of missing data and 
problems with floor and ceiling effects were less pronounced. Moreover, the 
transformation of the SIPSO subscores to interval level data confers advantages over the 
NEADL in terms of the types of statistical analyses that may be performed (see section 5.5). 
However, Rasch analysis for the SIPSO has only been performed in a population of younger 
stroke survivors (under 65) (Kersten et al 2010). Although there were no interactions 
between age and the SIPSO items in this age group, differential item functioning has not 
been explored in older patients and this may limit the generalizability of the transformed 
scale to the current study. 
The SIPSO physical and social subscores measure the underlying traits of reintegration 
following stroke. The conceptual relationship between the SIPSO subscores and patient 
care are complex, and are likely to be mediated by factors over and above delivered care 
processes. These mediating factors include the nature of specific impairments, recovery 
trajectories, mood, community rehabilitation and social networks.  
6.1.2 Identification of important predictor (process) variables 
Consideration of all the factors which may contribute to six month SIPSO scores is limited 
by the feasibility of capturing variables which represent them, and sample size. Process 
markers were identified through both statistical and clinical reasoning. In order to reduce 
the number of variables that were entered into the models, proxy or composite markers 
were chosen (i.e. SLT communication assessment represents whether or not an 
assessment was required (a proxy for dysphasia) and whether or not the assessment was 
performed). Other than whether or not ESD was planned, it has not been possible to 
capture detailed information regarding the period between discharge and the six month 
follow up questionnaire. This may limit the conclusions that may be drawn, as provision of 
post-discharge services and rehabilitation are likely to influence post-stroke reintegration. 
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In order to reduce the number of predictor variables to be entered into linear regression 
models such that the EPV was maintained below ten, three approaches were adopted. The 
first, univariate analysis, considers the association of individual process measures or 
predictors with patient outcome. Although this unadjusted approach is simple, there is no 
consideration for the mediating or confounding relationships of other factors. As such, 
although specific aspects of process may be identified for further exploration, the creation 
of models based solely on these univariate relationships is likely to include unimportant or 
exclude important predictors on the basis of chance alone (Altman D,  1999p 349).  
Moreover, the prominence of some of the relationships of individual process markers with 
outcome is removed when other factors are controlled for, e.g. although highly significant 
in univariate analysis, the presence of a urinary incontinence care plan failed to reach 
statistical significance as an important predictor of physical outcome in multivariable 
models.  
The second approach to refining predictor variables was through the use of regression 
trees. These offer a simple and powerful visual representation of the statistically important 
factors in terms of prediction of patient SIPSO subscores. The benefits of this approach are 
that there is no assumption based on the distribution of either the independent or 
dependent variables and no limit to the number of variables that may be entered into the 
tree model. The importance of each predictor, having taken account of all other predictors 
is considered, and the ‘split-point’ is made at the value of the independent variable that 
maximises the diversity of outcome. However, the regression trees are ‘data-driven’ and 
require clinical interpretation. Important factors may not appear in the trees due to 
idiosyncrasies of the study dataset. This leads to the third approach for variable selection: 
the inclusion in regression models of any clinically important predictor that has not been 
identified through ‘data-driven’ approaches.  
6.1.2.1 Process measures that are predictive of functional outcome in the study 
The determination of sample size for specification of regression models depends not only 
on achieving sufficient ‘events per variable’ in order to ensure that the model is not 
overfitted (Peduzzi P et al  1996), but also in ensuring that the sample size is adequate for 
individual predictors to distinguish a clinically relevant difference in patient outcome. The 
failure of Davenport et al to detect an effect of stroke unit care on patient outcome 
despite an adequate EPV (Davenport RJ et al  1996) is likely have been due to the study 
being underpowered to detect the effect, as highlighted by Mant in his response to the 
article (Mant J et al  1996) (see also section 2.1.8). 
If it is assumed that case-mix adjustment is sufficient to ‘level the field’ such that any 
residual variation in outcome is due to the delivery of specific care processes, the delivery 
of process measures must vary in order to detect the effect of deviation from process 
delivery on outcome. In Mant and Hick’s simulation study describing delivery of care 
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processes of proven association with outcome in myocardial infarction, the treatment 
effect of interventions were applied to theoretically identical populations to demonstrate 
the difference in sample size required to detect differences in mortality from myocardial 
infarction through measurement of process versus  outcome (Mant J et al  1995). Here it 
was demonstrated that the higher the proportion of patients receiving a particular process 
or combination of processes in a particular hospital, the smaller the sample size required 
to detect deviations from care process delivery through measurement of both process and 
outcome (Mant J et al  1995).  However, where the ‘treatment effect’ of specific 
interventions has not been determined  and the relationship between process and 
outcome is not known as is the case with many stroke process measures, the larger the 
proportion of patients receiving a particular care process  the harder it is likely to be to 
detect the effect of missing that process on patient outcome. For processes that near 
100% saturation, the magnitude of the effect of these processes of care on patient 
outcome, if any, is unknown.  
The process saturation in the study population Figure 44 (i.e. the lack of variability in 
patients that did and did not receive specific aspects of care process), is in concordance 
with the recent RCP NSSA audit where the median percentage achievement of the twelve 
key indicators across participating trusts in England, Wales and Northern Ireland was 
greater than 80% in all but 3 process markers audited (Intercollegiate Stroke Working Party 
2011). Although some of the process markers entered into the study models represent 
‘best-practice’ interventions for which there is good supporting randomised controlled trial 
evidence (e.g. treatment on a stroke unit (Stroke Unit Trialists' Collaboration 2007)), the 
demonstration that other interventions or processes of care are effective where such 
evidence is lacking is unlikely to be feasible in empirical post-stroke populations whilst 
there is such a degree of saturation of process markers; if the majority of the population 
receives an intervention routinely, it is difficult to discern the effect of not receiving that 
intervention on patient outcome. As the proportion of patients in whom a monitored 
process is achieved increases, the proportion in which it is not achieved, and therefore the 
variability, decreases.  This is especially pertinent as the effect of individual processes on 
outcome is likely to be small (the effects of individual processes that typically occur on a 
stroke unit are unlikely to be larger than the overall treatment effect of stroke unit care 
over general ward care (an estimated ARR of  4.4%)  (Sudlow C et al  2009; Stroke Unit 
Trialists' Collaboration 2007).  A lack of variability in the delivery of specific processes 
means that distinguishing patients with good over poor outcome conditional on the 
achievement of a specific care process will require a larger sample (analogous to a 
randomised controlled trial to determine the benefit of an intervention with a small 
treatment effect). The likelihood of type 2 errors is high (falsely rejecting a hypothesis that 
is true) and potentially important predictors in the models may fail to reach significance 
due to a lack of power. Whether the difference in outcome observed between levels of a 
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predictor reaches statistical significance is reflected in the model output by the‘t’ value and 
its significance level (which is the same as performing a t test between the model predictor 
and the reference value). The magnitude of the mean difference between the levels of the 
variable is represented by the beta co-efficient, the value by which the dependent value is 
increased for a unit increase in the independent variable. Standard errors for the beta co-
efficients are provided in the STATA output from which the standard deviations may be 
calculated from the formula for the standard error of the difference between two sample 
means [s.e. = √(s2/n1 +s
2/n2)] (where s.e. = standard error, s=standard deviation and n = 
sample size in each group (Altman D,  1999 p 160)). The power with which these t-tests 
have been performed during the modelling process can be calculated in STATA from the 
standard error, the observed difference in outcome between groups, the number of 
patients in each level of the variable and the α-significance level (set at 0.05). Using similar 
methodology to Mant in his criticism of the Davenport study (Mant J et al  1996; Davenport 
RJ et al  1996), I have used the example of the SLT communication assessment for the 
prediction of the social subscore of the SIPSO to demonstrate the large sample size that 
would be required to detect the difference in mean social SIPSO subscore between 
patients that do, and do not receive a SLT communication assessment resulting from 
Model 6. This process has some variability (“no” = 29/312 (9.3%), “yes” = 108/312 (34.6%), 
“no but” = 173/312 (55.4%)), although the absolute numbers of patients receiving the 
process is small compared with those in whom an assessment is not required (the “no but” 
dummy). Performing a power calculation in STATA reveals the probability of detecting a 
difference of 2 points on the physical SIPSO subscore between patients who do, and do not 
receive a SLT communication assessment (represented by the beta co-efficient for receipt 
of a communication assessment in the model) is just 33% (power 0.33). In order to detect 
such a difference with reasonable certainty (e.g. power 80%), would require 54 patients in 
the “no” group, 201 in the “yes” group and, accounting for those in whom an assessment is 
not appropriate (55% in the study population), a total sample size of 567 patients with 
complete data (working provided in Appendix 7.2E-1.4). Assuming that there are no 
missing data for process markers, and a return rate for outcome questionnaires of 70% 
(similar to that seen in the study), to detect the difference in SIPSO outcome between 
patients who do, and do not receive a SLT communication assessment with power of 80% 
would require a total sample size of ≈800 patients.  
Previous studies to identify important aspects of stroke care that may determine patient 
outcome after adjustment for case-mix have tended to focus on the prediction of 
dichotomised outcomes of mortality and dependency (Bravata DM. et al  2010; Evans A et 
al  2001; Lingsma HF et al  2008; Mohammed MA et al  2005; Weir N et al  2001) although 
attempts have been made to explore relationships between processes of care and 
discharge home (Indredavik B et al  1999) and functional outcomes (McNaughton H et al  
2003). In many of these studies, variations in outcome between institutions and individuals 
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are completely (Davenport RJ et al  1996; McNaughton H et al  2003) or partly (Lingsma HF 
et al  2008; Weir et al  2003) explained through differences in case-mix rather than 
differences in the delivery of care. Process markers which have been highlighted as 
potentially important predictors of outcome in previous studies include swallowing 
assessment (Bravata DM. et al  2010), measures to prevent aspiration (not further 
qualified) (Evans A et al  2001), early feeding (Evans A et al  2001), organised stroke unit 
care (Evans A et al  2001; Weir N et al  2001), prophylaxis for venous thromboembolism 
(Bravata DM. et al  2010), treatment of all episodes of hypoxia with supplemental oxygen 
(Bravata DM. et al  2010), early mobilisation (Lingsma HF et al  2008) and antiplatelet 
therapy within 48 hours (Lingsma HF et al  2008). Use of some of these interventions are 
corroborated (stroke unit care (Stroke Unit Trialists' Collaboration 2007), antiplatelet 
therapy (Chen Z-M et al  1997; International Stroke Trial Collaborative Group 1997)) or 
questioned (use of graduated compression stockings (CLOTS Trial Collaboration 2009)) in 
randomised controlled trials, and some are subject to ongoing investigation (the use of 
supplemental oxygen  (Roffe C 2011) and intermittent pneumatic compression devices 
(CLOTS Trial Collaboration 2011)). It has been postulated that the improved outcomes of 
patients admitted to acute stroke units are due to the prevention of complications of 
stroke, such as the prevention of infection (Govan et al  2007). Although many specific care 
processes which form existing stroke markers have not been linked to outcome in 
dedicated randomised trials, features of stroke unit care that are consistently provided in 
effective stroke units have been systematically identified from the Stroke Trialists’ 
systematic review of organised stroke unit care (Langhorne P et al  2002; Stroke Unit 
Trialists' Collaboration 2007). These were recently summarised by McArthur et al 
(McArthur et al  2011) and are reproduced in Table 59. 
 Important components of stroke unit care (from McArthur et al (2011), Table 59
based on Langhorne P et al  (2002)) 
Important components of 
stroke unit care 
Potentially important 
components of stroke unit care 
Components with no evidence of 
efficacy 
Staff with a specialist 
interest in stroke care 
Management of pyrexia, blood 
sugar, hypoxia, blood pressure, 
hydration, nutrition 
Routine use of compression 
stockings (CLOTS Trial 
Collaboration 2009) 
Early mobilisation Mouth care Early PEG feeding (Dennis M et al  
2006) 
Early investigation Swallowing assessment Routine use of nutritional 
supplements (Dennis et al 2006) 
Prompt pharmacotherapy Bladder and bowel care  
Physiological monitoring Provision of information for 
patients and carers 
 
Discharge planning Involvement of carers  
MDT goal setting   
Positioning   
Linear regression models were constructed from the variables identified through 
regression trees, univariate analysis and clinical reasoning. Important predictors featuring 
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in these models are highlighted in Table 60. Only variables reaching significance at the 
p<0.05 level are included here, although it is possible, indeed likely that the variables in the 
models that have not reached statistical significance still represent important predictors 
due to the possibility of type 2 errors for individual predictors. For the purposes of 
definition of a routine dataset, any clinically and statistically important predictor should be 
included. 
 Important predictors of outcome featuring in regression models Table 60
 With baseline assessment 
No baseline 
assessment 
 
Physical 
SIPSO 
Social SIPSO 
Physical 
SIPSO 
Social 
SIPSO 
Baseline NEADL     
Baseline EQ5D     
Propensity score     
Age at stroke     
Previous stroke     
Length of stay     
D/C to same address as admitted from     
SLT communication Ax   (21)  (1 or 21) (21) 
First ward ASU, CCU, HDU or ICU     
Some time spent on a stroke unit during  
inpatient spell 
    
Three process markers appeared in one or more of the four linear regression models (a 
formal Speech and Language communication assessment, admission to a ward where 
hyperacute stroke care can be delivered, and admission to a stroke unit for some of the 
inpatient spell) (Table 60). This is in concordance with the important features of care 
process identified through the previous systematic review of stroke unit care (Langhorne P 
et al  2002; McArthur KS et al  2011). Of these, only formal SLT communication retains 
prominence across the models (featuring in 3 out of 4). Of particular note is that SLT 
communication assessment is one of the process markers with greatest variability across 
the three levels of the variable which may, in part, explain its prominence in the models 
(Figure 44).  In accordance with the univariate analysis, patients who do not require a SLT 
assessment (“no but” code) have better physical and social SIPSO subscores at six months 
than those that require but do not receive an assessment. The caveat to this is that SLT 
communication assessment does not feature in the model to predict the physical subscore 
of the SIPSO where baseline assessments are also included in the model. This may reflect 
the possibility that the “no but” code is acting as a marker of case-mix but is overshadowed 
in the model to predict physical outcome where there are more explicit markers of 
baseline physical function present. In the model to predict physical subscore where these 
                                            
1 Where 1 = SLT communication assessment performed, and 2 = SLT 
communication assessment not required (“no but” code) 
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baseline functional assessments are excluded, not requiring an assessment is associated 
with intermediate physical outcomes scores (better than requiring and not receiving an 
assessment, but worse than if the assessment is performed). Here, it is likely that the 
outcomes of the heterogeneous group in whom “no but” codes are used (where 
assessments are either not required (mild strokes) or not appropriate (severe strokes)) fall, 
on average, between those in whom formal communication assessments are, or are not 
performed. These subtleties in the potential meaning of the prominence of different levels 
of the variables are important in their interpretation. Moreover, this represents an 
argument for the explicit capture of reasons why assessments are not indicated. This is 
particularly pertinent in routine care where, unless there is adequate and robust case-mix 
adjustment, the significance of different levels of the variable in terms of their relationship 
to outcome is difficult to interpret. In previous studies where markers from the RCP NSSA 
have been used, and in the report of the audit data from the RCP (Intercollegiate Stroke 
Working Party 2011), patients with a “no but” code are removed from the denominator 
(McNaughton H et al  2003; Weir N et al  2001) such that only patients who are eligible for 
interventions are included in the analysis.   
The distinction between clinical and statistical significance of the predictors is key in terms 
of determining the relative importance of the difference predictors. As the models are 
linear, the beta-coefficient is interpreted to represent the difference in the mean outcome 
(i.e. physical or social SIPSO subscore) for a one unit change in the independent variable. 
For example, for a dichotomous predictor, the beta-coefficient represents the change in 
outcome score for one level of the predictor with respect to the other, with all other 
variables being held constant. For a continuous predictor (for example age at stroke), the 
outcome changes by the value of the beta-coefficient for each additional year. The 
magnitude of the change in outcome therefore needs to be interpreted in this context, 
taking into consideration the units of measurement and any transformations of the data 
that have occurred. Data transformations make the relative relationship of length of stay 
to outcome subscore difficult to interpret. However the mean difference in outcome score 
for patients staying for B days rather than A days can be calculated from the following 
equation: 
(6) M		βNOP	_RST_UNVW_OXY	*	[log	(lengthofstayA	 1)	–	log	(lengthofstayB	 1)c																																																				
								 	βNOP_RST_UNVW_OXY ∗ elog (NYXPfgOhWfijk2
)(NYXPfgOhWfijl2
)m	
Where M = mean difference in outcome score 
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If a length of stay of one day is taken as a ‘reference’ value, then the differences in 
outcome score dependent on changes in length of stay (with all other variables being held 
constant) are shown in Table 61.  
It can be seen therefore, that the absolute difference in total SIPSO subscores attributable 
to each variable is very small (Table 62) and, although a highly statistically significant 
predictor of outcome, the differences in mean SIPSO subscore in the physical domain 
compared with a length of stay of one day is of questionable clinical significance (Table 61). 
 Differences in average outcome subscore for length of stay compared Table 61
with one day 
  Compared with a length of stay of one day:  
 With baseline assessments No  baseline assessments 
Length 
of stay 
Difference in 
average physical 
SIPSO subscore 
(1 dp) 
Difference in 
average social  
SIPSO subscore 
(1 dp) 
Difference in 
average physical 
SIPSO subscore 
(1 dp) 
 
Difference in 
average SIPSO 
social subscore 
(1 dp) 
1 0 0 0  0 
3 -0.4 -0.6 -0.1  -0.5 
5 -0.6 -1.0 -0.4  -0.8 
10 -0.9 -1.6 -0.6  -1.3 
30 -1.5 -2.5 -1.0  -2.0 
90 -2.0 -3.5 -1.3  -2.8 
 Beta co-efficients for statistically significant predictors in models, Table 62
p<0.05 significance level – excluding length of stay (significant in all 
models) 
 Change in SIPSO outcome per unit change in predictor 
 With baseline assessments No baseline assessments 
Predictor 
Physical 
subscore 
Social 
subscore
 
 
Physical 
subscore 
 
Social 
subscore
 
 
Baseline NEADL 0.11 0.06   
Baseline EQ5D 4.73 3.53   
Propensity score (SSV)   3.18  
Age at stroke -0.07    
Previous stroke   -2.61  
Discharged to same address as 
admitted from 
3.49  3.94 2.67 
SLT communication Ax (assessment 
performed) 
  2.87  
SLT communication Ax 
(no but code) 
 2.11 2.76 2.22 
First ward ASU, CCU, HDU or ICU   2.11  
Some time spent on a stroke unit 
during  inpatient spell 
   2.26 
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6.1.2.2 Predominance of proxy markers of severity in models  
Examination of the important predictor variables across the models reveals that markers of 
stroke severity predominate over markers of process. Two process markers feature 
prominently across the models as being associated with better outcomes: a “no but” code 
for a formal SLT assessment, and being discharged to the pre-admission address. No other 
process markers feature in more than one model. Discharge to the same address is 
associated with better physical outcomes, and a “no but” code for a communication 
assessment with a better social outcome. These markers remain in the models even when 
baseline assessments for severity are included (i.e. in the models that include baseline 
assessments). However, as discussed in section 6.1.2.1, it is likely that these process 
markers are actually acting as markers of stroke severity: discharge to the same address 
would usually reflect less physically impaired patients. It is likely that discharge to the same 
address is a proxy measure of independence, social support or ability to return to the pre-
stroke address with a package of care as opposed to discharge to a continuing care facility. 
Although discharge home may be for palliative care, these patients would not usually be 
expected to survive until six month follow up and therefore would not have been included 
in the sample.  
The models that do not contain baseline assessments are less explanatory of the variation 
in outcome than the models that do contain these assessments (adjusted R2 for model to 
predict physical SIPSO with baseline assessment = 0.52, without baseline assessments = 
0.43). Where process markers do feature in the models, these tend to reflect 
organisational processes: direct admission to a stroke unit or spending any part of the 
hospital spell on a stroke unit.  
Unfortunately as detailed information regarding the movement of patients around the 
hospital was unreliable it has not been possible to extract the proportions of individual 
patient’s stay spent on a stroke unit, or to explore the optimal proportion of a hospital 
spell that should be spent on a stroke unit to optimise outcome. Stroke unit care is a 
complex intervention, and is likely to reflect may different aspects of patient care. Its 
presence in the models may reflect that these models are underpowered to detect the 
effect of individual processes of care that occur within a stroke unit, or that many of the 
care processes were saturated.   
6.1.3 Length of stay as a marker of stroke severity 
Length of stay was a prominent predictor of patient outcome as measured with the SIPSO 
and featured in all the models. It is likely that length of stay is acting as a marker of stroke 
severity, and its inclusion in the models overshadowed the ‘best’ existing case-mix 
adjustment model (the SSV model) such that the propensity score (probability of a good 
outcome as predicted with the SSV case-mix adjustment model) reached statistical 
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significance in only one of the models (where physical subscore of the SIPSO was predicted 
without baseline assessments). There is a negative and highly significant correlation 
between the logarithm of length of stay and the propensity score r= -0.6, p<0.001), such 
that patients with higher propensity score (higher probability of good outcome) tend to 
have shorter lengths of stay. It is therefore likely that the two variables are collinear, hence 
the automated removal of propensity score from the model during stepwise variable 
selection procedures. If propensity score is forced back into the model, it is automatically 
removed by the STATA software due to collinearity.  
As with other markers of severity, length of stay is a complex marker and is likely to be 
acting as a proxy measure for several different aspects of patient care. For example, length 
of stay is likely to reflect stroke severity (patients with more severe strokes are more likely 
to require longer spells in hospital), the requirement for increased social support at 
discharge, rehousing, equipment and complications of stroke (e.g. intercurrent illness, or 
the requirement for feeding via percutaneous gastroenterostomy (PEG)). However, length 
of stay may have utility as an overarching variable to adjust for the combined effect of 
these factors and as a crude marker of stroke severity. Length of stay is not available until 
after hospital discharge and therefore could not be used for stratified randomisation in 
trials, or to determine prognostic information for individuals from baseline data. However, 
for adjustment in observational cohort studies, or in routine data collections it may offer 
improvements to over simplistic approaches such as age-sex standardisation, whilst acting 
as a pragmatic alternative more complex case-mix adjustment models.   
There are however, drawbacks to the approach. Reduction in length of stay is often 
targeted specifically as a positive outcome (Intercollegiate Stroke Working Party 2011). The 
introduction of Early Supported Discharge or community rehabilitation teams is a clear 
example of where length of stay may be shortened for certain groups of patients. 
However, patients who are ‘fit’ for these types of intervention are unlikely to be the same 
cohort as those with protracted lengths of stay due to severe strokes. Moreover, if 
necessary it would be possible to adjust for these interventions explicitly. Another possible 
factor confounding the relationship between stroke severity and length of stay would be 
discharge for palliative or nursing home care. Here a shorter length of stay may be 
associated with poorer outcome.  
In-hospital deaths also spuriously reduce the length of stay. In routine care, there is likely 
to be a higher proportion of inpatient deaths than has been observed in this study where 
patients in receipt of palliative care were excluded. The utility of length of stay as a case-
mix adjuster is for adjustment of outcomes in populations of survivors to hospital 
discharge. Inpatient deaths are therefore not included within this subgroup, although 
deaths between discharge and follow up could be included if death is considered as an 
outcome (e.g. independent survival).  
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Lengths of stay may also be affected by organisational factors (e.g. access to community 
rehabilitation facilities), and these would require specific consideration and additional 
adjustment. Length of stay could be used in this context as a marker of the efficiency of a 
stroke service – how rapidly patients are discharged conditional on their stroke severity.  
Between institutions comparison may be complicated by inconsistent measurements of 
length of hospital stay across diverse healthcare systems. These may be mitigated 
through the application of precise definitions of what constitutes acute hospital care, 
and the start and end points of an acute hospital stay (e.g. exclusion of residential 
rehabilitation facilities from the length of hospital stay). 
Providing external validity of length of stay as a univariate case-mix adjuster could be 
demonstrated in external datasets, application of consistent definitions to the routine 
recording of length of stay across healthcare systems could increase the feasibility and 
interpretability of large sets of observational data where outcomes are collected following 
discharge from hospital.  
Length of stay has often been used as an endpoint (outcome) in stroke studies, but we are 
not aware of it previously being used as an independent variable to adjust post-stroke 
populations for case-mix.  
6.1.3.1 Comparison of LOS with SSV case-mix adjustment model 
The utility of the SSV case-mix adjustment model and length of stay as a univariate adjuster 
were directly compared. However, it should be noted that this represents external 
validation of the SSV model (to predict an outcome that it was not designed to predict), 
but internal derivation of length of stay as a case-mix adjuster. The relative performance of 
the two models is therefore biased to favour length of stay. 
The SSV model was developed to predict probability of  good over poor outcome as 
determined with the dichotomised modified Rankin Scale (alive and independent vs. not) 
(Counsell C et al  2002). When used to predict this outcome in the study population, the 
SSV model had good discriminatory function (see 5.11). However, it was poorly calibrated 
with a tendency to both over pessimistic and over optimistic predictions in patients with 
mild to moderate strokes. The c-statistic of length of stay to predict the same outcome was 
comparable (SSV c-statistic (0.77 [0.71-0.84]; LOS c-statistic (0.79 [0.73-0.85]). This 
represents internal validation of length of stay to predict this outcome. As such, length of 
stay as a prominent predictor is likely to be overfitted to the study data, and the c statistics 
for LOS are likely to be higher than would be expected in an external dataset.  
In order to explore the utility of the SSV case-mix adjuster to predict the SIPSO outcomes, 
the SIPSO subscores were dichotomised to create two groups felt to reflect broadly the 
dichotomised OHS, i.e. some residual impairment, but not severe enough to interfere with 
daily living. It is perhaps unfair to expect the SSV model to be able to predict an outcome 
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that is was not developed to predict, but as the best available case-mix adjuster, if the 
model lacks generalisability to outcomes other than the OHS, its utility in observational 
cohorts where functional outcomes are measured, is limited.  
Despite this, the SSV model performed reasonably to predict the physical subscore of the 
SIPSO (c-statistic 0.73[0.65-0.79]), but less well to predict the social outcome (0.66[0.58-
0.72]). Length of stay was non-inferior to the SSV model, with c-statistics of 0.75[0.68-0.81] 
and 0.73[0.66-0.79] to predict the physical and social subscores respectively.  
6.1.4 Can outcome be predicted without the need for patient reported 
baseline assessments? 
Recording patient reported assessments of function in routine care is costly in terms of 
resource and infrastructure. Such assessments also add a layer of complexity to the 
interpretation of routine data. However, the addition of these baseline assessments to the 
models greatly improved model fit and increased the amount of variation in patient 
outcome that was explained. The change in the variables reaching significance on exclusion 
of influential cases in models without baseline assessments indicates that these models are 
less stable than the models where baseline assessments were included.  Indeed, for the 
models that included baseline functional assessments, more variance was explained 
through the model variables than through the residuals. It is a logical assumption that 
patient reported function at baseline will be linked to, and an important predictor of, 
patient reported function at six months.  
It is also of note, that process measures are more prominent in the models which do not 
contain the baseline assessments, and that the Barthel Index (as a measure of objective 
baseline function) does not reach significance in the model to predict either physical or 
social subscore of the SIPSO. It is possible, that the presence of process markers in these 
models is a consequence of suboptimal case-mix adjustment in the absence of a baseline 
marker of severity rather than a true reflection of the importance of individual process 
markers. The marked improved fit of the models when baseline assessments are included 
provides evidence to support this possibility.  
Baseline quality of life (as measured with the EuroQoL) was a particularly important 
predictor of patient outcome as measured with the SIPSO. This may be due to the EQ5D 
containing questions concerning mobility, self-care and ability to perform usual activities, 
constructs also contained within the SIPSO. Alternatively, the prominence of the baseline 
EQ5D may reflect the inclusion of a question pertaining to pain, a construct which is 
conceptually linked to patient outcome, but otherwise unmeasured in the study dataset. 
The value of a questionnaire to reflect quality of life in the week immediately following a 
stroke is debatable. This is likely to be a time of considerable emotional and physical stress, 
perhaps reflected in the perception of quality of life. Moreover, questions pertaining to 
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ability to perform usual activities (contained within the EQ5D) may be difficult to answer in 
the inpatient hospital setting. However, as the baseline EQ5D is such a strong predictor of 
six month SIPSO score, it would be beneficial to include it in a routine dataset for further 
exploration, although a question specifically relating to pain at baseline may warrant 
further exploration as an alternative measure.  
6.2  Alternative methodology for exploring the relationships between 
processes of care and patient outcome in observational cohorts 
Conducting randomised controlled trials for processes of care that are established as ‘best 
practice’ would clearly be unethical and this approach would therefore be precluded. 
Exploration of the relationships between processes of care and outcome therefore rely on 
(prospective or retrospective) observational data.  
An alternative approach to regression modelling to explore the effect of individual 
processes on patient outcome in observational cohorts could involve the use of 
instrumental variables. Instrumental variables are correlated with a covariate (process 
marker) but not the dependent variable (or any other variables which influence the 
dependent variable), such that any effect of the instrumental variable on the dependent 
variable is through its relationship with the covariate (Pearl J 2009 p 247; Newhouse et al 
1998) see also Figure 93. Therefore, the receipt of a particular process is conditional on the 
instrumental variable. For example, availability of a bed on a stroke unit is likely to be 
highly correlated with direct admission to a stroke unit, but unlikely to have direct 
association with patient outcome other than through the association with early stroke unit 
treatment. Assuming that factors such as stroke severity have no association with transfer 
to a stroke bed if one is available, direct admission to a stroke bed is therefore dependent 
on stroke bed availability and the latter could be considered to be acting as a quasi-
randomising variable (Figure 93, adapted from Newhouse et al 1998).  
Figure 93 Stroke unit bed availability as a possible instrumental variable.  
 
Such an approach has been used in a stroke study by (Xian et al  2011) to compare 
outcomes of patients admitted to stroke centres vs. non-specialist hospitals using distance 
Confounding case-mix variables 
 
Stroke unit bed 
availability  
Direct 
admission to 
stroke unit 
Outcome 
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from the hospital as the instrumental variable. The use of instrumental variables may 
therefore be useful in observational cohorts in circumstances where randomisation is 
unethical, or not practicable. This approach, however, requires further research.  
6.3 Study limitations  
6.3.1 Statistical and methodological weaknesses 
The linear regression models performed in this thesis are based on the assumptions that 
the latent trait of the SIPSO is conceptually linked to the predictor variables, and that the 
Rasch transformed SIPSO subscores represent the latent trait in an older post stroke 
population. It is possible that there are systematic differences in the way that SIPSO 
questions would be answered by older patients as compared to those of the younger post-
stroke population – i.e. there may be variability in the performance of the SIPSO scale 
across baseline patient characteristics. Differential item functioning (DIF) of age with 
respect to the latent trait has not been performed in an older population, and if 
differences were to exist in the manner that patients of different ages answer SIPSO 
questions, this may limit the utility or validity of the SIPSO, and the conclusions that may 
be drawn. This therefore represents a significant limitation of the work.  
Post estimation assumptions were generally met for the models generated in the study. 
The notable exception is the deviation from normality of residuals in model 4. This 
deviation is at the tails of the distribution suggesting it may be due to outliers. Re-running 
models without outliers did not improve normality, and resulted in previous stroke no 
longer featuring as an important predictor. The violation of normality assumptions may 
therefore represent the the absence of important predictors, and inferiority of models that 
do not include baseline assessments.  
The ordinal NEADL has been entered into models as a summed score, an approach which 
makes an assumption that it may be treated as a continuous variable. This assumption may 
be responsible for the deviations from linearity and normality of residuals in models to 
predict the physical subscore of the SIPSO. However, these deviations may also reflect the 
effect of particularly influential cases (i.e. cases with large residuals at high leverage 
points). In models containing the NEADL at baseline, these influential cases may have 
arisen through inconsistencies as regards whether the NEADL was completed with respect 
to pre- or post-stroke function. In future studies, the instructions in this regard would need 
to be made more explicit.  
The floor and ceiling effects of the NEADL and the SIPSO may limit the validity of the 
models. These effects cannot be mitigated through transformations of the data and 
modelling alternative distributions (e.g. using censored (Tobit) regression) may have 
helped to circumvent these problems.  
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Although attempts have been made to include clinically important variables in the models, 
the methodological approach to the identification of important predictors of patient 
outcome set out in this thesis is primarily data-driven. It is important in the development 
of any dataset for routine collection, that the choice of variables reflects clinical, as well as 
statistical reasoning. However, this is with the caveat that the dataset should be small 
enough to be feasible for routine collection. 
6.3.2 Representativeness of study population 
There is a potential for selection bias in the types of patient that were recruited as 
compared with the general post stroke population. The additional collection of 
anonymised screening data meant that an objective measurement of the 
representativeness of the study population was made. However, the number of patients 
screened across three sites in six months (656) is less than would be expected. A 
conservative estimate of a combined population of 1.5 million in Leeds, Bradford and York 
(Office for National Statistics 2011) and an annual UK stroke incidence of 1.3/1000 
population per year (based on London Stroke Register incidence data) (Saka O et al  2009) 
would mean that the number of patients screened would represent about two thirds of 
expected strokes in a six month period. In addition the main reason for non-eligibility of 
screened patients was a non-stroke diagnosis (74/193 = 38%, with 59 of these cases in 
York), which would tend to imply that many patients admitted with a label of “query 
stroke” have an alternative diagnosis. Two thirds of the patients that were screened and 
eligible for the study (463) were recruited (312), with the main reasons for non-
recruitment being the severity of stroke or its complications leading to the need for 
palliative care, patients not wishing to participate, or patients lacking capacity with no 
carer available for assent (Figure 33, p 120). When compared with the screened 
population, patients recruited into the study were younger (by seven years) and less 
disabled but no more likely to have a carer available. The difference in baseline Barthel 
Index (as a measure of disability) is likely to reflect patients in receipt or likely to receive 
palliative care being excluded from the study.  
The study sample therefore represents a group of patients aged between 31-95, median 
74, with equal sex distribution and baseline BI ranging from 0-20 (median 13) who were 
felt on admission, to be likely to survive to discharge. In this way, the study sample is 
reflective of a heterogeneous population of stroke survivors, rather than the general post-
stroke population. Consideration of consecutive hospital admissions (as would occur with a 
stroke register) includes patients that die in hospital. These patients would not have a date 
of discharge but a date of death and this may result in spuriously short lengths of stay 
given their stroke severity. The proposed use of length of stay as a case-mix adjuster is in 
the routine adjustment of functional post stroke outcomes. Patients in whom these are 
available form a subgroup of the general post stroke population, not containing patients 
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who do not survive to follow up. The exclusion from the study population of patients who 
were not felt to be likely to survive to discharge was therefore not unreasonable.  
A further potential cause of selection bias is withdrawals or non-response to six-month 
questionnaires. Patients who responded to the questionnaire compared with those that 
did not respond were older (median difference 7 years), with no difference in sex 
distribution. There is no difference in baseline BI or predicted probability of good outcome 
(as calculated with the SSV case-mix adjuster) between responders and non-responders to 
the questionnaires. There are, however, significant differences in both BI and propensity 
score between patients who responded and those that died or withdrew from the study. 
As the regression models were constructed to explore important prognostic factors in 
patients who survive, these differences were not felt be problematic.  
The number of study sites and the sample size are too small to draw conclusions regarding 
specific organisational or structural aspects of care and their relationship with patient 
outcome. However, there are specific features at individual sites that warrant specific 
consideration here as potential sources of bias. Firstly, the length of stay at York hospital 
was significantly shorter than at the other study sites. This may reflect the higher median 
BI at York, however, this may also reflect particular organisational structures at York that 
would  warrant further examination (e.g. staffing levels for therapists or a well-established 
Early Supported Discharge team).  
Bias due to exclusion of patients with dysphasia or cognitive impairment was reduced 
through the use of carer assent for recruitment. Over half of the patients included in the 
study were reported to have dysphasia at baseline. However, although the nature of the 
impairment (e.g. fluent vs non-fluent dysphasia) may have a bearing on ability to complete 
assessments, this was not specified. The presence of these impairments increases the 
likelihood of proxy responses to questionnaires. Although the proxy reliability of the SIPSO 
has been shown to be acceptable, this is likely to have affected the validity of the 
responses. Differential item functioning of the SIPSO items for patients with aphasia or 
cognitive impairment who self-complete the SIPSO has not been performed, and this may 
affect the scaling properties of the measure, and therefore the validity of results in 
subgroups with language or cognitive impairments. Future work to explore the scaling 
properties of the SIPSO in these patients would be useful.   
6.3.3  Data completeness and quality  
 The validity of the models generated in this study is reliant on the quality of the data from 
which they are derived. Similarly, the quality of data collected routinely (as occurs for the 
purposes of prospective audits such as SINAP, or for remuneration), are reliant on data 
capture processes. The increase in routine stroke data reporting requirements in recent 
years has not necessarily resulted in improvements to data collection infrastructure (see 
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section 1.2.1). Similar data capture methodology to that which was used in this study is 
often employed in routine data collection – i.e. data are extracted retrospectively from 
case-notes and existing hospital electronic records. Therefore the problems encountered 
during the study in terms of data quality and missingness are likely to be generalizable to 
routine data collections. Indeed, many of the problems encountered in attempting to 
obtain accurate data for the purposes of the research study are likely to be amplified in 
routine data collections where data collection resource may be scare, and motivation may 
be more focused on the volume, rather than the quality of data. In other words, if the 
rationale for capturing data is to meet mandatory data requirements for the purposes of 
remuneration or reporting, the emphasis is not necessarily on data quality and accuracy.  
The key to accuracy in data collection is in the specification and application of explicit 
definitions of individual data items – i.e. there should be little or no scope for 
interpretation at the point at which the data are extracted. It is preferable, therefore, to 
collect ‘hard’ data from which further information may be derived – i.e. dates and times 
that specific events occurred (e.g. date and time of admission, and date and time of 
imaging) rather than a series of tick boxes to indicate dichotomous responses as to 
whether or not a particular process was performed within a time frame (e.g. imaging 
within 24 hours of admission). The latter approach lacks both standardisation and 
validation. However, it was seen during the study, that often, the dates that were 
extracted from case-notes and hospital electronic systems were not accurate resulting in 
spurious data – indeed, many fields were not used due to concerns regarding their 
accuracy (for example patient movement around the hospital, or time of admission to 
hospital). For the purposes of the study, this led to the requirement for creation of 
composite variables (e.g. patient admitted to hospital on the same day, or day after their 
stroke), with the consequent loss of information, and ongoing concerns regarding data 
accuracy.  
The difficulties experienced in extracting accurate times of events from existing routine 
data sources highlights a major barrier to the use of these data to monitor routine care for 
the purposes of audit or remuneration. If these data are not recorded accurately, the 
information and conclusions that are derived from them are also not accurate. Future data 
collections should therefore be focused on collecting basic data (such as time of hospital 
admission) accurately, before more complex data are requested. Improvements to routine 
data collection may be made through electronic, point of care data capture – in this way, 
data may be captured according to explicit standard data definitions and recorded 
contemporaneously by those that create it. However, this approach requires both a 
significant change to patterns of current working and organisation-wide change in 
attitudes to data collection. This approach to data collection, adopting standard data 
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definitions to collect stroke data electronically at the point of patient care forms the basis 
of the next phase of the CIMSS project.  
 Missing data form another significant barrier to the accuracy of the study models, and 
may result in non-representativeness of the sample. As baseline data were extracted from 
case-notes, each process or case-mix data item has several potential causes of 
missingness: process performed but not recorded, not performed, performed and 
recorded but missed (not extracted) by the researchers. I had hoped to be able to identify 
the different causes of missing data, although this proved not to be feasible due to the 
complexity and additional work involved in capturing these data. These problems are, in 
part, a symptom of retrospective data extraction, especially if paper records are not 
standardised and instead collected from the narrative entries of a patient’s inpatient stay. 
This has specific implications for variables where “yes, no, no but” codes are required, as 
the distinction between “no” and “no but” may not be recorded explicitly. Recording of 
these data in a standardised format (e.g. on a stroke proforma) is becoming more 
widespread (all of the study sites in the study complete paper based stroke proformas 
during the course of the admission) and may help to overcome these problems. However, 
the presence of such a proforma is no guarantee that it is adequately and accurately 
completed. Moreover, attention to specific aspects of process on a proforma, may lead to 
saturation of these processes (missing process data were infrequent, and there was little 
variability in patients who did, and did not receive specific aspects of care process see 
Figure 44 and discussion in section 5.6.8). Patients with any missing process or baseline 
patient reported assessment data for the variables entered into the model were 
automatically excluded from the regression analysis by the STATA software. However, 
comparison of baseline BI between these patients and those with complete data did not 
reveal any significant differences.  
The return rate of six months outcomes questionnaires of 71% is acceptable for a postal 
questionnaire (Teale EA et al  2010). Examination of baseline and six month patient 
completed questionnaires did not reveal any pattern to the missingness (i.e. there were no 
questions that were consistently missed in the returned questionnaires).  
This study presents a pragmatic examination of the relationships between stroke care 
processes and patient reported outcomes following stroke, using methodology comparable 
to existing routine data collection infrastructure. The components of the study datasets 
have been determined through systematic examination of the stroke evidence base and, at 
the time of writing, include the best available case-mix adjustment model and the 
preferred patient reported postal outcomes instrument selected by expert and consumer 
groups. The process dataset comprised the markers from the 2008 RCP NSSA which, at the 
time of the development of the research datasets, was the most standardised and regular 
data collection in England, Northern Ireland and Wales (Royal College of Physicians 2009b). 
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Chapter 7 Conclusions 
7.1 Definition of a minimum dataset based on study findings 
The aims of this study were to identify which patient reported outcome measure(s), case-
mix adjuster and care process markers should be included in a routinely collected stroke 
dataset. A previous systematic review (Teale EA et al 2010) had identified candidate 
outcome instruments on the basis of their validity and reliability for postal collection 
following stroke. These were refined using group decision making techniques to the two 
preferred instruments of a group of consumers and stroke experts (the NEADL and the 
SIPSO). The SIPSO was chosen as the primary endpoint in the study due to its relatively 
superior properties in terms of completion rates and fewer floor and ceiling effects. 
However, in order to confirm the SIPSO instrument reflects the latent trait of reintegration 
in older stroke survivors, testing of differential item functioning with respect to age in an 
older population is required.   
Routine collection of patient outcomes following stroke is not currently performed in 
England, Northern Ireland and Wales. However, this is likely to change through the 
Outcomes Framework (Department of Health 2010e). An open competition held by the 
Department of Health to identify a marker of stroke recovery (the ‘Innovation in Outcomes 
competition’) has resulted in the modified Rankin Score at six months post stroke being 
incorporated into the Outcomes Framework (Department of Health 2011c). It is also 
possible that the Patient Reported Outcome Framework (PROMs) (Department of Health 
2008a) will expand to include stroke. A robust case-mix adjustment method for routine 
stroke outcomes data is therefore desirable. 
A systematic review performed as part of this thesis has identified the SSV case-mix 
adjustment model as the most clinically feasible and statistically robust model for use in 
routine stroke care for the prediction of dichotomised OHS (see Chapter 3) (Counsell C et al  
2002). This study has shown that despite being useful for stratified randomisation in 
clinical trials, the SSV adjustment model may lack generalizability, and therefore utility to 
predict outcomes other than the dichotomised OHS in routine empirical populations. This 
study identified that length of stay was a prominent predictor of both physical and social 
subscores of the SIPSO. Discriminatory properties of LOS in this (internal derivation) study 
showed that LOS was non-inferior to the SSV model in prediction of dichotomised OHS. 
This requires external validation.  
Adjusting for length of stay as a proxy for stroke severity may offer a pragmatic alternative 
to more complex case-mix adjustment methods in observational cohorts of survivors to 
hospital discharge. However, it is possible that LOS may be more useful as a measure of 
service efficiency rather than as a proxy for stroke severity and this requires further 
investigation.  
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The main determinants of post stroke outcome in this study have been identified as direct 
or proxy markers of stroke severity. This study does not add additional convincing evidence 
that the current (RCP NSSA) process markers are associated with improved patient 
outcomes. However, as the majority of these process markers are near saturation, 
demonstration of their benefits may be limited by a lack of variability, and by the sample 
size of the study. Moreover, process markers are masked by (or act as) case-mix or stroke 
severity variables in both regression trees and linear regression models. Where process 
markers do feature in models, this is largely as a reflection of organisational structure 
rather than the delivery of particular processes of care. The exception to this observation 
may be a formal communication assessment in patients in whom it is indicated which was 
associated with clinically significant better physical outcome in one model. However, this 
may represent a phenomenon particular to the study dataset and would require further 
examination and verification in external datasets. 
Markers of quality in stroke care have been changing rapidly and erratically since the 
publication of the National Stroke Strategy (Department of Health 2007b) (see also 1.2.1), 
often with little or no strong evidence to support the relationship between individual 
process markers and patient outcome. In the absence of this understanding  of these 
relationships, information may be misinterpreted, service development may misdirect 
resources and healthcare provider institutions be unfairly sanctioned on the basis of poorly 
comparable data (Lilford RJ et al  2004). Moreover, concerns regarding the accuracy and 
quality of these routinely collected data may further limit their utility. This study offers 
preliminary data as regards important core predictors of functional patient outcomes that 
may be used as the basis of a minimum dataset for further testing.  
 
7.2 Future work 
This thesis raises a number of unanswered questions which require further exploration and 
verification. Firstly, is length of stay a feasible and valid alternative to more complex 
methods of case-mix adjustment for routine and observational post-stroke cohorts? 
Further testing of this hypothesis through secondary use of the FOOD trial data is planned 
to determine the external validity of length of stay as a univariate case-mix adjuster. The 
FOOD trials comprised three international multicentre randomised controlled trials of early 
feeding (via PEG or nasogastric tube) versus ordinary diet with the primary endpoint of 
dichotomised OHS at 6 months post-randomisation. Randomisation was stratified 
according to the SSV case-mix adjustment model. Eligibility criteria were broad, comprising 
patients where consent was given (or obtained from a relative), admitted to hospital 
within 7 days of stroke (or inpatient stroke), where the responsible clinician was unclear as 
to the best method of feeding. Patients with subarachnoid haemorrhage or where 
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supplementary feeding was unlikely to be beneficial (e.g. TIA) or contraindicated (e.g. the 
morbidly obese, unconscious, or imminently dying) were excluded (Dennis M et al 2006). 
The FOOD trial data therefore represents a heterogeneous post-stroke population, and 
offers an opportunity to externally validate LOS against the SSV, and to test the calibration 
of LOS as a univariate predictor of dichotomised OHS in an external dataset.  
The Rasch analysis that has been performed on the SIPSO outcome measure was 
performed in a population of younger stroke survivors, with consequent uncertainty 
regarding the properties of the scale in older patients. The CIMSS study offers an 
opportunity to repeat this Rasch analysis in an older population, and to examine whether 
there is differential item functioning for baseline patient characteristics, especially age.  
A communication assessment performed in patients who required one, was the only 
variable featuring in the models that was likely to represent a true marker of care process. 
It is unclear from the current study whether it is the assessment, or any consequent 
therapy that afforded better outcomes in these patients. This therefore requires further 
verification, and exploration in an external dataset. 
In line with the direction of travel from Connecting for Health (Department of Health 
2011a), the development of a core stroke dataset for electronic collection should be based 
on the principles of robust data definitions (a data dictionary) and a standard way of 
combining data to derive metrics (a standard data model). Based on the findings from this 
study, the key fields for inclusion in such a dataset are outlined in Table 65, along with 
explicit data definitions. From these 17 fields, the important predictors, and case-mix 
variables identified in the study models may be derived. As data collection infrastructure 
improves, particular aspects of stroke care that are clinically important, where individual 
clinicians or services have particular data requirements, or where there are areas that 
require further research could then be added onto this core dataset in a modular and 
incremental fashion to describe further aspects of patient care. For example, the addition 
of a field to capture start and finish times of individual therapy sessions as a repeated 
measure would allow exploration of the optimal time frame within which a patient should 
be assessed by a therapist, patterns in delivery of therapy, total duration of therapy and 
possible ceiling effects of interventions. Moreover, if mandatory data reporting 
requirements were to change (for example to physiotherapy assessment within 24 hours), 
the individual data items that are collected need not change in order for the new metric to 
be derived. Of additional benefit is that this approach circumvents many of the problems 
with saturation of process markers through allowing the creation of continuous ‘time to 
event’ variables. Using the data in this way also allows overlap in existing data 
requirements to be exploited (as many fields are common to different markers and 
metrics) and offers reassurance that derived metrics are comparable.  
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The next phases of the CIMSS CLAHRC study focus on the Information Technology solution 
and behavioural change aspects of implementation of point of care (electronic) data 
capture in hospitals across West Yorkshire.  The dataset that is embedded within these 
hospitals is based on the findings from this study, with additional fields to allow trusts to 
produce reports to meet existing mandatory and voluntary data requirements. Once these 
data collection processes are embedded, future work may examine the feasibility of 
prospective point of care data capture and the data dictionary approach to stroke data.  
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Appendix A  Case-mix adjuster systematic review 
A-1 MEDLINE Search Strategy 
Devised by Deirdre Andre at the University of Leeds Healthcare Library 
1. cerebrovascular disorders/ 
2. exp basal ganglia cerebrovascular disease/ 
3. exp brain ischemia/ 
4. exp carotid artery diseases/ 
5. stroke/ 
6. exp brain infarction/ 
7. exp cerebrovascular trauma/ 
8. hypoxia-ischemia, brain/ 
9. exp intracranial arterial diseases/ 
10. exp intracranial arteriovenous malformations/ 
11. exp "intracranial embolism and thrombosis"/ 
12. exp intracranial hemorrhages/ 
13. vasospasm, intracranial/ 
14. vertebral artery dissection/ 
15. aneurysm, ruptured/ and exp brain/ 
16. brain injuries/ 
17. brain injury, chronic/ 
18. exp carotid arteries/ 
19. endarterectomy, carotid/ 
20. *heart septal defects, atrial/ or foramen ovale, patent/ 
21. *atrial fibrillation/ 
22. (stroke or poststroke or post-stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or 
apoplex$ or isch?emi$ attack$ or tia$1 or neurologic$ deficit$ or SAH or AVM).tw. 
23. ((brain$ or cerebr$ or cerebell$ or cortical or vertebrobasilar or hemispher$ or intracran$ or 
intracerebral or infratentorial or supratentorial or MCA or anterior circulation or posterior 
circulation or basal ganglia) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or 
hypox$ or vasospasm or obstruction or vasculopathy)).tw. 
24. ((lacunar or cortical) adj5 infarct$).tw. 
25. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraventricular 
or infratentorial or supratentorial or basal gangli$ or subarachnoid or putaminal or putamen or 
posterior fossa) adj5 (haemorrhage$ or hemorrhage$ or haematoma$ or hematoma$ or 
bleed$)).tw. 
26. ((brain or cerebral or intracranial or communicating or giant or basilar or vertebral artery or 
berry or saccular or ruptured) adj5 aneurysm$).tw. 
27. (vertebral artery dissection or cerebral art$ disease$).tw. 
28. ((brain or intracranial or basal ganglia or lenticulostriate) adj5 (vascular adj5 (disease$ or 
disorder or accident or injur$ or trauma$ or insult or event))).tw. 
29. ((isch?emic or apoplectic) adj5 (event or events or insult or attack$)).tw. 
30. ((cerebral vein or cerebral venous or sinus or sagittal) adj5 thrombo$).tw. 
31. (CVDST or CVT).tw. 
32. ((intracranial or cerebral art$ or basilar art$ or vertebral art$ or vertebrobasilar or vertebral 
basilar) adj5 (stenosis or isch?emia or insufficiency or arteriosclero$ or atherosclero$ or 
occlus$)).tw. 
33. ((venous or arteriovenous or brain vasc$) adj5 malformation$).tw. 
34. ((brain or cerebral) adj5 (angioma$ or hemangioma$ or haemangioma$)).tw. 
35. carotid$.tw. 
36. (patent foramen ovale or PFO).tw. 
37. ((atrial or atrium or auricular) adj fibrillation).tw. 
38. asymptomatic cervical bruit.tw. 
39. exp aphasia/ or anomia/ or hemiplegia/ or hemianopsia/ or exp paresis/ or deglutition 
disorders/ or dysarthria/ or pseudobulbar palsy/ or muscle spasticity/ 
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40. (aphasi$ or apraxi$ or dysphasi$ or dysphagi$ or deglutition disorder$ or swallow$ disorder$ or 
dysarthri$ or hemipleg$ or hemipar$ or paresis or paretic or hemianop$ or hemineglect or spasticity 
or anomi$ or dysnomi$ or acquired brain injur$ or hemiball$).tw. 
41. ((unilateral or visual or hemispatial or attentional or spatial) adj5 neglect).tw. 
42. or/1-41 
43. Risk Adjustment/ 
44. (case mix$ adj3 adjust$).tw. 
45. exp "Severity of Illness Index"/ 
46. Diagnosis-Related Groups/ 
47. DRG$1.tw. or diagnosis related group*.mp. or diagnostic related group*.mp. 
48. Prognosis/ 
49. exp "Outcome and Process Assessment (Health Care)"/ 
50. Comorbidity/ 
51. morbidity/ 
52. mortality/ 
53. survival rate/ 
54. or/43-53 
55. exp models, statistical/ 
56. ROC Curve/ 
57. roc curve.tw. 
58. exp Survival Analysis/ 
59. Data Interpretation, Statistical/ 
60. multivariate analysis/ 
61. or/55-60 
62. 42 and 61 and 54 
- 239 - 
 
A-2 Data extraction tables for studies describing models included in the review 
Belfast Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data 
collection 
Less 
than 
10% 
loss to 
follow-
up 
Assessment of 
a reliable 
outcome and 
at a fixed time 
point 
Sample 
size 
Modelling 
method and 
method of 
variable 
selection 
An EPV 
(events per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to collect 
at ward 
level? 
Fullerton 
(1988) 
Albert’s test 
score, leg 
function, 
conscious 
level, arm 
power, 
weighted 
mental score, 
non-specific 
ECG changes 
Within 48 
hours of 
stroke 
Yes Yes 4 level 
measure of 
dependency 
206 Linear logistic 
regression 
analysis 
(canonical 
discriminant 
analysis) 
35 
predictor 
variables 
and >40 
dummy 
variables 
EPV<10 
No No  No No 
Belfast Validation studies 
 Population Inception cohort Data source Loss to 
follow-up 
Outcome assessed Sample size Model performance 
Gladman (1992) Unselected consecutive patients admitted with stroke 
over 3 years 
‘On admission’ Prospective 
cohort study 
 Death at 3 months 102 Sensitivity 94%, 
specificity 29% 
Likelihood ratio 
1.3 (1.1-1.6) 
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Bristol Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data 
collection 
Less than 
10% loss to 
follow-up 
Assessment 
of a reliable 
outcome 
and at a 
fixed time 
point 
Sample 
size 
Modelling 
method 
and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Wade et 
al (1983) 
Age, 
hemianopia, 
arm motor 
deficit, sitting 
balance, 
urinary 
incontinence 
On admission 
to 
rehabilitation 
unit 
Yes 48/162 with 
insufficient 
data =30% 
No 
significant 
difference 
between 48 
patients 
with 
insufficient 
data and 
whole 
sample 
BI at six 
months post 
stroke 
(measured 
on 0-100 
scale) 
162 Multiple 
linear 
regression 
Yes Not stated Yes Correct 
prediction of 
6 month BI 
(within 5 
points) in 55% 
of cases 
Attendees at a 
non-residential 
rehabilitation 
facility – time 
from stroke to 
recruitment not 
uniform 
Yes 
Bristol Validation studies 
 Population Inception 
cohort 
Data source Loss to 
follow-up 
Outcome 
assessed 
Sample 
size 
Model performance 
Gladman 
et al 
(1992) 
Unselected 
consecutive patients 
admitted with stroke 
over 3 years 
7-10 days 
following 
acute 
admission to 
hospital 
Prospective cohort 
study 
 Barthel 
Index at 
3 months 
102 Sensitivity 100%, specificity 0%  
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Edinburgh Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective data 
collection 
Less than 
10% loss 
to follow-
up 
Assessment 
of a reliable 
outcome 
and at a 
fixed time 
point 
Sample 
size 
Modelling 
method 
and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion 
criteria that 
may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Prescott  
et al 
(1982) 
Upper limb 
motor 
function, 
proprioception, 
postural 
stability 
? Retrospective use 
of RCT data 
(patients 
randomised to 
treatment on a 
stroke unit) 
Yes, 
however 
30/100 
surviving 
patients 
untestable 
on at least 
one test 
at 4 weeks 
and 
ascribed 
worst 
outcome 
score 
 
7 level 
dependency 
scale 
155 Linear 
regression 
No No No 75% correct 
prediction of 
independence 
at week 4 
Minor and very 
severe strokes 
excluded 
Yes 
Edinburgh Validation studies 
 Population Inception 
cohort 
Data source Loss to 
follow-up 
Outcome 
assessed 
Sample 
size 
Model performance 
Gladman 
et al 
(1992) 
Unselected consecutive 
patients admitted with 
stroke over 3 years 
At four 
weeks 
from 
admission 
to acute 
hospital 
Prospective cohort 
study 
2/102 Death or 
prolonged 
hospital 
stay 
102 Sensitivity 55%, specificity 65%  
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G score Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data 
collection 
Less than 10% 
loss to follow-
up 
Assessment 
of a reliable 
outcome 
and at a 
fixed time 
point 
Sample 
size 
Modelling 
method 
and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Gompertz 
et al 
(1994) 
Limb paralysis, 
higher cerebral 
dysfunction+ 
hemiparesis+ 
hemianopia, 
drowsy, age, 
unconscious at 
onset, 
uncomplicated 
hemiparesis 
Within 24 
hours of 
stroke 
Prospective 
cohort 
study 
No 12% loss to 
follow-up, a 
further 5 had 
incomplete 
data. 
Characteristics 
of non-
responders not 
examined 
BI at six 
months 
361 
recruited 
(314 with 
complete 
data) 
None- 
adaptation 
of Guys 
score to 
simplify 
weights 
Yes   Prediction of 
BI<13 at 6 
months 
Sens: 47% 
Spec:73% 
LR 1.74 
No Yes 
 Validation studies: NONE 
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Guys Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data 
collection 
Less than 
10% loss 
to follow-
up 
Assessment of 
a reliable 
outcome and at 
a fixed time 
point 
Sample 
size 
Modelling 
method 
and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Allen 
(1984) 
Limb paralysis, 
higher cerebral 
dysfunction+ 
hemiparesis+ 
hemianopia, 
drowsy, age, 
unconscious at 
onset, 
uncomplicated 
hemiparesis 
Within 2 
weeks 
Yes 7% at 2 
months, 
14% at six 
months 
(excluded 
from 
analysis) 
Four point scale 
of dependency 
(dichotomised) 
at two months 
and six months 
148 Stepwise 
logistic 
regression  
50 
patients 
with poor 
outcome, 
10 
variables 
entered 
into 
model 
EPV<10 
No Stepwise 
variable 
selection 
89% correct 
allocation 
Patients over 76 
excluded 
Yes 
Guys Validation studies 
 Population Inception 
cohort 
Data source Loss to follow-
up 
Outcome 
assessed 
Sample size Model performance 
Gompertz 
(1994) 
Consecutive patients 
admitted with stroke 
1990-91 (UK) 
Within 24 
hours of 
stroke 
Prospective 
cohort study 
42 (12%) BI (postal) 
at six 
months 
361 Sensitivity 0.72, specificity 0.63 for 
prediction of poor outcome (Likelihood 
ratio 1.97) 
 
Gladman 
(1992) 
Unselected consecutive 
patients admitted with 
stroke over 3 years 
‘On 
admission’ 
Prospective 
cohort study 
 Death at 
3 months 
102 Sensitivity 58%, specificity 83% 
Likelihood ratio 3.3 (1.8-6.0) 
 
Muir et al 
(1996) 
All patients with 
Ischaemic and 
haemorrhagic stroke 
admitted to a single 
stroke unit. No 
restriction on age or 
stroke subtype 
Within 72 
hours of 
admission 
Prospective data 
collection 
Less than 10% Alive at 
home 
versus in 
care or 
dead at 3 
months 
408 Prediction of poor outcome when added to 
model with NIHSS (i.e. not an assessment of 
performance of Guys score in isolation) 
Sens  70% 
Spec 89% 
Predictive accuracy 82% 
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Johnston  Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data collection 
Less than 
10% loss 
to follow-
up 
Assessment of a 
reliable 
outcome and at 
a fixed time 
point 
Sample 
size 
Modelling 
method 
and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Johnston 
et al 
(2000) 
Age, NIHSS 
score, small 
vessel 
stroke, 
previous 
stroke, 
diabetes, 
pre-stroke 
disability, 
infarct 
volume 
6 hours 
from 
stroke 
onset 
Retrospective 
use of RCT data 
(RANTTAS) – 
intervention 
and control 
groups 
No 
NIHSS 
35/256 
BI 27/256 
GOS 
27/256 
(excluded 
from 
analysis) 
Excellent or poor 
outcome based 
on dichotomised 
NIHSS score, BI 
and Glasgow 
Outcome Score 
(GOS) at 3 
months 
256 Logistic 
regression 
models. All 
seven 
variables 
used.  
EPV<10 
(NIHSS), 
EPV≥10 
(BI and 
GOS) 
 
Six 
models 
specified  
Yes No C statistics >0.8 
for all models 
except 
prediction of 
devastating 
outcome with 
NIHSS (0.79) 
Unclear No 
Johnston  Validation studies 
 Population Inception 
cohort 
Data source Loss to 
follow-
up 
Outcome 
assessed 
Sample size Model performance 
Johnston et al 
(2003) 
Ischaemic stroke population 
eligible for thrombolytic 
therapy 
Within 3 
hours of 
symptom 
onset 
Retrospective use of placebo 
arm of RCT (NINDS trial)  
 Excellent 
or very 
poor 
outcome 
as above 
299 
EPV >10 for 
all models 
Five out of six models have excellent discrimination (c statistic >0.8) 
C statistic for prediction of devastating outcome with NIHSS 0.75 
Calibration: Over optimistic  predictions of excellent recovery with NIHSS 
for patients in middle band of stroke severity 
Johnson et al 
(2004) 
Ischaemic stroke population 
eligible for thrombolytic 
therapy 
Within 3 
hours of 
symptom 
onset 
Retrospective use of 
intervention and control arm 
of RCT (NINDS trial) 
 Excellent 
or very 
poor 
outcome 
as above 
615 
 
Study used model to calculate differences in unadjusted 
(univariate) and adjusted (using pre-specified models) odds 
ratios for prediction of excellent or very poor outcome. 
Model performance not measured.  
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Lincoln Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in model 
Adequate 
inception 
cohort 
Prospective 
data 
collection 
Less 
than 
10% loss 
to 
follow-
up 
Assessment of 
a reliable 
outcome and 
at a fixed time 
point 
Sample 
size 
Modelling 
method 
and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect at 
ward 
level? 
Lincoln 
et al 
(1989) 
Age, sex, marital 
status, side of 
stroke, weeks 
post stroke, tests 
of motor function, 
ADL, perception, 
language, 
memory, 
cognition, 
incontinence 
No – one 
week post 
admission 
to rehab 
facility (1-13 
weeks post 
stroke) 
Yes No  
16/70 
lost to 
follow 
up at 9 
months 
Rivermead 
gross function 
score, ADL 
status at 
discharge and 
nine months, 
discharge 
destination 
70 Stepwise 
regression 
No No Stepwise 
variable 
selection 
81% of cases 
correctly 
classified 
Post-acute 
patients admitted 
to rehabilitation 
unit 
No 
Lincoln Validation studies 
 Population Inception cohort Data source Loss to 
follow-up 
Outcome 
assessed 
Sample size Model performance 
Lincoln et al (1990) Prospective observational cohort admitted 
to rehab stroke unit 
One week post transfer to 
stroke unit 
Data capture for purposes of 
validation study 
 Discharge 
destination 
57 
EPV<10 
Sensitivity 98%, 
specificity 25% 
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mNIHSS Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data collection 
Less than 
10% loss 
to follow-
up 
Assessment 
of a reliable 
outcome and 
at a fixed 
time point 
Sample 
size 
Modelling 
method and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Lyden 
et al 
(2001) 
Items 1B, 1C, 
2,3,5 a&b, 6 
a&b, 8, 9, 11 
from the NIHSS 
Conscious level, 
gaze, visual 
fields, upper and 
lower limb 
power, sensory 
function , 
language and 
neglect 
Within 24 
hours of 
stroke 
onset 
Retrospective 
use of data 
from 2 placebo-
controlled trials 
of rt-PA in 
acute ischaemic 
stroke (NINDS-
rtPA (REF)).  
Not 
specified 
 
Good/poor 
outcome BI 
>95, mRS <1 
and GOS=1 
mNIHSS<1  at 
90 days 
291 Developed 
through 
factor 
analysis of 
the NIHSS_15 
, redundant 
items 
dropped to 
produce the 
mNIHSS 
(Lyden et al 
1999) 
   Performs 
identically to 
the NIHSS 
when 
substituted 
into a model 
to predict 
outcome after 
ICH 
Patients eligible 
for thrombolysis 
 
mNIHSS 
performed by 
specialists 
certified in 
administration of 
NIHSS 
 
 Validation studies (psychometric testing) 
 Population Inception cohort Data source Loss to 
follow-up 
Outcome 
assessed 
Sample size Model performance 
Meyer et al 
(2002) 
Ischaemic and 
haemorrhagic 
stroke 
Inpatients and 
outpatients 
No specification for time 
since event 
Prospective 
cohort 
 BI, mRS 27 for validity 
assessments 
Examines reliability / validity of mNIHSS rather than model 
performance. Good inter-rater reliability  and concurrent validity. Valid 
predictor of NIHSS.  
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NIHSS + 
age 
Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data 
collection 
Less 
than 
10% loss 
to 
follow-
up 
Assessment of 
a reliable 
outcome and 
at a fixed time 
point 
Sample 
size 
Modelling 
method and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect at 
ward 
level? 
Weimar 
(2004) 
Age 
NIHSS 
Within 6 
hours of 
onset 
Data 
extracted 
from 
prospective 
stroke 
database 
Yes BI≤95 (model 
1) and 
mortality 100 
days mortality 
(model 2) 
1079 Backwards 
and forwards 
selection 
logistic 
regression 
analysis 
Model 1 
EPV>10 
Model 2 
EPV<10 
Yes Yes, and 
interaction 
terms 
Prediction of 
BI≤95 
Sensitivity 
63% 
Specificity 
83% 
Prediction of 
mortality 
Sens  59% 
Spec 92% 
 No 
NIHSS+age Validation studies 
 Population Inception 
cohort 
Data source Loss to follow-up Outcome assessed Sample size Model performance 
Weimar 
(2004) 
Same sample as used 
to validate Weimar 
models 1&2.  
13 acute hospitals in 
Germany 2001-2002. 
Pre-stroke mRS>2.  
Within 6 
hours of 
onset 
Prospective data 
collection  
Centres with>10% loss to follow up 
not included. Patients with 
incomplete data excluded 
275/1582 (17%) but did not differ 
significantly from those included 
BI<95 and death at 120 
days 
1307 120 day BI<95 
Sens 63%  
Spec 83% 
120 day mortality 
Sens 58% 
Spec 92% 
 
Kӧnig et al 
(2008) 
Combined data from 
11 randomised stroke 
trials. 
Inclusion/exclusion 
criteria for individual 
trials not specified 
Within 6 
hours of 
onset 
Retrospective 
analysis of VISTA 
data (Virtual 
International 
Stroke Trials 
Archive). 
BI 795/5843=14% 
Mortality <10% 
BI or mortality at 90 days 5843 BI <95 at 90 days  c statistic = 0.808 
90 day mortality c statistic = 0.706 
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NIHSS_8 Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included 
in model 
Adequate 
inception 
cohort 
Prospective 
data 
collection 
Less than 
10% loss 
to follow-
up 
Assessment of 
a reliable 
outcome and 
at a fixed time 
point 
Sample size Modelling 
method 
and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Tirschwell 
et al 
(2002) 
NIHSS_15 items 
1a, 2,3,4 6a&b 
9, 10 
conscious level, 
gaze visual 
fields, facial 
paresis and 
lower limb 
motor scores, 
language and 
dysarthria 
Within 
24 
hours 
Secondary 
use of data 
from 
placebo arm 
of three 
RCTs 
Patients 
with 
complete 
data 
selected 
Dichotomised 
‘Global 
outcome score’ 
(good/poor) 
derived from 
NIHSS_15 (≤1), 
mRS (≤1 and BI 
≥95) 
223 Forward 
and 
backward 
stepwise 
logistic 
regression  
No No Stepwise 
regression 
C statistic for 
model to 
predict good 
outcome = 
0.87 
NIHSS>5 at onset Yes 
NIHSS_8 Validation studies 
 Population Inception 
cohort 
Data source Loss to follow-
up 
Outcome 
assessed 
Sample 
size 
Model performance 
Tirschwell 
et al 
(2002) 
Acute ischaemic 
stroke 
3-5 hours 
post 
onset 
Treatment and 
control arms of 
RCT of rt-PA in 
acute ischaemic 
stroke 
Only pts with 
complete data 
included 
Dichotomised 
(good/poor) 
NIHSS_15≤1, 
mRS≤1, 
GOS=1, BI ≥95 
at three 
months 
531 C statistic for prediction of good outcome = 0.77  
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Orpington Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data 
collection 
Less 
than 
10% 
loss to 
follow-
up 
Assessment 
of a reliable 
outcome and 
at a fixed 
time point 
Sample 
size 
Modelling 
method 
and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Kalra & 
Crome 
(1993) 
Arm power, 
proprioception, 
balance, 
cognition 
Within 72 
hours of 
admission 
Yes Yes BI at 
discharge or 
16 weeks 
96 Linear 
regression 
Yes No (BI treated 
as interval 
variable) 
No Strong 
correlation 
between 
Orpington score 
and discharge 
or 16 week BI 
(r2 = 0.89, 
p<0.001) 
Stroke patients 
>75 years. 
 
 
 
Orpington Validation studies 
 Population Inception 
cohort 
Data source Loss to 
follow-up 
Outcome assessed Sample size Model performance 
Lai (1998) Patients with severe strokes, coma, 
dependent or from nursing home prior to 
stroke excluded 
Within 14 
days of 
stroke  
Prospective cohort 
study 
 BI 
SF-36 
At 1,3 and 6 months post 
stroke 
184 Linear regression modelling, BI treated 
as interval data. 
R2 = 0.62 to predict BI at one month, 
less than 0.5 at 3 and six months 
Studenski (2001) Patients with coma, hepatic, renal or heart 
failure excluded, patients admitted from 
nursing care or dependent prior to stroke 
excluded 
Within 2 
weeks of 
stroke 
Retrospective use of 
data from a prospective 
cohort study 
11% Five markers of functional 
independence at 3 and 6 
months: 
(in)dependence 
 in personal care, 
independent in meal 
preparation, medication and 
community mobility 
413 Area under ROC (equivalent to c statistic 
for dichotomous outcomes) greater 
than 0.8 for all outcomes at 3 months, 
and 0.74-0.80 at six months 
Kalra et al (1994) Patients over 75 admitted to hospital with 
acute stroke, excluding  patients with pre-
stroke dependency, cognitive impairment 
or those admitted from institutional care 
At two 
weeks 
from 
stroke 
Prospective cohort 
study 
 BI, discharge destination, 
level of dependence (3 level 
score) at discharge from 
hospital 
217 OPS measured at two weeks to predict 
independent living at discharge  
Sens  96% 
Spec 36% 
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Six Simple Variables Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data collection 
Less 
than 
10% 
loss to 
follow-
up 
Assessment 
of a reliable 
outcome and 
at a fixed 
time point 
Sample 
size 
Modelling 
method and 
method of 
variable 
selection 
An EPV 
(events per 
variable) of 
10 or more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion 
criteria that 
may limit 
generalisability 
Feasible 
to 
collect 
at ward 
level? 
Counsell 
et al 
2002 
Age  
Living alone  
Independent 
pre stroke 
Normal GCS 
verbal score 
Able to lift 
both arms 
Able to walk 
Assessments 
performed up 
to 30 days 
after stroke, 
proportion of 
assessments 
after 14 days 
small, median 
delay 4 days 
Retrospective 
use of data 
collected 
prospectively  
(Oxford 
Community 
Stroke Study 
data) 
No loss 
to 
follow 
up 
Survival at 30 
days, 6 
month 
independent 
survival 
530 Forward 
stepwise 
logistic 
regression 
(independent 
survival) and 
Cox 
proportional 
hazards (30 
day survival) 
18 variables 
entered.  
30 day 
survival 
EPV=3.8 
6 month 
independent 
survival: EPV 
= 15 
Yes Stepwise 
variable 
selection 
C statistic 
0.88 30 day 
survival 
 
0.84 6 month 
independent 
survival  
Developed on 
community 
stroke data, 45% 
of patients were 
not admitted to 
hospital.  
Yes 
SSV Validation studies 
 Population Inception 
cohort 
Data source Loss to follow-
up 
Outcome assessed Sample size Model performance 
Counsell et al 
2002 
Two cohorts one community and 
one hospital inpatients 
Within 30 
days of 
onset 
Retrospective use of 
prospective cohort study data 
 Survival at 30 days, 6 
month independent 
survival 
538 
community  
1330 
Hospital 
based 
30 day survival:  
Community cohort c statistic 0.88 
Hospital cohort c statistic 0.86 
6 month independent survival: 
Community cohort c statistic 0.84 
Hospital cohort 0.84 
FOOD trial 
(2003) 
Dennis (2006) 
Dennis (2003) 
 
Patients hospitalised with acute 
stroke 
Within 7 
days  
Prospective RCT trial data 
(FOOD trial) 
 6 month 
independent survival 
2955 
EPV >10 
Independent survival c statistic 0.79 
Calibration: tends to predict over optimistic 
outcomes in patients with milder strokes, pessimistic 
predictions for more severe strokes 
Lewis et al 
(2008) 
Patients with ischaemic stroke 
eligible for thrombolysis 
Within 6 
hours of 
acute stroke 
Prospective RCT trial data 
(IST-3) 
 Independent survival  
30 day survival 
537 
EPV>10 
6 month independent survival: c statistic = 0.82 
30 day survival, c statistic = 0.73 
Calibration for 6 month independent  survival was 
good 
30 day survival, higher number of observed than 
predicted outcomes (i.e. Over pessimistic prediction) 
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 Population Inception 
cohort 
Data source Loss to follow-
up 
Outcome assessed Sample size Model performance 
SSV continued         
Reid et al 
(2007) 
Acute and hyperacute ischaemic 
and haemorrhagic stroke  
At first 
assessment, 
273/538 
(51%) within 
6h 
Prospective cohort study 
(Stroke Outcomes Study) 
 6 month mRS≤2 
 
538 
EPV>10 
mRS≤2 at 6 months c statistic 0.79 
Good calibration 
 
Weir et al 
(2001) 
Five Scottish hospitals 1995-97. 
Two teaching hospitals, 3 district 
hospitals 
Within 30 
days of 
admission 
Retrospective data extraction 
from case-notes 
 6 month mortality 2724 C statistic 0.84 
Hosmer-Lemeshow goodness of fit χ
2 
14.2, df 10, 
p=0.164 (good calibration) 
Weir et al 
(2003) 
Acute stroke On 
admission 
Prospective cohort    92 Aimed to establish inter-rater reliability of variable 
measurement for the SSV model.  
Kappa statistics for prospective and retrospective 
study were > 0.6 for all or all variables except ability 
to walk obtained from retrospective case-note 
review (κ 0.55) 
Five Scottish hospitals 1995-97. 
Two teaching hospitals, 3 district 
hospitals 
Records 
from the day 
of admission 
Retrospective case-note data 
as part of an observational 
study (Weir et al 2001) 
  200 
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Tilling Development 
 Internal validity Statistical validity Feasibility 
Citation Variables included 
in model 
Adequate 
inception 
cohort 
Prospective 
data 
collection 
Less than 
10% loss 
to 
follow-
up 
Assessment of 
a reliable 
outcome and 
at a fixed time 
point 
Sample 
size 
Modelling 
method 
and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Tilling 
(2001) 
Sex, age, ethnicity, 
prestroke 
handicap, limb 
weakness, 
dysphasia, 
dysarthria, 
incontinence, 
conscious, 
swallowing deficit, 
stroke subtype 
Within 2 
weeks of 
stroke 
Retrospective 
use of 
randomised 
controlled trial 
data 
Includes 
patients 
assessed 
at least 
once 
Barthel Index 
at 2, 4, 6 and 
12 months post 
randomisation 
299 
patient 
Multilevel 
modelling 
Yes Yes (BI 
treated as 
continuous 
variable) 
No Not specified 
for 
development 
study 
Hospital based 
cohort able to 
transfer 
independently 
Yes 
Tilling Validation studies 
 Population Inception 
cohort 
Data source Loss to follow-
up 
Outcome 
assessed 
Sample 
size 
Model performance 
Tilling et al (2001) Unselected 
observational 
cohort or first 
strokes 
 South London 
Stroke Register 
1995-1998 
 Barthel 
Index 
710 Average difference between predicted and 
observed BI -0.4 (limits of agreement -7 to +6) 
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Uppsala Development 
 Internal validity Statistical validity Feasibility 
Citation Variables included 
in model 
Adequate 
inception 
cohort 
Prospective 
data 
collection 
Less 
than 
10% 
loss to 
follow-
up 
Assessment 
of a reliable 
outcome and 
at a fixed 
time point 
Sample 
size 
Modelling 
method and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to collect 
at ward 
level? 
Frithz et 
al (1976) 
Adaptation of 
Mathew’s score (0-
100) Conscious 
level, orientation, 
dysphasia, 
conjugate gaze 
palsy, facial 
weakness, arm 
power, 
Performance 
Disability scale, 
reflexes, sensation 
On 
admission 
to hospital 
Data 
extracted 
from case-
notes.  
 Mortality at 
one month 
344 Logistic 
regression 
Yes Unclear Yes Not reported Patients over 70 
excluded 
 
Uppsala Validation studies 
 Population Inception 
cohort 
Data source Loss to 
follow-up 
Outcome 
assessed 
Sample 
size 
Model performance 
Gladman 
et al 
(1992) 
Unselected consecutive 
patients admitted with 
stroke over 3 years 
‘On 
admission’ 
to acute 
hospital 
Prospective cohort study  Death at 3 
months 
102 Sensitivity 30%, specificity 96% 
Likelihood ratio 7 (2.1-24) 
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Weimar 
models 
Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data 
collection 
Less than 10% 
loss to follow-
up 
Assessment 
of a reliable 
outcome 
and at a 
fixed time 
point 
Sample 
size 
Modelling 
method 
and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion 
criteria that may 
limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Weimar et al 
(2002) 
Model 1 
Neurological 
complications, 
fever, lacunar 
infarct, 
diabetes, 
previous 
stroke, sex, 
age, mRS, 
NIHSS score on 
admission 
Within 72 
hours of 
admission 
Data 
extracted 
from 
prospective 
stroke 
database 
(the German 
Stroke 
Database) 
No, 53/260 
(20.4%) lost to 
follow up. Their 
characteristics 
were 
specifically 
examined and 
did not differ 
significantly 
from sample 
 
BI ≤95 at 
100 days 
 
1754 Backwards 
stepwise 
logistic 
regression 
modelling 
41 
variables 
EPV>10 
 
Yes Yes Sensitivity 
77% 
Specificity 
84% 
R
2
 0.55 
 No 
Model 2 
Fever, age, 
NIHSS score on 
admission 
   Death at 
100 days 
  EPV<10 Yes Yes Sensitivity 
49% 
Specificity 
95% 
R
2
 0.41 
 No 
Weimar 
models 
Validation studies 
 Population Inception 
cohort 
Data source Loss to 
follow-up 
Outcome 
assessed 
Sample 
size 
Model performance 
German 
Stroke Study 
Collaboration 
(2004) 
13 acute hospitals in 
Germany 2001-2002. 
Pre-stroke mRS>2.  
Within 24 
hours of 
admission 
Prospective data 
collection  
Centres 
with>10% 
loss to 
follow up 
not included 
BI<95 
and 
death at 
120 days 
1470 120 day <BI95 
Sens  68% 
Spec 86% 
120 day mortality 
Sens 47% 
Spec 96% 
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Weimar_ICH Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included 
in model 
Adequate 
inception 
cohort 
Prospective 
data collection 
Less than 
10% loss to 
follow-up 
Assessment 
of a 
reliable 
outcome 
and at a 
fixed time 
point 
Sample 
size 
Modelling 
method 
and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion 
criteria that 
may limit 
generalisability? 
Feasible to 
collect at 
ward level? 
Weimar 
(2006) 
NIHSS 
Age 
Within 6 h of 
intracerebral 
haemorrhage 
Yes from 
hospitals with 
an acute stroke 
unit  
No 
53/260=20% 
(did not 
differ 
significantly 
from those 
with 
complete 
data) 
BI at 100 
days  
260 Forwards 
and 
backwards 
logistic 
regression 
analysis 
>10  Stepwise 
selection 
C statistic 
BI>95 = 
0.861 
 
Pre-stroke mRS 
of ≥3 
Only includes 
ICH and 
excludes 
comatose 
patients 
No 
 Validation studies 
 Population Inception 
cohort 
Data source Loss to 
follow-up 
Outcome 
assessed 
Sample 
size 
Model performance 
Weimar 
(2006) 
Consecutive admissions 
with ICH 1998-1999 in 30 
hospitals, with prestroke 
mRS≥3 
Within 6 
hours 
Retrospective 
cohort 
 BI at 100 
days 
173 C statistic 0.876  
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Young Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data 
collection 
Less than 
10% loss 
to follow-
up 
Assessment 
of a reliable 
outcome and 
at a fixed 
time point 
Sample 
size 
Modelling 
method 
and 
method of 
variable 
selection 
An EPV 
(events per 
variable) of 
10 or more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Young 
et al 
(2001) 
Gait speed, 
prestroke FAI 
score, AMT, 
AMT missing, 
sensory 
neglect, 
COPD, side of 
hemiplegia 
Recruitment 
on discharge 
from hospital 
or within 6 
weeks of 
stroke if not 
admitted 
Yes Yes. Only 
complete 
data used 
FAI at 12 
months 
207 Forwards 
and 
backwards 
stepwise 
logistic 
regression  
 
No 
17 
predictors, 
100 
patients 
with poor 
outcome 
Yes Yes Poor FAI at 1 
year 
Sens:75% 
Spec 80%  
Post-acute 
patients admitted 
to rehab unit, 
some not patients 
not admitted to 
hospital 
Yes 
Young Validation studies 
 Population Inception 
cohort 
Data source Loss to 
follow-up 
Outcome 
assessed 
Sample size Model performance 
Young Community post-acute 
cohort 
 Community based 
stroke trial 
 FAI at six 
months 
108 Correct assignment to good/poor outcome in 76% of 
cases 
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A-2.1 Studies using existing impairment or severity scales to predict outcome 
Canadian Neurological Score (CNS)  
 Validation studies 
Citation Variables included in model Population Inception 
cohort 
Data source Loss to 
follow-
up 
Outcome 
assessed 
Sample 
size 
Model performance 
Muir et al 
(1996) 
 All patients with Ischaemic and 
haemorrhagic stroke admitted to a 
single stroke unit. No restriction on 
age or stroke subtype 
Within 72 
hours of 
admission 
Prospective 
data collection 
Less than 
10% 
Alive at home 
versus in care or 
dead at 3 months 
408 Prediction of poor outcome when 
added to model with NIHSS (i.e. not 
an assessment of performance of 
CNS in isolation) 
Sens  71% 
Spec 89% 
Predictive accuracy 82% 
Middle Cerebral Artery Neurological Score (MCANS) or Orgogozo score  
 Validation studies 
Citation Variables included in model Population Inception 
cohort 
Data source Loss to 
follow-
up 
Outcome 
assessed 
Sample 
size 
Model performance 
Muir et al 
(1996) 
Conscious level, communications, gaze, 
facial movement, arm raise, hand 
movement, upper and lower limb tone, leg 
raise, foot dorsiflexion 
All patients with Ischaemic and 
haemorrhagic stroke admitted to a 
single stroke unit. No restriction on 
age or stroke subtype 
Within 72 
hours of 
admission 
Prospective 
data collection 
Less than 
10% 
Alive at home 
versus in care or 
dead at 3 months 
408 Prediction of poor outcome  
Sens  71% 
Spec 89% 
Predictive accuracy 82% 
NIHSS   
 Validation studies 
Citation Variables included in model Population Inception 
cohort 
Data source Loss to 
follow-
up 
Outcome 
assessed 
Sample 
size 
Model performance 
Muir et al 
(1996) 
NIHSS_15 All patients with Ischaemic and 
haemorrhagic stroke admitted to a 
single stroke unit. No restriction on 
age or stroke subtype 
Within 72 
hours of 
admission 
Prospective 
data collection 
Less than 
10% 
Alive at home 
versus in care or 
dead at 3 months 
408 Prediction of poor outcome 
Sens 71% 
Spec 90% 
Predictive accuracy 83% 
Lai (1998) NIHSS_15 Patients with severe strokes, coma, 
dependent or from nursing home 
prior to stroke excluded 
Within 14 
days of stroke 
Prospective 
cohort study 
 BI 
SF-36 
At 1,3 and 6 
months post 
stroke 
184 Linear regression modelling, BI 
treated as interval data. 
R
2 
=0.56 for at 1 month. R
2 
below 
0.5 at 3 and six months 
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A-2.2 Studies using split sample (internal) validation 
 
Anderson (Development) 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data collection 
Less 
than 
10% 
loss to 
follow-
up 
Assessment 
of a reliable 
outcome and 
at a fixed 
time point 
Sample 
size 
Modelling 
method and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Anderson 
et al 
(1994) 
Coma, cardiac 
failure, urinary 
incontinence, 
severe paresis, 
atrial 
fibrillation 
Within 
weeks of 
stroke 
onset 
(median 5 
days) 
Retrospective 
use data from 
patients 
registered in a 
population 
based study of 
acute stroke 
 
Yes Mortality at 1 
year 
492 Stepwise Cox 
proportional 
hazards 
14 
variables  
 Stepwise 
variable 
selection 
Sens 90% 
Spec 83% 
19% of patients 
not admitted to 
hospital,  
Yes 
 No external validation studies (authors used split-sample internal validation) 
Ischaemic Stroke Survival Score (ISSS) (Development) 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data collection 
Less 
than 
10% 
loss to 
follow-
up 
Assessment 
of a reliable 
outcome and 
at a fixed 
time point 
Sample 
size 
Modelling 
method and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Williams 
(2000) 
Age 
Scandinavian 
Stroke Score, 
Rapid Disability 
Rating Scale 
score, previous 
stroke 
Within 3 
hours of 
stroke 
onset 
Retrospective 
use both arms of 
placebo-
controlled trial 
data (Stroke 
Treatment with 
Ancrod Trial 
STAT) 
Yes 1 year 
survival 
453 Logistic 
regression 
modelling 
EPV>10  Yes ISSS model in 
training data 
set  
 R
2
 =0.3 
C statistic in 
validation set 
(split sample) 
0.86 
Ischaemic strokes, 
exclusion of 
minor or very 
severe strokes 
No  
 No external validation studies (authors used split-sample internal validation) 
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Masiero Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data collection 
Less 
than 
10% 
loss to 
follow-
up 
Assessment of 
a reliable 
outcome and 
at a fixed time 
point 
Sample 
size 
Modelling 
method and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Masiero 
et al 
(2007) 
Age 
TCT 
FIM 
Within 24 
hours of 
admission 
to rehab 
unit, and 
within 8 
weeks of 
stroke 
Yes  No 
Dichotomised 
Functional 
Ambulation 
Classification 
at discharge 
from 
rehabilitation 
facility 
100 Logistic 
regression 
modelling 
No, 12 
variables, 
48 with 
poor 
outcome 
Yes No To predict 
good/poor 
outcome  
C statistic = 
0.94 
Sens 87% 
Spec 96% 
Up to 8 weeks post 
first stroke, 
patients with 
hemiplegia, 
admitted for 
inpatient rehab, no 
additional 
preclusion to gait 
or exercise 
training, significant 
dysphasia or 
cognitive 
impairment 
No 
 No external validation studies (authors used split-sample internal validation) 
Wang Development 
 Internal validity Statistical validity Feasibility 
Citation Variables 
included in 
model 
Adequate 
inception 
cohort 
Prospective 
data collection 
Less 
than 
10% 
loss to 
follow-
up 
Assessment of 
a reliable 
outcome and 
at a fixed time 
point 
Sample 
size 
Modelling 
method and 
method of 
variable 
selection 
An EPV 
(events 
per 
variable) 
of 10 or 
more 
Linearity 
assumptions 
tested and 
met? 
Collinearity 
addressed 
Model 
performance 
Inclusion or 
exclusion criteria 
that may limit 
generalisability? 
Feasible 
to 
collect 
at ward 
level? 
Wang et 
al 
(2003) 
Conscious level, 
dysphagia, UIC, 
both sides 
affected, 
hyperthermia, 
IHD, peripheral 
vascular 
disease, 
diabetes 
 Retrospective 
cohort study 
(data 
extraction 
from case-
notes) for ICD 
stroke coded 
admissions 
1995-1997 
Yes 1 year 
mortality 
Split 
sample 
223 
training 
set 
217 
validation 
set 
Cox-
proportional 
hazards. 
Variables 
selected 
through uni-
variate 
analysis  
EPV<10 
(48 
deaths in 
training 
set) 
  Validation 
set to predict 
1 year 
mortality 
Sens 56% 
Spec 91% 
PPV 60% 
 Yes 
 No external validation studies (authors used split-sample internal validation) 
- 260 - 
 
A-3 Standardised and studentised residuals 
Examination of ‘raw’ residuals retains the units for the Y variable and these must therefore 
be interpreted in this context (Waterman R 1999). More useful for identification of outliers 
are residuals that have been standardised according to their standard deviation from the 
expected sample mean.  
However, as the calculation of the standard deviation for an individual point and its estimate 
are not independent, particularly influential points will alter the regression line thus 
affecting the size of the residual (Fox J, 1997 p 272; Waterman R 1999).  
This problem may be overcome through calculation of studentised residuals, where an 
individual point xi is omitted from the estimation of the standard deviation, such that the 
standardisation becomes independent of the observed value of xi (Fox J, 1997 p 272; 
Waterman R 1999).  
For example, if point xi in Figure 94 is exerting undue influence (leverage) on a regression 
line (1), calculating the standardised residual from estimates including xi will falsely lower 
the magnitude of |ri| to give ri’. However, if xi is excluded from the calculation of model 
estimates, the studentised residual is created (ri(-i)) based on the unbiased regression line 
(2) (Fox J, 1997 p 272; Waterman R, 1999). 
Figure 94 Demonstration of studentised residuals 
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Appendix B  Study variables 
Demographics  
Age at stroke onset 
Type of residence (pre-stroke) 
Has main carer 
Lived alone pre-stroke 
Ethnicity 
Gender 
Process indicators  
Admitted directly to stroke unit  
Proportion of stay spent on stroke unit  
Planned follow up by ESD 
Post-hospital spell in NHS facility (e.g. intermediate care) 
Discharge to the same address  
Imaging within 24 hours 
Thrombolysis given (date and time) 
Swallowing screen within 24 hours of admission to hospital  
Commenced antiplatelet within 48 hours of stroke  
Physiotherapy assessment within 72 hours of admission to hospital) 
Weighed at least once during admission 
Evidence of mood assessment before discharge  
Evidence of MDT rehabilitation goal setting  
Occupational therapy assessment within 4 working days of admission  
Visual field testing (RCP) 
Sensory assessment (RCP) 
Formal swallowing assessment within 72 hours of admission (RCP) 
Formal communication assessment within 7 days (RCP) 
Evidence within MDT notes of SW assessment within 7 days of referral (RCP) 
Evidence of cognitive status assessment (RCP) 
Malnutrition screening (RCP) 
Continence promotion plan (RCP)) 
Receipt of fluids within 24 hours of stroke (RCP) 
Receipt of nutrition within 72 hours of admission (RCP) 
Case-mix data  
Classification of stroke 
Radiological classification of stroke 
Pathological classification of stroke (OCSP) 
Side of weakness  
Six-simple variable case-mix adjustment variables 
(Age) 
Lived alone prior to stroke 
Independent in ADL prior to stroke 
Able to lift both arms above head (MRC power score>=3) 
Able to walk unaided 
Normal verbal GCS score 
Univariate predictors 
Drowsy since onset of stroke 
Speech or language problems 
Confusion at presentation 
New urinary incontinence or newly catheterised since stroke onset 
Previous disabling stroke 
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B-1 Instructions to delegates at the group decision making workshop to refine 
study outcome instruments 
Part 1 
We would like you (on the post it notes provided and working individually) to generate a list 
of the properties of a stroke outcomes instrument which you consider to be important. 
Write one idea on each piece of paper. Be inclusive and generic at this stage (e.g. does it 
measure relevant constructs, depth of questions, breadth of questions, length etc.) 
[Similar constructs are grouped together on a flip-chart and numbered] 
On an index card, please choose the five ideas that you feel are most important, and write 
the numbers, vertically down the side of the card 
Please then rank the ideas from 1 (most important) to 5 (least important) 
Part 2 – Paired weighting 
Please consider each scale in relation to the criteria we have collectively identified to be 
most important in the instruments. 
For each pair of scales please circle the one which you feel fulfils these criteria the best. 
At the end of each row, please add up the number of times you have circled each 
instrument. This gives your ranking as to which you feel is the most useful instrument 
according to the criteria we have established. 
     Total   
NEADL 
FAI 
NEADL 
SIPSO 
NEADL 
LHS 
NEADL 
EQ5D 
 
 
NEADL = 
 FAI 
SIPSO 
FAI 
LHS 
FAI 
EQ5D 
 
 
FAI = 
  SIPSO 
LHS 
SIPSO 
EQ5D 
 
 
SIPSO = 
   LHS 
EQ5D 
 
 
LHS = 
    
 
 EQ5D = 
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B-2 The Oxford Handicap Scale and modified Rankin Scale 
 Oxford Handicap Scale (postal version) from Dennis et al 2006 Table 63
Grade Description 
0 I have no symptoms at all 
1 I have a few symptoms but these do not interfere with m everyday life 
2 
I have symptoms which have caused some changes in my life but I am still able 
to look after myself 
3 
I have symptoms which have significantly changed my life and I need some help 
in looking after myself 
4 
I have quite severe symptoms which mean I need to have help from other 
people but I am not so bad as to need attention day and night 
5 
I have major symptoms which severely handicap me and I need constant 
attention day and night 
 
 Modified Rankin Scale from van Swieten et al 1988 Table 64
Grade Description 
0 No symptoms at all 
1 No significant disability despite symptoms: able to carry out all usual duties and 
activities 
2 Slight disability: unable to carry out all previous activities but able to look after 
own affairs without assistance 
3 Moderate disability: requiring some help, but able to walk without assistance 
4 Moderately severe disability: unable to walk without assistance, and unable to 
attend to own bodily needs without assiatance 
5 Severe disability: bedridden, incontinent, and requiring constant nursing care 
and attention 
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B-3 Subjective Index of Physical and Social Outcome (from Trigg et al 2000) 
Please answer all questions 
Physical Subscore 
1. Since your stroke, how much difficulty do you have dressing yourself fully? 
(Circle One Number) 
No difficulty at all....……………………………………………………………………………………………………. 4 
Slight difficulty………………………………………………………………………………………………………….... 3 
Some difficulty……………………………………………………………………………………………………………. 2 
A lot of difficulty…………………………………………………………………………………………………………. 1 
I cannot dress myself fully………………………………………………………………………………………….. 0 
  
2. Since your stroke, how much difficulty do you have moving around all areas of the home? 
(Circle One Number) 
No difficulty at all……………………………………………………………………………………………………….. 4 
Slight difficulty…………………………………………………………………………………………………………… 3 
Some difficulty…………………………………………………………………………………………………………… 2 
A lot of difficulty………………………………………………………………………………………………………… 1 
I cannot move around all areas of the home……………………………………………………………… 0 
  
3. Since your stroke, how satisfied are you with your overall ability to perform daily activities in and around 
the home? 
(Circle One Number) 
Completely satisfied………………………………………………………….......................................... 4 
Mostly satisfied………………………………………………………………............................................ 3 
Fairly satisfied……………………………………………………………………………………………………………. 2 
Not very satisfied……………………………………………………………………………………………………….. 1 
Completely dissatisfied………………………………………………………………………………………………. 0 
  
4. Since your stroke, how much difficulty do you have shopping for and carrying a few items (1 bag of 
shopping or less) when at the shops? 
(Circle One Number) 
No difficulty at all……………………………………………………………………………………………………….. 4 
Slight difficulty…………………………………………………………………………………………………………… 3 
Some difficulty…………………………………………………………………………………………………………… 2 
A lot of difficulty…………………………………………………………………………………………………………. 1 
I cannot shop for and carry a few items…….……………………………………………………………….. 0 
  
5. Since your stroke, how independent are you in your ability to move around your local neighbourhood? 
(Circle One Number) 
I am completely independent…………………………………………………………………………………….. 4 
I prefer to have someone else with me……………………………………..................................... 3 
I need occasional assistance from someone……………………………………………………………….. 2 
I need assistance much of the time…………………………………………………………………………….. 1 
I am completely dependent on others………………………………………………………………………… 0 
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Social subscore 
 
 
6. Since your stroke, how often do you feel bored with your free time at home? 
(Circle One Number) 
I am never bored with my free time…………………………………………………………………………… 4 
A little of my free time……………………………………………………………………………………………….. 3 
Some of my free time…………………………………………………………………………………………………. 2 
Most of my free time………………………………………………………………………………………………….. 1 
All of my free time……………………………………………………………………………………………………… 0 
  
7. Since your stroke, how would you describe the amount of communication between you and your 
friends/associates? 
(Circle One Number) 
A great deal………………………………………………………………………………………………………………… 4 
Quite a lot…………………………………………………………………………………………………………………… 3 
Some………………………………………………………………………….................................................. 2 
A little bit……………………………………………………………………………………………………………………. 1 
None………………………………………………………………………………………………………………………….. 0 
.  
8. Since your stroke, how satisfied are you with the level of interests and activities you share with your 
friends/associates? 
(Circle One Number) 
Completely satisfied…………………………………………………………........................................... 4 
Mostly satisfied………………………………………………………………............................................ 3 
Fairly satisfied…………………………………………………………………………………………………………….. 2 
Not very satisfied………………………………………………………………………………………………………… 1 
Completely dissatisfied………………………………………………………………………………………………. 0 
  
9. Since your stroke, how often do you visit friends/others? 
(Circle One Number) 
Most days…………………………………………………………………………………………………………………… 4 
At least once a week…………………………………………………………………………………………………… 3 
At least once a fortnight……………………………………………………………………………………………… 2 
Once a month or less………………………………………………………………………………………………….. 1 
Never…………………………………………………………………………................................................... 0 
  
10. Since your stroke, how do you feel about your appearance when out in public? 
(Circle One Number) 
Perfectly happy……………………………………………………………….............................................. 4 
Slightly self-conscious………………………………………………………............................................ 3 
Fairly self-conscious……………………………………………………………………………………………………. 2 
Very self-conscious……………………………………………………………………………………………………… 1 
I try to avoid going out in public…………………………………………………………………………………. 0 
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B-4 Statistical plan 
• Data cleaning and missing data pattern analysis (baseline data) 
• Outliers and tests of normality of continuous variables 
• Examination of return rates and missing data analysis for outcomes questionnaire 
packs 
• Descriptive statistics including: 
• Floor and ceiling effects of baseline and six month patient completed questionnaires 
• Examination of representativeness of study sample 
o Exploration of process-outcome linkages in the study population 
o Univariate (unadjusted) analyses 
• Construction of decision trees to predict CIMSS study outcomes to identify 
important predictors 
• Identification and testing of potential interaction terms 
• Stratification of the sample using the SSV model (e.g. using propensity score as a 
continuous variable in models, or stratification according to matched propensity 
score) 
• Construction of regression models to predict study outcomes using important 
clinical variables and predictors identified in decision trees  
• Performance of the SSV case-mix adjuster in terms of:  
o Model discrimination (measured with c statistics) 
o Calibration of the SSV in the CIMSS study population (calibration plots) 
• Exploration of potential univariate predictors of outcome that could be used in 
addition to, or instead of the SSV case-mix adjuster 
• Replication of models in MLWin software and with Markov Chain MonteCarlo 
(MCMC) iterations to explore stability and convergence of the beta coefficients 
• Identification of key process and case-mix variables that are important in 
determining outcome to be included in core dataset for further testing 
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Appendix C  Regression and Classification Trees 
Figure 95 shows an example of a regression tree to predict the (continuous) outcome of the 
physical subscore of the SIPSO and includes all the predictors, case-mix variable and baseline 
assessments used in the CIMSS study population. At the top of the tree, the condition length 
of stay >=33.5 is stipulated. For the purposes of interpretation of the tree, this has been 
interpreted as <=33 or >=34 (as length of stay has been recorded in whole days). If the 
length of stay was longer than 33 days, the left hand branch is followed; otherwise the right 
hand branch is selected. The length of the ‘legs’ for each predictor denotes its relative 
importance. Thus it can be seen from the example that, in this regression tree, the length of 
stay is the main determinant of physical SIPSO subscore. Other predictors and their relative 
importance are presented until, at the bottom of each terminal branch, a value for the 
predicted physical SIPSO score is given if all the preceding conditions are met. Thus, using 
this tree in this dataset, a patient with a length of stay of greater than 34 days and a 
probability of poor outcome as predicted with the SSV case-mix adjuster (propensity score) 
of greater than 0.1 has a predicted SIPSO physical score of 9.5 (path A highlighted on Figure 
95), whilst a patient with a length of 33 days or fewer, a baseline NEADL of greater than 62 
and a baseline EuroQoL utility score of greater than 0.79 has a predicted physical SIPSO 
subscore of 19.42 (path B on Figure 95).  
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Figure 95 Interpretation of regression trees using example of prediction of physical SIPSO subscore 
     Baseline EQ5D   utility score <0.79 
Length of stay >=33.5 
Propensity Score <0.10 
Baseline NEADL < 45.5 
Baseline EQ5D utility score <0.63 Baseline NEADL < 61.5 
Formal SLT swallowing assessment = Yes 
              Baseline  GHQ_12 >=4.5 
Baseline BI   <16.5 
 Baseline BI   >=11.5 
3.35 8.23 
Predicted SIPSO = 9.50 
4.74 8.83 
12.62 
10.37 
10.20 16.43 
16.51 
16.56 Predicted SIPSO 
score = 19.42 
 Length of stay > =56.5 
Length of stay >=33.5 
Propensity score >=0.1 
Length of stay <33.5 
Baseline NEADL >45.5 
Baseline NEADL >61.5 
Baseline EQ5D >0.79 
B A 
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Appendix D  Descriptive statistics 
D-1 Equivalence of proportions for sex between screened and recruited 
populations 
The working for statistical tests performed during data cleaning and descriptive statistics 
are shown here  
D-1.1 Equivalence of proportions for sex between screened and recruited 
populations 
    Screened 337  
    Recruited 312  
 Mean Standard error 95% confidence interval 
Screened  0.56 0.27 0.51 0.61 
Recruited 0.51 0.28 0.45 0.56 
Difference 0.054 0.040   
Probability difference ≠0: 0.16 
 
D-1.2 Significant difference in age by gender (recruited patients) 
Two-sample Wilcoxon rank-sum (Mann-Whitney) test age by gender 
      Gender    |      obs    rank sum    expected 
-------------+--------------------------------- 
        Male      |      154     20100.5       24101 
      Female    |      158     28727.5       24727 
-------------+--------------------------------- 
    Combined |      312       48828       48828 
 
Ho: age at stroke(males) = age at stroke(females) 
             z =  -5.024 
    Prob > |z| =   <0.001 
D-1.3 Age by recruitment to study 
 
Two-sample Wilcoxon rank-sum (Mann-Whitney) test 
 
patient_recruited |      obs    rank sum    expected 
-------------+--------------------------------- 
not recruited       |      343      126016      112504 
   recruited           |      312       88824      102336 
-------------+--------------------------------- 
    Combined         |      655      214840      214840 
 
Ho: age(patient not recruited) = age(patient recruited) 
             z =   5.589 
    Prob > |z| =   <0.001 
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D-2 Baseline stroke severity data 
D-2.1 Significant difference in Baseline Barthel Index between patients recruited 
and not recruited into study 
 
patient recruited  |      obs    rank sum    expected 
-------------+--------------------------------- 
       false                 |      319       79578     97454.5 
        true                |      291      106777     88900.5 
-------------+--------------------------------- 
    combined         |      610      186355      186355 
 
 
Ho: total BI(not recruited) = total BI(recruited ) 
             z =  -8.303 
    Prob > |z| =  <0.001 
D-2.2 Kruskal-Wallis equivalence of medians test Barthel Index by site in patients 
not recruited into study 
Kruskal-Wallis equality-of-populations rank test 
 
  +---------------------------+ 
  |     site   | Obs  | Rank Sum  | 
  |----------+-----+---------- | 
  | Bradford  |  94   | 14721.00  | 
  |    Leeds    |  56   |  8103.50    | 
  |     York     | 169  | 28215.50   | 
  +---------------------------+ 
 
chi-squared =     2.628 with 2 d.f. 
probability =       0.2687 
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D-2.3 Two way Mann-Whitney U tests to identify significant differences in 
baseline Barthel Index between sites for patients recruited into the study 
 
Two-sample Wilcoxon rank-sum (Mann-Whitney) tests 
 
        site       |      obs    rank sum    expected 
-------------+--------------------------------- 
    Bradford    |       63      5746.5      5638.5 
       Leeds      |      115     10184.5     10292.5 
-------------+--------------------------------- 
    combined  |      178       15931       15931 
 
Ho: total BI(Bradford) = total BI(Leeds) 
             z =   0.330 
    Prob > |z| =   0.7417 
 
        site      |      obs    rank sum    expected 
-------------+--------------------------------- 
    Bradford   |       63      4808.5      5575.5 
        York       |      113     10767.5     10000.5 
-------------+--------------------------------- 
    combined  |      176       15576       15576 
 
Ho: total BI(Bradford) = total BI(York) 
             z =  -2.392 
    Prob > |z| =   0.0168 
 
        site         |      obs    rank sum    expected 
-------------+--------------------------------- 
       Leeds       |      115       11576     13167.5 
        York        |      113       14530     12938.5 
-------------+--------------------------------- 
    combined  |      228       26106       26106 
 
Ho: total BI (Leeds) = total BI (York) 
             z =  -3.215 
    Prob > |z| =   0.0013 (reject Ho) 
 
D-2.4 Difference in median baseline Barthel Index between categories of response 
D-2.4.1 Kruskal Wallis test (BI by response category) 
  +------------------------------+ 
  |    response     | Obs  | Rank Sum  | 
  |-------------+-----+---------- | 
  | no response  |  67    | 10855.50  | 
  |    response      | 187   | 32814.00 | 
  |        dead         |  44    |  3296.50   | 
  |    withdrew     |  13   |  1550.00    | 
  +------------------------------+ 
 
chi-squared with ties =    47.670 with 3 d.f. 
probability =    <0.001 
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D-2.4.2 Pairwise comparisons of BI between levels of response (Mann-Whitney U tests) 
    Response  |      obs    rank sum    expected 
-------------+--------------------------------- 
 no response  |       67      7975.5      8542.5 
    response     |      187     24409.5     23842.5 
-------------+--------------------------------- 
    combined   |      254       32385       32385 
Ho: Baseline BI (non-responders) = Baseline BI (responders) 
             z =  -1.111    Prob > |z| =   0.2666 
________________________________________________________________________ 
    response  |      obs    rank sum    expected 
-------------+--------------------------------- 
 no response  |       67      4601.5        3752 
        dead  |       44      1614.5        2464 
-------------+--------------------------------- 
    combined  |      111        6216        6216 
Ho: Baseline Barthel (non response) = Baseline BI (dead) 
             z =   5.155    Prob > |z| =   <0.001 
________________________________________________________________________ 
    response  |      obs    rank sum    expected 
-------------+--------------------------------- 
 no response  |       67      2834.5      2713.5 
    withdrew  |       13       405.5       526.5 
-------------+--------------------------------- 
    combined  |       80        3240        3240 
Ho: Baseline BI (no response) = Baseline BI (withdrew) 
             z =   1.591    Prob > |z| =   0.1117 
________________________________________________________________________ 
    response  |      obs    rank sum    expected 
-------------+--------------------------------- 
    response  |      187     24291.5       21692 
        dead  |       44      2504.5        5104 
-------------+--------------------------------- 
    combined  |      231       26796       26796 
Ho: Baseline BI (responders)= Baseline BI (dead) 
             z =   6.563    Prob > |z| =  <0.001 (reject Ho) 
________________________________________________________________________ 
    response  |      obs    rank sum    expected 
-------------+--------------------------------- 
    response  |      187       19269     18793.5 
    withdrew  |       13         831      1306.5 
-------------+--------------------------------- 
    combined  |      200       20100       20100 
Ho: Baseline BI (response) = Baseline BI (withdrew) 
             z =   2.377    Prob > |z| =   0.0174 
________________________________________________________________________ 
    response  |      obs    rank sum    expected 
-------------+--------------------------------- 
        dead  |       44      1157.5        1276 
    withdrew  |       13       495.5         377 
-------------+--------------------------------- 
    combined  |       57        1653        1653 
Ho: Baseline BI (dead) = Baseline BI (withdrew) 
             z =  -2.293    Prob > |z| =   0.0219 
________________________________________________________________________ 
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Appendix E  Model construction and checks of assumptions 
E-1 Association between specific impairments and assessments 
E-1.1 Chi squared tests of association between specific impairments and 
corresponding assessments 
  |     SLT communication assessment 
             |        No        Yes     No but  |     Total 
-----------+---------------------------------+---------- 
   No dysphasia | 4           9    104  |       117  
             | 3.42        7.69       88.89 |    100.00  
-----------+---------------------------------+---------- 
      Dysphasia |         53          82          59  |       194  
             |      27.32  42.27      30.41  |    100.00  
-----------+---------------------------------+---------- 
     Total   |         57          91         163  |       311  
             |      18.33      29.26      52.41  |    100.00  
 
          Pearson chi2(2) = 100.1835   Pr =< 0.001 
 
New urinary |    Urinary continence care plan 
Incontinence  |         No         Yes      No but  |  Total 
-----------+---------------------------------+---------- 
     No new incontinence  |  19     20 197  | 236  
               |       8.05        8.47       83.47  |     100.00  
-----------+---------------------------------+---------- 
      New incontinence  |         14          46           9  |         69  
               |    20.29      66.67   13.04  |     100.00  
-----------+---------------------------------+---------- 
     Total    |         33          66         206  |        305  
               |      10.82    21.64  67.54  |   100.00 
 
          Pearson chi2(2) = 130.1537   Pr = <0.001 
E-1.2 Likelihood ratio test for transformed length of stay in the prediction of 
physical subscore of the SIPSO 
Model 10 Likelihood ratio test to determine if linearity is improved through categorising 
the log transformed length of stay variable 
Regression model of SIPSO physical subscore on categorised length of stay (log 
transformed) cut into 5 equally sized groups (Model A) 
------------------------------------------------------------------------------ 
SIPSO physical  
subscore        Coef.    Std. Err . t     P>|t|      [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
_LOS_cut_1  |  0.22    1.27     0.17    0.87    - 2.29     2.73 
_LOS_cut_2  | 1.27   1.41 0.90  0.37  4.05 1.50 
_LOS_cut_3  | 3.63 1.38 2.62 0.01 6.36 0.90 
_LOS_cut_4  | 4.92 1.51 3.26 0.001 7.90 1.94 
_LOS_cut_5  | 10.17 1.42 7.17 <0.001 12.96  7.37 
       _cons | 15.76 1.03 15.27 <0.001 13.72 17.79 
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Linear regression model of SIPSO physical subscore on log transformed length of stay 
(continuous variable) (Model B) 
------------------------------------------------------------------------------ 
SIPSO Physical 
Subscore | Coef Std. Err t P>|t| [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
log_(LOS+1)  | 3.14 0.34 9.12 <0.001 3.82 2.46 
       _cons  | 20.39 0.91 22.37 <0.001 18.59 22.19 
Estimates store B 
Likelihood ratio test that model A is significantly different from model B 
Likelihood-ratio test                   LR chi2(4)  =      4.76 
(Assumption: B nested in A)           Prob > chi2 =    0.3124 
 
Therefore cannot reject the assumption that model A deviates from the linear model 
(model B is nested in model A) 
 
E-1.3 Variance inflation factors (VIF) for examination of potential collinearity 
(Model 2) 
 
Variable    VIF 1/VIF   
   
Baseline EQ5D   1.85 0.541835 
log_(LOS+1)   1.66 0.601100 
Baseline NEADL   1.21 0.826535 
Age at stroke   1.09 0.917088 
Discharged to same address 1.07 0.938279 
   
Mean VIF   1.38 
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E-1.4 Sample size required to detect significant difference in SIPSO social 
subscore dependent on receipt of SLT communication assessment 
Calculation of sample size of two equal sized groups is given by  
(7) o  5pqrst ∗ u  
where N=total sample size (equal groups), E=expected difference in outcome score 
between groups, s = standard deviation and P = 7.9, a constant based on the α-significance 
level (set here at 0.05) and the power (set here at 80%) (Whitley E et al  2002). The 
standard deviation of a sample can be calculated from the standard error of the mean for 
two groups given by the formula: 
(8)   5 p 
K* 		 
Kts 
								v    w 1
 	 15 
Where n = number of patients in each of “no” (n1) and “yes” (n2) groups for receipt of SLT 
communication assessment in the sample used to calculate the standard error.  
Using Model 6 (p 177), se = 1.311, n1 = 29, n2 = 108, such that s = 4.65, E = -2 
Therefore, N =[ 2/(-2/4.65)2] * 7.9 = 85 for each group such that the total sample size =170. 
Using formulae from (Whitley E et al  2002), the adjustment for calculation of the sum total 
of two unequal groups is given by:  
(9) ox 	 y(
2)tz 		 		 {|	∗[
2(*}~t )ctz(*}~t ) 	 	
Where k = n2 /n1  
And each individual group is given by  
(10) yx(
2)	and	 yx(
2)	such	that	n1		54,	n2		201	
Accounting for the 55% of patients in whom SLT assessments are not indicated, 
255/0.45≈567 patients with complete data would be required to detect the difference with 
power of 80%. 
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E-2 Length of stay as a univariate case-mix adjuster 
E-2.1 ROC curves to calculate c statistic for length of stay to predict dichotomised 
study outcomes 
E-2.1.1 Receiver Operating Curve (ROC) and c-statistic for length of stay to predict 
dichotomised OHS,  
 
C statistic (AUC) = 0.794 [95% CI 0.73-0.85] 
E-2.1.2 ROC and c-statistics for length of stay to predict physical SIPSO subscore 
(dichotomised at 15 and excluding dead patients) 
 
C statistic 0.75 95% confidence interval 0.68-0.81 
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E-2.1.3 Receiver Operating Curves (and c-statistics) for length of stay to predict social 
SIPSO subscore (dichotomised at 15 and excluding dead patients) 
 
C-statistic 0.73 95% confidence intervals 0.66-0.79 
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Appendix F  CIMSS dataset fields 
The requisite fields from which the important predictors identified in the study may be derived are outlined in Table 65. 
 Fields required to derive important predictors of SIPSO physical and social subscores in the study Table 65
Field Definition 
Baseline NEADL 
NEADL completed by patient, or proxy within 7 days of  admission with respect to activities performed in the 
few weeks leading up to stroke 
Baseline EQ5D EQ5D completed by patient, or proxy within 7 days of admission, with respect to the current day 
Date of birth  
Independent in ADL prior to admission 
Record as yes / no – pre-stroke BI of 19 or 20. No report of requirements for assistnace in ADL from pt or 
carer 
Lived alone prior to admission No other person registered as living at address 
GCS (verbal score) Five point verbal component of the Glasgow Coma Score 
Able to walk without assistance at presentation Able to walk without support of another person. Does not include use of walking aids 
MRC power score (both arms) MRC power grade (scored 0 to 5) in both upper limbs 
Date / time SLT therapy session commenced (communication) Date and time SLT start therapy session 
Reason SLT intervention not required/indicated  Unconscious, no speech, language or communication deficit, receiving palliative care 
Date/time admission to hospital/trust  Date and time patient first arrived at hospital (A&E or assessment unit) 
Date discharged from acute hospital/death 
Date patient discharged from the acute trust (or rehabilitation unit within the trust if inpatient rehabilitation 
has been provided) to home, community rehabilitation facility or care home.  
Date/time admission to ward/bed Date / time patient arrives at allocated bed.  
Ward type Acute stroke unit, MAU, CCU, HDU, ITU, general medical ward etc. 
Previous disabling stroke Any previous stroke resulting in limitations to ADL, a pre-stroke OHS >=3 or a pre-stroke BI < 19 
Address on admission  
Address on discharge  
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